{
  "document": [
    {
      "_creationTimestamp": "2022-12-10T08:42:45.919Z",
      "_newestOpId": "d5a827ec-0a9c-490b-979c-738cc340fdda",
      "_ops": [],
      "article": {
        "MedlineCitation": {
          "Article": {
            "Abstract": "Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease, which warrants the critical need to identify new therapeutic targets. We show that Zinc Fingers and Homeoboxes 2 (ZHX2) is amplified or overexpressed in TNBC cell lines and patients. Functionally, depletion of ZHX2 inhibited TNBC cell growth and invasion in vitro, orthotopic tumor growth, and spontaneous lung metastasis in vivo. Mechanistically, ZHX2 bound with hypoxia-inducible factor (HIF) family members and positively regulated HIF1α activity in TNBC. Integrated ChIP-seq and gene expression profiling demonstrated that ZHX2 co-occupied with HIF1α on transcriptionally active promoters marked by H3K4me3 and H3K27ac, thereby promoting gene expression. Among the identified ZHX2 and HIF1α coregulated genes, overexpression of AP2B1, COX20, KDM3A, or PTGES3L could partially rescue TNBC cell growth defect by ZHX2 depletion, suggested that these downstream targets contribute to the oncogenic role of ZHX2 in an accumulative fashion. Furthermore, multiple residues (R491, R581, and R674) on ZHX2 are important in regulating its phenotype, which correspond with their roles on controlling ZHX2 transcriptional activity in TNBC cells. These studies establish that ZHX2 activates oncogenic HIF1α signaling, therefore serving as a potential therapeutic target for TNBC.",
            "ArticleTitle": "ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer.",
            "AuthorList": [
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.",
                    "email": null
                  },
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Wentong",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0003-0047-1198"
                  }
                ],
                "Initials": "W",
                "LastName": "Fang"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Chengheng",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0002-9073-3835"
                  }
                ],
                "Initials": "C",
                "LastName": "Liao"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Rachel",
                "Identifier": [],
                "Initials": "R",
                "LastName": "Shi"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  },
                  {
                    "Affiliation": "Department of Genetics, Neuroscience Center; University of North Carolina School of Medicine, Chapel Hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Jeremy M",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0003-3906-1663"
                  }
                ],
                "Initials": "JM",
                "LastName": "Simon"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  },
                  {
                    "Affiliation": "UNC Neuroscience Center, Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Travis S",
                "Identifier": [],
                "Initials": "TS",
                "LastName": "Ptacek"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Giada",
                "Identifier": [],
                "Initials": "G",
                "LastName": "Zurlo"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Shanghai Institute of Immunology, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Youqiong",
                "Identifier": [],
                "Initials": "Y",
                "LastName": "Ye"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Leng",
                "Identifier": [],
                "Initials": "L",
                "LastName": "Han"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Cheng",
                "Identifier": [],
                "Initials": "C",
                "LastName": "Fan"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Lei",
                "Identifier": [],
                "Initials": "L",
                "LastName": "Bao"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan.",
                    "email": null
                  },
                  {
                    "Affiliation": "Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program, Institute of Chemistry, Academia Sinica, Taiwan.",
                    "email": null
                  },
                  {
                    "Affiliation": "Department of Chemistry, National Tsing-Hua University, Hsinchu, Taiwan.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Christopher Llynard",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0002-3114-7369"
                  }
                ],
                "Initials": "CL",
                "LastName": "Ortiz"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Hong-Rui",
                "Identifier": [],
                "Initials": "HR",
                "LastName": "Lin"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Ujjawal",
                "Identifier": [],
                "Initials": "U",
                "LastName": "Manocha"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Weibo",
                "Identifier": [],
                "Initials": "W",
                "LastName": "Luo"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  },
                  {
                    "Affiliation": "Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Yan",
                "Identifier": [],
                "Initials": "Y",
                "LastName": "Peng"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel hill, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "William Y",
                "Identifier": [],
                "Initials": "WY",
                "LastName": "Kim"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan.",
                    "email": null
                  },
                  {
                    "Affiliation": "Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program, Institute of Chemistry, Academia Sinica, Taiwan.",
                    "email": null
                  },
                  {
                    "Affiliation": "Physics Division, National Center for Theoretical Sciences, Hsinchu, Taiwan.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Lee-Wei",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0002-3971-6386"
                  }
                ],
                "Initials": "LW",
                "LastName": "Yang"
              },
              {
                "AffiliationInfo": [
                  {
                    "Affiliation": "Department of Pathology, University of Texas Southwestern Medical Center, Dallas, United States.",
                    "email": null
                  }
                ],
                "CollectiveName": null,
                "ForeName": "Qing",
                "Identifier": [
                  {
                    "Source": "ORCID",
                    "id": "0000-0002-6595-8995"
                  }
                ],
                "Initials": "Q",
                "LastName": "Zhang"
              }
            ],
            "Journal": {
              "ISOAbbreviation": "Elife",
              "ISSN": {
                "IssnType": "Electronic",
                "value": "2050-084X"
              },
              "JournalIssue": {
                "Issue": null,
                "PubDate": {
                  "Day": "15",
                  "Month": "Nov",
                  "Year": "2021"
                },
                "Volume": "10"
              },
              "Title": "eLife"
            },
            "PublicationTypeList": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ]
          },
          "ChemicalList": [
            {
              "NameOfSubstance": {
                "UI": "C497442",
                "value": "HIF1A protein, human"
              },
              "RegistryNumber": "0"
            },
            {
              "NameOfSubstance": {
                "UI": "D018398",
                "value": "Homeodomain Proteins"
              },
              "RegistryNumber": "0"
            },
            {
              "NameOfSubstance": {
                "UI": "D051795",
                "value": "Hypoxia-Inducible Factor 1, alpha Subunit"
              },
              "RegistryNumber": "0"
            },
            {
              "NameOfSubstance": {
                "UI": "D014157",
                "value": "Transcription Factors"
              },
              "RegistryNumber": "0"
            },
            {
              "NameOfSubstance": {
                "UI": "C476826",
                "value": "ZHX2 protein, human"
              },
              "RegistryNumber": "0"
            }
          ],
          "InvestigatorList": [],
          "KeywordList": [
            "VHL",
            "ZHX2",
            "cancer biology",
            "hif 1alpha",
            "human",
            "triple negative breast cancer"
          ],
          "MeshheadingList": [
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D063646",
                "value": "Carcinogenesis"
              },
              "QualifierName": [
                {
                  "MajorTopicYN": "Y",
                  "UI": "Q000235",
                  "value": "genetics"
                }
              ]
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D045744",
                "value": "Cell Line, Tumor"
              },
              "QualifierName": []
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D020869",
                "value": "Gene Expression Profiling"
              },
              "QualifierName": []
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "Y",
                "UI": "D015972",
                "value": "Gene Expression Regulation, Neoplastic"
              },
              "QualifierName": []
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D018398",
                "value": "Homeodomain Proteins"
              },
              "QualifierName": [
                {
                  "MajorTopicYN": "Y",
                  "UI": "Q000235",
                  "value": "genetics"
                },
                {
                  "MajorTopicYN": "N",
                  "UI": "Q000378",
                  "value": "metabolism"
                }
              ]
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D006801",
                "value": "Humans"
              },
              "QualifierName": []
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D051795",
                "value": "Hypoxia-Inducible Factor 1, alpha Subunit"
              },
              "QualifierName": [
                {
                  "MajorTopicYN": "Y",
                  "UI": "Q000235",
                  "value": "genetics"
                },
                {
                  "MajorTopicYN": "N",
                  "UI": "Q000378",
                  "value": "metabolism"
                }
              ]
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D014157",
                "value": "Transcription Factors"
              },
              "QualifierName": [
                {
                  "MajorTopicYN": "Y",
                  "UI": "Q000235",
                  "value": "genetics"
                },
                {
                  "MajorTopicYN": "N",
                  "UI": "Q000378",
                  "value": "metabolism"
                }
              ]
            },
            {
              "DescriptorName": {
                "MajorTopicYN": "N",
                "UI": "D064726",
                "value": "Triple Negative Breast Neoplasms"
              },
              "QualifierName": [
                {
                  "MajorTopicYN": "Y",
                  "UI": "Q000235",
                  "value": "genetics"
                }
              ]
            }
          ]
        },
        "PubmedData": {
          "ArticleIdList": [
            {
              "IdType": "pubmed",
              "id": "34779768"
            },
            {
              "IdType": "pmc",
              "id": "PMC8673836"
            },
            {
              "IdType": "doi",
              "id": "10.7554/eLife.70412"
            },
            {
              "IdType": "pii",
              "id": "70412"
            }
          ],
          "History": [
            {
              "PubMedPubDate": {
                "Day": "16",
                "Month": "5",
                "Year": "2021"
              },
              "PubStatus": "received"
            },
            {
              "PubMedPubDate": {
                "Day": "14",
                "Month": "11",
                "Year": "2021"
              },
              "PubStatus": "accepted"
            },
            {
              "PubMedPubDate": {
                "Day": "16",
                "Month": "11",
                "Year": "2021"
              },
              "PubStatus": "pubmed"
            },
            {
              "PubMedPubDate": {
                "Day": "22",
                "Month": "1",
                "Year": "2022"
              },
              "PubStatus": "medline"
            },
            {
              "PubMedPubDate": {
                "Day": "15",
                "Month": "11",
                "Year": "2021"
              },
              "PubStatus": "entrez"
            }
          ],
          "ReferenceList": [
            {
              "Reference": [
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.3816/CBC.2009.s.008"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2919761"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19596646"
                    }
                  ],
                  "Citation": "Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clinical Breast Cancer. 2009;9 Suppl 2:S73–S81. doi: 10.3816/CBC.2009.s.008."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1074/jbc.M406026200"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "15247232"
                    }
                  ],
                  "Citation": "Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. The Journal of Biological Chemistry. 2004;279:38458–38465. doi: 10.1074/jbc.M406026200."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1111/j.1365-2141.2007.06956.x"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "18353163"
                    }
                  ],
                  "Citation": "Armellini A, Sarasquete ME, García-Sanz R, Chillón MC, Balanzategui A, Alcoceba M, Fuertes M, López R, Hernández JM, Fernández-Calvo J, Sierra M, Megido M, Orfão A, Gutiérrez NC, González M, San Miguel JF. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. British Journal of Haematology. 2008;141:212–215. doi: 10.1111/j.1365-2141.2007.06956.x."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1063/1.448118"
                    }
                  ],
                  "Citation": "Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics. 1984;81:3684–3690. doi: 10.1063/1.448118."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/nar/28.1.235"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC102472"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "10592235"
                    }
                  ],
                  "Citation": "Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Research. 2000;28:235–242. doi: 10.1093/nar/28.1.235."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1186/1472-6807-10-13"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2893186"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "20509910"
                    }
                  ],
                  "Citation": "Bird LE, Ren J, Nettleship JE, Folkers GE, Owens RJ, Stammers DK. Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains. BMC Structural Biology. 2010;10:13. doi: 10.1186/1472-6807-10-13."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/jnci/93.4.309"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "11181778"
                    }
                  ],
                  "Citation": "Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. Journal of the National Cancer Institute. 2001;93:309–314. doi: 10.1093/jnci/93.4.309."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.cell.2016.05.042"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4930557"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "27368101"
                    }
                  ],
                  "Citation": "Briggs KJ, Koivunen P, Cao S, Backus KM, Olenchock BA, Patel H, Zhang Q, Signoretti S, Gerfen GJ, Richardson AL, Witkiewicz AK, Cravatt BF, Clardy J, Kaelin WG. Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine. Cell. 2016;166:126–139. doi: 10.1016/j.cell.2016.05.042."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nrc1367"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "15170446"
                    }
                  ],
                  "Citation": "Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nature Reviews. Cancer. 2004;4:437–447. doi: 10.1038/nrc1367."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nature11412"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3465532"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "23000897"
                    }
                  ],
                  "Citation": "Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. doi: 10.1038/nature11412."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1172/JCI95089"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC5919820"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "29629903"
                    }
                  ],
                  "Citation": "Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, Kumar A, Wang JE, Wang C, Zou X, Xing C, Wang Y, Luo W. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. The Journal of Clinical Investigation. 2018;128:1937–1955. doi: 10.1172/JCI95089."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.cell.2015.09.033"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4603750"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "26451490"
                    }
                  ],
                  "Citation": "Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GMK, Factor RE, Collins LC, Allison KH, Chen Y-Y, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, TCGA Research Network. Perou CM. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163:506–519. doi: 10.1016/j.cell.2015.09.033."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nature10983"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3440846"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "22522925"
                    }
                  ],
                  "Citation": "Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group. Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale A-L, Brenton JD, Tavaré S, Caldas C, Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346–352. doi: 10.1038/nature10983."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1002/jcc.26027"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "31294857"
                    }
                  ],
                  "Citation": "Daoudi S, Semmeq A, Badawi M, Assfeld X, Arfaoui Y, Pastore M. Electronic structure and optical properties of isolated and TiO2 -grafted free base porphyrins for water oxidation: A challenging test case for DFT and TD-DFT. Journal of Computational Chemistry. 2019;40:2530–2538. doi: 10.1002/jcc.26027."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1063/1.464397"
                    }
                  ],
                  "Citation": "Darden T, York D, Pedersen L. Particle mesh Ewald: An N ⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics. 1993;98:10089–10092. doi: 10.1063/1.464397."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1136/jcp.48.9.876"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC502883"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "7490328"
                    }
                  ],
                  "Citation": "Detre S, Saclani Jotti G, Dowsett M. A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. Journal of Clinical Pathology. 1995;48:876–878. doi: 10.1136/jcp.48.9.876."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/bioinformatics/bts635"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3530905"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "23104886"
                    }
                  ],
                  "Citation": "Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi: 10.1093/bioinformatics/bts635."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/nar/gkm276"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC1933214"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "17488841"
                    }
                  ],
                  "Citation": "Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Research. 2007;35:W522–W525. doi: 10.1093/nar/gkm276."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1126/scisignal.2004088"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4160307"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "23550210"
                    }
                  ],
                  "Citation": "Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling. 2013;6:pl1. doi: 10.1126/scisignal.2004088."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1259/0007-1285-26-312-638"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "13106296"
                    }
                  ],
                  "Citation": "Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. The British Journal of Radiology. 1953;26:638–648. doi: 10.1259/0007-1285-26-312-638."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1021/bi9620060"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "9154919"
                    }
                  ],
                  "Citation": "Gruschus JM, Tsao DH, Wang LH, Nirenberg M, Ferretti JA. Interactions of the vnd/NK-2 homeodomain with DNA by nuclear magnetic resonance spectroscopy: basis of binding specificity. Biochemistry. 1997;36:5372–5380. doi: 10.1021/bi9620060."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1158/1078-0432.CCR-06-2882"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "17908964"
                    }
                  ],
                  "Citation": "Guan Y, Kuo W-L, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao J-H, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, Gray JW. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clinical Cancer Research. 2007;13:5745–5755. doi: 10.1158/1078-0432.CCR-06-2882."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1007/s10549-009-0674-9"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "20020197"
                    }
                  ],
                  "Citation": "Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Research and Treatment. 2010;123:725–731. doi: 10.1007/s10549-009-0674-9."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.ejca.2009.06.027"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19643597"
                    }
                  ],
                  "Citation": "Heitz F, Harter P, Lueck HJ, Fissler-Eckhoff A, Lorenz-Salehi F, Scheil-Bertram S, Traut A, du Bois A. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. European Journal of Cancer. 2009;45:2792–2798. doi: 10.1016/j.ejca.2009.06.027."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1074/jbc.275.7.4571"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "10671482"
                    }
                  ],
                  "Citation": "Hell K, Tzagoloff A, Neupert W, Stuart RA. Identification of Cox20p, a novel protein involved in the maturation and assembly of cytochrome oxidase subunit 2. The Journal of Biological Chemistry. 2000;275:4571–4578. doi: 10.1074/jbc.275.7.4571."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1021/ct5010406"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "26574392"
                    }
                  ],
                  "Citation": "Hopkins CW, Le Grand S, Walker RC, Roitberg AE. Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning. Journal of Chemical Theory and Computation. 2015;11:1864–1874. doi: 10.1021/ct5010406."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "pubmed",
                      "id": "17447851"
                    }
                  ],
                  "Citation": "Hu S, Zhang M, Lv Z, Bi J, Dong Y, Wen J. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Neoplasma. 2007;54:207–211."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1158/2159-8290.CD-19-0837"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC7058506"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "31810986"
                    }
                  ],
                  "Citation": "Hu L, Xie H, Liu X, Potjewyd F, James LI, Wilkerson EM, Herring LE, Xie L, Chen X, Cabrera JC, Hong K, Liao C, Tan X, Baldwin AS, Gong K, Zhang Q. TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss. Cancer Discovery. 2020;10:460–475. doi: 10.1158/2159-8290.CD-19-0837."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1126/science.1059817"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "11292862"
                    }
                  ],
                  "Citation": "Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;Vol. 292:464–468. doi: 10.1126/science.1059817."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nmeth.3658"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4700514"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "26569599"
                    }
                  ],
                  "Citation": "Ivani I, Dans PD, Noy A, Pérez A, Faustino I, Hospital A, Walther J, Andrio P, Goñi R, Balaceanu A, Portella G, Battistini F, Gelpí JL, González C, Vendruscolo M, Laughton CA, Harris SA, Case DA, Orozco M. Parmbsc1: a refined force field for DNA simulations. Nature Methods. 2016;13:55–58. doi: 10.1038/nmeth.3658."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1126/science.1059796"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "11292861"
                    }
                  ],
                  "Citation": "Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;Vol. 292:468–472. doi: 10.1126/science.1059796."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/s41586-020-2969-2"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC8439149"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "33299191"
                    }
                  ],
                  "Citation": "Jin X, Demere Z, Nair K, Ali A, Ferraro GB, Natoli T, Deik A, Petronio L, Tang AA, Zhu C, Wang L, Rosenberg D, Mangena V, Roth J, Chung K, Jain RK, Clish CB, Vander Heiden MG, Golub TR. A metastasis map of human cancer cell lines. Nature. 2020;588:331–336. doi: 10.1038/s41586-020-2969-2."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1021/jp902584c"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2755304"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19757835"
                    }
                  ],
                  "Citation": "Joung IS. Molecular dynamics simulations of the dynamic and energetic properties of alkali and halide ions using water-model-specific ion parameters. The Journal of Physical Chemistry. B. 2009;113:13279–13290. doi: 10.1021/jp902584c."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1042/BJ20030171"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC1223552"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "12741956"
                    }
                  ],
                  "Citation": "Kawata H, Yamada K, Shou Z, Mizutani T, Yazawa T, Yoshino M, Sekiguchi T, Kajitani T, Miyamoto K. Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. The Biochemical Journal. 2003;373:747–757. doi: 10.1042/BJ20030171."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.3390/microorganisms7110575"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6920987"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "31752220"
                    }
                  ],
                  "Citation": "Keerthiraju E, Du C, Tucker G, Greetham D. A Role for COX20 in Tolerance to Oxidative Stress and Programmed Cell Death in Saccharomyces cerevisiae. Microorganisms. 2019;7:575. doi: 10.3390/microorganisms7110575."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1242/jcs.033522"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19033387"
                    }
                  ],
                  "Citation": "Lau AW, Chou MM. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. Journal of Cell Science. 2008;121:4008–4017. doi: 10.1242/jcs.033522."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1371/journal.pmed.1002201"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC5189935"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "28027327"
                    }
                  ],
                  "Citation": "Lefebvre C, Bachelot T, Filleron T, Pedrero M, Campone M, Soria J-C, Massard C, Lévy C, Arnedos M, Lacroix-Triki M, Garrabey J, Boursin Y, Deloger M, Fu Y, Commo F, Scott V, Lacroix L, Dieci MV, Kamal M, Diéras V, Gonçalves A, Ferrerro J-M, Romieu G, Vanlemmens L, Mouret Reynier M-A, Théry J-C, Le Du F, Guiu S, Dalenc F, Clapisson G, Bonnefoi H, Jimenez M, Le Tourneau C, André F. Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis. PLOS Medicine. 2016;13:e1002201. doi: 10.1371/journal.pmed.1002201."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1158/2159-8290.CD-20-0288"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC7642036"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "32690540"
                    }
                  ],
                  "Citation": "Liao C, Zhang Y, Fan C, Herring LE, Liu J, Locasale JW, Takada M, Zhou J, Zurlo G, Hu L, Simon JM, Ptacek TS, Andrianov VG, Loza E, Peng Y, Yang H, Perou CM, Zhang Q. Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer. Cancer Discovery. 2020;10:1706–1721. doi: 10.1158/2159-8290.CD-20-0288."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1002/cncr.23930"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2835546"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "18833576"
                    }
                  ],
                  "Citation": "Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113:2638–2645. doi: 10.1002/cncr.23930."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.molcel.2020.01.009"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC7093231"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "32023483"
                    }
                  ],
                  "Citation": "Liu X, Simon JM, Xie H, Hu L, Wang J, Zurlo G, Fan C, Ptacek TS, Herring L, Tan X, Li M, Baldwin AS, Kim WY, Wu T, Kirschner MW, Gong K, Zhang Q. Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss. Molecular Cell. 2020;77:1294–1306. doi: 10.1016/j.molcel.2020.01.009."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1186/s13059-014-0550-8"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4302049"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "25516281"
                    }
                  ],
                  "Citation": "Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology. 2014;15:550. doi: 10.1186/s13059-014-0550-8."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.18632/oncotarget.2832"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4359216"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "25473899"
                    }
                  ],
                  "Citation": "Ma H, Yue X, Gao L, Liang X, Yan W, Zhang Z, Shan H, Zhang H, Spear BT, Ma C. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. Oncotarget. 2015;6:1049–1063. doi: 10.18632/oncotarget.2832."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1021/acs.jctc.5b00255"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4821407"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "26574453"
                    }
                  ],
                  "Citation": "Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. Journal of Chemical Theory and Computation. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/carcin/bgt086"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3616676"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "23455378"
                    }
                  ],
                  "Citation": "Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, Cavenee WK. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013;34:725–738. doi: 10.1093/carcin/bgt086."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1021/ct300418h"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "26605738"
                    }
                  ],
                  "Citation": "Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. Journal of Chemical Theory and Computation. 2012;8:3314–3321. doi: 10.1021/ct300418h."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1002/gcc.20920"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "21987443"
                    }
                  ],
                  "Citation": "Nagel S, Schneider B, Rosenwald A, Meyer C, Kaufmann M, Drexler HG, MacLeod RAF. t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2. Genes, Chromosomes and Cancer. 2011;50:996–1009. doi: 10.1002/gcc.20920."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.leukres.2011.10.019"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "22078940"
                    }
                  ],
                  "Citation": "Nagel S, Schneider B, Meyer C, Kaufmann M, Drexler HG, Macleod RAF. Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. Leukemia Research. 2012;36:646–655. doi: 10.1016/j.leukres.2011.10.019."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/annonc/mdp407"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19840953"
                    }
                  ],
                  "Citation": "Niwińska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT) Annals of Oncology. 2010;21:942–948. doi: 10.1093/annonc/mdp407."
                },
                {
                  "ArticleIdList": null,
                  "Citation": "Ohnishi S, Sasagawa A, Saito K, Koshiba S, Inoue M, Kigawa T, Yokoyama S, RIKEN Structural Genomics/Proteomics Initiative (RSGI)  2020. Solution structure of the third homeobox domain of Zinc fingers and homeoboxes protein 2. RCSB Protein Data Bank. https://www.rcsb.org/structure/2dmp"
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1002/acn3.661"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6331954"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "30656193"
                    }
                  ],
                  "Citation": "Otero MG, Tiongson E, Diaz F, Haude K, Panzer K, Collier A, Kim J, Adams D, Tifft CJ, Cui H, Millian Zamora F, Au MG, Graham JM, Jr, Buckley DJ, Lewis R, Toro C, Bai R, Turner L, Mathews KD, Gahl W, Pierson TM. Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy. Annals of Clinical and Translational Neurology. 2019;6:154–160. doi: 10.1002/acn3.661."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1080/00268978800101881"
                    }
                  ],
                  "Citation": "Pastor RW, Brooks BR, Szabo A. An analysis of the accuracy of Langevin and molecular dynamics algorithms. Molecular Physics. 2006;65:1409–1419. doi: 10.1080/00268978800101881."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nmeth.4197"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC5600148"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "28263959"
                    }
                  ],
                  "Citation": "Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nature Methods. 2017;14:417–419. doi: 10.1038/nmeth.4197."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/ncomms11479"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4866047"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "27161491"
                    }
                  ],
                  "Citation": "Pereira B, Chin S-F, Rueda OM, Vollan H-KM, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut S-J, Tsui DWY, Liu B, Dawson S-J, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale A-L, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C. The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nature Communications. 2016;7:11479. doi: 10.1038/ncomms11479."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1073/pnas.0408555102"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC544306"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "15626755"
                    }
                  ],
                  "Citation": "Perincheri S, Dingle RWC, Peterson ML, Spear BT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. PNAS. 2005;102:396–401. doi: 10.1073/pnas.0408555102."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/bioinformatics/btq033"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2832824"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "20110278"
                    }
                  ],
                  "Citation": "Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–842. doi: 10.1093/bioinformatics/btq033."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/nar/gkw257"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4987876"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "27079975"
                    }
                  ],
                  "Citation": "Ramírez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, Dündar F, Manke T. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Research. 2016;44:W160–W165. doi: 10.1093/nar/gkw257."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/s41596-018-0103-9"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6607905"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "30664679"
                    }
                  ],
                  "Citation": "Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C, Merico D, Bader GD. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nature Protocols. 2019;14:482–517. doi: 10.1038/s41596-018-0103-9."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/s1097-2765(01)00336-7"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "11583619"
                    }
                  ],
                  "Citation": "Reményi A, Tomilin A, Pohl E, Lins K, Philippsen A, Reinbold R, Schöler HR, Wilmanns M. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Molecular Cell. 2001;8:569–580. doi: 10.1016/s1097-2765(01)00336-7."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1186/1471-2164-15-331"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4035062"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "24885402"
                    }
                  ],
                  "Citation": "Rhie SK, Hazelett DJ, Coetzee SG, Yan C, Noushmehr H, Coetzee GA. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. BMC Genomics. 2014;15:331. doi: 10.1186/1471-2164-15-331."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/protein/12.2.85"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "10195279"
                    }
                  ],
                  "Citation": "Rost B. Twilight zone of protein sequence alignments. Protein Engineering. 1999;12:85–94. doi: 10.1093/protein/12.2.85."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/onc.2009.441"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2969168"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "19946328"
                    }
                  ],
                  "Citation": "Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29:625–634. doi: 10.1038/onc.2009.441."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1016/j.cell.2012.01.021"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3437543"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "22304911"
                    }
                  ],
                  "Citation": "Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399–408. doi: 10.1016/j.cell.2012.01.021."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/nrg3682"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "24614317"
                    }
                  ],
                  "Citation": "Shlyueva D, Stampfel G, Stark A. Transcriptional enhancers: from properties to genome-wide predictions. Nature Reviews. Genetics. 2014;15:272–286. doi: 10.1038/nrg3682."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/35563"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "9490409"
                    }
                  ],
                  "Citation": "Tan S, Richmond TJ. Crystal structure of the yeast MATalpha2/MCM1/DNA ternary complex. Nature. 1998;391:660–666. doi: 10.1038/35563."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/ncomms3035"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3724450"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "23792809"
                    }
                  ],
                  "Citation": "Wang L, Chang J, Varghese D, Dellinger M, Kumar S, Best AM, Ruiz J, Bruick R, Peña-Llopis S, Xu J, Babinski DJ, Frantz DE, Brekken RA, Quinn AM, Simeonov A, Easmon J, Martinez ED. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nature Communications. 2013;4:2035. doi: 10.1038/ncomms3035."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1093/nar/gky427"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6030848"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "29788355"
                    }
                  ],
                  "Citation": "Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research. 2018;46:W296–W303. doi: 10.1093/nar/gky427."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.3390/cancers12051098"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC7280979"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "32354028"
                    }
                  ],
                  "Citation": "Yoo J, Jeon YH, Cho HY, Lee SW, Kim GW, Lee DH, Kwon SH. Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target. Cancers. 2020;12:1098. doi: 10.3390/cancers12051098."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1053/j.gastro.2012.02.049"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC3367107"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "22406477"
                    }
                  ],
                  "Citation": "Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, Liu X, Ma H, Guo M, Spear BT, Gong Y, Ma C. Zinc Fingers and Homeoboxes 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Represses Expression of Cyclins A and E. Gastroenterology. 2012;142:1559–1570. doi: 10.1053/j.gastro.2012.02.049."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1186/gb-2008-9-9-r137"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC2592715"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "18798982"
                    }
                  ],
                  "Citation": "Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nussbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based Analysis of ChIP-Seq (MACS) Genome Biology. 2008;9:R137. doi: 10.1186/gb-2008-9-9-r137."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1126/science.aap8411"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6154478"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "30026228"
                    }
                  ],
                  "Citation": "Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, Liu XD, Jonasch E, Xie L, Chen X, Yao X, Teh BT, Tan P, Zheng X, Li M, Lawrence C, Fan J, Geng J, Liu X, Hu L, Wang J, Liao C, Hong K, Zurlo G, Parker JS, Auman JT, Perou CM, Rathmell WK, Kim WY, Kirschner MW, Kaelin WG, Baldwin AS, Zhang Q. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018;Vol. 361:290–295. doi: 10.1126/science.aap8411."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1101/gad.242131.114"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC4083087"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "24990963"
                    }
                  ],
                  "Citation": "Zheng X, Zhai B, Koivunen P, Shin SJ, Lu G, Liu J, Geisen C, Chakraborty AA, Moslehi JJ, Smalley DM, Wei X, Chen X, Chen Z, Beres JM, Zhang J, Tsao JL, Brenner MC, Zhang Y, Fan C, DePinho RA, Paik J, Gygi SP, Kaelin WG, Zhang Q. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase. Genes & Development. 2014;28:1429–1444. doi: 10.1101/gad.242131.114."
                },
                {
                  "ArticleIdList": [
                    {
                      "IdType": "doi",
                      "id": "10.1038/s41467-019-13168-4"
                    },
                    {
                      "IdType": "pmc",
                      "id": "PMC6858455"
                    },
                    {
                      "IdType": "pubmed",
                      "id": "31729379"
                    }
                  ],
                  "Citation": "Zurlo G, Liu X, Takada M, Fan C, Simon JM, Ptacek TS, Rodriguez J, von Kriegsheim A, Liu J, Locasale JW, Robinson A, Zhang J, Holler JM, Kim B, Zikánová M, Bierau J, Xie L, Chen X, Li M, Perou CM, Zhang Q. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer. Nature Communications. 2019;10:5177. doi: 10.1038/s41467-019-13168-4."
                }
              ],
              "ReferenceList": [],
              "Title": null
            }
          ]
        }
      },
      "authorProfiles": [
        {
          "ForeName": "Wentong",
          "LastName": "Fang",
          "abbrevName": "Fang W",
          "email": null,
          "isCollectiveName": false,
          "name": "Wentong Fang",
          "orcid": "0000-0003-0047-1198"
        },
        {
          "ForeName": "Chengheng",
          "LastName": "Liao",
          "abbrevName": "Liao C",
          "email": null,
          "isCollectiveName": false,
          "name": "Chengheng Liao",
          "orcid": "0000-0002-9073-3835"
        },
        {
          "ForeName": "Rachel",
          "LastName": "Shi",
          "abbrevName": "Shi R",
          "email": null,
          "isCollectiveName": false,
          "name": "Rachel Shi",
          "orcid": null
        },
        {
          "ForeName": "Jeremy",
          "LastName": "Simon",
          "abbrevName": "Simon JM",
          "email": null,
          "isCollectiveName": false,
          "name": "Jeremy M Simon",
          "orcid": "0000-0003-3906-1663"
        },
        {
          "ForeName": "Travis",
          "LastName": "Ptacek",
          "abbrevName": "Ptacek TS",
          "email": null,
          "isCollectiveName": false,
          "name": "Travis S Ptacek",
          "orcid": null
        },
        {
          "ForeName": "Giada",
          "LastName": "Zurlo",
          "abbrevName": "Zurlo G",
          "email": null,
          "isCollectiveName": false,
          "name": "Giada Zurlo",
          "orcid": null
        },
        {
          "ForeName": "Youqiong",
          "LastName": "Ye",
          "abbrevName": "Ye Y",
          "email": null,
          "isCollectiveName": false,
          "name": "Youqiong Ye",
          "orcid": null
        },
        {
          "ForeName": "Leng",
          "LastName": "Han",
          "abbrevName": "Han L",
          "email": null,
          "isCollectiveName": false,
          "name": "Leng Han",
          "orcid": null
        },
        {
          "ForeName": "Cheng",
          "LastName": "Fan",
          "abbrevName": "Fan C",
          "email": null,
          "isCollectiveName": false,
          "name": "Cheng Fan",
          "orcid": null
        },
        {
          "ForeName": "Lei",
          "LastName": "Bao",
          "abbrevName": "Bao L",
          "email": null,
          "isCollectiveName": false,
          "name": "Lei Bao",
          "orcid": null
        },
        {
          "ForeName": "Christopher",
          "LastName": "Ortiz",
          "abbrevName": "Ortiz CL",
          "email": null,
          "isCollectiveName": false,
          "name": "Christopher Llynard Ortiz",
          "orcid": "0000-0002-3114-7369"
        },
        {
          "ForeName": "Hong-Rui",
          "LastName": "Lin",
          "abbrevName": "Lin HR",
          "email": null,
          "isCollectiveName": false,
          "name": "Hong-Rui Lin",
          "orcid": null
        },
        {
          "ForeName": "Ujjawal",
          "LastName": "Manocha",
          "abbrevName": "Manocha U",
          "email": null,
          "isCollectiveName": false,
          "name": "Ujjawal Manocha",
          "orcid": null
        },
        {
          "ForeName": "Weibo",
          "LastName": "Luo",
          "abbrevName": "Luo W",
          "email": null,
          "isCollectiveName": false,
          "name": "Weibo Luo",
          "orcid": null
        },
        {
          "ForeName": "Yan",
          "LastName": "Peng",
          "abbrevName": "Peng Y",
          "email": null,
          "isCollectiveName": false,
          "name": "Yan Peng",
          "orcid": null
        },
        {
          "ForeName": "William",
          "LastName": "Kim",
          "abbrevName": "Kim WY",
          "email": null,
          "isCollectiveName": false,
          "name": "William Y Kim",
          "orcid": null
        },
        {
          "ForeName": "Lee-Wei",
          "LastName": "Yang",
          "abbrevName": "Yang LW",
          "email": null,
          "isCollectiveName": false,
          "name": "Lee-Wei Yang",
          "orcid": "0000-0002-3971-6386"
        },
        {
          "ForeName": "Qing",
          "LastName": "Zhang",
          "abbrevName": "Zhang Q",
          "email": null,
          "isCollectiveName": false,
          "name": "Qing Zhang",
          "orcid": "0000-0002-6595-8995"
        }
      ],
      "correspondence": {
        "authorEmail": [],
        "emails": []
      },
      "createdDate": 1670661765,
      "entries": [
        {
          "id": "13f57ee3-df7d-4ec8-b8ca-0efdd62f99d5"
        },
        {
          "id": "3295573e-31b2-40c4-99f1-4dbf6a34990a"
        },
        {
          "id": "3fd6a28f-483e-4eb4-ab6f-0a9025bd9cd1"
        }
      ],
      "id": "71478983-b540-43b3-a552-2085dd6b0659",
      "issues": {
        "authorEmail": null,
        "paperId": null
      },
      "lastEditedDate": 1670661992,
      "liveId": "8ac6d9c1-a12e-4fc8-ad55-0b80e8a3f84c",
      "lock": null,
      "locked": false,
      "organisms": [],
      "provided": {
        "authorEmail": "user@email.org",
        "authorName": "John Doe",
        "name": "John Doe",
        "paperId": "Some paper id"
      },
      "referencedPapers": [
        {
          "pmid": "33299191",
          "pubmed": {
            "ISODate": "2020-12-01T00:00:00.000Z",
            "abstract": "Most deaths from cancer are explained by metastasis, and yet large-scale metastasis research has been impractical owing to the complexity of in vivo models. Here we introduce an in vivo barcoding strategy that is capable of determining the metastatic potential of human cancer cell lines in mouse xenografts at scale. We validated the robustness, scalability and reproducibility of the method and applied it to 500 cell lines1,2 spanning 21 types of solid tumour. We created a first-generation metastasis map (MetMap) that reveals organ-specific patterns of metastasis, enabling these patterns to be associated with clinical and genomic features. We demonstrate the utility of MetMap by investigating the molecular basis of breast cancers capable of metastasizing to the brain-a principal cause of death in patients with this type of cancer. Breast cancers capable of metastasizing to the brain showed evidence of altered lipid metabolism. Perturbation of lipid metabolism in these cells curbed brain metastasis development, suggesting a therapeutic strategy to combat the disease and demonstrating the utility of MetMap as a resource to support metastasis research.",
            "authors": {
              "abbreviation": "Xin Jin, Zelalem Demere, Karthik Nair, ..., Todd R Golub",
              "authorList": [
                {
                  "ForeName": "Xin",
                  "LastName": "Jin",
                  "abbrevName": "Jin X",
                  "email": "xjin@broadinstitute.org",
                  "isCollectiveName": false,
                  "name": "Xin Jin",
                  "orcid": "0000-0003-4167-1743"
                },
                {
                  "ForeName": "Zelalem",
                  "LastName": "Demere",
                  "abbrevName": "Demere Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zelalem Demere",
                  "orcid": null
                },
                {
                  "ForeName": "Karthik",
                  "LastName": "Nair",
                  "abbrevName": "Nair K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Karthik Nair",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ali",
                  "abbrevName": "Ali A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ali",
                  "orcid": null
                },
                {
                  "ForeName": "Gino",
                  "LastName": "Ferraro",
                  "abbrevName": "Ferraro GB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gino B Ferraro",
                  "orcid": "0000-0002-1587-4259"
                },
                {
                  "ForeName": "Ted",
                  "LastName": "Natoli",
                  "abbrevName": "Natoli T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ted Natoli",
                  "orcid": null
                },
                {
                  "ForeName": "Amy",
                  "LastName": "Deik",
                  "abbrevName": "Deik A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Amy Deik",
                  "orcid": null
                },
                {
                  "ForeName": "Lia",
                  "LastName": "Petronio",
                  "abbrevName": "Petronio L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lia Petronio",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Tang",
                  "abbrevName": "Tang AA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew A Tang",
                  "orcid": null
                },
                {
                  "ForeName": "Cong",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cong Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Li",
                  "LastName": "Wang",
                  "abbrevName": "Wang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Li Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Danny",
                  "LastName": "Rosenberg",
                  "abbrevName": "Rosenberg D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Danny Rosenberg",
                  "orcid": null
                },
                {
                  "ForeName": "Vamsi",
                  "LastName": "Mangena",
                  "abbrevName": "Mangena V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vamsi Mangena",
                  "orcid": "0000-0003-2662-0366"
                },
                {
                  "ForeName": "Jennifer",
                  "LastName": "Roth",
                  "abbrevName": "Roth J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jennifer Roth",
                  "orcid": null
                },
                {
                  "ForeName": "Kwanghun",
                  "LastName": "Chung",
                  "abbrevName": "Chung K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kwanghun Chung",
                  "orcid": "0000-0002-8167-3340"
                },
                {
                  "ForeName": "Rakesh",
                  "LastName": "Jain",
                  "abbrevName": "Jain RK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rakesh K Jain",
                  "orcid": "0000-0001-7571-3548"
                },
                {
                  "ForeName": "Clary",
                  "LastName": "Clish",
                  "abbrevName": "Clish CB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Clary B Clish",
                  "orcid": "0000-0001-8259-9245"
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Vander Heiden",
                  "abbrevName": "Vander Heiden MG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew G Vander Heiden",
                  "orcid": "0000-0002-6702-4192"
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Golub",
                  "abbrevName": "Golub TR",
                  "email": "golub@broadinstitute.org",
                  "isCollectiveName": false,
                  "name": "Todd R Golub",
                  "orcid": "0000-0003-0113-2403"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Xin",
                  "LastName": "Jin",
                  "email": [
                    "xjin@broadinstitute.org"
                  ],
                  "name": "Xin Jin"
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Golub",
                  "email": [
                    "golub@broadinstitute.org"
                  ],
                  "name": "Todd R Golub"
                }
              ]
            },
            "doi": "10.1038/s41586-020-2969-2",
            "pmid": "33299191",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Nature 588 2020",
            "title": "A metastasis map of human cancer cell lines."
          }
        },
        {
          "pmid": "32690540",
          "pubmed": {
            "ISODate": "2020-11-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease. Because of its heterogeneity and lack of hormone receptors or HER2 expression, targeted therapy is limited. Here, by performing a functional siRNA screening for 2-OG-dependent enzymes, we identified gamma-butyrobetaine hydroxylase 1 (BBOX1) as an essential gene for TNBC tumorigenesis. BBOX1 depletion inhibits TNBC cell growth while not affecting normal breast cells. Mechanistically, BBOX1 binds with the calcium channel inositol-1,4,5-trisphosphate receptor type 3 (IP3R3) in an enzymatic-dependent manner and prevents its ubiquitination and proteasomal degradation. BBOX1 depletion suppresses IP3R3-mediated endoplasmic reticulum calcium release, therefore impairing calcium-dependent energy-generating processes including mitochondrial respiration and mTORC1-mediated glycolysis, which leads to apoptosis and impaired cell-cycle progression in TNBC cells. Therapeutically, genetic depletion or pharmacologic inhibition of BBOX1 inhibits TNBC tumor growth in vitro and in vivo. Our study highlights the importance of targeting the previously uncharacterized BBOX1-IP3R3-calcium oncogenic signaling axis in TNBC. SIGNIFICANCE: We provide evidence from unbiased screens that BBOX1 is a potential therapeutic target in TNBC and that genetic knockdown or pharmacologic inhibition of BBOX1 leads to decreased TNBC cell fitness. This study lays the foundation for developing effective BBOX1 inhibitors for treatment of this lethal disease.This article is highlighted in the In This Issue feature, p. 1611.",
            "authors": {
              "abbreviation": "Chengheng Liao, Yang Zhang, Cheng Fan, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Yang",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yang Zhang",
                  "orcid": "0000-0002-6595-8995"
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Laura",
                  "LastName": "Herring",
                  "abbrevName": "Herring LE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laura E Herring",
                  "orcid": "0000-0003-4496-7312"
                },
                {
                  "ForeName": "Juan",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Juan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Jason",
                  "LastName": "Locasale",
                  "abbrevName": "Locasale JW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jason W Locasale",
                  "orcid": "0000-0002-7766-3502"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": "0000-0002-5777-3325"
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": "0000-0001-5600-5634"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Travis",
                  "LastName": "Ptacek",
                  "abbrevName": "Ptacek TS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Travis S Ptacek",
                  "orcid": null
                },
                {
                  "ForeName": "Victor",
                  "LastName": "Andrianov",
                  "abbrevName": "Andrianov VG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Victor G Andrianov",
                  "orcid": null
                },
                {
                  "ForeName": "Einars",
                  "LastName": "Loza",
                  "abbrevName": "Loza E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Einars Loza",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Peng",
                  "abbrevName": "Peng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Peng",
                  "orcid": "0000-0001-5765-6260"
                },
                {
                  "ForeName": "Huanghe",
                  "LastName": "Yang",
                  "abbrevName": "Yang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Huanghe Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "Qing.Zhang@UTSouthwestern.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "Qing.Zhang@UTSouthwestern.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1158/2159-8290.CD-20-0288",
            "pmid": "32690540",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Discov 10 2020",
            "title": "Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "32354028",
          "pubmed": {
            "ISODate": "2020-04-28T00:00:00.000Z",
            "abstract": "Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1 histone demethylases that promote gene expression. The KDM3 subfamily primarily consists of four proteins (KDM3A-D). All four proteins contain the catalytic Jumonji C domain (JmjC) at their C-termini, but whether KDM3C has demethylase activity is under debate. In addition, KDM3 proteins contain a zinc-finger domain for DNA binding and an LXXLL motif for interacting with nuclear receptors. Of the KDM3 proteins, KDM3A is especially deregulated or overexpressed in multiple cancers, making it a potential cancer therapeutic target. However, no KDM3A-selective inhibitors have been identified to date because of the lack of structural information. Uncovering the distinct physiological and pathological functions of KDM3A and their structure will give insight into the development of novel selective inhibitors. In this review, we focus on recent studies highlighting the oncogenic functions of KDM3A in cancer. We also discuss existing KDM3A-related inhibitors and review their potential as therapeutic agents for overcoming cancer.",
            "authors": {
              "abbreviation": "Jung Yoo, Yu Hyun Jeon, Ha Young Cho, ..., So Hee Kwon",
              "authorList": [
                {
                  "ForeName": "Jung",
                  "LastName": "Yoo",
                  "abbrevName": "Yoo J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jung Yoo",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Jeon",
                  "abbrevName": "Jeon YH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Hyun Jeon",
                  "orcid": null
                },
                {
                  "ForeName": "Ha",
                  "LastName": "Cho",
                  "abbrevName": "Cho HY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ha Young Cho",
                  "orcid": null
                },
                {
                  "ForeName": "Sang",
                  "LastName": "Lee",
                  "abbrevName": "Lee SW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sang Wu Lee",
                  "orcid": null
                },
                {
                  "ForeName": "Go",
                  "LastName": "Kim",
                  "abbrevName": "Kim GW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Go Woon Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Dong",
                  "LastName": "Lee",
                  "abbrevName": "Lee DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dong Hoon Lee",
                  "orcid": null
                },
                {
                  "ForeName": "So",
                  "LastName": "Kwon",
                  "abbrevName": "Kwon SH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "So Hee Kwon",
                  "orcid": "0000-0002-3753-4415"
                }
              ],
              "contacts": []
            },
            "doi": "10.3390/cancers12051098",
            "pmid": "32354028",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Cancers (Basel) 12 2020",
            "title": "Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target."
          }
        },
        {
          "pmid": "32023483",
          "pubmed": {
            "ISODate": "2020-03-19T00:00:00.000Z",
            "abstract": "von Hippel-Lindau (VHL) is a critical tumor suppressor in clear cell renal cell carcinomas (ccRCCs). It is important to identify additional therapeutic targets in ccRCC downstream of VHL loss besides hypoxia-inducible factor 2α (HIF2α). By performing a genome-wide screen, we identified Scm-like with four malignant brain tumor domains 1 (SFMBT1) as a candidate pVHL target. SFMBT1 was considered to be a transcriptional repressor but its role in cancer remains unclear. ccRCC patients with VHL loss-of-function mutations displayed elevated SFMBT1 protein levels. SFMBT1 hydroxylation on Proline residue 651 by EglN1 mediated its ubiquitination and degradation governed by pVHL. Depletion of SFMBT1 abolished ccRCC cell proliferation in vitro and inhibited orthotopic tumor growth in vivo. Integrated analyses of ChIP-seq, RNA-seq, and patient prognosis identified sphingosine kinase 1 (SPHK1) as a key SFMBT1 target gene contributing to its oncogenic phenotype. Therefore, the pVHL-SFMBT1-SPHK1 axis serves as a potential therapeutic avenue for ccRCC.",
            "authors": {
              "abbreviation": "Xijuan Liu, Jeremy M Simon, Haibiao Xie, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": null
                },
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Travis",
                  "LastName": "Ptacek",
                  "abbrevName": "Ptacek TS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Travis S Ptacek",
                  "orcid": null
                },
                {
                  "ForeName": "Laura",
                  "LastName": "Herring",
                  "abbrevName": "Herring L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laura Herring",
                  "orcid": null
                },
                {
                  "ForeName": "Xianming",
                  "LastName": "Tan",
                  "abbrevName": "Tan X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xianming Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": null
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "Qing.Zhang@UTSouthwestern.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "Qing.Zhang@UTSouthwestern.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1016/j.molcel.2020.01.009",
            "pmid": "32023483",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Mol Cell 77 2020",
            "title": "Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss."
          }
        },
        {
          "pmid": "31810986",
          "pubmed": {
            "ISODate": "2020-03-01T00:00:00.000Z",
            "abstract": "TANK binding kinase 1 (TBK1) is an important kinase involved in the innate immune response. Here we discover that TBK1 is hyperactivated by von Hippel-Lindau (VHL) loss or hypoxia in cancer cells. Tumors from patients with kidney cancer with VHL loss display elevated TBK1 phosphorylation. Loss of TBK1 via genetic ablation, pharmacologic inhibition, or a new cereblon-based proteolysis targeting chimera specifically inhibits VHL-deficient kidney cancer cell growth, while leaving VHL wild-type cells intact. TBK1 depletion also significantly blunts kidney tumorigenesis in an orthotopic xenograft model in vivo. Mechanistically, TBK1 hydroxylation on Proline 48 triggers VHL as well as the phosphatase PPM1B binding that leads to decreased TBK1 phosphorylation. We identify that TBK1 phosphorylates p62/SQSTM1 on Ser366, which is essential for p62 stability and kidney cancer cell proliferation. Our results establish that TBK1, distinct from its role in innate immune signaling, is a synthetic lethal target in cancer with VHL loss. SIGNIFICANCE: The mechanisms that lead to TBK1 activation in cancer and whether this activation is connected to its role in innate immunity remain unclear. Here, we discover that TBK1, distinct from its role in innate immunity, is activated by VHL loss or hypoxia in cancer.See related commentary by Bakouny and Barbie, p. 348.This article is highlighted in the In This Issue feature, p. 327.",
            "authors": {
              "abbreviation": "Lianxin Hu, Haibiao Xie, Xijuan Liu, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Frances",
                  "LastName": "Potjewyd",
                  "abbrevName": "Potjewyd F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Frances Potjewyd",
                  "orcid": null
                },
                {
                  "ForeName": "Lindsey",
                  "LastName": "James",
                  "abbrevName": "James LI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lindsey I James",
                  "orcid": "0000-0002-6034-7116"
                },
                {
                  "ForeName": "Emily",
                  "LastName": "Wilkerson",
                  "abbrevName": "Wilkerson EM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Emily M Wilkerson",
                  "orcid": null
                },
                {
                  "ForeName": "Laura",
                  "LastName": "Herring",
                  "abbrevName": "Herring LE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laura E Herring",
                  "orcid": null
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Johnny",
                  "LastName": "Cabrera",
                  "abbrevName": "Cabrera JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Johnny Castillo Cabrera",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": "0000-0001-5521-4418"
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Xianming",
                  "LastName": "Tan",
                  "abbrevName": "Tan X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xianming Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": "Qing.Zhang@UTSouthwestern.edu",
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "Qing.Zhang@UTSouthwestern.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "email": [
                    "Qing.Zhang@UTSouthwestern.edu",
                    "gongkan_pku@126.com"
                  ],
                  "name": "Kan Gong"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "Qing.Zhang@UTSouthwestern.edu",
                    "gongkan_pku@126.com"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1158/2159-8290.CD-19-0837",
            "pmid": "31810986",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Cancer Discov 10 2020",
            "title": "TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss."
          }
        },
        {
          "pmid": "31752220",
          "pubmed": {
            "ISODate": "2019-11-18T00:00:00.000Z",
            "abstract": "Industrial production of bioethanol from lignocellulosic materials (LCM's) is reliant on a microorganism being tolerant to the stresses inherent to fermentation. Previous work has highlighted the importance of a cytochrome oxidase chaperone gene (COX20) in improving yeast tolerance to acetic acid, a common inhibitory compound produced during pre-treatment of LCM's. The presence of acetic acid has been shown to induce oxidative stress and programmed cell death, so the role of COX20 in oxidative stress was determined. Analysis using flow cytometry revealed that COX20 expression was associated with reduced levels of reactive oxygen species (ROS) in hydrogen peroxide and metal-induced stress, and there was a reduction in apoptotic and necrotic cells when compared with a strain without COX20. Results on the functionality of COX20 have revealed that overexpression of COX20 induced respiratory growth in Δimp1 and Δcox18, two genes whose presence is essential for yeast respiratory growth. COX20 also has a role in protecting the yeast cell against programmed cell death.",
            "authors": {
              "abbreviation": "Ethiraju Keerthiraju, Chenyu Du, Gregory Tucker, Darren Greetham",
              "authorList": [
                {
                  "ForeName": "Ethiraju",
                  "LastName": "Keerthiraju",
                  "abbrevName": "Keerthiraju E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ethiraju Keerthiraju",
                  "orcid": null
                },
                {
                  "ForeName": "Chenyu",
                  "LastName": "Du",
                  "abbrevName": "Du C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chenyu Du",
                  "orcid": null
                },
                {
                  "ForeName": "Gregory",
                  "LastName": "Tucker",
                  "abbrevName": "Tucker G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gregory Tucker",
                  "orcid": null
                },
                {
                  "ForeName": "Darren",
                  "LastName": "Greetham",
                  "abbrevName": "Greetham D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Darren Greetham",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3390/microorganisms7110575",
            "pmid": "31752220",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Microorganisms 7 2019",
            "title": "A Role for COX20 in Tolerance to Oxidative Stress and Programmed Cell Death in Saccharomyces cerevisiae."
          }
        },
        {
          "pmid": "31729379",
          "pubmed": {
            "ISODate": "2019-11-15T00:00:00.000Z",
            "abstract": "Protein hydroxylation affects protein stability, activity, and interactome, therefore contributing to various diseases including cancers. However, the transiency of the hydroxylation reaction hinders the identification of hydroxylase substrates. By developing an enzyme-substrate trapping strategy coupled with TAP-TAG or orthogonal GST- purification followed by mass spectrometry, we identify adenylosuccinate lyase (ADSL) as an EglN2 hydroxylase substrate in triple negative breast cancer (TNBC). ADSL expression is higher in TNBC than other breast cancer subtypes or normal breast tissues. ADSL knockout impairs TNBC cell proliferation and invasiveness in vitro and in vivo. An integrated transcriptomics and metabolomics analysis reveals that ADSL activates the oncogenic cMYC pathway by regulating cMYC protein level via a mechanism requiring ADSL proline 24 hydroxylation. Hydroxylation-proficient ADSL, by affecting adenosine levels, represses the expression of the long non-coding RNA MIR22HG, thus upregulating cMYC protein level. Our findings highlight the role of ADSL hydroxylation in controlling cMYC and TNBC tumorigenesis.",
            "authors": {
              "abbreviation": "Giada Zurlo, Xijuan Liu, Mamoru Takada, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Travis",
                  "LastName": "Ptacek",
                  "abbrevName": "Ptacek TS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Travis S Ptacek",
                  "orcid": null
                },
                {
                  "ForeName": "Javier",
                  "LastName": "Rodriguez",
                  "abbrevName": "Rodriguez J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Javier Rodriguez",
                  "orcid": null
                },
                {
                  "ForeName": "Alex",
                  "LastName": "von Kriegsheim",
                  "abbrevName": "von Kriegsheim A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alex von Kriegsheim",
                  "orcid": null
                },
                {
                  "ForeName": "Juan",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Juan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Jason",
                  "LastName": "Locasale",
                  "abbrevName": "Locasale JW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jason W Locasale",
                  "orcid": "0000-0002-7766-3502"
                },
                {
                  "ForeName": "Adam",
                  "LastName": "Robinson",
                  "abbrevName": "Robinson A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Adam Robinson",
                  "orcid": null
                },
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Jessica",
                  "LastName": "Holler",
                  "abbrevName": "Holler JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jessica M Holler",
                  "orcid": null
                },
                {
                  "ForeName": "Baek",
                  "LastName": "Kim",
                  "abbrevName": "Kim B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Baek Kim",
                  "orcid": "0000-0001-7986-4335"
                },
                {
                  "ForeName": "Marie",
                  "LastName": "Zikánová",
                  "abbrevName": "Zikánová M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marie Zikánová",
                  "orcid": null
                },
                {
                  "ForeName": "Jörgen",
                  "LastName": "Bierau",
                  "abbrevName": "Bierau J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jörgen Bierau",
                  "orcid": null
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": null
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "Qing.Zhang@utsouthwestern.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "Qing.Zhang@utsouthwestern.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1038/s41467-019-13168-4",
            "pmid": "31729379",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nat Commun 10 2019",
            "title": "Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer."
          }
        },
        {
          "pmid": "31294857",
          "pubmed": {
            "ISODate": "2019-11-05T00:00:00.000Z",
            "abstract": "Seven free base porphyrins employed in dye-sensitized photoelectrosynthetic cells are investigated with the aim of benchmarking the ability of different density functional theory (DFT) and time-dependent DFT approaches in reproducing their structure, vertical, and E0-0 excitation energies and the energy levels alignment (red-ox properties) at the interface with the TiO2 . We find that both vertical and E0-0 excitation energies are accurately reproduced by range-separated functionals, among which the ωB97X-D delivers the lowest absolute deviations from experiments. When the dye/TiO2 interface is modeled, the physical interfacial energetics is only obtained when the B3LYP functional is employed; on the other hand, M06-2X (54% of exchange) and the two long-range corrected approaches tested (CAM-B3LYP and ωB97X-D) excessively destabilize the semiconductor conduction band levels with respect to the dye's lowest unoccupied molecular orbitals (LUMOs), predicting no pathway for electron injection. © 2019 Wiley Periodicals, Inc.",
            "authors": {
              "abbreviation": "Syrine Daoudi, Abderrahmane Semmeq, Michael Badawi, ..., Mariachiara Pastore",
              "authorList": [
                {
                  "ForeName": "Syrine",
                  "LastName": "Daoudi",
                  "abbrevName": "Daoudi S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Syrine Daoudi",
                  "orcid": null
                },
                {
                  "ForeName": "Abderrahmane",
                  "LastName": "Semmeq",
                  "abbrevName": "Semmeq A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Abderrahmane Semmeq",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Badawi",
                  "abbrevName": "Badawi M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Badawi",
                  "orcid": null
                },
                {
                  "ForeName": "Xavier",
                  "LastName": "Assfeld",
                  "abbrevName": "Assfeld X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xavier Assfeld",
                  "orcid": "0000-0003-4227-6825"
                },
                {
                  "ForeName": "Youssef",
                  "LastName": "Arfaoui",
                  "abbrevName": "Arfaoui Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Youssef Arfaoui",
                  "orcid": null
                },
                {
                  "ForeName": "Mariachiara",
                  "LastName": "Pastore",
                  "abbrevName": "Pastore M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mariachiara Pastore",
                  "orcid": "0000-0003-4793-1964"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/jcc.26027",
            "pmid": "31294857",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Comput Chem 40 2019",
            "title": "Electronic structure and optical properties of isolated and TiO2 -grafted free base porphyrins for water oxidation: A challenging test case for DFT and TD-DFT."
          }
        },
        {
          "pmid": "30664679",
          "pubmed": {
            "ISODate": "2019-02-01T00:00:00.000Z",
            "abstract": "Pathway enrichment analysis helps researchers gain mechanistic insight into gene lists generated from genome-scale (omics) experiments. This method identifies biological pathways that are enriched in a gene list more than would be expected by chance. We explain the procedures of pathway enrichment analysis and present a practical step-by-step guide to help interpret gene lists resulting from RNA-seq and genome-sequencing experiments. The protocol comprises three major steps: definition of a gene list from omics data, determination of statistically enriched pathways, and visualization and interpretation of the results. We describe how to use this protocol with published examples of differentially expressed genes and mutated cancer genes; however, the principles can be applied to diverse types of omics data. The protocol describes innovative visualization techniques, provides comprehensive background and troubleshooting guidelines, and uses freely available and frequently updated software, including g:Profiler, Gene Set Enrichment Analysis (GSEA), Cytoscape and EnrichmentMap. The complete protocol can be performed in ~4.5 h and is designed for use by biologists with no prior bioinformatics training.",
            "authors": {
              "abbreviation": "Jüri Reimand, Ruth Isserlin, Veronique Voisin, ..., Gary D Bader",
              "authorList": [
                {
                  "ForeName": "Jüri",
                  "LastName": "Reimand",
                  "abbrevName": "Reimand J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jüri Reimand",
                  "orcid": null
                },
                {
                  "ForeName": "Ruth",
                  "LastName": "Isserlin",
                  "abbrevName": "Isserlin R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ruth Isserlin",
                  "orcid": "0000-0002-6805-2080"
                },
                {
                  "ForeName": "Veronique",
                  "LastName": "Voisin",
                  "abbrevName": "Voisin V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Veronique Voisin",
                  "orcid": null
                },
                {
                  "ForeName": "Mike",
                  "LastName": "Kucera",
                  "abbrevName": "Kucera M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mike Kucera",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Tannus-Lopes",
                  "abbrevName": "Tannus-Lopes C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Tannus-Lopes",
                  "orcid": null
                },
                {
                  "ForeName": "Asha",
                  "LastName": "Rostamianfar",
                  "abbrevName": "Rostamianfar A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Asha Rostamianfar",
                  "orcid": null
                },
                {
                  "ForeName": "Lina",
                  "LastName": "Wadi",
                  "abbrevName": "Wadi L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lina Wadi",
                  "orcid": null
                },
                {
                  "ForeName": "Mona",
                  "LastName": "Meyer",
                  "abbrevName": "Meyer M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mona Meyer",
                  "orcid": null
                },
                {
                  "ForeName": "Jeff",
                  "LastName": "Wong",
                  "abbrevName": "Wong J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeff Wong",
                  "orcid": null
                },
                {
                  "ForeName": "Changjiang",
                  "LastName": "Xu",
                  "abbrevName": "Xu C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Changjiang Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Daniele",
                  "LastName": "Merico",
                  "abbrevName": "Merico D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniele Merico",
                  "orcid": "0000-0002-3728-4401"
                },
                {
                  "ForeName": "Gary",
                  "LastName": "Bader",
                  "abbrevName": "Bader GD",
                  "email": "gary.bader@utoronto.ca",
                  "isCollectiveName": false,
                  "name": "Gary D Bader",
                  "orcid": "0000-0003-0185-8861"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Gary",
                  "LastName": "Bader",
                  "email": [
                    "gary.bader@utoronto.ca"
                  ],
                  "name": "Gary D Bader"
                }
              ]
            },
            "doi": "10.1038/s41596-018-0103-9",
            "pmid": "30664679",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Nat Protoc 14 2019",
            "title": "Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap."
          }
        },
        {
          "pmid": "30656193",
          "pubmed": {
            "ISODate": "2019-01-01T00:00:00.000Z",
            "abstract": "COX20/FAM36A encodes a mitochondrial complex IV assembly factor important for COX2 activation. Only one homozygous COX20 missense mutation has been previously described in two separate consanguineous families. We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy. Exome sequencing in all four subjects identified the same novel COX20 variants. One variant affected the splice donor site of intron-one (c.41A>G), while the other variant (c.157+3G>C) affected the splice donor site of intron-two. cDNA and protein analysis indicated that no full-length cDNA or protein was generated. These subjects expand the phenotype associated with COX20 deficiency.",
            "authors": {
              "abbreviation": "Maria G Otero, Emmanuelle Tiongson, Frank Diaz, ..., Tyler Mark Pierson",
              "authorList": [
                {
                  "ForeName": "Maria",
                  "LastName": "Otero",
                  "abbrevName": "Otero MG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria G Otero",
                  "orcid": null
                },
                {
                  "ForeName": "Emmanuelle",
                  "LastName": "Tiongson",
                  "abbrevName": "Tiongson E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Emmanuelle Tiongson",
                  "orcid": null
                },
                {
                  "ForeName": "Frank",
                  "LastName": "Diaz",
                  "abbrevName": "Diaz F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Frank Diaz",
                  "orcid": null
                },
                {
                  "ForeName": "Katrina",
                  "LastName": "Haude",
                  "abbrevName": "Haude K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Katrina Haude",
                  "orcid": null
                },
                {
                  "ForeName": "Karin",
                  "LastName": "Panzer",
                  "abbrevName": "Panzer K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Karin Panzer",
                  "orcid": null
                },
                {
                  "ForeName": "Ashley",
                  "LastName": "Collier",
                  "abbrevName": "Collier A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ashley Collier",
                  "orcid": null
                },
                {
                  "ForeName": "Jaemin",
                  "LastName": "Kim",
                  "abbrevName": "Kim J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jaemin Kim",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Adams",
                  "abbrevName": "Adams D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David Adams",
                  "orcid": null
                },
                {
                  "ForeName": "Cynthia",
                  "LastName": "Tifft",
                  "abbrevName": "Tifft CJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cynthia J Tifft",
                  "orcid": null
                },
                {
                  "ForeName": "Hong",
                  "LastName": "Cui",
                  "abbrevName": "Cui H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hong Cui",
                  "orcid": null
                },
                {
                  "ForeName": "Francisca",
                  "LastName": "Millian Zamora",
                  "abbrevName": "Millian Zamora F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francisca Millian Zamora",
                  "orcid": null
                },
                {
                  "ForeName": "Margaret",
                  "LastName": "Au",
                  "abbrevName": "Au MG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Margaret G Au",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Graham",
                  "abbrevName": "Graham JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John M Graham",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Buckley",
                  "abbrevName": "Buckley DJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David J Buckley",
                  "orcid": null
                },
                {
                  "ForeName": "Richard",
                  "LastName": "Lewis",
                  "abbrevName": "Lewis R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Richard Lewis",
                  "orcid": null
                },
                {
                  "ForeName": "Camilo",
                  "LastName": "Toro",
                  "abbrevName": "Toro C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Camilo Toro",
                  "orcid": null
                },
                {
                  "ForeName": "Renkui",
                  "LastName": "Bai",
                  "abbrevName": "Bai R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Renkui Bai",
                  "orcid": null
                },
                {
                  "ForeName": "Lesley",
                  "LastName": "Turner",
                  "abbrevName": "Turner L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lesley Turner",
                  "orcid": null
                },
                {
                  "ForeName": "Katherine",
                  "LastName": "Mathews",
                  "abbrevName": "Mathews KD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Katherine D Mathews",
                  "orcid": null
                },
                {
                  "ForeName": "William",
                  "LastName": "Gahl",
                  "abbrevName": "Gahl W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Gahl",
                  "orcid": null
                },
                {
                  "ForeName": "Tyler",
                  "LastName": "Pierson",
                  "abbrevName": "Pierson TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tyler Mark Pierson",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/acn3.661",
            "pmid": "30656193",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D052060",
                "value": "Research Support, N.I.H., Intramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Ann Clin Transl Neurol 6 2019",
            "title": "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
          }
        },
        {
          "pmid": "30026228",
          "pubmed": {
            "ISODate": "2018-07-20T00:00:00.000Z",
            "abstract": "Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor κB activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.",
            "authors": {
              "abbreviation": "Jing Zhang, Tao Wu, Jeremy Simon, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": "0000-0001-5380-3905"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": "0000-0002-3961-9009"
                },
                {
                  "ForeName": "Ryoichi",
                  "LastName": "Saito",
                  "abbrevName": "Saito R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ryoichi Saito",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Xian-De",
                  "LastName": "Liu",
                  "abbrevName": "Liu XD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian-De Liu",
                  "orcid": "0000-0002-9639-0458"
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Jonasch",
                  "abbrevName": "Jonasch E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric Jonasch",
                  "orcid": "0000-0003-0943-2806"
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaosai",
                  "LastName": "Yao",
                  "abbrevName": "Yao X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaosai Yao",
                  "orcid": "0000-0001-9729-0726"
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Teh",
                  "abbrevName": "Teh BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Tean Teh",
                  "orcid": "0000-0003-1514-1124"
                },
                {
                  "ForeName": "Patrick",
                  "LastName": "Tan",
                  "abbrevName": "Tan P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Patrick Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": "0000-0003-3034-4421"
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": "0000-0001-5337-4901"
                },
                {
                  "ForeName": "Cortney",
                  "LastName": "Lawrence",
                  "abbrevName": "Lawrence C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cortney Lawrence",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Fan",
                  "abbrevName": "Fan J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Fan",
                  "orcid": "0000-0003-3842-2391"
                },
                {
                  "ForeName": "Jiang",
                  "LastName": "Geng",
                  "abbrevName": "Geng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiang Geng",
                  "orcid": "0000-0002-7202-2167"
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Joel",
                  "LastName": "Parker",
                  "abbrevName": "Parker JS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joel S Parker",
                  "orcid": "0000-0003-2080-6901"
                },
                {
                  "ForeName": "J",
                  "LastName": "Auman",
                  "abbrevName": "Auman JT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Todd Auman",
                  "orcid": "0000-0002-9328-8829"
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "W",
                  "LastName": "Rathmell",
                  "abbrevName": "Rathmell WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kimryn Rathmell",
                  "orcid": "0000-0002-4984-0225"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": "0000-0001-6540-6130"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": "0000-0002-0574-4856"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": "0000-0003-1246-1333"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "qing_zhang@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "qing_zhang@med.unc.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1126/science.aap8411",
            "pmid": "30026228",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 361 2018",
            "title": "VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma."
          }
        },
        {
          "pmid": "29788355",
          "pubmed": {
            "ISODate": "2018-07-02T00:00:00.000Z",
            "abstract": "Homology modelling has matured into an important technique in structural biology, significantly contributing to narrowing the gap between known protein sequences and experimentally determined structures. Fully automated workflows and servers simplify and streamline the homology modelling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modelling results, their visualization and interpretation. Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modelling 25 years ago and been continuously further developed. Recently, its functionality has been extended to the modelling of homo- and heteromeric complexes. Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homology modelling. Other major improvements include the implementation of a new modelling engine, ProMod3 and the introduction a new local model quality estimation method, QMEANDisCo. SWISS-MODEL is freely available at https://swissmodel.expasy.org.",
            "authors": {
              "abbreviation": "Andrew Waterhouse, Martino Bertoni, Stefan Bienert, ..., Torsten Schwede",
              "authorList": [
                {
                  "ForeName": "Andrew",
                  "LastName": "Waterhouse",
                  "abbrevName": "Waterhouse A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew Waterhouse",
                  "orcid": null
                },
                {
                  "ForeName": "Martino",
                  "LastName": "Bertoni",
                  "abbrevName": "Bertoni M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Martino Bertoni",
                  "orcid": null
                },
                {
                  "ForeName": "Stefan",
                  "LastName": "Bienert",
                  "abbrevName": "Bienert S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stefan Bienert",
                  "orcid": null
                },
                {
                  "ForeName": "Gabriel",
                  "LastName": "Studer",
                  "abbrevName": "Studer G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gabriel Studer",
                  "orcid": null
                },
                {
                  "ForeName": "Gerardo",
                  "LastName": "Tauriello",
                  "abbrevName": "Tauriello G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gerardo Tauriello",
                  "orcid": null
                },
                {
                  "ForeName": "Rafal",
                  "LastName": "Gumienny",
                  "abbrevName": "Gumienny R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rafal Gumienny",
                  "orcid": null
                },
                {
                  "ForeName": "Florian",
                  "LastName": "Heer",
                  "abbrevName": "Heer FT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Florian T Heer",
                  "orcid": null
                },
                {
                  "ForeName": "Tjaart",
                  "LastName": "de Beer",
                  "abbrevName": "de Beer TAP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tjaart A P de Beer",
                  "orcid": null
                },
                {
                  "ForeName": "Christine",
                  "LastName": "Rempfer",
                  "abbrevName": "Rempfer C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christine Rempfer",
                  "orcid": null
                },
                {
                  "ForeName": "Lorenza",
                  "LastName": "Bordoli",
                  "abbrevName": "Bordoli L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lorenza Bordoli",
                  "orcid": null
                },
                {
                  "ForeName": "Rosalba",
                  "LastName": "Lepore",
                  "abbrevName": "Lepore R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosalba Lepore",
                  "orcid": null
                },
                {
                  "ForeName": "Torsten",
                  "LastName": "Schwede",
                  "abbrevName": "Schwede T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Torsten Schwede",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1093/nar/gky427",
            "pmid": "29788355",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nucleic Acids Res 46 2018",
            "title": "SWISS-MODEL: homology modelling of protein structures and complexes."
          }
        },
        {
          "pmid": "29629903",
          "pubmed": {
            "ISODate": "2018-05-01T00:00:00.000Z",
            "abstract": "Altered epigenetic reprogramming contributes to breast cancer progression and metastasis. How the epigenetic reader mediates breast cancer progression remains poorly understood. Here, we showed that the epigenetic reader zinc finger MYND-type containing 8 (ZMYND8) is induced by HIF-1 and HIF-2 in breast cancer cells and also upregulated in human breast tumors, and is correlated with poor survival of patients with breast cancer. Genetic deletion of ZMYND8 decreases breast cancer cell colony formation, migration, and invasion in vitro, and inhibits breast tumor growth and metastasis to the lungs in mice. The ZMYND8's oncogenic effect in breast cancer requires HIF-1 and HIF-2. We further showed that ZMYND8 interacts with HIF-1α and HIF-2α and enhances elongation of the global HIF-induced oncogenic genes by increasing recruitment of BRD4 and subsequent release of paused RNA polymerase II in breast cancer cells. ZMYND8 acetylation at lysines 1007 and 1034 by p300 is required for HIF activation and breast cancer progression and metastasis. These findings uncover a primary epigenetic mechanism of HIF activation and HIF-mediated breast cancer progression, and discover a possible molecular target for the diagnosis and treatment of breast cancer.",
            "authors": {
              "abbreviation": "Yan Chen, Bo Zhang, Lei Bao, ..., Weibo Luo",
              "authorList": [
                {
                  "ForeName": "Yan",
                  "LastName": "Chen",
                  "abbrevName": "Chen Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Lei",
                  "LastName": "Bao",
                  "abbrevName": "Bao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lei Bao",
                  "orcid": null
                },
                {
                  "ForeName": "Lai",
                  "LastName": "Jin",
                  "abbrevName": "Jin L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lai Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Mingming",
                  "LastName": "Yang",
                  "abbrevName": "Yang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingming Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Peng",
                  "abbrevName": "Peng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Peng",
                  "orcid": null
                },
                {
                  "ForeName": "Ashwani",
                  "LastName": "Kumar",
                  "abbrevName": "Kumar A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ashwani Kumar",
                  "orcid": null
                },
                {
                  "ForeName": "Jennifer",
                  "LastName": "Wang",
                  "abbrevName": "Wang JE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jennifer E Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chenliang",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chenliang Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Xuan",
                  "LastName": "Zou",
                  "abbrevName": "Zou X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuan Zou",
                  "orcid": null
                },
                {
                  "ForeName": "Chao",
                  "LastName": "Xing",
                  "abbrevName": "Xing C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chao Xing",
                  "orcid": null
                },
                {
                  "ForeName": "Yingfei",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yingfei Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Weibo",
                  "LastName": "Luo",
                  "abbrevName": "Luo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weibo Luo",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1172/JCI95089",
            "pmid": "29629903",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Clin Invest 128 2018",
            "title": "ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis."
          }
        },
        {
          "pmid": "28263959",
          "pubmed": {
            "ISODate": "2017-04-01T00:00:00.000Z",
            "abstract": "We introduce Salmon, a lightweight method for quantifying transcript abundance from RNA-seq reads. Salmon combines a new dual-phase parallel inference algorithm and feature-rich bias models with an ultra-fast read mapping procedure. It is the first transcriptome-wide quantifier to correct for fragment GC-content bias, which, as we demonstrate here, substantially improves the accuracy of abundance estimates and the sensitivity of subsequent differential expression analysis.",
            "authors": {
              "abbreviation": "Rob Patro, Geet Duggal, Michael I Love, ..., Carl Kingsford",
              "authorList": [
                {
                  "ForeName": "Rob",
                  "LastName": "Patro",
                  "abbrevName": "Patro R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rob Patro",
                  "orcid": null
                },
                {
                  "ForeName": "Geet",
                  "LastName": "Duggal",
                  "abbrevName": "Duggal G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Geet Duggal",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Love",
                  "abbrevName": "Love MI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael I Love",
                  "orcid": null
                },
                {
                  "ForeName": "Rafael",
                  "LastName": "Irizarry",
                  "abbrevName": "Irizarry RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rafael A Irizarry",
                  "orcid": null
                },
                {
                  "ForeName": "Carl",
                  "LastName": "Kingsford",
                  "abbrevName": "Kingsford C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carl Kingsford",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nmeth.4197",
            "pmid": "28263959",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Nat Methods 14 2017",
            "title": "Salmon provides fast and bias-aware quantification of transcript expression."
          }
        },
        {
          "pmid": "28027327",
          "pubmed": {
            "ISODate": "2016-12-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Major advances have been achieved in the characterization of early breast cancer (eBC) genomic profiles. Metastatic breast cancer (mBC) is associated with poor outcomes, yet limited information is available on the genomic profile of this disease. This study aims to decipher mutational profiles of mBC using next-generation sequencing. METHODS AND FINDINGS: Whole-exome sequencing was performed on 216 tumor-blood pairs from mBC patients who underwent a biopsy in the context of the SAFIR01, SAFIR02, SHIVA, or Molecular Screening for Cancer Treatment Optimization (MOSCATO) prospective trials. Mutational profiles from 772 primary breast tumors from The Cancer Genome Atlas (TCGA) were used as a reference for comparing primary and mBC mutational profiles. Twelve genes (TP53, PIK3CA, GATA3, ESR1, MAP3K1, CDH1, AKT1, MAP2K4, RB1, PTEN, CBFB, and CDKN2A) were identified as significantly mutated in mBC (false discovery rate [FDR] < 0.1). Eight genes (ESR1, FSIP2, FRAS1, OSBPL3, EDC4, PALB2, IGFN1, and AGRN) were more frequently mutated in mBC as compared to eBC (FDR < 0.01). ESR1 was identified both as a driver and as a metastatic gene (n = 22, odds ratio = 29, 95% CI [9-155], p = 1.2e-12) and also presented with focal amplification (n = 9) for a total of 31 mBCs with either ESR1 mutation or amplification, including 27 hormone receptor positive (HR+) and HER2 negative (HER2-) mBCs (19%). HR+/HER2- mBC presented a high prevalence of mutations on genes located on the mechanistic target of rapamycin (mTOR) pathway (TSC1 and TSC2) as compared to HR+/HER2- eBC (respectively 6% and 0.7%, p = 0.0004). Other actionable genes were more frequently mutated in HR+ mBC, including ERBB4 (n = 8), NOTCH3 (n = 7), and ALK (n = 7). Analysis of mutational signatures revealed a significant increase in APOBEC-mediated mutagenesis in HR+/HER2- metastatic tumors as compared to primary TCGA samples (p < 2e-16). The main limitations of this study include the absence of bone metastases and the size of the cohort, which might not have allowed the identification of rare mutations and their effect on survival. CONCLUSIONS: This work reports the results of the analysis of the first large-scale study on mutation profiles of mBC. This study revealed genomic alterations and mutational signatures involved in the resistance to therapies, including actionable mutations.",
            "authors": {
              "abbreviation": "Celine Lefebvre, Thomas Bachelot, Thomas Filleron, ..., Fabrice André",
              "authorList": [
                {
                  "ForeName": "Celine",
                  "LastName": "Lefebvre",
                  "abbrevName": "Lefebvre C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Celine Lefebvre",
                  "orcid": null
                },
                {
                  "ForeName": "Thomas",
                  "LastName": "Bachelot",
                  "abbrevName": "Bachelot T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Thomas Bachelot",
                  "orcid": null
                },
                {
                  "ForeName": "Thomas",
                  "LastName": "Filleron",
                  "abbrevName": "Filleron T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Thomas Filleron",
                  "orcid": "0000-0003-0724-0659"
                },
                {
                  "ForeName": "Marion",
                  "LastName": "Pedrero",
                  "abbrevName": "Pedrero M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marion Pedrero",
                  "orcid": null
                },
                {
                  "ForeName": "Mario",
                  "LastName": "Campone",
                  "abbrevName": "Campone M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mario Campone",
                  "orcid": null
                },
                {
                  "ForeName": "Jean-Charles",
                  "LastName": "Soria",
                  "abbrevName": "Soria JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jean-Charles Soria",
                  "orcid": null
                },
                {
                  "ForeName": "Christophe",
                  "LastName": "Massard",
                  "abbrevName": "Massard C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christophe Massard",
                  "orcid": null
                },
                {
                  "ForeName": "Christelle",
                  "LastName": "Lévy",
                  "abbrevName": "Lévy C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christelle Lévy",
                  "orcid": null
                },
                {
                  "ForeName": "Monica",
                  "LastName": "Arnedos",
                  "abbrevName": "Arnedos M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Monica Arnedos",
                  "orcid": null
                },
                {
                  "ForeName": "Magali",
                  "LastName": "Lacroix-Triki",
                  "abbrevName": "Lacroix-Triki M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Magali Lacroix-Triki",
                  "orcid": null
                },
                {
                  "ForeName": "Julie",
                  "LastName": "Garrabey",
                  "abbrevName": "Garrabey J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Julie Garrabey",
                  "orcid": null
                },
                {
                  "ForeName": "Yannick",
                  "LastName": "Boursin",
                  "abbrevName": "Boursin Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yannick Boursin",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Deloger",
                  "abbrevName": "Deloger M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc Deloger",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Fu",
                  "abbrevName": "Fu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Fu",
                  "orcid": "0000-0002-1497-1794"
                },
                {
                  "ForeName": "Frédéric",
                  "LastName": "Commo",
                  "abbrevName": "Commo F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Frédéric Commo",
                  "orcid": null
                },
                {
                  "ForeName": "Véronique",
                  "LastName": "Scott",
                  "abbrevName": "Scott V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Véronique Scott",
                  "orcid": null
                },
                {
                  "ForeName": "Ludovic",
                  "LastName": "Lacroix",
                  "abbrevName": "Lacroix L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ludovic Lacroix",
                  "orcid": "0000-0003-2535-1010"
                },
                {
                  "ForeName": "Maria",
                  "LastName": "Dieci",
                  "abbrevName": "Dieci MV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria Vittoria Dieci",
                  "orcid": "0000-0002-3967-9861"
                },
                {
                  "ForeName": "Maud",
                  "LastName": "Kamal",
                  "abbrevName": "Kamal M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maud Kamal",
                  "orcid": null
                },
                {
                  "ForeName": "Véronique",
                  "LastName": "Diéras",
                  "abbrevName": "Diéras V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Véronique Diéras",
                  "orcid": null
                },
                {
                  "ForeName": "Anthony",
                  "LastName": "Gonçalves",
                  "abbrevName": "Gonçalves A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anthony Gonçalves",
                  "orcid": null
                },
                {
                  "ForeName": "Jean-Marc",
                  "LastName": "Ferrerro",
                  "abbrevName": "Ferrerro JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jean-Marc Ferrerro",
                  "orcid": "0000-0003-0069-3743"
                },
                {
                  "ForeName": "Gilles",
                  "LastName": "Romieu",
                  "abbrevName": "Romieu G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gilles Romieu",
                  "orcid": null
                },
                {
                  "ForeName": "Laurence",
                  "LastName": "Vanlemmens",
                  "abbrevName": "Vanlemmens L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laurence Vanlemmens",
                  "orcid": null
                },
                {
                  "ForeName": "Marie-Ange",
                  "LastName": "Mouret Reynier",
                  "abbrevName": "Mouret Reynier MA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marie-Ange Mouret Reynier",
                  "orcid": null
                },
                {
                  "ForeName": "Jean-Christophe",
                  "LastName": "Théry",
                  "abbrevName": "Théry JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jean-Christophe Théry",
                  "orcid": null
                },
                {
                  "ForeName": "Fanny",
                  "LastName": "Le Du",
                  "abbrevName": "Le Du F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fanny Le Du",
                  "orcid": null
                },
                {
                  "ForeName": "Séverine",
                  "LastName": "Guiu",
                  "abbrevName": "Guiu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Séverine Guiu",
                  "orcid": null
                },
                {
                  "ForeName": "Florence",
                  "LastName": "Dalenc",
                  "abbrevName": "Dalenc F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Florence Dalenc",
                  "orcid": null
                },
                {
                  "ForeName": "Gilles",
                  "LastName": "Clapisson",
                  "abbrevName": "Clapisson G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gilles Clapisson",
                  "orcid": "0000-0002-5725-519X"
                },
                {
                  "ForeName": "Hervé",
                  "LastName": "Bonnefoi",
                  "abbrevName": "Bonnefoi H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hervé Bonnefoi",
                  "orcid": null
                },
                {
                  "ForeName": "Marta",
                  "LastName": "Jimenez",
                  "abbrevName": "Jimenez M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marta Jimenez",
                  "orcid": null
                },
                {
                  "ForeName": "Christophe",
                  "LastName": "Le Tourneau",
                  "abbrevName": "Le Tourneau C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christophe Le Tourneau",
                  "orcid": null
                },
                {
                  "ForeName": "Fabrice",
                  "LastName": "André",
                  "abbrevName": "André F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fabrice André",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1371/journal.pmed.1002201",
            "pmid": "28027327",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "PLoS Med 13 2016",
            "title": "Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis."
          }
        },
        {
          "pmid": "27368101",
          "pubmed": {
            "ISODate": "2016-06-30T00:00:00.000Z",
            "abstract": "The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-negative breast cancer (TNBC). The HIFα subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degradation. We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1α in such cells under normoxic conditions. Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion. EglN1, the main HIFα prolyl-hydroxylase, undergoes oxidative self-inactivation in the absence of cysteine both in biochemical assays and in cells, resulting in HIF1α accumulation. Therefore, EglN1 senses both oxygen and cysteine.",
            "authors": {
              "abbreviation": "Kimberly J Briggs, Peppi Koivunen, Shugeng Cao, ..., William G Kaelin",
              "authorList": [
                {
                  "ForeName": "Kimberly",
                  "LastName": "Briggs",
                  "abbrevName": "Briggs KJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kimberly J Briggs",
                  "orcid": null
                },
                {
                  "ForeName": "Peppi",
                  "LastName": "Koivunen",
                  "abbrevName": "Koivunen P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peppi Koivunen",
                  "orcid": null
                },
                {
                  "ForeName": "Shugeng",
                  "LastName": "Cao",
                  "abbrevName": "Cao S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shugeng Cao",
                  "orcid": null
                },
                {
                  "ForeName": "Keriann",
                  "LastName": "Backus",
                  "abbrevName": "Backus KM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Keriann M Backus",
                  "orcid": null
                },
                {
                  "ForeName": "Benjamin",
                  "LastName": "Olenchock",
                  "abbrevName": "Olenchock BA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Benjamin A Olenchock",
                  "orcid": null
                },
                {
                  "ForeName": "Hetalben",
                  "LastName": "Patel",
                  "abbrevName": "Patel H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hetalben Patel",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Sabina",
                  "LastName": "Signoretti",
                  "abbrevName": "Signoretti S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sabina Signoretti",
                  "orcid": null
                },
                {
                  "ForeName": "Gary",
                  "LastName": "Gerfen",
                  "abbrevName": "Gerfen GJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gary J Gerfen",
                  "orcid": null
                },
                {
                  "ForeName": "Andrea",
                  "LastName": "Richardson",
                  "abbrevName": "Richardson AL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrea L Richardson",
                  "orcid": null
                },
                {
                  "ForeName": "Agnieszka",
                  "LastName": "Witkiewicz",
                  "abbrevName": "Witkiewicz AK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Agnieszka K Witkiewicz",
                  "orcid": null
                },
                {
                  "ForeName": "Benjamin",
                  "LastName": "Cravatt",
                  "abbrevName": "Cravatt BF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Benjamin F Cravatt",
                  "orcid": null
                },
                {
                  "ForeName": "Jon",
                  "LastName": "Clardy",
                  "abbrevName": "Clardy J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jon Clardy",
                  "orcid": null
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": "william_kaelin@dfci.harvard.edu",
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "email": [
                    "william_kaelin@dfci.harvard.edu"
                  ],
                  "name": "William G Kaelin"
                }
              ]
            },
            "doi": "10.1016/j.cell.2016.05.042",
            "pmid": "27368101",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Cell 166 2016",
            "title": "Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine."
          }
        },
        {
          "pmid": "27161491",
          "pubmed": {
            "ISODate": "2016-05-10T00:00:00.000Z",
            "abstract": "The genomic landscape of breast cancer is complex, and inter- and intra-tumour heterogeneity are important challenges in treating the disease. In this study, we sequence 173 genes in 2,433 primary breast tumours that have copy number aberration (CNA), gene expression and long-term clinical follow-up data. We identify 40 mutation-driver (Mut-driver) genes, and determine associations between mutations, driver CNA profiles, clinical-pathological parameters and survival. We assess the clonal states of Mut-driver mutations, and estimate levels of intra-tumour heterogeneity using mutant-allele fractions. Associations between PIK3CA mutations and reduced survival are identified in three subgroups of ER-positive cancer (defined by amplification of 17q23, 11q13-14 or 8q24). High levels of intra-tumour heterogeneity are in general associated with a worse outcome, but highly aggressive tumours with 11q13-14 amplification have low levels of intra-tumour heterogeneity. These results emphasize the importance of genome-based stratification of breast cancer, and have important implications for designing therapeutic strategies.",
            "authors": {
              "abbreviation": "Bernard Pereira, Suet-Feung Chin, Oscar M Rueda, ..., Carlos Caldas",
              "authorList": [
                {
                  "ForeName": "Bernard",
                  "LastName": "Pereira",
                  "abbrevName": "Pereira B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bernard Pereira",
                  "orcid": null
                },
                {
                  "ForeName": "Suet-Feung",
                  "LastName": "Chin",
                  "abbrevName": "Chin SF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Suet-Feung Chin",
                  "orcid": null
                },
                {
                  "ForeName": "Oscar",
                  "LastName": "Rueda",
                  "abbrevName": "Rueda OM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Oscar M Rueda",
                  "orcid": null
                },
                {
                  "ForeName": "Hans-Kristian",
                  "LastName": "Vollan",
                  "abbrevName": "Vollan HK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hans-Kristian Moen Vollan",
                  "orcid": null
                },
                {
                  "ForeName": "Elena",
                  "LastName": "Provenzano",
                  "abbrevName": "Provenzano E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elena Provenzano",
                  "orcid": null
                },
                {
                  "ForeName": "Helen",
                  "LastName": "Bardwell",
                  "abbrevName": "Bardwell HA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Helen A Bardwell",
                  "orcid": null
                },
                {
                  "ForeName": "Michelle",
                  "LastName": "Pugh",
                  "abbrevName": "Pugh M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michelle Pugh",
                  "orcid": null
                },
                {
                  "ForeName": "Linda",
                  "LastName": "Jones",
                  "abbrevName": "Jones L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linda Jones",
                  "orcid": null
                },
                {
                  "ForeName": "Roslin",
                  "LastName": "Russell",
                  "abbrevName": "Russell R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roslin Russell",
                  "orcid": null
                },
                {
                  "ForeName": "Stephen-John",
                  "LastName": "Sammut",
                  "abbrevName": "Sammut SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stephen-John Sammut",
                  "orcid": null
                },
                {
                  "ForeName": "Dana",
                  "LastName": "Tsui",
                  "abbrevName": "Tsui DW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dana W Y Tsui",
                  "orcid": null
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Liu",
                  "abbrevName": "Liu B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Sarah-Jane",
                  "LastName": "Dawson",
                  "abbrevName": "Dawson SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sarah-Jane Dawson",
                  "orcid": null
                },
                {
                  "ForeName": "Jean",
                  "LastName": "Abraham",
                  "abbrevName": "Abraham J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jean Abraham",
                  "orcid": null
                },
                {
                  "ForeName": "Helen",
                  "LastName": "Northen",
                  "abbrevName": "Northen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Helen Northen",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Peden",
                  "abbrevName": "Peden JF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John F Peden",
                  "orcid": null
                },
                {
                  "ForeName": "Abhik",
                  "LastName": "Mukherjee",
                  "abbrevName": "Mukherjee A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Abhik Mukherjee",
                  "orcid": null
                },
                {
                  "ForeName": "Gulisa",
                  "LastName": "Turashvili",
                  "abbrevName": "Turashvili G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gulisa Turashvili",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Green",
                  "abbrevName": "Green AR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew R Green",
                  "orcid": null
                },
                {
                  "ForeName": "Steve",
                  "LastName": "McKinney",
                  "abbrevName": "McKinney S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steve McKinney",
                  "orcid": "0000-0002-1611-0867"
                },
                {
                  "ForeName": "Arusha",
                  "LastName": "Oloumi",
                  "abbrevName": "Oloumi A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Arusha Oloumi",
                  "orcid": null
                },
                {
                  "ForeName": "Sohrab",
                  "LastName": "Shah",
                  "abbrevName": "Shah S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sohrab Shah",
                  "orcid": "0000-0001-6402-523X"
                },
                {
                  "ForeName": "Nitzan",
                  "LastName": "Rosenfeld",
                  "abbrevName": "Rosenfeld N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nitzan Rosenfeld",
                  "orcid": null
                },
                {
                  "ForeName": "Leigh",
                  "LastName": "Murphy",
                  "abbrevName": "Murphy L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leigh Murphy",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Bentley",
                  "abbrevName": "Bentley DR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David R Bentley",
                  "orcid": null
                },
                {
                  "ForeName": "Ian",
                  "LastName": "Ellis",
                  "abbrevName": "Ellis IO",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ian O Ellis",
                  "orcid": null
                },
                {
                  "ForeName": "Arnie",
                  "LastName": "Purushotham",
                  "abbrevName": "Purushotham A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Arnie Purushotham",
                  "orcid": null
                },
                {
                  "ForeName": "Sarah",
                  "LastName": "Pinder",
                  "abbrevName": "Pinder SE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sarah E Pinder",
                  "orcid": null
                },
                {
                  "ForeName": "Anne-Lise",
                  "LastName": "Børresen-Dale",
                  "abbrevName": "Børresen-Dale AL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anne-Lise Børresen-Dale",
                  "orcid": null
                },
                {
                  "ForeName": "Helena",
                  "LastName": "Earl",
                  "abbrevName": "Earl HM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Helena M Earl",
                  "orcid": null
                },
                {
                  "ForeName": "Paul",
                  "LastName": "Pharoah",
                  "abbrevName": "Pharoah PD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Paul D Pharoah",
                  "orcid": null
                },
                {
                  "ForeName": "Mark",
                  "LastName": "Ross",
                  "abbrevName": "Ross MT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mark T Ross",
                  "orcid": null
                },
                {
                  "ForeName": "Samuel",
                  "LastName": "Aparicio",
                  "abbrevName": "Aparicio S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Samuel Aparicio",
                  "orcid": null
                },
                {
                  "ForeName": "Carlos",
                  "LastName": "Caldas",
                  "abbrevName": "Caldas C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carlos Caldas",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncomms11479",
            "pmid": "27161491",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nat Commun 7 2016",
            "title": "The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes."
          }
        },
        {
          "pmid": "27079975",
          "pubmed": {
            "ISODate": "2016-07-08T00:00:00.000Z",
            "abstract": "We present an update to our Galaxy-based web server for processing and visualizing deeply sequenced data. Its core tool set, deepTools, allows users to perform complete bioinformatic workflows ranging from quality controls and normalizations of aligned reads to integrative analyses, including clustering and visualization approaches. Since we first described our deepTools Galaxy server in 2014, we have implemented new solutions for many requests from the community and our users. Here, we introduce significant enhancements and new tools to further improve data visualization and interpretation. deepTools continue to be open to all users and freely available as a web service at deeptools.ie-freiburg.mpg.de The new deepTools2 suite can be easily deployed within any Galaxy framework via the toolshed repository, and we also provide source code for command line usage under Linux and Mac OS X. A public and documented API for access to deepTools functionality is also available.",
            "authors": {
              "abbreviation": "Fidel Ramírez, Devon P Ryan, Björn Grüning, ..., Thomas Manke",
              "authorList": [
                {
                  "ForeName": "Fidel",
                  "LastName": "Ramírez",
                  "abbrevName": "Ramírez F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fidel Ramírez",
                  "orcid": null
                },
                {
                  "ForeName": "Devon",
                  "LastName": "Ryan",
                  "abbrevName": "Ryan DP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Devon P Ryan",
                  "orcid": null
                },
                {
                  "ForeName": "Björn",
                  "LastName": "Grüning",
                  "abbrevName": "Grüning B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Björn Grüning",
                  "orcid": "0000-0002-3079-6586"
                },
                {
                  "ForeName": "Vivek",
                  "LastName": "Bhardwaj",
                  "abbrevName": "Bhardwaj V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vivek Bhardwaj",
                  "orcid": null
                },
                {
                  "ForeName": "Fabian",
                  "LastName": "Kilpert",
                  "abbrevName": "Kilpert F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fabian Kilpert",
                  "orcid": null
                },
                {
                  "ForeName": "Andreas",
                  "LastName": "Richter",
                  "abbrevName": "Richter AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andreas S Richter",
                  "orcid": "0000-0002-4166-0991"
                },
                {
                  "ForeName": "Steffen",
                  "LastName": "Heyne",
                  "abbrevName": "Heyne S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steffen Heyne",
                  "orcid": null
                },
                {
                  "ForeName": "Friederike",
                  "LastName": "Dündar",
                  "abbrevName": "Dündar F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Friederike Dündar",
                  "orcid": null
                },
                {
                  "ForeName": "Thomas",
                  "LastName": "Manke",
                  "abbrevName": "Manke T",
                  "email": "manke@ie-freiburg.mpg.de",
                  "isCollectiveName": false,
                  "name": "Thomas Manke",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Thomas",
                  "LastName": "Manke",
                  "email": [
                    "manke@ie-freiburg.mpg.de"
                  ],
                  "name": "Thomas Manke"
                }
              ]
            },
            "doi": "10.1093/nar/gkw257",
            "pmid": "27079975",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nucleic Acids Res 44 2016",
            "title": "deepTools2: a next generation web server for deep-sequencing data analysis."
          }
        },
        {
          "pmid": "26605738",
          "pubmed": {
            "ISODate": "2012-09-11T00:00:00.000Z",
            "abstract": "MM-PBSA is a post-processing end-state method to calculate free energies of molecules in solution. MMPBSA.py is a program written in Python for streamlining end-state free energy calculations using ensembles derived from molecular dynamics (MD) or Monte Carlo (MC) simulations. Several implicit solvation models are available with MMPBSA.py, including the Poisson-Boltzmann Model, the Generalized Born Model, and the Reference Interaction Site Model. Vibrational frequencies may be calculated using normal mode or quasi-harmonic analysis to approximate the solute entropy. Specific interactions can also be dissected using free energy decomposition or alanine scanning. A parallel implementation significantly speeds up the calculation by dividing frames evenly across available processors. MMPBSA.py is an efficient, user-friendly program with the flexibility to accommodate the needs of users performing end-state free energy calculations. The source code can be downloaded at http://ambermd.org/ with AmberTools, released under the GNU General Public License.",
            "authors": {
              "abbreviation": "Bill R Miller, T Dwight McGee, Jason M Swails, ..., Adrian E Roitberg",
              "authorList": [
                {
                  "ForeName": "Bill",
                  "LastName": "Miller",
                  "abbrevName": "Miller BR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bill R Miller",
                  "orcid": null
                },
                {
                  "ForeName": "T",
                  "LastName": "McGee",
                  "abbrevName": "McGee TD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "T Dwight McGee",
                  "orcid": null
                },
                {
                  "ForeName": "Jason",
                  "LastName": "Swails",
                  "abbrevName": "Swails JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jason M Swails",
                  "orcid": null
                },
                {
                  "ForeName": "Nadine",
                  "LastName": "Homeyer",
                  "abbrevName": "Homeyer N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nadine Homeyer",
                  "orcid": null
                },
                {
                  "ForeName": "Holger",
                  "LastName": "Gohlke",
                  "abbrevName": "Gohlke H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Holger Gohlke",
                  "orcid": null
                },
                {
                  "ForeName": "Adrian",
                  "LastName": "Roitberg",
                  "abbrevName": "Roitberg AE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Adrian E Roitberg",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1021/ct300418h",
            "pmid": "26605738",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Chem Theory Comput 8 2012",
            "title": "MMPBSA.py: An Efficient Program for End-State Free Energy Calculations."
          }
        },
        {
          "pmid": "26574453",
          "pubmed": {
            "ISODate": "2015-08-11T00:00:00.000Z",
            "abstract": "Molecular mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required. The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified. Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94. The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters. Improvement in all amino acids was obtained as compared to ff99SB. Parameters were also generated for alternate protonation states of ionizable side chains. Average errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB. We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB. Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides. The best results were obtained from a physically motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region. Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reproduction of NMR χ1 scalar coupling measurements for proteins in solution. We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.",
            "authors": {
              "abbreviation": "James A Maier, Carmenza Martinez, Koushik Kasavajhala, ..., Carlos Simmerling",
              "authorList": [
                {
                  "ForeName": "James",
                  "LastName": "Maier",
                  "abbrevName": "Maier JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James A Maier",
                  "orcid": null
                },
                {
                  "ForeName": "Carmenza",
                  "LastName": "Martinez",
                  "abbrevName": "Martinez C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carmenza Martinez",
                  "orcid": null
                },
                {
                  "ForeName": "Koushik",
                  "LastName": "Kasavajhala",
                  "abbrevName": "Kasavajhala K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Koushik Kasavajhala",
                  "orcid": null
                },
                {
                  "ForeName": "Lauren",
                  "LastName": "Wickstrom",
                  "abbrevName": "Wickstrom L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lauren Wickstrom",
                  "orcid": null
                },
                {
                  "ForeName": "Kevin",
                  "LastName": "Hauser",
                  "abbrevName": "Hauser KE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kevin E Hauser",
                  "orcid": null
                },
                {
                  "ForeName": "Carlos",
                  "LastName": "Simmerling",
                  "abbrevName": "Simmerling C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carlos Simmerling",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1021/acs.jctc.5b00255",
            "pmid": "26574453",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Chem Theory Comput 11 2015",
            "title": "ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB."
          }
        },
        {
          "pmid": "26574392",
          "pubmed": {
            "ISODate": "2015-04-14T00:00:00.000Z",
            "abstract": "Previous studies have shown that the method of hydrogen mass repartitioning (HMR) is a potentially useful tool for accelerating molecular dynamics (MD) simulations. By repartitioning the mass of heavy atoms into the bonded hydrogen atoms, it is possible to slow the highest-frequency motions of the macromolecule under study, thus allowing the time step of the simulation to be increased by up to a factor of 2. In this communication, we investigate further how this mass repartitioning allows the simulation time step to be increased in a stable fashion without significantly increasing discretization error. To this end, we ran a set of simulations with different time steps and mass distributions on a three-residue peptide to get a comprehensive view of the effect of mass repartitioning and time step increase on a system whose accessible phase space is fully explored in a relatively short amount of time. We next studied a 129-residue protein, hen egg white lysozyme (HEWL), to verify that the observed behavior extends to a larger, more-realistic, system. Results for the protein include structural comparisons from MD trajectories, as well as comparisons of pKa calculations via constant-pH MD. We also calculated a potential of mean force (PMF) of a dihedral rotation for the MTS [(1-oxyl-2,2,5,5-tetramethyl-pyrroline-3-methyl)methanethiosulfonate] spin label via umbrella sampling with a set of regular MD trajectories, as well as a set of mass-repartitioned trajectories with a time step of 4 fs. Since no significant difference in kinetics or thermodynamics is observed by the use of fast HMR trajectories, further evidence is provided that long-time-step HMR MD simulations are a viable tool for accelerating MD simulations for molecules of biochemical interest.",
            "authors": {
              "abbreviation": "Chad W Hopkins, Scott Le Grand, Ross C Walker, Adrian E Roitberg",
              "authorList": [
                {
                  "ForeName": "Chad",
                  "LastName": "Hopkins",
                  "abbrevName": "Hopkins CW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chad W Hopkins",
                  "orcid": null
                },
                {
                  "ForeName": "Scott",
                  "LastName": "Le Grand",
                  "abbrevName": "Le Grand S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Scott Le Grand",
                  "orcid": null
                },
                {
                  "ForeName": "Ross",
                  "LastName": "Walker",
                  "abbrevName": "Walker RC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ross C Walker",
                  "orcid": null
                },
                {
                  "ForeName": "Adrian",
                  "LastName": "Roitberg",
                  "abbrevName": "Roitberg AE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Adrian E Roitberg",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1021/ct5010406",
            "pmid": "26574392",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "J Chem Theory Comput 11 2015",
            "title": "Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning."
          }
        },
        {
          "pmid": "26569599",
          "pubmed": {
            "ISODate": "2016-01-01T00:00:00.000Z",
            "abstract": "We present parmbsc1, a force field for DNA atomistic simulation, which has been parameterized from high-level quantum mechanical data and tested for nearly 100 systems (representing a total simulation time of ∼ 140 μs) covering most of DNA structural space. Parmbsc1 provides high-quality results in diverse systems. Parameters and trajectories are available at http://mmb.irbbarcelona.org/ParmBSC1/.",
            "authors": {
              "abbreviation": "Ivan Ivani, Pablo D Dans, Agnes Noy, ..., Modesto Orozco",
              "authorList": [
                {
                  "ForeName": "Ivan",
                  "LastName": "Ivani",
                  "abbrevName": "Ivani I",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ivan Ivani",
                  "orcid": null
                },
                {
                  "ForeName": "Pablo",
                  "LastName": "Dans",
                  "abbrevName": "Dans PD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pablo D Dans",
                  "orcid": "0000-0002-5927-372X"
                },
                {
                  "ForeName": "Agnes",
                  "LastName": "Noy",
                  "abbrevName": "Noy A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Agnes Noy",
                  "orcid": null
                },
                {
                  "ForeName": "Alberto",
                  "LastName": "Pérez",
                  "abbrevName": "Pérez A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alberto Pérez",
                  "orcid": null
                },
                {
                  "ForeName": "Ignacio",
                  "LastName": "Faustino",
                  "abbrevName": "Faustino I",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ignacio Faustino",
                  "orcid": null
                },
                {
                  "ForeName": "Adam",
                  "LastName": "Hospital",
                  "abbrevName": "Hospital A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Adam Hospital",
                  "orcid": null
                },
                {
                  "ForeName": "Jürgen",
                  "LastName": "Walther",
                  "abbrevName": "Walther J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jürgen Walther",
                  "orcid": null
                },
                {
                  "ForeName": "Pau",
                  "LastName": "Andrio",
                  "abbrevName": "Andrio P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pau Andrio",
                  "orcid": null
                },
                {
                  "ForeName": "Ramon",
                  "LastName": "Goñi",
                  "abbrevName": "Goñi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ramon Goñi",
                  "orcid": null
                },
                {
                  "ForeName": "Alexandra",
                  "LastName": "Balaceanu",
                  "abbrevName": "Balaceanu A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alexandra Balaceanu",
                  "orcid": null
                },
                {
                  "ForeName": "Guillem",
                  "LastName": "Portella",
                  "abbrevName": "Portella G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guillem Portella",
                  "orcid": null
                },
                {
                  "ForeName": "Federica",
                  "LastName": "Battistini",
                  "abbrevName": "Battistini F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Federica Battistini",
                  "orcid": null
                },
                {
                  "ForeName": "Josep",
                  "LastName": "Gelpí",
                  "abbrevName": "Gelpí JL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Josep Lluis Gelpí",
                  "orcid": "0000-0002-0566-7723"
                },
                {
                  "ForeName": "Carlos",
                  "LastName": "González",
                  "abbrevName": "González C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carlos González",
                  "orcid": "0000-0001-8796-1282"
                },
                {
                  "ForeName": "Michele",
                  "LastName": "Vendruscolo",
                  "abbrevName": "Vendruscolo M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michele Vendruscolo",
                  "orcid": null
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Laughton",
                  "abbrevName": "Laughton CA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles A Laughton",
                  "orcid": null
                },
                {
                  "ForeName": "Sarah",
                  "LastName": "Harris",
                  "abbrevName": "Harris SA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sarah A Harris",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Case",
                  "abbrevName": "Case DA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David A Case",
                  "orcid": null
                },
                {
                  "ForeName": "Modesto",
                  "LastName": "Orozco",
                  "abbrevName": "Orozco M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Modesto Orozco",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nmeth.3658",
            "pmid": "26569599",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nat Methods 13 2016",
            "title": "Parmbsc1: a refined force field for DNA simulations."
          }
        },
        {
          "pmid": "26451490",
          "pubmed": {
            "ISODate": "2015-10-08T00:00:00.000Z",
            "abstract": "Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88 mixed IDC/ILC. Besides E-cadherin loss, the best known ILC genetic hallmark, we identified mutations targeting PTEN, TBX3, and FOXA1 as ILC enriched features. PTEN loss associated with increased AKT phosphorylation, which was highest in ILC among all breast cancer subtypes. Spatially clustered FOXA1 mutations correlated with increased FOXA1 expression and activity. Conversely, GATA3 mutations and high expression characterized luminal A IDC, suggesting differential modulation of ER activity in ILC and IDC. Proliferation and immune-related signatures determined three ILC transcriptional subtypes associated with survival differences. Mixed IDC/ILC cases were molecularly classified as ILC-like and IDC-like revealing no true hybrid features. This multidimensional molecular atlas sheds new light on the genetic bases of ILC and provides potential clinical options.",
            "authors": {
              "abbreviation": "Giovanni Ciriello, Michael L Gatza, Andrew H Beck, ..., Charles M Perou",
              "authorList": [
                {
                  "ForeName": "Giovanni",
                  "LastName": "Ciriello",
                  "abbrevName": "Ciriello G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giovanni Ciriello",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Gatza",
                  "abbrevName": "Gatza ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael L Gatza",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Beck",
                  "abbrevName": "Beck AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Beck",
                  "orcid": null
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Wilkerson",
                  "abbrevName": "Wilkerson MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew D Wilkerson",
                  "orcid": null
                },
                {
                  "ForeName": "Suhn",
                  "LastName": "Rhie",
                  "abbrevName": "Rhie SK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Suhn K Rhie",
                  "orcid": null
                },
                {
                  "ForeName": "Alessandro",
                  "LastName": "Pastore",
                  "abbrevName": "Pastore A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alessandro Pastore",
                  "orcid": null
                },
                {
                  "ForeName": "Hailei",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hailei Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "McLellan",
                  "abbrevName": "McLellan M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael McLellan",
                  "orcid": null
                },
                {
                  "ForeName": "Christina",
                  "LastName": "Yau",
                  "abbrevName": "Yau C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christina Yau",
                  "orcid": null
                },
                {
                  "ForeName": "Cyriac",
                  "LastName": "Kandoth",
                  "abbrevName": "Kandoth C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cyriac Kandoth",
                  "orcid": null
                },
                {
                  "ForeName": "Reanne",
                  "LastName": "Bowlby",
                  "abbrevName": "Bowlby R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Reanne Bowlby",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Shen",
                  "abbrevName": "Shen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Shen",
                  "orcid": null
                },
                {
                  "ForeName": "Sikander",
                  "LastName": "Hayat",
                  "abbrevName": "Hayat S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sikander Hayat",
                  "orcid": null
                },
                {
                  "ForeName": "Robert",
                  "LastName": "Fieldhouse",
                  "abbrevName": "Fieldhouse R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Robert Fieldhouse",
                  "orcid": null
                },
                {
                  "ForeName": "Susan",
                  "LastName": "Lester",
                  "abbrevName": "Lester SC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Susan C Lester",
                  "orcid": null
                },
                {
                  "ForeName": "Gary",
                  "LastName": "Tse",
                  "abbrevName": "Tse GM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gary M K Tse",
                  "orcid": null
                },
                {
                  "ForeName": "Rachel",
                  "LastName": "Factor",
                  "abbrevName": "Factor RE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rachel E Factor",
                  "orcid": null
                },
                {
                  "ForeName": "Laura",
                  "LastName": "Collins",
                  "abbrevName": "Collins LC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laura C Collins",
                  "orcid": null
                },
                {
                  "ForeName": "Kimberly",
                  "LastName": "Allison",
                  "abbrevName": "Allison KH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kimberly H Allison",
                  "orcid": null
                },
                {
                  "ForeName": "Yunn-Yi",
                  "LastName": "Chen",
                  "abbrevName": "Chen YY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yunn-Yi Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Kristin",
                  "LastName": "Jensen",
                  "abbrevName": "Jensen K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kristin Jensen",
                  "orcid": null
                },
                {
                  "ForeName": "Nicole",
                  "LastName": "Johnson",
                  "abbrevName": "Johnson NB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nicole B Johnson",
                  "orcid": null
                },
                {
                  "ForeName": "Steffi",
                  "LastName": "Oesterreich",
                  "abbrevName": "Oesterreich S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steffi Oesterreich",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Mills",
                  "abbrevName": "Mills GB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon B Mills",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Cherniack",
                  "abbrevName": "Cherniack AD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew D Cherniack",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Robertson",
                  "abbrevName": "Robertson G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Robertson",
                  "orcid": null
                },
                {
                  "ForeName": "Christopher",
                  "LastName": "Benz",
                  "abbrevName": "Benz C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christopher Benz",
                  "orcid": null
                },
                {
                  "ForeName": "Chris",
                  "LastName": "Sander",
                  "abbrevName": "Sander C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chris Sander",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Laird",
                  "abbrevName": "Laird PW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter W Laird",
                  "orcid": null
                },
                {
                  "ForeName": "Katherine",
                  "LastName": "Hoadley",
                  "abbrevName": "Hoadley KA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Katherine A Hoadley",
                  "orcid": null
                },
                {
                  "ForeName": "Tari",
                  "LastName": "King",
                  "abbrevName": "King TA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tari A King",
                  "orcid": null
                },
                {
                  "ForeName": null,
                  "LastName": null,
                  "abbrevName": "TCGA Research Network",
                  "email": null,
                  "isCollectiveName": true,
                  "name": "TCGA Research Network",
                  "orcid": null
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": "cperou@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "email": [
                    "cperou@med.unc.edu"
                  ],
                  "name": "Charles M Perou"
                }
              ]
            },
            "doi": "10.1016/j.cell.2015.09.033",
            "pmid": "26451490",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell 163 2015",
            "title": "Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer."
          }
        },
        {
          "pmid": "25516281",
          "pubmed": {
            "ISODate": "2014-01-01T00:00:00.000Z",
            "abstract": "In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate numbers, discreteness, large dynamic range and the presence of outliers require a suitable statistical approach. We present DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression. The DESeq2 package is available at http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html webcite.",
            "authors": {
              "abbreviation": "Michael I Love, Wolfgang Huber, Simon Anders",
              "authorList": [
                {
                  "ForeName": "Michael",
                  "LastName": "Love",
                  "abbrevName": "Love MI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael I Love",
                  "orcid": null
                },
                {
                  "ForeName": "Wolfgang",
                  "LastName": "Huber",
                  "abbrevName": "Huber W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wolfgang Huber",
                  "orcid": null
                },
                {
                  "ForeName": "Simon",
                  "LastName": "Anders",
                  "abbrevName": "Anders S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Simon Anders",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1186/s13059-014-0550-8",
            "pmid": "25516281",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Genome Biol 15 2014",
            "title": "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2."
          }
        },
        {
          "pmid": "25473899",
          "pubmed": {
            "ISODate": "2015-01-20T00:00:00.000Z",
            "abstract": "We previously reported the tumor suppressor function of Zinc-fingers and homeoboxes 2 (ZHX2) in hepatocellular carcinoma (HCC). Other studies indicate the association of increased ZHX2 expression with improved response to high dose chemotherapy in multiple myeloma. Here, we aim to test whether increased ZHX2 levels in HCC cells repress multidrug resistance 1(MDR1) expression resulting in increased sensitivity to chemotherapeutic drugs. We showed evidence that increased ZHX2 levels correlated with reduced MDR1 expression and enhanced the cytotoxicity of CDDP and ADM in different HCC cell lines. Consistently, elevated ZHX2 significantly reduced ADM efflux in HepG2 cells and greatly increased the CDDP-mediated suppression of liver tumor growth in vivo. Furthermore, immunohistochemical staining demonstrated the inverse correlation of ZHX2 and MDR1 expression in HCC tissues. Luciferase report assay showed that ZHX2 repressed the MDR1 promoter activity, while knockdown of NF-YA or mutating the NF-Y binding site eliminated this ZHX2-mediated repression of MDR1 transcription. Co-IP and ChIP assay further suggested that ZHX2 interacted with NF-YA and reduced NF-Y binding to the MDR1 promoter. Taken together, we clarify that ZHX2 represses NF-Y-mediated activation of MDR1 transcription and, in doing so, enhances the effects of chemotherapeutics in HCC cells both in vitro and in vivo.",
            "authors": {
              "abbreviation": "Hongxin Ma, Xuetian Yue, Lifen Gao, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Wenjiang",
                  "LastName": "Yan",
                  "abbrevName": "Yan W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wenjiang Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Zhenyu",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhenyu Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Haixia",
                  "LastName": "Shan",
                  "abbrevName": "Shan H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haixia Shan",
                  "orcid": null
                },
                {
                  "ForeName": "Hualin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hualin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Brett",
                  "LastName": "Spear",
                  "abbrevName": "Spear BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Brett T Spear",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.2832",
            "pmid": "25473899",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Oncotarget 6 2015",
            "title": "ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA."
          }
        },
        {
          "pmid": "24990963",
          "pubmed": {
            "ISODate": "2014-07-01T00:00:00.000Z",
            "abstract": "The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can hydroxylate FOXO3a on two specific prolyl residues in vitro and in vivo. Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a. FOXO transcription factors can repress Cyclin D1 transcription. Failure to hydroxylate FOXO3a promotes its accumulation in cells, which in turn suppresses Cyclin D1 expression. These findings provide new insights into post-transcriptional control of FOXO3a and provide a new avenue for pharmacologically altering Cyclin D1 activity.",
            "authors": {
              "abbreviation": "Xingnan Zheng, Bo Zhai, Peppi Koivunen, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Zhai",
                  "abbrevName": "Zhai B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Zhai",
                  "orcid": null
                },
                {
                  "ForeName": "Peppi",
                  "LastName": "Koivunen",
                  "abbrevName": "Koivunen P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peppi Koivunen",
                  "orcid": null
                },
                {
                  "ForeName": "Sandra",
                  "LastName": "Shin",
                  "abbrevName": "Shin SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sandra J Shin",
                  "orcid": null
                },
                {
                  "ForeName": "Gang",
                  "LastName": "Lu",
                  "abbrevName": "Lu G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gang Lu",
                  "orcid": null
                },
                {
                  "ForeName": "Jiayun",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiayun Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Christoph",
                  "LastName": "Geisen",
                  "abbrevName": "Geisen C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christoph Geisen",
                  "orcid": null
                },
                {
                  "ForeName": "Abhishek",
                  "LastName": "Chakraborty",
                  "abbrevName": "Chakraborty AA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Abhishek A Chakraborty",
                  "orcid": null
                },
                {
                  "ForeName": "Javid",
                  "LastName": "Moslehi",
                  "abbrevName": "Moslehi JJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Javid J Moslehi",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Smalley",
                  "abbrevName": "Smalley DM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David M Smalley",
                  "orcid": null
                },
                {
                  "ForeName": "Xin",
                  "LastName": "Wei",
                  "abbrevName": "Wei X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xin Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Zhengming",
                  "LastName": "Chen",
                  "abbrevName": "Chen Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhengming Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Justine",
                  "LastName": "Beres",
                  "abbrevName": "Beres JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Justine M Beres",
                  "orcid": null
                },
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jen",
                  "LastName": "Tsao",
                  "abbrevName": "Tsao JL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jen Lan Tsao",
                  "orcid": null
                },
                {
                  "ForeName": "Mitchell",
                  "LastName": "Brenner",
                  "abbrevName": "Brenner MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mitchell C Brenner",
                  "orcid": null
                },
                {
                  "ForeName": "Yuqing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuqing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Ronald",
                  "LastName": "DePinho",
                  "abbrevName": "DePinho RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ronald A DePinho",
                  "orcid": null
                },
                {
                  "ForeName": "Jihye",
                  "LastName": "Paik",
                  "abbrevName": "Paik J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jihye Paik",
                  "orcid": null
                },
                {
                  "ForeName": "Steven",
                  "LastName": "Gygi",
                  "abbrevName": "Gygi SP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steven P Gygi",
                  "orcid": null
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1101/gad.242131.114",
            "pmid": "24990963",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Genes Dev 28 2014",
            "title": "Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase."
          }
        },
        {
          "pmid": "24885402",
          "pubmed": {
            "ISODate": "2014-05-02T00:00:00.000Z",
            "abstract": "BACKGROUND: The precise nature of how cell type specific chromatin structures at enhancer sites affect gene expression is largely unknown. Here we identified cell type specific enhancers coupled with gene expression in two different types of breast epithelial cells, HMEC (normal breast epithelial cells) and MDAMB231 (triple negative breast cancer cell line). RESULTS: Enhancers were defined by modified neighboring histones [using chromatin immunoprecipitation followed by sequencing (ChIP-seq)] and nucleosome depletion [using formaldehyde-assisted isolation of regulatory elements followed by sequencing (FAIRE-seq)]. Histone modifications at enhancers were related to the expression levels of nearby genes up to 750 kb away. These expression levels were correlated with enhancer status (poised or active), defined by surrounding histone marks. Furthermore, about fifty percent of poised and active enhancers contained nucleosome-depleted regions. We also identified response element motifs enriched at these enhancer sites that revealed key transcription factors (e.g. TP63) likely involved in regulating breast epithelial enhancer-mediated gene expression. By utilizing expression data, potential target genes of more than 600 active enhancers were identified. These genes were involved in proteolysis, epidermis development, cell adhesion, mitosis, cell cycle, and DNA replication. CONCLUSIONS: These findings facilitate the understanding of epigenetic regulation specifically, such as the relationships between regulatory elements and gene expression and generally, how breast epithelial cellular phenotypes are determined by cell type specific enhancers.",
            "authors": {
              "abbreviation": "Suhn Kyong Rhie, Dennis J Hazelett, Simon G Coetzee, ..., Gerhard A Coetzee",
              "authorList": [
                {
                  "ForeName": "Suhn",
                  "LastName": "Rhie",
                  "abbrevName": "Rhie SK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Suhn Kyong Rhie",
                  "orcid": null
                },
                {
                  "ForeName": "Dennis",
                  "LastName": "Hazelett",
                  "abbrevName": "Hazelett DJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dennis J Hazelett",
                  "orcid": null
                },
                {
                  "ForeName": "Simon",
                  "LastName": "Coetzee",
                  "abbrevName": "Coetzee SG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Simon G Coetzee",
                  "orcid": null
                },
                {
                  "ForeName": "Chunli",
                  "LastName": "Yan",
                  "abbrevName": "Yan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunli Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Houtan",
                  "LastName": "Noushmehr",
                  "abbrevName": "Noushmehr H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Houtan Noushmehr",
                  "orcid": null
                },
                {
                  "ForeName": "Gerhard",
                  "LastName": "Coetzee",
                  "abbrevName": "Coetzee GA",
                  "email": "coetzee@usc.edu",
                  "isCollectiveName": false,
                  "name": "Gerhard A Coetzee",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Gerhard",
                  "LastName": "Coetzee",
                  "email": [
                    "coetzee@usc.edu"
                  ],
                  "name": "Gerhard A Coetzee"
                }
              ]
            },
            "doi": "10.1186/1471-2164-15-331",
            "pmid": "24885402",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "BMC Genomics 15 2014",
            "title": "Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells."
          }
        },
        {
          "pmid": "24614317",
          "pubmed": {
            "ISODate": "2014-04-01T00:00:00.000Z",
            "abstract": "Cellular development, morphology and function are governed by precise patterns of gene expression. These are established by the coordinated action of genomic regulatory elements known as enhancers or cis-regulatory modules. More than 30 years after the initial discovery of enhancers, many of their properties have been elucidated; however, despite major efforts, we only have an incomplete picture of enhancers in animal genomes. In this Review, we discuss how properties of enhancer sequences and chromatin are used to predict enhancers in genome-wide studies. We also cover recently developed high-throughput methods that allow the direct testing and identification of enhancers on the basis of their activity. Finally, we discuss recent technological advances and current challenges in the field of regulatory genomics.",
            "authors": {
              "abbreviation": "Daria Shlyueva, Gerald Stampfel, Alexander Stark",
              "authorList": [
                {
                  "ForeName": "Daria",
                  "LastName": "Shlyueva",
                  "abbrevName": "Shlyueva D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daria Shlyueva",
                  "orcid": null
                },
                {
                  "ForeName": "Gerald",
                  "LastName": "Stampfel",
                  "abbrevName": "Stampfel G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gerald Stampfel",
                  "orcid": null
                },
                {
                  "ForeName": "Alexander",
                  "LastName": "Stark",
                  "abbrevName": "Stark A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alexander Stark",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nrg3682",
            "pmid": "24614317",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Nat Rev Genet 15 2014",
            "title": "Transcriptional enhancers: from properties to genome-wide predictions."
          }
        },
        {
          "pmid": "23792809",
          "pubmed": {
            "ISODate": "2013-01-01T00:00:00.000Z",
            "abstract": "The pharmacological inhibition of general transcriptional regulators has the potential to block growth through targeting multiple tumorigenic signalling pathways simultaneously. Here, using an innovative cell-based screen, we identify a structurally unique small molecule (named JIB-04) that specifically inhibits the activity of the Jumonji family of histone demethylases in vitro, in cancer cells, and in tumours in vivo. Unlike known inhibitors, JIB-04 is not a competitive inhibitor of α-ketoglutarate. In cancer, but not in patient-matched normal cells, JIB-04 alters a subset of transcriptional pathways and blocks viability. In mice, JIB-04 reduces tumour burden and prolongs survival. Importantly, we find that patients with breast tumours that overexpress Jumonji demethylases have significantly lower survival. Thus, JIB-04, a novel inhibitor of Jumonji demethylases in vitro and in vivo, constitutes a unique potential therapeutic and research tool against cancer, and validates the use of unbiased cellular screens to discover chemical modulators with disease relevance.",
            "authors": {
              "abbreviation": "Lei Wang, Jianjun Chang, Diana Varghese, ..., Elisabeth D Martinez",
              "authorList": [
                {
                  "ForeName": "Lei",
                  "LastName": "Wang",
                  "abbrevName": "Wang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lei Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jianjun",
                  "LastName": "Chang",
                  "abbrevName": "Chang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianjun Chang",
                  "orcid": null
                },
                {
                  "ForeName": "Diana",
                  "LastName": "Varghese",
                  "abbrevName": "Varghese D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Diana Varghese",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Dellinger",
                  "abbrevName": "Dellinger M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Dellinger",
                  "orcid": null
                },
                {
                  "ForeName": "Subodh",
                  "LastName": "Kumar",
                  "abbrevName": "Kumar S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Subodh Kumar",
                  "orcid": null
                },
                {
                  "ForeName": "Anne",
                  "LastName": "Best",
                  "abbrevName": "Best AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anne M Best",
                  "orcid": null
                },
                {
                  "ForeName": "Julio",
                  "LastName": "Ruiz",
                  "abbrevName": "Ruiz J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Julio Ruiz",
                  "orcid": null
                },
                {
                  "ForeName": "Richard",
                  "LastName": "Bruick",
                  "abbrevName": "Bruick R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Richard Bruick",
                  "orcid": null
                },
                {
                  "ForeName": "Samuel",
                  "LastName": "Peña-Llopis",
                  "abbrevName": "Peña-Llopis S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Samuel Peña-Llopis",
                  "orcid": null
                },
                {
                  "ForeName": "Junjie",
                  "LastName": "Xu",
                  "abbrevName": "Xu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Junjie Xu",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Babinski",
                  "abbrevName": "Babinski DJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David J Babinski",
                  "orcid": null
                },
                {
                  "ForeName": "Doug",
                  "LastName": "Frantz",
                  "abbrevName": "Frantz DE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Doug E Frantz",
                  "orcid": null
                },
                {
                  "ForeName": "Rolf",
                  "LastName": "Brekken",
                  "abbrevName": "Brekken RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rolf A Brekken",
                  "orcid": null
                },
                {
                  "ForeName": "Amy",
                  "LastName": "Quinn",
                  "abbrevName": "Quinn AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Amy M Quinn",
                  "orcid": null
                },
                {
                  "ForeName": "Anton",
                  "LastName": "Simeonov",
                  "abbrevName": "Simeonov A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anton Simeonov",
                  "orcid": null
                },
                {
                  "ForeName": "Johnny",
                  "LastName": "Easmon",
                  "abbrevName": "Easmon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Johnny Easmon",
                  "orcid": null
                },
                {
                  "ForeName": "Elisabeth",
                  "LastName": "Martinez",
                  "abbrevName": "Martinez ED",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elisabeth D Martinez",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncomms3035",
            "pmid": "23792809",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Nat Commun 4 2013",
            "title": "A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth."
          }
        },
        {
          "pmid": "23550210",
          "pubmed": {
            "ISODate": "2013-04-02T00:00:00.000Z",
            "abstract": "The cBioPortal for Cancer Genomics (http://cbioportal.org) provides a Web resource for exploring, visualizing, and analyzing multidimensional cancer genomics data. The portal reduces molecular profiling data from cancer tissues and cell lines into readily understandable genetic, epigenetic, gene expression, and proteomic events. The query interface combined with customized data storage enables researchers to interactively explore genetic alterations across samples, genes, and pathways and, when available in the underlying data, to link these to clinical outcomes. The portal provides graphical summaries of gene-level data from multiple platforms, network visualization and analysis, survival analysis, patient-centric queries, and software programmatic access. The intuitive Web interface of the portal makes complex cancer genomics profiles accessible to researchers and clinicians without requiring bioinformatics expertise, thus facilitating biological discoveries. Here, we provide a practical guide to the analysis and visualization features of the cBioPortal for Cancer Genomics.",
            "authors": {
              "abbreviation": "Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, ..., Nikolaus Schultz",
              "authorList": [
                {
                  "ForeName": "Jianjiong",
                  "LastName": "Gao",
                  "abbrevName": "Gao J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianjiong Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Bülent",
                  "LastName": "Aksoy",
                  "abbrevName": "Aksoy BA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bülent Arman Aksoy",
                  "orcid": null
                },
                {
                  "ForeName": "Ugur",
                  "LastName": "Dogrusoz",
                  "abbrevName": "Dogrusoz U",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ugur Dogrusoz",
                  "orcid": null
                },
                {
                  "ForeName": "Gideon",
                  "LastName": "Dresdner",
                  "abbrevName": "Dresdner G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gideon Dresdner",
                  "orcid": null
                },
                {
                  "ForeName": "Benjamin",
                  "LastName": "Gross",
                  "abbrevName": "Gross B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Benjamin Gross",
                  "orcid": null
                },
                {
                  "ForeName": "S",
                  "LastName": "Sumer",
                  "abbrevName": "Sumer SO",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S Onur Sumer",
                  "orcid": null
                },
                {
                  "ForeName": "Yichao",
                  "LastName": "Sun",
                  "abbrevName": "Sun Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yichao Sun",
                  "orcid": null
                },
                {
                  "ForeName": "Anders",
                  "LastName": "Jacobsen",
                  "abbrevName": "Jacobsen A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anders Jacobsen",
                  "orcid": null
                },
                {
                  "ForeName": "Rileen",
                  "LastName": "Sinha",
                  "abbrevName": "Sinha R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rileen Sinha",
                  "orcid": null
                },
                {
                  "ForeName": "Erik",
                  "LastName": "Larsson",
                  "abbrevName": "Larsson E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Erik Larsson",
                  "orcid": null
                },
                {
                  "ForeName": "Ethan",
                  "LastName": "Cerami",
                  "abbrevName": "Cerami E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ethan Cerami",
                  "orcid": null
                },
                {
                  "ForeName": "Chris",
                  "LastName": "Sander",
                  "abbrevName": "Sander C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chris Sander",
                  "orcid": null
                },
                {
                  "ForeName": "Nikolaus",
                  "LastName": "Schultz",
                  "abbrevName": "Schultz N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nikolaus Schultz",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1126/scisignal.2004088",
            "pmid": "23550210",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Sci Signal 6 2013",
            "title": "Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal."
          }
        },
        {
          "pmid": "23455378",
          "pubmed": {
            "ISODate": "2013-04-01T00:00:00.000Z",
            "abstract": "Chemotherapy and molecularly targeted approaches represent two very different modes of cancer treatment and each is associated with unique benefits and limitations. Both types of therapy share the overarching limitation of the emergence of drug resistance, which prevents these drugs from eliciting lasting clinical benefit. This review will provide an overview of the various mechanisms of resistance to each of these classes of drugs and examples of drug combinations that have been tested clinically. This analysis supports the contention that understanding modes of resistance to both chemotherapy and molecularly targeted therapies may be very useful in selecting those drugs of each class that will have complementing mechanisms of sensitivity and thereby represent reasonable combination therapies.",
            "authors": {
              "abbreviation": "Kenta Masui, Beatrice Gini, Jill Wykosky, ..., Webster K Cavenee",
              "authorList": [
                {
                  "ForeName": "Kenta",
                  "LastName": "Masui",
                  "abbrevName": "Masui K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kenta Masui",
                  "orcid": null
                },
                {
                  "ForeName": "Beatrice",
                  "LastName": "Gini",
                  "abbrevName": "Gini B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Beatrice Gini",
                  "orcid": null
                },
                {
                  "ForeName": "Jill",
                  "LastName": "Wykosky",
                  "abbrevName": "Wykosky J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jill Wykosky",
                  "orcid": null
                },
                {
                  "ForeName": "Ciro",
                  "LastName": "Zanca",
                  "abbrevName": "Zanca C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ciro Zanca",
                  "orcid": null
                },
                {
                  "ForeName": "Paul",
                  "LastName": "Mischel",
                  "abbrevName": "Mischel PS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Paul S Mischel",
                  "orcid": null
                },
                {
                  "ForeName": "Frank",
                  "LastName": "Furnari",
                  "abbrevName": "Furnari FB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Frank B Furnari",
                  "orcid": null
                },
                {
                  "ForeName": "Webster",
                  "LastName": "Cavenee",
                  "abbrevName": "Cavenee WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Webster K Cavenee",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1093/carcin/bgt086",
            "pmid": "23455378",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Carcinogenesis 34 2013",
            "title": "A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments."
          }
        },
        {
          "pmid": "23104886",
          "pubmed": {
            "ISODate": "2013-01-01T00:00:00.000Z",
            "abstract": "MOTIVATION: Accurate alignment of high-throughput RNA-seq data is a challenging and yet unsolved problem because of the non-contiguous transcript structure, relatively short read lengths and constantly increasing throughput of the sequencing technologies. Currently available RNA-seq aligners suffer from high mapping error rates, low mapping speed, read length limitation and mapping biases. RESULTS: To align our large (>80 billon reads) ENCODE Transcriptome RNA-seq dataset, we developed the Spliced Transcripts Alignment to a Reference (STAR) software based on a previously undescribed RNA-seq alignment algorithm that uses sequential maximum mappable seed search in uncompressed suffix arrays followed by seed clustering and stitching procedure. STAR outperforms other aligners by a factor of >50 in mapping speed, aligning to the human genome 550 million 2 × 76 bp paired-end reads per hour on a modest 12-core server, while at the same time improving alignment sensitivity and precision. In addition to unbiased de novo detection of canonical junctions, STAR can discover non-canonical splices and chimeric (fusion) transcripts, and is also capable of mapping full-length RNA sequences. Using Roche 454 sequencing of reverse transcription polymerase chain reaction amplicons, we experimentally validated 1960 novel intergenic splice junctions with an 80-90% success rate, corroborating the high precision of the STAR mapping strategy. AVAILABILITY AND IMPLEMENTATION: STAR is implemented as a standalone C++ code. STAR is free open source software distributed under GPLv3 license and can be downloaded from http://code.google.com/p/rna-star/.",
            "authors": {
              "abbreviation": "Alexander Dobin, Carrie A Davis, Felix Schlesinger, ..., Thomas R Gingeras",
              "authorList": [
                {
                  "ForeName": "Alexander",
                  "LastName": "Dobin",
                  "abbrevName": "Dobin A",
                  "email": "dobin@cshl.edu",
                  "isCollectiveName": false,
                  "name": "Alexander Dobin",
                  "orcid": null
                },
                {
                  "ForeName": "Carrie",
                  "LastName": "Davis",
                  "abbrevName": "Davis CA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carrie A Davis",
                  "orcid": null
                },
                {
                  "ForeName": "Felix",
                  "LastName": "Schlesinger",
                  "abbrevName": "Schlesinger F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Felix Schlesinger",
                  "orcid": null
                },
                {
                  "ForeName": "Jorg",
                  "LastName": "Drenkow",
                  "abbrevName": "Drenkow J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jorg Drenkow",
                  "orcid": null
                },
                {
                  "ForeName": "Chris",
                  "LastName": "Zaleski",
                  "abbrevName": "Zaleski C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chris Zaleski",
                  "orcid": null
                },
                {
                  "ForeName": "Sonali",
                  "LastName": "Jha",
                  "abbrevName": "Jha S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sonali Jha",
                  "orcid": null
                },
                {
                  "ForeName": "Philippe",
                  "LastName": "Batut",
                  "abbrevName": "Batut P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Philippe Batut",
                  "orcid": null
                },
                {
                  "ForeName": "Mark",
                  "LastName": "Chaisson",
                  "abbrevName": "Chaisson M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mark Chaisson",
                  "orcid": null
                },
                {
                  "ForeName": "Thomas",
                  "LastName": "Gingeras",
                  "abbrevName": "Gingeras TR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Thomas R Gingeras",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Alexander",
                  "LastName": "Dobin",
                  "email": [
                    "dobin@cshl.edu"
                  ],
                  "name": "Alexander Dobin"
                }
              ]
            },
            "doi": "10.1093/bioinformatics/bts635",
            "pmid": "23104886",
            "pubTypes": [
              {
                "UI": "D023362",
                "value": "Evaluation Study"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Bioinformatics 29 2013",
            "title": "STAR: ultrafast universal RNA-seq aligner."
          }
        },
        {
          "pmid": "23000897",
          "pubmed": {
            "ISODate": "2012-10-04T00:00:00.000Z",
            "abstract": "We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays. Our ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers; however, there were numerous subtype-associated and novel gene mutations including the enrichment of specific mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype. We identified two novel protein-expression-defined subgroups, possibly produced by stromal/microenvironmental elements, and integrated analyses identified specific signalling pathways dominant in each molecular subtype including a HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature within the HER2-enriched expression subtype. Comparison of basal-like breast tumours with high-grade serous ovarian tumours showed many molecular commonalities, indicating a related aetiology and similar therapeutic opportunities. The biological finding of the four main breast cancer subtypes caused by different subsets of genetic and epigenetic abnormalities raises the hypothesis that much of the clinically observable plasticity and heterogeneity occurs within, and not across, these major biological subtypes of breast cancer.",
            "authors": {
              "abbreviation": "Cancer Genome Atlas Network",
              "authorList": [
                {
                  "ForeName": null,
                  "LastName": null,
                  "abbrevName": "Cancer Genome Atlas Network",
                  "email": null,
                  "isCollectiveName": true,
                  "name": "Cancer Genome Atlas Network",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature11412",
            "pmid": "23000897",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Nature 490 2012",
            "title": "Comprehensive molecular portraits of human breast tumours."
          }
        },
        {
          "pmid": "22522925",
          "pubmed": {
            "ISODate": "2012-04-18T00:00:00.000Z",
            "abstract": "The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ~40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.",
            "authors": {
              "abbreviation": "Christina Curtis, Sohrab P Shah, Suet-Feung Chin, ..., Samuel Aparicio",
              "authorList": [
                {
                  "ForeName": "Christina",
                  "LastName": "Curtis",
                  "abbrevName": "Curtis C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christina Curtis",
                  "orcid": null
                },
                {
                  "ForeName": "Sohrab",
                  "LastName": "Shah",
                  "abbrevName": "Shah SP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sohrab P Shah",
                  "orcid": null
                },
                {
                  "ForeName": "Suet-Feung",
                  "LastName": "Chin",
                  "abbrevName": "Chin SF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Suet-Feung Chin",
                  "orcid": null
                },
                {
                  "ForeName": "Gulisa",
                  "LastName": "Turashvili",
                  "abbrevName": "Turashvili G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gulisa Turashvili",
                  "orcid": null
                },
                {
                  "ForeName": "Oscar",
                  "LastName": "Rueda",
                  "abbrevName": "Rueda OM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Oscar M Rueda",
                  "orcid": null
                },
                {
                  "ForeName": "Mark",
                  "LastName": "Dunning",
                  "abbrevName": "Dunning MJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mark J Dunning",
                  "orcid": null
                },
                {
                  "ForeName": "Doug",
                  "LastName": "Speed",
                  "abbrevName": "Speed D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Doug Speed",
                  "orcid": null
                },
                {
                  "ForeName": "Andy",
                  "LastName": "Lynch",
                  "abbrevName": "Lynch AG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andy G Lynch",
                  "orcid": null
                },
                {
                  "ForeName": "Shamith",
                  "LastName": "Samarajiwa",
                  "abbrevName": "Samarajiwa S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shamith Samarajiwa",
                  "orcid": null
                },
                {
                  "ForeName": "Yinyin",
                  "LastName": "Yuan",
                  "abbrevName": "Yuan Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yinyin Yuan",
                  "orcid": null
                },
                {
                  "ForeName": "Stefan",
                  "LastName": "Gräf",
                  "abbrevName": "Gräf S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stefan Gräf",
                  "orcid": null
                },
                {
                  "ForeName": "Gavin",
                  "LastName": "Ha",
                  "abbrevName": "Ha G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gavin Ha",
                  "orcid": null
                },
                {
                  "ForeName": "Gholamreza",
                  "LastName": "Haffari",
                  "abbrevName": "Haffari G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gholamreza Haffari",
                  "orcid": null
                },
                {
                  "ForeName": "Ali",
                  "LastName": "Bashashati",
                  "abbrevName": "Bashashati A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ali Bashashati",
                  "orcid": null
                },
                {
                  "ForeName": "Roslin",
                  "LastName": "Russell",
                  "abbrevName": "Russell R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roslin Russell",
                  "orcid": null
                },
                {
                  "ForeName": "Steven",
                  "LastName": "McKinney",
                  "abbrevName": "McKinney S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steven McKinney",
                  "orcid": null
                },
                {
                  "ForeName": null,
                  "LastName": null,
                  "abbrevName": "METABRIC Group",
                  "email": null,
                  "isCollectiveName": true,
                  "name": "METABRIC Group",
                  "orcid": null
                },
                {
                  "ForeName": "Anita",
                  "LastName": "Langerød",
                  "abbrevName": "Langerød A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anita Langerød",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Green",
                  "abbrevName": "Green A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew Green",
                  "orcid": null
                },
                {
                  "ForeName": "Elena",
                  "LastName": "Provenzano",
                  "abbrevName": "Provenzano E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elena Provenzano",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Wishart",
                  "abbrevName": "Wishart G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Wishart",
                  "orcid": null
                },
                {
                  "ForeName": "Sarah",
                  "LastName": "Pinder",
                  "abbrevName": "Pinder S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sarah Pinder",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Watson",
                  "abbrevName": "Watson P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter Watson",
                  "orcid": null
                },
                {
                  "ForeName": "Florian",
                  "LastName": "Markowetz",
                  "abbrevName": "Markowetz F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Florian Markowetz",
                  "orcid": null
                },
                {
                  "ForeName": "Leigh",
                  "LastName": "Murphy",
                  "abbrevName": "Murphy L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leigh Murphy",
                  "orcid": null
                },
                {
                  "ForeName": "Ian",
                  "LastName": "Ellis",
                  "abbrevName": "Ellis I",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ian Ellis",
                  "orcid": null
                },
                {
                  "ForeName": "Arnie",
                  "LastName": "Purushotham",
                  "abbrevName": "Purushotham A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Arnie Purushotham",
                  "orcid": null
                },
                {
                  "ForeName": "Anne-Lise",
                  "LastName": "Børresen-Dale",
                  "abbrevName": "Børresen-Dale AL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anne-Lise Børresen-Dale",
                  "orcid": null
                },
                {
                  "ForeName": "James",
                  "LastName": "Brenton",
                  "abbrevName": "Brenton JD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James D Brenton",
                  "orcid": null
                },
                {
                  "ForeName": "Simon",
                  "LastName": "Tavaré",
                  "abbrevName": "Tavaré S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Simon Tavaré",
                  "orcid": null
                },
                {
                  "ForeName": "Carlos",
                  "LastName": "Caldas",
                  "abbrevName": "Caldas C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carlos Caldas",
                  "orcid": null
                },
                {
                  "ForeName": "Samuel",
                  "LastName": "Aparicio",
                  "abbrevName": "Aparicio S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Samuel Aparicio",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature10983",
            "pmid": "22522925",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 486 2012",
            "title": "The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups."
          }
        },
        {
          "pmid": "22406477",
          "pubmed": {
            "ISODate": "2012-06-01T00:00:00.000Z",
            "abstract": "BACKGROUND & AIMS: Zinc-fingers and homeoboxes 2 (ZHX2) represses transcription of several genes associated with liver cancer. However, little is known about the role of ZHX2 in the development of hepatocellular carcinoma (HCC). We investigated the mechanisms by which ZHX2 might affect proliferation of HCC cells. METHODS: We overexpressed and knocked down ZHX2 in HCC cells and analyzed the effects on proliferation, colony formation, and the cell cycle. We also analyzed the effects of ZHX2 overexpression in growth of HepG2.2.15 tumor xenografts in nude mice. Chromatin immunoprecipitation and luciferase reporter assays were used to measure binding of ZHX2 target promoters. Levels of ZHX2 in HCC samples were evaluated by immunohistochemistry. RESULTS: ZHX2 overexpression significantly reduced proliferation of HCC cells and growth of tumor xenografts in mice; it led to G1 arrest and reduced levels of Cyclins A and E in HCC cell lines. ZHX2 bound to promoter regions of CCNA2 (which encodes Cyclin A) and CCNE1 (which encodes Cyclin E) and inhibited their transcription. Knockdown of Cyclin A or Cyclin E reduced the increased proliferation mediated by ZHX2 knockdown. Nuclear localization of ZHX2 was required for it to inhibit proliferation of HCC cells in culture and in mice. Nuclear localization of ZHX2 was reduced in human HCC samples, even in small tumors (diameter, <5 cm), compared with adjacent nontumor tissues. Moreover, reduced nuclear levels of ZHX2 correlated with reduced survival times of patients, high levels of tumor microvascularization, and hepatocyte proliferation. CONCLUSIONS: ZHX2 inhibits HCC cell proliferation by preventing expression of Cyclins A and E, and reduces growth of xenograft tumors in mice. Loss of nuclear ZHX2 might be an early step in the development of HCC.",
            "authors": {
              "abbreviation": "Xuetian Yue, Zhenyu Zhang, Xiaohong Liang, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Zhenyu",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhenyu Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaoning",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaoning Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Di",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Di Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiao",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiao Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Min",
                  "LastName": "Guo",
                  "abbrevName": "Guo M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Brett",
                  "LastName": "Spear",
                  "abbrevName": "Spear BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Brett T Spear",
                  "orcid": null
                },
                {
                  "ForeName": "Yaoqin",
                  "LastName": "Gong",
                  "abbrevName": "Gong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yaoqin Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1053/j.gastro.2012.02.049",
            "pmid": "22406477",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Gastroenterology 142 2012",
            "title": "Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E."
          }
        },
        {
          "pmid": "22304911",
          "pubmed": {
            "ISODate": "2012-02-03T00:00:00.000Z",
            "abstract": "Oxygen homeostasis represents an organizing principle for understanding metazoan evolution, development, physiology, and pathobiology. The hypoxia-inducible factors (HIFs) are transcriptional activators that function as master regulators of oxygen homeostasis in all metazoan species. Rapid progress is being made in elucidating homeostatic roles of HIFs in many physiological systems, determining pathological consequences of HIF dysregulation in chronic diseases, and investigating potential targeting of HIFs for therapeutic purposes.",
            "authors": {
              "abbreviation": "Gregg L Semenza",
              "authorList": [
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": "gsemenza@jhmi.edu",
                  "isCollectiveName": false,
                  "name": "Gregg L Semenza",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "email": [
                    "gsemenza@jhmi.edu"
                  ],
                  "name": "Gregg L Semenza"
                }
              ]
            },
            "doi": "10.1016/j.cell.2012.01.021",
            "pmid": "22304911",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Cell 148 2012",
            "title": "Hypoxia-inducible factors in physiology and medicine."
          }
        },
        {
          "pmid": "22078940",
          "pubmed": {
            "ISODate": "2012-05-01T00:00:00.000Z",
            "abstract": "Recently, we identified a novel chromosomal rearrangement in Hodgkin lymphoma (HL), t(4;8)(q27;q24), which targets homeobox gene ZHX2 at the recurrent breakpoint 8q24. This aberration deletes the far upstream region of ZHX2 and results in silenced transcription pinpointing loss of activatory elements. Here, we have looked for potential binding sites within this deleted region to analyze the transcriptional deregulation of this tumor suppressor gene in B-cell malignancies. SiRNA-mediated knockdown and reporter gene analyses identified two transcription factors, homeodomain protein MSX1 and bZIP protein XBP1, directly regulating ZHX2 expression. Furthermore, MSX1-cofactor histone H1C mediated repression of ZHX2 and showed enhanced expression levels in cell line L-1236. As demonstrated by fluorescence in situ hybridization and genomic array analysis, the gene loci of MSX1 at 4p16 and H1C at 6p22 were rearranged in several HL cell lines, correlating with their altered expression activity. The expression of XBP1 was reduced in 6/7 HL cell lines as compared to primary hematopoietic cells. Taken together, our results demonstrate multiple mechanisms decreasing expression of tumor suppressor gene ZHX2 in HL cell lines: loss of enhancing binding sites, reduced expression of activators MSX1 and XBP1, and overexpression of MSX1-corepressor H1C. Moreover, chromosomal deregulations of genes involved in this regulative network highlight their role in development and malignancy of B-cells.",
            "authors": {
              "abbreviation": "Stefan Nagel, Björn Schneider, Corinna Meyer, ..., Roderick A F Macleod",
              "authorList": [
                {
                  "ForeName": "Stefan",
                  "LastName": "Nagel",
                  "abbrevName": "Nagel S",
                  "email": "sna@dsmz.de",
                  "isCollectiveName": false,
                  "name": "Stefan Nagel",
                  "orcid": null
                },
                {
                  "ForeName": "Björn",
                  "LastName": "Schneider",
                  "abbrevName": "Schneider B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Björn Schneider",
                  "orcid": null
                },
                {
                  "ForeName": "Corinna",
                  "LastName": "Meyer",
                  "abbrevName": "Meyer C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Corinna Meyer",
                  "orcid": null
                },
                {
                  "ForeName": "Maren",
                  "LastName": "Kaufmann",
                  "abbrevName": "Kaufmann M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maren Kaufmann",
                  "orcid": null
                },
                {
                  "ForeName": "Hans",
                  "LastName": "Drexler",
                  "abbrevName": "Drexler HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hans G Drexler",
                  "orcid": null
                },
                {
                  "ForeName": "Roderick",
                  "LastName": "Macleod",
                  "abbrevName": "Macleod RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roderick A F Macleod",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Stefan",
                  "LastName": "Nagel",
                  "email": [
                    "sna@dsmz.de"
                  ],
                  "name": "Stefan Nagel"
                }
              ]
            },
            "doi": "10.1016/j.leukres.2011.10.019",
            "pmid": "22078940",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Leuk Res 36 2012",
            "title": "Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma."
          }
        },
        {
          "pmid": "21987443",
          "pubmed": {
            "ISODate": "2011-12-01T00:00:00.000Z",
            "abstract": "Hodgkin/Reed-Sternberg (HRS) cells represent the malignant fraction of infiltrated lymph nodes in Hodgkin lymphoma (HL). Although HRS cells display multiple chromosomal aberrations, few are recurrent and the targeted genes unknown. However, understanding the pathology of HL and developing rational therapies may well require identifying putative deregulated genes. Here, we analyzed the karyotype of the well-defined HL cell line L-1236 by spectral karyotyping and identified multiple abnormalities, therein, notably t(4;8)(q27;q24) which includes two breakpoint regions previously highlighted in HL. Target genes at 4q27 and 8q24 were shortlisted by high density genomic arrays and fluorescence in situ hybridization. Expression analysis of candidate target genes revealed conspicuous activation of phosphodiesterase PDE5A at 4q27 and inhibition of homeobox gene ZHX2 at 8q24. Treatment of L-1236 with PDE5A-inhibitor sildenafil or with siRNA directed against PDE5A and concomitant stimulation with cyclic guanosine monophosphate (cGMP) resulted in enhanced apoptosis, indicating PDE5A as an oncogene. Expression profiling of L-1236 cells following siRNA-mediated knockdown of ZHX2 showed inhibition of genes regulating differentiation and apoptosis, suggesting tumor suppressor activity of ZHX2. Downstream genes included STAT1 and several STAT1-target genes, indicating activation of STAT1-signaling by ZHX2 as analyzed by RQ-PCR and western blot. Taken together, we have identified a novel aberration with recurrent breakpoints in HL, t(4;8)(q27;q24), which activate PDE5A and repress ZHX2, deregulating apoptosis, differentiation, and STAT1-signaling in HL cells.",
            "authors": {
              "abbreviation": "Stefan Nagel, Björn Schneider, Andreas Rosenwald, ..., Roderick A F MacLeod",
              "authorList": [
                {
                  "ForeName": "Stefan",
                  "LastName": "Nagel",
                  "abbrevName": "Nagel S",
                  "email": "sna@dsmz.de",
                  "isCollectiveName": false,
                  "name": "Stefan Nagel",
                  "orcid": null
                },
                {
                  "ForeName": "Björn",
                  "LastName": "Schneider",
                  "abbrevName": "Schneider B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Björn Schneider",
                  "orcid": null
                },
                {
                  "ForeName": "Andreas",
                  "LastName": "Rosenwald",
                  "abbrevName": "Rosenwald A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andreas Rosenwald",
                  "orcid": null
                },
                {
                  "ForeName": "Corinna",
                  "LastName": "Meyer",
                  "abbrevName": "Meyer C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Corinna Meyer",
                  "orcid": null
                },
                {
                  "ForeName": "Maren",
                  "LastName": "Kaufmann",
                  "abbrevName": "Kaufmann M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maren Kaufmann",
                  "orcid": null
                },
                {
                  "ForeName": "Hans",
                  "LastName": "Drexler",
                  "abbrevName": "Drexler HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hans G Drexler",
                  "orcid": null
                },
                {
                  "ForeName": "Roderick",
                  "LastName": "MacLeod",
                  "abbrevName": "MacLeod RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roderick A F MacLeod",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Stefan",
                  "LastName": "Nagel",
                  "email": [
                    "sna@dsmz.de"
                  ],
                  "name": "Stefan Nagel"
                }
              ]
            },
            "doi": "10.1002/gcc.20920",
            "pmid": "21987443",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Genes Chromosomes Cancer 50 2011",
            "title": "t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2."
          }
        },
        {
          "pmid": "20509910",
          "pubmed": {
            "ISODate": "2010-05-28T00:00:00.000Z",
            "abstract": "BACKGROUND: Zhx1 to 3 (zinc-fingers and homeoboxes) form a set of paralogous genes encoding multi-domain proteins. ZHX proteins consist of two zinc fingers followed by five homeodomains. ZHXs have biological roles in cell cycle control by acting as co-repressors of the transcriptional regulator Nuclear Factor Y. As part of a structural genomics project we have expressed single and multi-domain fragments of the different human ZHX genes for use in structure determination. RESULTS: A total of 30 single and multiple domain ZHX1-3 constructs selected from bioinformatics protocols were screened for soluble expression in E. coli using high throughput methodologies. Two homeodomains were crystallized leading to structures for ZHX1 HD4 and ZHX2 HD2. ZHX1 HD4, although closest matched to homeodomains from 'homez' and 'engrailed', showed structural differences, notably an additional C-terminal helix (helix V) which wrapped over helix I thereby making extensive contacts. Although ZHX2 HD2-3 was successfully expressed and purified, proteolysis occurred during crystallization yielding crystals of just HD2. The structure of ZHX2 HD2 showed an unusual open conformation with helix I undergoing 'domain-swapping' to form a homodimer. CONCLUSIONS: Although multiple-domain constructs of ZHX1 selected by bioinformatics studies could be expressed solubly, only single homeodomains yielded crystals. The crystal structure of ZHX1 HD4 showed additional hydrophobic interactions relative to many known homeodomains via extensive contacts formed by the novel C-terminal helix V with, in particular, helix I. Additionally, the replacement of some charged covariant residues (which are commonly observed to form salt bridges in non-homeotherms such as the Drosophila 'engrailed' homeodomain), by apolar residues further increases hydrophobic contacts within ZHX1 HD4, and potentially stability, relative to engrailed homeodomain. ZHX1 HD4 helix V points away from the normally observed DNA major groove binding site on homeodomains and thus would not obstruct the putative binding of nucleic acid. In contrast, for ZHX2 HD2 the observed altered conformation involving rearrangement of helix I, relative to the canonical homeodomain fold, disrupts the normal DNA binding site, although protein-protein binding is possible as observed in homodimer formation.",
            "authors": {
              "abbreviation": "Louise E Bird, Jingshan Ren, Joanne E Nettleship, ..., David K Stammers",
              "authorList": [
                {
                  "ForeName": "Louise",
                  "LastName": "Bird",
                  "abbrevName": "Bird LE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Louise E Bird",
                  "orcid": null
                },
                {
                  "ForeName": "Jingshan",
                  "LastName": "Ren",
                  "abbrevName": "Ren J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jingshan Ren",
                  "orcid": null
                },
                {
                  "ForeName": "Joanne",
                  "LastName": "Nettleship",
                  "abbrevName": "Nettleship JE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joanne E Nettleship",
                  "orcid": null
                },
                {
                  "ForeName": "Gert",
                  "LastName": "Folkers",
                  "abbrevName": "Folkers GE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gert E Folkers",
                  "orcid": null
                },
                {
                  "ForeName": "Raymond",
                  "LastName": "Owens",
                  "abbrevName": "Owens RJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raymond J Owens",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Stammers",
                  "abbrevName": "Stammers DK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David K Stammers",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1186/1472-6807-10-13",
            "pmid": "20509910",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "BMC Struct Biol 10 2010",
            "title": "Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains."
          }
        },
        {
          "pmid": "20110278",
          "pubmed": {
            "ISODate": "2010-03-15T00:00:00.000Z",
            "abstract": "MOTIVATION: Testing for correlations between different sets of genomic features is a fundamental task in genomics research. However, searching for overlaps between features with existing web-based methods is complicated by the massive datasets that are routinely produced with current sequencing technologies. Fast and flexible tools are therefore required to ask complex questions of these data in an efficient manner. RESULTS: This article introduces a new software suite for the comparison, manipulation and annotation of genomic features in Browser Extensible Data (BED) and General Feature Format (GFF) format. BEDTools also supports the comparison of sequence alignments in BAM format to both BED and GFF features. The tools are extremely efficient and allow the user to compare large datasets (e.g. next-generation sequencing data) with both public and custom genome annotation tracks. BEDTools can be combined with one another as well as with standard UNIX commands, thus facilitating routine genomics tasks as well as pipelines that can quickly answer intricate questions of large genomic datasets. AVAILABILITY AND IMPLEMENTATION: BEDTools was written in C++. Source code and a comprehensive user manual are freely available at http://code.google.com/p/bedtools CONTACT: aaronquinlan@gmail.com; imh4y@virginia.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",
            "authors": {
              "abbreviation": "Aaron R Quinlan, Ira M Hall",
              "authorList": [
                {
                  "ForeName": "Aaron",
                  "LastName": "Quinlan",
                  "abbrevName": "Quinlan AR",
                  "email": "aaronquinlan@gmail.com",
                  "isCollectiveName": false,
                  "name": "Aaron R Quinlan",
                  "orcid": null
                },
                {
                  "ForeName": "Ira",
                  "LastName": "Hall",
                  "abbrevName": "Hall IM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ira M Hall",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Aaron",
                  "LastName": "Quinlan",
                  "email": [
                    "aaronquinlan@gmail.com"
                  ],
                  "name": "Aaron R Quinlan"
                }
              ]
            },
            "doi": "10.1093/bioinformatics/btq033",
            "pmid": "20110278",
            "pubTypes": [
              {
                "UI": "D003160",
                "value": "Comparative Study"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Bioinformatics 26 2010",
            "title": "BEDTools: a flexible suite of utilities for comparing genomic features."
          }
        },
        {
          "pmid": "20020197",
          "pubmed": {
            "ISODate": "2010-10-01T00:00:00.000Z",
            "abstract": "Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots, which can be used to assess the relevance of the expression levels of various genes on the clinical outcome both in untreated and treated breast cancer patients. A background database was established using gene expression data and survival information of 1,809 patients downloaded from GEO (Affymetrix HGU133A and HGU133+2 microarrays). The median relapse free survival is 6.43 years, 968/1,231 patients are estrogen-receptor (ER) positive, and 190/1,369 are lymph-node positive. After quality control and normalization only probes present on both Affymetrix platforms were retained (n = 22,277). In order to analyze the prognostic value of a particular gene, the cohorts are divided into two groups according to the median (or upper/lower quartile) expression of the gene. The two groups can be compared in terms of relapse free survival, overall survival, and distant metastasis free survival. A survival curve is displayed, and the hazard ratio with 95% confidence intervals and logrank P value are calculated and displayed. Additionally, three subgroups of patients can be assessed: systematically untreated patients, endocrine-treated ER positive patients, and patients with a distribution of clinical characteristics representative of those seen in general clinical practice in the US. Web address: www.kmplot.com . We used this integrative data analysis tool to confirm the prognostic power of the proliferation-related genes TOP2A and TOP2B, MKI67, CCND2, CCND3, CCNDE2, as well as CDKN1A, and TK2. We also validated the capability of microarrays to determine estrogen receptor status in 1,231 patients. The tool is highly valuable for the preliminary assessment of biomarkers, especially for research groups with limited bioinformatic resources.",
            "authors": {
              "abbreviation": "Balazs Györffy, Andras Lanczky, Aron C Eklund, ..., Zoltan Szallasi",
              "authorList": [
                {
                  "ForeName": "Balazs",
                  "LastName": "Györffy",
                  "abbrevName": "Györffy B",
                  "email": "zsalab2@yahoo.com",
                  "isCollectiveName": false,
                  "name": "Balazs Györffy",
                  "orcid": null
                },
                {
                  "ForeName": "Andras",
                  "LastName": "Lanczky",
                  "abbrevName": "Lanczky A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andras Lanczky",
                  "orcid": null
                },
                {
                  "ForeName": "Aron",
                  "LastName": "Eklund",
                  "abbrevName": "Eklund AC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Aron C Eklund",
                  "orcid": null
                },
                {
                  "ForeName": "Carsten",
                  "LastName": "Denkert",
                  "abbrevName": "Denkert C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carsten Denkert",
                  "orcid": null
                },
                {
                  "ForeName": "Jan",
                  "LastName": "Budczies",
                  "abbrevName": "Budczies J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jan Budczies",
                  "orcid": null
                },
                {
                  "ForeName": "Qiyuan",
                  "LastName": "Li",
                  "abbrevName": "Li Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qiyuan Li",
                  "orcid": null
                },
                {
                  "ForeName": "Zoltan",
                  "LastName": "Szallasi",
                  "abbrevName": "Szallasi Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zoltan Szallasi",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Balazs",
                  "LastName": "Györffy",
                  "email": [
                    "zsalab2@yahoo.com"
                  ],
                  "name": "Balazs Györffy"
                }
              ]
            },
            "doi": "10.1007/s10549-009-0674-9",
            "pmid": "20020197",
            "pubTypes": [
              {
                "UI": "D003160",
                "value": "Comparative Study"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Breast Cancer Res Treat 123 2010",
            "title": "An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients."
          }
        },
        {
          "pmid": "19946328",
          "pubmed": {
            "ISODate": "2010-02-04T00:00:00.000Z",
            "abstract": "Adaptation of cancer cells to their microenvironment is an important driving force in the clonal selection that leads to invasive and metastatic disease. O2 concentrations are markedly reduced in many human cancers compared with normal tissue, and a major mechanism mediating adaptive responses to reduced O2 availability (hypoxia) is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1). This review summarizes the current state of knowledge regarding the molecular mechanisms by which HIF-1 contributes to cancer progression, focusing on (1) clinical data associating increased HIF-1 levels with patient mortality; (2) preclinical data linking HIF-1 activity with tumor growth; (3) molecular data linking specific HIF-1 target gene products to critical aspects of cancer biology and (4) pharmacological data showing anticancer effects of HIF-1 inhibitors in mouse models of human cancer.",
            "authors": {
              "abbreviation": "G L Semenza",
              "authorList": [
                {
                  "ForeName": "G",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": "gsemenza@jhmi.edu",
                  "isCollectiveName": false,
                  "name": "G L Semenza",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "G",
                  "LastName": "Semenza",
                  "email": [
                    "gsemenza@jhmi.edu"
                  ],
                  "name": "G L Semenza"
                }
              ]
            },
            "doi": "10.1038/onc.2009.441",
            "pmid": "19946328",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Oncogene 29 2010",
            "title": "Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics."
          }
        },
        {
          "pmid": "19840953",
          "pubmed": {
            "ISODate": "2010-05-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Patients with breast cancer brain metastasis are a heterogeneous group in relation to tumor biology and outcome. MATERIALS AND METHODS: The group of 222 breast cancer patients with brain metastasis was divided into three biological subgroups. The propensity of biological subtypes for metastases to the brain and survivals depending on biological subtype, recursive partitioning analysis of Radiation Therapy Oncology Group (RPA RTOG) prognostic class and the use of systemic treatment after whole-brain radiotherapy were assessed. RESULTS: The rate of patients with triple-negative, human epidermal growth factor receptor 2 (HER2)-positive and luminal breast cancer with brain metastases was 28%, 53% and 19%, respectively. Median survival from brain metastases in triple-negative, HER2-positive and luminal subtype was 3.7, 9 and 15 months, respectively. Median survival from brain metastases in RPA RTOG prognostic class I, II and III was 15, 11 and 3 months, respectively. In the luminal and in the triple-negative subtype, systemic therapy prolonged survival from 3 to 14 months and from 3 to 4 months, respectively. In HER2-positive subtype, median survival without further treatment, after chemotherapy and after chemotherapy with targeted therapy were 3, 8 and 11 months, respectively. CONCLUSIONS: HER2-positive and triple-negative breast cancers have special predilection for metastases to the brain. Survival from brain metastases depended on performance status and the use of systemic treatment.",
            "authors": {
              "abbreviation": "A Niwińska, M Murawska, K Pogoda",
              "authorList": [
                {
                  "ForeName": "A",
                  "LastName": "Niwińska",
                  "abbrevName": "Niwińska A",
                  "email": "alphaonetau@poczta.onet.pl",
                  "isCollectiveName": false,
                  "name": "A Niwińska",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Murawska",
                  "abbrevName": "Murawska M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Murawska",
                  "orcid": null
                },
                {
                  "ForeName": "K",
                  "LastName": "Pogoda",
                  "abbrevName": "Pogoda K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "K Pogoda",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "A",
                  "LastName": "Niwińska",
                  "email": [
                    "alphaonetau@poczta.onet.pl"
                  ],
                  "name": "A Niwińska"
                }
              ]
            },
            "doi": "10.1093/annonc/mdp407",
            "pmid": "19840953",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Ann Oncol 21 2010",
            "title": "Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)."
          }
        },
        {
          "pmid": "19757835",
          "pubmed": {
            "ISODate": "2009-10-08T00:00:00.000Z",
            "abstract": "The dynamic and energetic properties of the alkali and halide ions were calculated using molecular dynamics (MD) and free energy simulations with various different water and ion force fields including our recently developed water-model-specific ion parameters. The properties calculated were activity coefficients, diffusion coefficients, residence times of atomic pairs, association constants, and solubility. Through calculation of these properties, we can assess the validity and range of applicability of the simple pair potential models and better understand their limitations. Due to extreme computational demands, the activity coefficients were only calculated for a subset of the models. The results qualitatively agree with experiment. Calculated diffusion coefficients and residence times between cation-anion, water-cation, and water-anion showed differences depending on the choice of water and ion force field used. The calculated solubilities of the alkali-halide salts were generally lower than the true solubility of the salts. However, for both the TIP4P(EW) and SPC/E water-model-specific ion parameters, solubility was reasonably well-reproduced. Finally, the correlations among the various properties led to the following conclusions: (1) The reliability of the ion force fields is significantly affected by the specific choice of water model. (2) Ion-ion interactions are very important to accurately simulate the properties, especially solubility. (3) The SPC/E and TIP4P(EW) water-model-specific ion force fields are preferred for simulation in high salt environments compared to the other ion force fields.",
            "authors": {
              "abbreviation": "In Suk Joung, Thomas E Cheatham",
              "authorList": [
                {
                  "ForeName": "In",
                  "LastName": "Joung",
                  "abbrevName": "Joung IS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "In Suk Joung",
                  "orcid": null
                },
                {
                  "ForeName": "Thomas",
                  "LastName": "Cheatham",
                  "abbrevName": "Cheatham TE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Thomas E Cheatham",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1021/jp902584c",
            "pmid": "19757835",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "J Phys Chem B 113 2009",
            "title": "Molecular dynamics simulations of the dynamic and energetic properties of alkali and halide ions using water-model-specific ion parameters."
          }
        },
        {
          "pmid": "19643597",
          "pubmed": {
            "ISODate": "2009-11-01T00:00:00.000Z",
            "abstract": "PURPOSE: Evaluation of the influence of immunohistochemically defined breast cancer (BC) subtypes and other risk factors on the development of cerebral metastases (CM). METHODS: Exploratory analysis of a hospital-based prospective tumour registry including all patients with primary BC treated in our EUSOMA breast unit between 1998 and 2006. RESULTS: The study cohort contained 2441 patients, including 284 patients (11.6%) with triple-negative (oestrogen receptor (ER), progesterone receptor (PR) and HER2-negative) and 245 patients (10.1%) with HER2-overexpressing BC subtypes. Overall, 80 patients (3.3%) developed CM within a median follow-up period of 47 months, 19 (23.8%) of them with triple-negative and 19 (23.8%) with HER2-positive tumours. Therefore, 6.7% of all patients with triple-negative and 7.8% of patients with HER2-positive breast cancer developed CM. Multivariate analysis indicated that the highest risk for CM was triple-negative breast cancer. Further independent risk factors were: HER2-overexpression, early onset BC (age<50 years), and large tumour size (pT3/4). Among those patients developing CM, triple-negative BC showed the shortest interval between primary diagnosis and occurrence of CM with a median of 22 months, compared to 30 and 63.5 months in HER2-positive and ER+/HER2- BC, respectively. Survival after occurrence of CM did not differ among the subtypes. CONCLUSION: Patients with triple-negative or HER2-positive BC have a higher risk for CM compared with patients bearing the ER+/HER2- phenotype and develop CM earlier in the course of disease. A risk profile for CM might help adjust surveillance in high risk populations and identify patients with a need for new treatment strategies.",
            "authors": {
              "abbreviation": "Florian Heitz, Philipp Harter, Hans-Joachim Lueck, ..., Andreas du Bois",
              "authorList": [
                {
                  "ForeName": "Florian",
                  "LastName": "Heitz",
                  "abbrevName": "Heitz F",
                  "email": "florian.heitz@gmx.net",
                  "isCollectiveName": false,
                  "name": "Florian Heitz",
                  "orcid": null
                },
                {
                  "ForeName": "Philipp",
                  "LastName": "Harter",
                  "abbrevName": "Harter P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Philipp Harter",
                  "orcid": null
                },
                {
                  "ForeName": "Hans-Joachim",
                  "LastName": "Lueck",
                  "abbrevName": "Lueck HJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hans-Joachim Lueck",
                  "orcid": null
                },
                {
                  "ForeName": "Annette",
                  "LastName": "Fissler-Eckhoff",
                  "abbrevName": "Fissler-Eckhoff A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Annette Fissler-Eckhoff",
                  "orcid": null
                },
                {
                  "ForeName": "Fatemeh",
                  "LastName": "Lorenz-Salehi",
                  "abbrevName": "Lorenz-Salehi F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fatemeh Lorenz-Salehi",
                  "orcid": null
                },
                {
                  "ForeName": "Stefanie",
                  "LastName": "Scheil-Bertram",
                  "abbrevName": "Scheil-Bertram S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stefanie Scheil-Bertram",
                  "orcid": null
                },
                {
                  "ForeName": "Alexander",
                  "LastName": "Traut",
                  "abbrevName": "Traut A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alexander Traut",
                  "orcid": null
                },
                {
                  "ForeName": "Andreas",
                  "LastName": "du Bois",
                  "abbrevName": "du Bois A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andreas du Bois",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Florian",
                  "LastName": "Heitz",
                  "email": [
                    "florian.heitz@gmx.net"
                  ],
                  "name": "Florian Heitz"
                }
              ]
            },
            "doi": "10.1016/j.ejca.2009.06.027",
            "pmid": "19643597",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Eur J Cancer 45 2009",
            "title": "Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases."
          }
        },
        {
          "pmid": "19596646",
          "pubmed": {
            "ISODate": "2009-06-01T00:00:00.000Z",
            "abstract": "Of the estimated 1 million cases of breast cancer diagnosed annually worldwide, it is estimated that over 170,000 will harbor the triple-negative (estrogen receptor/progesterone receptor/HER2-negative) phenotype. Most, though not all, triple-negative breast cancers will be basal-like on gene expression micorarrays. The basal-like molecular subtype exhibits a unique molecular profile and set of risk factors, aggressive and early pattern of metastasis, limited treatment options, and poor prognosis. Large population-based studies have identified a higher proportion of triple-negative breast tumors among premenopausal African American women, and a suggestion that increased parity, younger age at first-term pregnancy, shorter duration of breast feeding, and elevated hip-to-waist ratio might be particular risk factors. When BRCA1 mutation carriers develop breast cancer, it is usually basal-like; given the central role of BRCA1 in DNA repair, this could have profound therapeutic implications. When diagnosed, triple-negative breast cancers illustrate preferential relapse in visceral organs, including the central nervous system. Although initial response to chemotherapy might be more profound, relapse is early and common among triple-negative breast cancers compared with luminal breast cancers. The armamentarium of \"targeted therapeutics\" for triple-negative breast cancer is evolving and includes strategies to inhibit angiogenesis, epidermal growth factor receptor, and other kinases. Finally, the positive association between triple-negative breast cancer and BRCA mutations makes inhibition of poly(adenosine diphosphate-ribose) polymerase-1 an attractive therapeutic strategy that is in active study.",
            "authors": {
              "abbreviation": "Carey K Anders, Lisa A Carey",
              "authorList": [
                {
                  "ForeName": "Carey",
                  "LastName": "Anders",
                  "abbrevName": "Anders CK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Carey K Anders",
                  "orcid": null
                },
                {
                  "ForeName": "Lisa",
                  "LastName": "Carey",
                  "abbrevName": "Carey LA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lisa A Carey",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3816/CBC.2009.s.008",
            "pmid": "19596646",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Clin Breast Cancer 9 Suppl 2 2009",
            "title": "Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer."
          }
        },
        {
          "pmid": "19033387",
          "pubmed": {
            "ISODate": "2008-12-15T00:00:00.000Z",
            "abstract": "The ADP-ribosylation factor 6 (Arf6) GTPase functions as a key regulator of endocytic trafficking, participating in clathrin-independent endocytosis in most cell types. Unexpectedly, we found that siRNA-mediated depletion of clathrin or of adaptor protein 2 (AP-2)-complex subunits alters trafficking of Arf6 pathway cargo proteins, such as major histocompatibility complex class I (MHCI) and beta1 integrin. Internalization of these cargoes from the plasma membrane was not affected in cells depleted of clathrin, but was modestly delayed in cells lacking AP-2. Furthermore, depletion of clathrin or AP-2 altered the intracellular distribution of MHCI and beta1 integrin, inducing clustering in a perinuclear region. Despite this altered localization in both depleted populations, enhanced lysosomal targeting of MHCI was observed uniquely in cells that lack AP-2. Total levels of MHCI were modestly but consistently reduced in AP-2-depleted cells, and restored by the lysosomal inhibitor bafilomycin A. Furthermore, the half-life of surface-derived MHCI was reduced in AP-2-depleted cells. Consistent with enhanced degradative sorting, colocalization of Arf6 cargo with the late endosome and lysosome markers CD63 and Lamp1 was increased in cells depleted of AP-2 but not clathrin. These studies indicate a role for AP-2 in maintaining normal post-endocytic trafficking through the Arf6-regulated, non-clathrin pathway, and reveal pervasive effects of clathrin and AP-2 depletion on the endosomal and lysosomal system.",
            "authors": {
              "abbreviation": "Alan W Lau, Margaret M Chou",
              "authorList": [
                {
                  "ForeName": "Alan",
                  "LastName": "Lau",
                  "abbrevName": "Lau AW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alan W Lau",
                  "orcid": null
                },
                {
                  "ForeName": "Margaret",
                  "LastName": "Chou",
                  "abbrevName": "Chou MM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Margaret M Chou",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1242/jcs.033522",
            "pmid": "19033387",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "J Cell Sci 121 2008",
            "title": "The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway."
          }
        },
        {
          "pmid": "18833576",
          "pubmed": {
            "ISODate": "2008-11-15T00:00:00.000Z",
            "abstract": "BACKGROUND: The purpose of the current study was to characterize the outcomes of patients with metastatic triple-negative breast cancers, including the risk and clinical consequences of central nervous system (CNS) recurrence. METHODS: Using pharmacy and pathology records, a study group of 116 patients who were treated for metastatic triple-negative breast cancer at Dana-Farber Cancer Institute between January 2000 and June 2006 was identified. RESULTS: The median survival from time of metastatic diagnosis was 13.3 months. Sixteen patients (14%) were diagnosed with CNS involvement at the time of initial metastatic diagnosis; overall, 46% of patients were diagnosed with CNS metastases before death. The median survival after a diagnosis of CNS metastasis was 4.9 months. The age-adjusted and race-adjusted rate of death for patients whose first presentation included a CNS metastasis was 3.4 times (95% confidence interval, 1.9-6.1 times) that of patients without a CNS lesion at the time of first metastatic presentation. Of the 53 patients who developed brain metastases, only 3 patients were judged to have stable or responsive systemic disease in the face of progressive CNS disease at the last follow-up before death. CONCLUSIONS: Triple-negative breast cancer is associated with poor survival after recurrence. CNS recurrence is common, but death as a direct consequence of CNS progression in the setting of controlled systemic disease is uncommon. Thus, it does not appear that the high rate of CNS involvement is because of a sanctuary effect, but rather is due to the lack of effective therapies in general for this aggressive subtype of breast cancer. New treatment strategies are needed.",
            "authors": {
              "abbreviation": "Nancy U Lin, Elizabeth Claus, Jessica Sohl, ..., Eric P Winer",
              "authorList": [
                {
                  "ForeName": "Nancy",
                  "LastName": "Lin",
                  "abbrevName": "Lin NU",
                  "email": "nlin@partners.org",
                  "isCollectiveName": false,
                  "name": "Nancy U Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Elizabeth",
                  "LastName": "Claus",
                  "abbrevName": "Claus E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elizabeth Claus",
                  "orcid": null
                },
                {
                  "ForeName": "Jessica",
                  "LastName": "Sohl",
                  "abbrevName": "Sohl J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jessica Sohl",
                  "orcid": null
                },
                {
                  "ForeName": "Abdul",
                  "LastName": "Razzak",
                  "abbrevName": "Razzak AR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Abdul R Razzak",
                  "orcid": null
                },
                {
                  "ForeName": "Amal",
                  "LastName": "Arnaout",
                  "abbrevName": "Arnaout A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Amal Arnaout",
                  "orcid": null
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Winer",
                  "abbrevName": "Winer EP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric P Winer",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Nancy",
                  "LastName": "Lin",
                  "email": [
                    "nlin@partners.org"
                  ],
                  "name": "Nancy U Lin"
                }
              ]
            },
            "doi": "10.1002/cncr.23930",
            "pmid": "18833576",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer 113 2008",
            "title": "Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases."
          }
        },
        {
          "pmid": "18798982",
          "pubmed": {
            "ISODate": "2008-01-01T00:00:00.000Z",
            "abstract": "We present Model-based Analysis of ChIP-Seq data, MACS, which analyzes data generated by short read sequencers such as Solexa's Genome Analyzer. MACS empirically models the shift size of ChIP-Seq tags, and uses it to improve the spatial resolution of predicted binding sites. MACS also uses a dynamic Poisson distribution to effectively capture local biases in the genome, allowing for more robust predictions. MACS compares favorably to existing ChIP-Seq peak-finding algorithms, and is freely available.",
            "authors": {
              "abbreviation": "Yong Zhang, Tao Liu, Clifford A Meyer, ..., X Shirley Liu",
              "authorList": [
                {
                  "ForeName": "Yong",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yong Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Liu",
                  "abbrevName": "Liu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Clifford",
                  "LastName": "Meyer",
                  "abbrevName": "Meyer CA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Clifford A Meyer",
                  "orcid": null
                },
                {
                  "ForeName": "Jérôme",
                  "LastName": "Eeckhoute",
                  "abbrevName": "Eeckhoute J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jérôme Eeckhoute",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Johnson",
                  "abbrevName": "Johnson DS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David S Johnson",
                  "orcid": null
                },
                {
                  "ForeName": "Bradley",
                  "LastName": "Bernstein",
                  "abbrevName": "Bernstein BE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bradley E Bernstein",
                  "orcid": null
                },
                {
                  "ForeName": "Chad",
                  "LastName": "Nusbaum",
                  "abbrevName": "Nusbaum C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chad Nusbaum",
                  "orcid": null
                },
                {
                  "ForeName": "Richard",
                  "LastName": "Myers",
                  "abbrevName": "Myers RM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Richard M Myers",
                  "orcid": null
                },
                {
                  "ForeName": "Myles",
                  "LastName": "Brown",
                  "abbrevName": "Brown M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Myles Brown",
                  "orcid": null
                },
                {
                  "ForeName": "Wei",
                  "LastName": "Li",
                  "abbrevName": "Li W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wei Li",
                  "orcid": null
                },
                {
                  "ForeName": "X",
                  "LastName": "Liu",
                  "abbrevName": "Liu XS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "X Shirley Liu",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1186/gb-2008-9-9-r137",
            "pmid": "18798982",
            "pubTypes": [
              {
                "UI": "D003160",
                "value": "Comparative Study"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Genome Biol 9 2008",
            "title": "Model-based analysis of ChIP-Seq (MACS)."
          }
        },
        {
          "pmid": "18353163",
          "pubmed": {
            "ISODate": "2008-04-01T00:00:00.000Z",
            "abstract": "RAN, ZHX2 and RCBTB2 (CHC1L) expression was evaluated by quantitative real time reverse transcription polymerase chain reaction in plasma cells from 85 monoclonal gammopathies: 58 symptomatic multiple myeloma (MM) (52 untreated, six relapsed), eight smouldering MM, five monoclonal gammopathy of undetermined significance, four plasma cell leukaemias and 10 myeloid cell lines. ZHX2 was weakly expressed in high-risk/proliferative disease compared to low-risk or indolent disease. High ZHX2 expression was associated with better response and longer survival after high-dose therapy. RCBTB2 expression was weaker in hyperdiploid versus non-hyperdiploid cases while RAN was more expressed in symptomatic MM and cell lines.",
            "authors": {
              "abbreviation": "A Armellini, M E Sarasquete, R García-Sanz, ..., J F San Miguel",
              "authorList": [
                {
                  "ForeName": "A",
                  "LastName": "Armellini",
                  "abbrevName": "Armellini A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Armellini",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Sarasquete",
                  "abbrevName": "Sarasquete ME",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M E Sarasquete",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "García-Sanz",
                  "abbrevName": "García-Sanz R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R García-Sanz",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Chillón",
                  "abbrevName": "Chillón MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M C Chillón",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Balanzategui",
                  "abbrevName": "Balanzategui A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Balanzategui",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Alcoceba",
                  "abbrevName": "Alcoceba M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Alcoceba",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Fuertes",
                  "abbrevName": "Fuertes M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Fuertes",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "López",
                  "abbrevName": "López R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R López",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Hernández",
                  "abbrevName": "Hernández JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J M Hernández",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Fernández-Calvo",
                  "abbrevName": "Fernández-Calvo J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Fernández-Calvo",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Sierra",
                  "abbrevName": "Sierra M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Sierra",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Megido",
                  "abbrevName": "Megido M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Megido",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Orfão",
                  "abbrevName": "Orfão A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Orfão",
                  "orcid": null
                },
                {
                  "ForeName": "N",
                  "LastName": "Gutiérrez",
                  "abbrevName": "Gutiérrez NC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "N C Gutiérrez",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "González",
                  "abbrevName": "González M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M González",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "San Miguel",
                  "abbrevName": "San Miguel JF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J F San Miguel",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1111/j.1365-2141.2007.06956.x",
            "pmid": "18353163",
            "pubTypes": [
              {
                "UI": "D016430",
                "value": "Clinical Trial"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Br J Haematol 141 2008",
            "title": "Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma."
          }
        },
        {
          "pmid": "17908964",
          "pubmed": {
            "ISODate": "2007-10-01T00:00:00.000Z",
            "abstract": "PURPOSE: This study was designed to elucidate the role of amplification at 8q24 in the pathophysiology of ovarian and breast cancer because increased copy number at this locus is one of the most frequent genomic abnormalities in these cancers. EXPERIMENTAL DESIGN: To accomplish this, we assessed the association of amplification at 8q24 with outcome in ovarian cancers using fluorescence in situ hybridization to tissue microarrays and measured responses of ovarian and breast cancer cell lines to specific small interfering RNAs against the oncogene MYC and a putative noncoding RNA, PVT1, both of which map to 8q24. RESULTS: Amplification of 8q24 was associated with significantly reduced survival duration. In addition, small interfering RNA-mediated reduction in either PVT1 or MYC expression inhibited proliferation in breast and ovarian cancer cell lines in which they were both amplified and overexpressed but not in lines in which they were not amplified/overexpressed. Inhibition of PVT1 expression also induced a strong apoptotic response in cell lines in which it was overexpressed but not in lines in which it was not amplified/overexpressed. Inhibition of MYC, on the other hand, did not induce an apoptotic response in cell lines in which MYC was amplified and overexpressed. CONCLUSIONS: These results suggest that MYC and PVT1 contribute independently to ovarian and breast pathogenesis when overexpressed because of genomic abnormalities. They also suggest that PVT1-mediated inhibition of apoptosis may explain why amplification of 8q24 is associated with reduced survival duration in patients treated with agents that act through apoptotic mechanisms.",
            "authors": {
              "abbreviation": "Yinghui Guan, Wen-Lin Kuo, Jackie L Stilwell, ..., Joe W Gray",
              "authorList": [
                {
                  "ForeName": "Yinghui",
                  "LastName": "Guan",
                  "abbrevName": "Guan Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yinghui Guan",
                  "orcid": null
                },
                {
                  "ForeName": "Wen-Lin",
                  "LastName": "Kuo",
                  "abbrevName": "Kuo WL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wen-Lin Kuo",
                  "orcid": null
                },
                {
                  "ForeName": "Jackie",
                  "LastName": "Stilwell",
                  "abbrevName": "Stilwell JL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jackie L Stilwell",
                  "orcid": null
                },
                {
                  "ForeName": "Hirokuni",
                  "LastName": "Takano",
                  "abbrevName": "Takano H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hirokuni Takano",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "Lapuk",
                  "abbrevName": "Lapuk AV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna V Lapuk",
                  "orcid": null
                },
                {
                  "ForeName": "Jane",
                  "LastName": "Fridlyand",
                  "abbrevName": "Fridlyand J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jane Fridlyand",
                  "orcid": null
                },
                {
                  "ForeName": "Jian-Hua",
                  "LastName": "Mao",
                  "abbrevName": "Mao JH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jian-Hua Mao",
                  "orcid": null
                },
                {
                  "ForeName": "Mamie",
                  "LastName": "Yu",
                  "abbrevName": "Yu M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamie Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Melinda",
                  "LastName": "Miller",
                  "abbrevName": "Miller MA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Melinda A Miller",
                  "orcid": null
                },
                {
                  "ForeName": "Jennifer",
                  "LastName": "Santos",
                  "abbrevName": "Santos JL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jennifer L Santos",
                  "orcid": null
                },
                {
                  "ForeName": "Steve",
                  "LastName": "Kalloger",
                  "abbrevName": "Kalloger SE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Steve E Kalloger",
                  "orcid": null
                },
                {
                  "ForeName": "Joseph",
                  "LastName": "Carlson",
                  "abbrevName": "Carlson JW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joseph W Carlson",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Ginzinger",
                  "abbrevName": "Ginzinger DG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David G Ginzinger",
                  "orcid": null
                },
                {
                  "ForeName": "Susan",
                  "LastName": "Celniker",
                  "abbrevName": "Celniker SE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Susan E Celniker",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Mills",
                  "abbrevName": "Mills GB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon B Mills",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Huntsman",
                  "abbrevName": "Huntsman DG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David G Huntsman",
                  "orcid": null
                },
                {
                  "ForeName": "Joe",
                  "LastName": "Gray",
                  "abbrevName": "Gray JW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joe W Gray",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1158/1078-0432.CCR-06-2882",
            "pmid": "17908964",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Clin Cancer Res 13 2007",
            "title": "Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer."
          }
        },
        {
          "pmid": "17488841",
          "pubmed": {
            "ISODate": "2007-07-01T00:00:00.000Z",
            "abstract": "Real-world observable physical and chemical characteristics are increasingly being calculated from the 3D structures of biomolecules. Methods for calculating pK(a) values, binding constants of ligands, and changes in protein stability are readily available, but often the limiting step in computational biology is the conversion of PDB structures into formats ready for use with biomolecular simulation software. The continued sophistication and integration of biomolecular simulation methods for systems- and genome-wide studies requires a fast, robust, physically realistic and standardized protocol for preparing macromolecular structures for biophysical algorithms. As described previously, the PDB2PQR web server addresses this need for electrostatic field calculations (Dolinsky et al., Nucleic Acids Research, 32, W665-W667, 2004). Here we report the significantly expanded PDB2PQR that includes the following features: robust standalone command line support, improved pK(a) estimation via the PROPKA framework, ligand parameterization via PEOE_PB charge methodology, expanded set of force fields and easily incorporated user-defined parameters via XML input files, and improvement of atom addition and optimization code. These features are available through a new web interface (http://pdb2pqr.sourceforge.net/), which offers users a wide range of options for PDB file conversion, modification and parameterization.",
            "authors": {
              "abbreviation": "Todd J Dolinsky, Paul Czodrowski, Hui Li, ..., Nathan A Baker",
              "authorList": [
                {
                  "ForeName": "Todd",
                  "LastName": "Dolinsky",
                  "abbrevName": "Dolinsky TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Todd J Dolinsky",
                  "orcid": null
                },
                {
                  "ForeName": "Paul",
                  "LastName": "Czodrowski",
                  "abbrevName": "Czodrowski P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Paul Czodrowski",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Li",
                  "abbrevName": "Li H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Li",
                  "orcid": null
                },
                {
                  "ForeName": "Jens",
                  "LastName": "Nielsen",
                  "abbrevName": "Nielsen JE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jens E Nielsen",
                  "orcid": null
                },
                {
                  "ForeName": "Jan",
                  "LastName": "Jensen",
                  "abbrevName": "Jensen JH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jan H Jensen",
                  "orcid": null
                },
                {
                  "ForeName": "Gerhard",
                  "LastName": "Klebe",
                  "abbrevName": "Klebe G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gerhard Klebe",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Baker",
                  "abbrevName": "Baker NA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan A Baker",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1093/nar/gkm276",
            "pmid": "17488841",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              }
            ],
            "reference": "Nucleic Acids Res 35 2007",
            "title": "PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations."
          }
        },
        {
          "pmid": "17447851",
          "pubmed": {
            "ISODate": "2007-01-01T00:00:00.000Z",
            "abstract": "Zinc-fingers and homeoboxes 2 (ZHX2) is a novel transcriptional repressor. ZHX2 protein expression and its clinicopathological significance in hepatocellular carcinoma (HCC) remain largely unknown. The aim of this study was to analyze ZHX2 protein expression in a range of liver tissues obtained from cholangitis, cirrhosis, adjacent non-tumorous tissues, primary HCC tissues, and matched metastatic lesions by using Tissue microarray (TMA) technology and compare our findings with clinicopathological parameters. ZHX2 protein expression was detected only in HCC tissues. ZHX2 expression was associated with clinical stage of the disease. The rate of ZHX2 expression was approximately twice as high in stage III-IV (31.25%) compared with stage I-II (16.5%). These results demonstrated that ZHX2 protein may take part in hepatocellular carcinogenesis and HCC progression. In addition, ZHX2 expression in primary lesions with metastasis was significantly higher than without metastasis. ZHX2 expression in metastatic lesions (45.5%) was as approximately twice as higher than that in primary lesions (24.2%) from the same patient. According to these results, ZHX2 was associated with metastasis in HCC.",
            "authors": {
              "abbreviation": "S Hu, M Zhang, Z Lv, ..., J Wen",
              "authorList": [
                {
                  "ForeName": "S",
                  "LastName": "Hu",
                  "abbrevName": "Hu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S Hu",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Z",
                  "LastName": "Lv",
                  "abbrevName": "Lv Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Lv",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Bi",
                  "abbrevName": "Bi J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Bi",
                  "orcid": null
                },
                {
                  "ForeName": "Y",
                  "LastName": "Dong",
                  "abbrevName": "Dong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Y Dong",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Wen",
                  "abbrevName": "Wen J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Wen",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": null,
            "pmid": "17447851",
            "pubTypes": [
              {
                "UI": "D003160",
                "value": "Comparative Study"
              },
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Neoplasma 54 2007",
            "title": "Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis."
          }
        },
        {
          "pmid": "15626755",
          "pubmed": {
            "ISODate": "2005-01-11T00:00:00.000Z",
            "abstract": "The alpha-fetoprotein (AFP) and H19 genes are transcribed at high levels in the mammalian fetal liver but are rapidly repressed postnatally. This repression in the liver is controlled, at least in part, by the Afr1 gene. Afr1 was defined >25 years ago when BALB/cJ mice were found to have 5- to 20-fold higher adult serum AFP levels compared with all other mouse strains; subsequent studies showed that this elevation was due to higher Afp expression in the liver. H19, which has become a model for genomic imprinting, was identified initially in a screen for Afr1-regulated genes. The BALB/cJ allele (Afr1(b)) is recessive to the wild-type allele (Afr1(a)), consistent with the idea that Afr1 functions as a repressor. By high-resolution mapping, we identified a gene that maps to the Afr1 interval on chromosome 15 and encodes a putative zinc fingers and homeoboxes (ZHX) protein. In BALB/cJ mice, this gene contains a murine endogenous retrovirus within its first intron and produces predominantly an aberrant transcript that no longer encodes a functional protein. Liver-specific overexpression of a Zhx2 transgene restores wild-type H19 repression on a BALB/cJ background, confirming that this gene is responsible for hereditary persistence of Afp and H19 in the livers of BALB/cJ mice. Thus we have identified a genetically defined transcription factor that is involved in developmental gene silencing in mammals. We present a model to explain the liver-specific phenotype in BALB/cJ mice, even though Afr1 is a ubiquitously expressed gene.",
            "authors": {
              "abbreviation": "Sudhir Perincheri, R W Cameron Dingle, Martha L Peterson, Brett T Spear",
              "authorList": [
                {
                  "ForeName": "Sudhir",
                  "LastName": "Perincheri",
                  "abbrevName": "Perincheri S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sudhir Perincheri",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "Dingle",
                  "abbrevName": "Dingle RW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R W Cameron Dingle",
                  "orcid": null
                },
                {
                  "ForeName": "Martha",
                  "LastName": "Peterson",
                  "abbrevName": "Peterson ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Martha L Peterson",
                  "orcid": null
                },
                {
                  "ForeName": "Brett",
                  "LastName": "Spear",
                  "abbrevName": "Spear BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Brett T Spear",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.0408555102",
            "pmid": "15626755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 102 2005",
            "title": "Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene."
          }
        },
        {
          "pmid": "15247232",
          "pubmed": {
            "ISODate": "2004-09-10T00:00:00.000Z",
            "abstract": "Hypoxia-inducible factor (HIF) is a transcriptional regulator that plays a key role in many aspects of oxygen homeostasis. The heterodimeric HIF complex is regulated by proteolysis of its alpha-subunits, following oxygen-dependent hydroxylation of specific prolyl residues. Although three HIF prolyl hydroxylases, PHD1, PHD2, and PHD3, have been identified that have the potential to catalyze this reaction, the contribution of each isoform to the physiological regulation of HIF remains uncertain. Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1alpha and HIF-2alpha subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme. Thus in different cell types, isoform-specific patterns of PHD induction by hypoxia and estrogen alter both the relative abundance of the PHDs and their relative contribution to the regulation of HIF. In addition, the PHDs manifest specificity for different prolyl hydroxylation sites within each HIF-alpha subunit, and a degree of selectively between HIF-1alpha and HIF-2alpha isoforms, indicating that differential PHD inhibition has the potential to selectively alter the characteristics of HIF activation.",
            "authors": {
              "abbreviation": "Rebecca J Appelhoff, Ya-Min Tian, Raju R Raval, ..., Jonathan M Gleadle",
              "authorList": [
                {
                  "ForeName": "Rebecca",
                  "LastName": "Appelhoff",
                  "abbrevName": "Appelhoff RJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rebecca J Appelhoff",
                  "orcid": null
                },
                {
                  "ForeName": "Ya-Min",
                  "LastName": "Tian",
                  "abbrevName": "Tian YM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ya-Min Tian",
                  "orcid": null
                },
                {
                  "ForeName": "Raju",
                  "LastName": "Raval",
                  "abbrevName": "Raval RR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raju R Raval",
                  "orcid": null
                },
                {
                  "ForeName": "Helen",
                  "LastName": "Turley",
                  "abbrevName": "Turley H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Helen Turley",
                  "orcid": null
                },
                {
                  "ForeName": "Adrian",
                  "LastName": "Harris",
                  "abbrevName": "Harris AL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Adrian L Harris",
                  "orcid": null
                },
                {
                  "ForeName": "Christopher",
                  "LastName": "Pugh",
                  "abbrevName": "Pugh CW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christopher W Pugh",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Ratcliffe",
                  "abbrevName": "Ratcliffe PJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter J Ratcliffe",
                  "orcid": null
                },
                {
                  "ForeName": "Jonathan",
                  "LastName": "Gleadle",
                  "abbrevName": "Gleadle JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jonathan M Gleadle",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1074/jbc.M406026200",
            "pmid": "15247232",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Biol Chem 279 2004",
            "title": "Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor."
          }
        },
        {
          "pmid": "15170446",
          "pubmed": {
            "ISODate": "2004-06-01T00:00:00.000Z",
            "abstract": null,
            "authors": {
              "abbreviation": "J Martin Brown, William R Wilson",
              "authorList": [
                {
                  "ForeName": "J",
                  "LastName": "Brown",
                  "abbrevName": "Brown JM",
                  "email": "mbrown@stanford.edu",
                  "isCollectiveName": false,
                  "name": "J Martin Brown",
                  "orcid": null
                },
                {
                  "ForeName": "William",
                  "LastName": "Wilson",
                  "abbrevName": "Wilson WR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William R Wilson",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "J",
                  "LastName": "Brown",
                  "email": [
                    "mbrown@stanford.edu"
                  ],
                  "name": "J Martin Brown"
                }
              ]
            },
            "doi": "10.1038/nrc1367",
            "pmid": "15170446",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Nat Rev Cancer 4 2004",
            "title": "Exploiting tumour hypoxia in cancer treatment."
          }
        },
        {
          "pmid": "13106296",
          "pubmed": {
            "ISODate": "1953-12-01T00:00:00.000Z",
            "abstract": null,
            "authors": {
              "abbreviation": "L H GRAY, A D CONGER, M EBERT, ..., O C SCOTT",
              "authorList": [
                {
                  "ForeName": "L",
                  "LastName": "GRAY",
                  "abbrevName": "GRAY LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "L H GRAY",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "CONGER",
                  "abbrevName": "CONGER AD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A D CONGER",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "EBERT",
                  "abbrevName": "EBERT M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M EBERT",
                  "orcid": null
                },
                {
                  "ForeName": "S",
                  "LastName": "HORNSEY",
                  "abbrevName": "HORNSEY S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S HORNSEY",
                  "orcid": null
                },
                {
                  "ForeName": "O",
                  "LastName": "SCOTT",
                  "abbrevName": "SCOTT OC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "O C SCOTT",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1259/0007-1285-26-312-638",
            "pmid": "13106296",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Br J Radiol 26 1953",
            "title": "The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy."
          }
        },
        {
          "pmid": "12741956",
          "pubmed": {
            "ISODate": "2003-08-01T00:00:00.000Z",
            "abstract": "Zinc-fingers and homeoboxes (ZHX) 1 is a transcription factor that interacts with the activation domain of the A subunit of nuclear factor-Y (NF-YA). Using a yeast two-hybrid system, a novel ubiquitous transcription factor ZHX2 as a ZHX1-interacting protein was cloned. ZHX2 consists of 837 amino acid residues and contains two zinc-finger motifs and five homeodomains (HDs) as well as ZHX1. The mRNA is expressed among various tissues. ZHX2 not only forms a heterodimer with ZHX1, but also forms a homodimer. Moreover, ZHX2 interacts with the activation domain of NF-YA. Further analysis revealed that ZHX2 is a transcriptional repressor that is localized in the nuclei. Since ZHX2 shares a number of properties in common with ZHX1, we conclude that all these come under the ZHX family. The minimal functional domains of ZHX2 were then characterized. The dimerization domain with both ZHX1 and ZHX2 is the region containing HD1, the domain that interacts with NF-YA is the HD1 to HD2 region, the repressor domain is the HD1 to a proline-rich region. Lastly, using an immunoprecipitation assay, we showed that ZHX2 intrinsically interacts with NF-YA in HEK-293 cells and that ZHX2 represses the promoter activity of the cdc25C gene stimulated by NF-Y in Drosophila Schneider line 2 cells. Thus the ZHX family of proteins may participate in the expression of a number of NF-Y-regulated genes via a more organized transcription network.",
            "authors": {
              "abbreviation": "Hiroko Kawata, Kazuya Yamada, Zhangfei Shou, ..., Kaoru Miyamoto",
              "authorList": [
                {
                  "ForeName": "Hiroko",
                  "LastName": "Kawata",
                  "abbrevName": "Kawata H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hiroko Kawata",
                  "orcid": null
                },
                {
                  "ForeName": "Kazuya",
                  "LastName": "Yamada",
                  "abbrevName": "Yamada K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kazuya Yamada",
                  "orcid": null
                },
                {
                  "ForeName": "Zhangfei",
                  "LastName": "Shou",
                  "abbrevName": "Shou Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhangfei Shou",
                  "orcid": null
                },
                {
                  "ForeName": "Tetsuya",
                  "LastName": "Mizutani",
                  "abbrevName": "Mizutani T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tetsuya Mizutani",
                  "orcid": null
                },
                {
                  "ForeName": "Takashi",
                  "LastName": "Yazawa",
                  "abbrevName": "Yazawa T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Takashi Yazawa",
                  "orcid": null
                },
                {
                  "ForeName": "Miki",
                  "LastName": "Yoshino",
                  "abbrevName": "Yoshino M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Miki Yoshino",
                  "orcid": null
                },
                {
                  "ForeName": "Toshio",
                  "LastName": "Sekiguchi",
                  "abbrevName": "Sekiguchi T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Toshio Sekiguchi",
                  "orcid": null
                },
                {
                  "ForeName": "Takashi",
                  "LastName": "Kajitani",
                  "abbrevName": "Kajitani T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Takashi Kajitani",
                  "orcid": null
                },
                {
                  "ForeName": "Kaoru",
                  "LastName": "Miyamoto",
                  "abbrevName": "Miyamoto K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kaoru Miyamoto",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1042/BJ20030171",
            "pmid": "12741956",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Biochem J 373 2003",
            "title": "Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor."
          }
        },
        {
          "pmid": "11583619",
          "pubmed": {
            "ISODate": "2001-09-01T00:00:00.000Z",
            "abstract": "Two crystal structures of Oct-1 POU domain bound to DNA provide a rationale for differential, conformation-dependent recruitment of transcription cofactors. The POU-homeo and POU-specific subdomains of Oct-1 contain two different nonoverlapping pairs of surface patches that are capable of forming unrelated protein-protein interfaces. Members of the POU factor family contain one or two conserved sequence motifs in the interface that are known to be phosphorylated, as noted for Oct-1 and Pit-1. Modeling of Oct-4 reveals the unique case where the same conserved sequence is located in both interfaces. Our studies provide the basis for two distinct dimeric POU factor arrangements that are dictated by the architecture of each DNA response element. We suggest interface swapping in dimers could be a general mechanism of modulating the activity of transcription factors.",
            "authors": {
              "abbreviation": "A Reményi, A Tomilin, E Pohl, ..., M Wilmanns",
              "authorList": [
                {
                  "ForeName": "A",
                  "LastName": "Reményi",
                  "abbrevName": "Reményi A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Reményi",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Tomilin",
                  "abbrevName": "Tomilin A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Tomilin",
                  "orcid": null
                },
                {
                  "ForeName": "E",
                  "LastName": "Pohl",
                  "abbrevName": "Pohl E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "E Pohl",
                  "orcid": null
                },
                {
                  "ForeName": "K",
                  "LastName": "Lins",
                  "abbrevName": "Lins K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "K Lins",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Philippsen",
                  "abbrevName": "Philippsen A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Philippsen",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "Reinbold",
                  "abbrevName": "Reinbold R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R Reinbold",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Schöler",
                  "abbrevName": "Schöler HR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H R Schöler",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Wilmanns",
                  "abbrevName": "Wilmanns M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Wilmanns",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1016/s1097-2765(01)00336-7",
            "pmid": "11583619",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Mol Cell 8 2001",
            "title": "Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping."
          }
        },
        {
          "pmid": "11292862",
          "pubmed": {
            "ISODate": "2001-04-20T00:00:00.000Z",
            "abstract": "HIF (hypoxia-inducible factor) is a transcription factor that plays a pivotal role in cellular adaptation to changes in oxygen availability. In the presence of oxygen, HIF is targeted for destruction by an E3 ubiquitin ligase containing the von Hippel-Lindau tumor suppressor protein (pVHL). We found that human pVHL binds to a short HIF-derived peptide when a conserved proline residue at the core of this peptide is hydroxylated. Because proline hydroxylation requires molecular oxygen and Fe(2+), this protein modification may play a key role in mammalian oxygen sensing.",
            "authors": {
              "abbreviation": "M Ivan, K Kondo, H Yang, ..., W G Kaelin",
              "authorList": [
                {
                  "ForeName": "M",
                  "LastName": "Ivan",
                  "abbrevName": "Ivan M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Ivan",
                  "orcid": null
                },
                {
                  "ForeName": "K",
                  "LastName": "Kondo",
                  "abbrevName": "Kondo K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "K Kondo",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Yang",
                  "abbrevName": "Yang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H Yang",
                  "orcid": null
                },
                {
                  "ForeName": "W",
                  "LastName": "Kim",
                  "abbrevName": "Kim W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kim",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Valiando",
                  "abbrevName": "Valiando J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Valiando",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Ohh",
                  "abbrevName": "Ohh M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Ohh",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Salic",
                  "abbrevName": "Salic A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Salic",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Asara",
                  "abbrevName": "Asara JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J M Asara",
                  "orcid": null
                },
                {
                  "ForeName": "W",
                  "LastName": "Lane",
                  "abbrevName": "Lane WS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W S Lane",
                  "orcid": null
                },
                {
                  "ForeName": "W",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W G Kaelin",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1126/science.1059817",
            "pmid": "11292862",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              }
            ],
            "reference": "Science 292 2001",
            "title": "HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing."
          }
        },
        {
          "pmid": "11292861",
          "pubmed": {
            "ISODate": "2001-04-20T00:00:00.000Z",
            "abstract": "Hypoxia-inducible factor (HIF) is a transcriptional complex that plays a central role in the regulation of gene expression by oxygen. In oxygenated and iron replete cells, HIF-alpha subunits are rapidly destroyed by a mechanism that involves ubiquitylation by the von Hippel-Lindau tumor suppressor (pVHL) E3 ligase complex. This process is suppressed by hypoxia and iron chelation, allowing transcriptional activation. Here we show that the interaction between human pVHL and a specific domain of the HIF-1alpha subunit is regulated through hydroxylation of a proline residue (HIF-1alpha P564) by an enzyme we have termed HIF-alpha prolyl-hydroxylase (HIF-PH). An absolute requirement for dioxygen as a cosubstrate and iron as cofactor suggests that HIF-PH functions directly as a cellular oxygen sensor.",
            "authors": {
              "abbreviation": "P Jaakkola, D R Mole, Y M Tian, ..., P J Ratcliffe",
              "authorList": [
                {
                  "ForeName": "P",
                  "LastName": "Jaakkola",
                  "abbrevName": "Jaakkola P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "P Jaakkola",
                  "orcid": null
                },
                {
                  "ForeName": "D",
                  "LastName": "Mole",
                  "abbrevName": "Mole DR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "D R Mole",
                  "orcid": null
                },
                {
                  "ForeName": "Y",
                  "LastName": "Tian",
                  "abbrevName": "Tian YM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Y M Tian",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Wilson",
                  "abbrevName": "Wilson MI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M I Wilson",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Gielbert",
                  "abbrevName": "Gielbert J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Gielbert",
                  "orcid": null
                },
                {
                  "ForeName": "S",
                  "LastName": "Gaskell",
                  "abbrevName": "Gaskell SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S J Gaskell",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "von Kriegsheim",
                  "abbrevName": "von Kriegsheim A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A von Kriegsheim",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Hebestreit",
                  "abbrevName": "Hebestreit HF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H F Hebestreit",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Mukherji",
                  "abbrevName": "Mukherji M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Mukherji",
                  "orcid": null
                },
                {
                  "ForeName": "C",
                  "LastName": "Schofield",
                  "abbrevName": "Schofield CJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "C J Schofield",
                  "orcid": null
                },
                {
                  "ForeName": "P",
                  "LastName": "Maxwell",
                  "abbrevName": "Maxwell PH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "P H Maxwell",
                  "orcid": null
                },
                {
                  "ForeName": "C",
                  "LastName": "Pugh",
                  "abbrevName": "Pugh CW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "C W Pugh",
                  "orcid": null
                },
                {
                  "ForeName": "P",
                  "LastName": "Ratcliffe",
                  "abbrevName": "Ratcliffe PJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "P J Ratcliffe",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1126/science.1059796",
            "pmid": "11292861",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 292 2001",
            "title": "Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation."
          }
        },
        {
          "pmid": "11181778",
          "pubmed": {
            "ISODate": "2001-02-21T00:00:00.000Z",
            "abstract": "BACKGROUND: Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that regulates gene expression in critical pathways involved in tumor growth and metastases. In this report, we investigated whether the level of HIF-1 alpha is increased during carcinogenesis in breast tissue and is associated with other tumor biomarkers. METHODS: Paraffin-embedded clinical specimens from five pathologic stages of breast tumorigenesis and from normal breast tissue were used. HIF-1 alpha protein and the biomarkers vascular endothelial growth factor (VEGF), HER-2/neu, p53, Ki-67, and estrogen receptor (ER) were identified immunohistochemically, and microvessel density (a measure of angiogenesis) was determined. Associations among levels of HIF-1 alpha and these biomarkers were tested statistically. All statistical tests are two-sided. RESULTS: The frequency of HIF-1 alpha-positive cells in a specimen increased with the specimen's pathologic stage (P<.001, chi(2) test for trend) as follows: normal breast tissue (0 specimens with > or = 1% HIF-1 alpha-positive cells in 10 specimens tested), ductal hyperplastic lesions (0 in 10), well-differentiated ductal carcinomas in situ (DCIS) (11 in 20), well-differentiated invasive breast cancers (12 in 20), poorly differentiated DCIS (17 in 20), and poorly differentiated invasive carcinomas (20 in 20). Increased levels of HIF-1 alpha were statistically significantly associated with high proliferation and increased expression of VEGF and ER proteins. In DCIS lesions, increased levels of HIF-1 alpha were statistically significantly associated with increased microvessel density. HIF-1alpha showed a borderline association with HER-2/neu but no association with p53. CONCLUSIONS: The level of HIF-1 alpha increases as the pathologic stage increases and is higher in poorly differentiated lesions than in the corresponding type of well-differentiated lesions. Increased levels of HIF-1 alpha are associated with increased proliferation and increased expression of ER and VEGF. Thus, increased levels of HIF-1 alpha are potentially associated with more aggressive tumors.",
            "authors": {
              "abbreviation": "R Bos, H Zhong, C F Hanrahan, ..., E van der Wall",
              "authorList": [
                {
                  "ForeName": "R",
                  "LastName": "Bos",
                  "abbrevName": "Bos R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R Bos",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Zhong",
                  "abbrevName": "Zhong H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H Zhong",
                  "orcid": null
                },
                {
                  "ForeName": "C",
                  "LastName": "Hanrahan",
                  "abbrevName": "Hanrahan CF",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "C F Hanrahan",
                  "orcid": null
                },
                {
                  "ForeName": "E",
                  "LastName": "Mommers",
                  "abbrevName": "Mommers EC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "E C Mommers",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G L Semenza",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Pinedo",
                  "abbrevName": "Pinedo HM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H M Pinedo",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Abeloff",
                  "abbrevName": "Abeloff MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M D Abeloff",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Simons",
                  "abbrevName": "Simons JW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J W Simons",
                  "orcid": null
                },
                {
                  "ForeName": "P",
                  "LastName": "van Diest",
                  "abbrevName": "van Diest PJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "P J van Diest",
                  "orcid": null
                },
                {
                  "ForeName": "E",
                  "LastName": "van der Wall",
                  "abbrevName": "van der Wall E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "E van der Wall",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1093/jnci/93.4.309",
            "pmid": "11181778",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              }
            ],
            "reference": "J Natl Cancer Inst 93 2001",
            "title": "Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis."
          }
        },
        {
          "pmid": "10671482",
          "pubmed": {
            "ISODate": "2000-02-18T00:00:00.000Z",
            "abstract": "We have identified Cox20p, a 23.8-kDa protein of the mitochondrial inner membrane that is involved in the biogenesis of the yeast cytochrome oxidase complex. Cytochrome oxidase subunit 2 (Cox2p) accumulates as a precursor in cox20 mutants, suggesting a defect in biogenesis of this mitochondrially encoded protein. The inability of cox20 mutants to process the subunit 2 precursor (pCox2p) is not due to impaired export of the protein across the inner membrane or to an inactive Imp1p/Imp2p peptidase. Rather, Cox20p specifically binds the newly synthesized pCox2p, a step required to present the exported pCox2p as a substrate to the Imp1p peptidase. All of the endogenous pCox2p accumulated in an Deltaimp1 mutant, and a small fraction of Cox2p in wild type yeast, is detected in a complex with Cox20p. Following maturation Cox2p remained associated with Cox20p, prior to assembling into the cytochrome oxidase complex. We propose that Cox20p acts as a membrane-bound chaperone necessary for cleavage of pCox2p and for interaction of the mature protein with other subunits of cytochrome oxidase in a later step of the assembly process.",
            "authors": {
              "abbreviation": "K Hell, A Tzagoloff, W Neupert, R A Stuart",
              "authorList": [
                {
                  "ForeName": "K",
                  "LastName": "Hell",
                  "abbrevName": "Hell K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "K Hell",
                  "orcid": null
                },
                {
                  "ForeName": "A",
                  "LastName": "Tzagoloff",
                  "abbrevName": "Tzagoloff A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "A Tzagoloff",
                  "orcid": null
                },
                {
                  "ForeName": "W",
                  "LastName": "Neupert",
                  "abbrevName": "Neupert W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Neupert",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "Stuart",
                  "abbrevName": "Stuart RA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R A Stuart",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1074/jbc.275.7.4571",
            "pmid": "10671482",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              }
            ],
            "reference": "J Biol Chem 275 2000",
            "title": "Identification of Cox20p, a novel protein involved in the maturation and assembly of cytochrome oxidase subunit 2."
          }
        },
        {
          "pmid": "10592235",
          "pubmed": {
            "ISODate": "2000-01-01T00:00:00.000Z",
            "abstract": "The Protein Data Bank (PDB; http://www.rcsb.org/pdb/ ) is the single worldwide archive of structural data of biological macromolecules. This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.",
            "authors": {
              "abbreviation": "H M Berman, J Westbrook, Z Feng, ..., P E Bourne",
              "authorList": [
                {
                  "ForeName": "H",
                  "LastName": "Berman",
                  "abbrevName": "Berman HM",
                  "email": "berman@rcsb.rutgers.edu",
                  "isCollectiveName": false,
                  "name": "H M Berman",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Westbrook",
                  "abbrevName": "Westbrook J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Westbrook",
                  "orcid": null
                },
                {
                  "ForeName": "Z",
                  "LastName": "Feng",
                  "abbrevName": "Feng Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Feng",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Gilliland",
                  "abbrevName": "Gilliland G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Gilliland",
                  "orcid": null
                },
                {
                  "ForeName": "T",
                  "LastName": "Bhat",
                  "abbrevName": "Bhat TN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "T N Bhat",
                  "orcid": null
                },
                {
                  "ForeName": "H",
                  "LastName": "Weissig",
                  "abbrevName": "Weissig H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "H Weissig",
                  "orcid": null
                },
                {
                  "ForeName": "I",
                  "LastName": "Shindyalov",
                  "abbrevName": "Shindyalov IN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "I N Shindyalov",
                  "orcid": null
                },
                {
                  "ForeName": "P",
                  "LastName": "Bourne",
                  "abbrevName": "Bourne PE",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "P E Bourne",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "H",
                  "LastName": "Berman",
                  "email": [
                    "berman@rcsb.rutgers.edu"
                  ],
                  "name": "H M Berman"
                }
              ]
            },
            "doi": "10.1093/nar/28.1.235",
            "pmid": "10592235",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013486",
                "value": "Research Support, U.S. Gov't, Non-P.H.S."
              },
              {
                "UI": "D013487",
                "value": "Research Support, U.S. Gov't, P.H.S."
              }
            ],
            "reference": "Nucleic Acids Res 28 2000",
            "title": "The Protein Data Bank."
          }
        },
        {
          "pmid": "10195279",
          "pubmed": {
            "ISODate": "1999-02-01T00:00:00.000Z",
            "abstract": "Sequence alignments unambiguously distinguish between protein pairs of similar and non-similar structure when the pairwise sequence identity is high (>40% for long alignments). The signal gets blurred in the twilight zone of 20-35% sequence identity. Here, more than a million sequence alignments were analysed between protein pairs of known structures to re-define a line distinguishing between true and false positives for low levels of similarity. Four results stood out. (i) The transition from the safe zone of sequence alignment into the twilight zone is described by an explosion of false negatives. More than 95% of all pairs detected in the twilight zone had different structures. More precisely, above a cut-off roughly corresponding to 30% sequence identity, 90% of the pairs were homologous; below 25% less than 10% were. (ii) Whether or not sequence homology implied structural identity depended crucially on the alignment length. For example, if 10 residues were similar in an alignment of length 16 (>60%), structural similarity could not be inferred. (iii) The 'more similar than identical' rule (discarding all pairs for which percentage similarity was lower than percentage identity) reduced false positives significantly. (iv) Using intermediate sequences for finding links between more distant families was almost as successful: pairs were predicted to be homologous when the respective sequence families had proteins in common. All findings are applicable to automatic database searches.",
            "authors": {
              "abbreviation": "B Rost",
              "authorList": [
                {
                  "ForeName": "B",
                  "LastName": "Rost",
                  "abbrevName": "Rost B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "B Rost",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1093/protein/12.2.85",
            "pmid": "10195279",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Protein Eng 12 1999",
            "title": "Twilight zone of protein sequence alignments."
          }
        },
        {
          "pmid": "9490409",
          "pubmed": {
            "ISODate": "1998-02-12T00:00:00.000Z",
            "abstract": "The structure of a complex containing the homeodomain repressor protein MATalpha2 and the MADS-box transcription factor MCM1 bound to DNA has been determined by X-ray crystallography at 2.25 A resolution. It reveals the protein-protein interactions responsible for cooperative binding of MATalpha2 and MCM1 to DNA. The otherwise flexible amino-terminal extension of the MATalpha2 homeodomain forms a beta-hairpin that grips the MCM1 surface through parallel beta-strand hydrogen bonds and close-packed, predominantly hydrophobic, side chains. DNA bending induced by MCM1 brings the two proteins closer together, facilitating their interaction. An unusual feature of the complex is that an eight-amino-acid sequence adopts an alpha-helical conformation in one of two copies of the MATalpha2 monomer and a beta-strand conformation in the other. This 'chameleon' sequence of MATalpha2 may be important for recognizing natural operator sites.",
            "authors": {
              "abbreviation": "S Tan, T J Richmond",
              "authorList": [
                {
                  "ForeName": "S",
                  "LastName": "Tan",
                  "abbrevName": "Tan S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S Tan",
                  "orcid": null
                },
                {
                  "ForeName": "T",
                  "LastName": "Richmond",
                  "abbrevName": "Richmond TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "T J Richmond",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/35563",
            "pmid": "9490409",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 391 1998",
            "title": "Crystal structure of the yeast MATalpha2/MCM1/DNA ternary complex."
          }
        },
        {
          "pmid": "9154919",
          "pubmed": {
            "ISODate": "1997-05-06T00:00:00.000Z",
            "abstract": "The interactions responsible for the nucleotide sequence-specific binding of the vnd/NK-2 homeodomain of Drosophila melanogaster to its consensus DNA binding site have been identified. A three-dimensional structure of the vnd/NK-2 homeodomain-DNA complex is presented, with emphasis on the structure of regions of observed protein-DNA contacts. This structure is based on protein-DNA distance restraints derived from NMR data, along with homology modeling, solvated molecular dynamics, and results from methylation and ethylation interference experiments. Helix III of the homeodomain binds in the major groove of the DNA and the N-terminal arm binds in the minor groove, in analogy with other homeodomain-DNA complexes whose structures have been reported. The vnd/NK-2 homeodomain recognizes the unusual DNA consensus sequence 5'-CAAGTG-3'. The roles in sequence specificity and strength of binding of individual amino acid residues that make contact with the DNA are described. We show, based primarily on the observed protein-DNA contacts, that the interaction of Y54 with the DNA is the major determinant of this uncommon nucleotide binding specificity in the vnd/NK-2 homeodomain-DNA complex.",
            "authors": {
              "abbreviation": "J M Gruschus, D H Tsao, L H Wang, ..., J A Ferretti",
              "authorList": [
                {
                  "ForeName": "J",
                  "LastName": "Gruschus",
                  "abbrevName": "Gruschus JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J M Gruschus",
                  "orcid": null
                },
                {
                  "ForeName": "D",
                  "LastName": "Tsao",
                  "abbrevName": "Tsao DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "D H Tsao",
                  "orcid": null
                },
                {
                  "ForeName": "L",
                  "LastName": "Wang",
                  "abbrevName": "Wang LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "L H Wang",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Nirenberg",
                  "abbrevName": "Nirenberg M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Nirenberg",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Ferretti",
                  "abbrevName": "Ferretti JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J A Ferretti",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1021/bi9620060",
            "pmid": "9154919",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Biochemistry 36 1997",
            "title": "Interactions of the vnd/NK-2 homeodomain with DNA by nuclear magnetic resonance spectroscopy: basis of binding specificity."
          }
        },
        {
          "pmid": "7490328",
          "pubmed": {
            "ISODate": "1995-09-01T00:00:00.000Z",
            "abstract": "Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. The most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue. A \"quickscore\" has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the IHA quickscore for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quickscore and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score. A positive cut off quickscore of > or = 3 has been suggested.",
            "authors": {
              "abbreviation": "S Detre, G Saclani Jotti, M Dowsett",
              "authorList": [
                {
                  "ForeName": "S",
                  "LastName": "Detre",
                  "abbrevName": "Detre S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "S Detre",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Saclani Jotti",
                  "abbrevName": "Saclani Jotti G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Saclani Jotti",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Dowsett",
                  "abbrevName": "Dowsett M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Dowsett",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1136/jcp.48.9.876",
            "pmid": "7490328",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Clin Pathol 48 1995",
            "title": "A \"quickscore\" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas."
          }
        }
      ],
      "relatedPapers": [
        {
          "pmid": "36037364",
          "pubmed": {
            "ISODate": "2022-09-06T00:00:00.000Z",
            "abstract": "Clear cell renal cell carcinoma (ccRCC) is characterized by the loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of an E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor α (HIF-α) (including HIF1α and HIF2α) and Zinc Fingers And Homeoboxes 2 (ZHX2). Our recent research showed that ZHX2 contributed to ccRCC tumorigenesis in a HIF-independent manner. However, it is still unknown whether ZHX2 could be modified through deubiquitination even in the absence of pVHL. Here, we performed a deubiquitinase (DUB) complementary DNA (cDNA) library binding screen and identified USP13 as a DUB that bound ZHX2 and promoted ZHX2 deubiquitination. As a result, USP13 promoted ZHX2 protein stability in an enzymatically dependent manner, and depletion of USP13 led to ZHX2 down-regulation in ccRCC. Functionally, USP13 depletion led to decreased cell proliferation measured by two-dimensional (2D) colony formation and three-dimensional (3D) anchorage-independent growth. Furthermore, USP13 was essential for ccRCC tumor growth in vivo, and the effect was partially mediated by its regulation on ZHX2. Our findings support that USP13 may be a key effector in ccRCC tumorigenesis.",
            "authors": {
              "abbreviation": "Haibiao Xie, Jin Zhou, Xijuan Liu, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": "0000-0001-6729-8479"
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Yawei",
                  "LastName": "Xu",
                  "abbrevName": "Xu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yawei Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Austin",
                  "LastName": "Hepperla",
                  "abbrevName": "Hepperla AJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Austin J Hepperla",
                  "orcid": "0000-0002-0107-2001"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hongwei",
                  "LastName": "Yao",
                  "abbrevName": "Yao H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongwei Yao",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": "0000-0002-9073-3835"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119854119",
            "pmid": "36037364",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer."
          }
        },
        {
          "pmid": "24670641",
          "pubmed": {
            "ISODate": "2014-04-03T00:00:00.000Z",
            "abstract": "Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours, but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)--a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)--is a highly aggressive malignancy with limited treatment options. Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1α (HIF1α) is known to be hyperactivated in TNBCs. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Xi Chen, Dimitrios Iliopoulos, Qing Zhang, ..., Laurie H Glimcher",
              "authorList": [
                {
                  "ForeName": "Xi",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Dimitrios",
                  "LastName": "Iliopoulos",
                  "abbrevName": "Iliopoulos D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dimitrios Iliopoulos",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qianzi",
                  "LastName": "Tang",
                  "abbrevName": "Tang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qianzi Tang",
                  "orcid": null
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Greenblatt",
                  "abbrevName": "Greenblatt MB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew B Greenblatt",
                  "orcid": null
                },
                {
                  "ForeName": "Maria",
                  "LastName": "Hatziapostolou",
                  "abbrevName": "Hatziapostolou M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria Hatziapostolou",
                  "orcid": null
                },
                {
                  "ForeName": "Elgene",
                  "LastName": "Lim",
                  "abbrevName": "Lim E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elgene Lim",
                  "orcid": null
                },
                {
                  "ForeName": "Wai",
                  "LastName": "Tam",
                  "abbrevName": "Tam WL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wai Leong Tam",
                  "orcid": null
                },
                {
                  "ForeName": "Min",
                  "LastName": "Ni",
                  "abbrevName": "Ni M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min Ni",
                  "orcid": null
                },
                {
                  "ForeName": "Yiwen",
                  "LastName": "Chen",
                  "abbrevName": "Chen Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yiwen Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Junhua",
                  "LastName": "Mai",
                  "abbrevName": "Mai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Junhua Mai",
                  "orcid": null
                },
                {
                  "ForeName": "Haifa",
                  "LastName": "Shen",
                  "abbrevName": "Shen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haifa Shen",
                  "orcid": null
                },
                {
                  "ForeName": "Dorothy",
                  "LastName": "Hu",
                  "abbrevName": "Hu DZ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dorothy Z Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Stanley",
                  "LastName": "Adoro",
                  "abbrevName": "Adoro S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stanley Adoro",
                  "orcid": null
                },
                {
                  "ForeName": "Bella",
                  "LastName": "Hu",
                  "abbrevName": "Hu B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bella Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Minkyung",
                  "LastName": "Song",
                  "abbrevName": "Song M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minkyung Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chen",
                  "LastName": "Tan",
                  "abbrevName": "Tan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Melissa",
                  "LastName": "Landis",
                  "abbrevName": "Landis MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Melissa D Landis",
                  "orcid": null
                },
                {
                  "ForeName": "Mauro",
                  "LastName": "Ferrari",
                  "abbrevName": "Ferrari M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mauro Ferrari",
                  "orcid": null
                },
                {
                  "ForeName": "Sandra",
                  "LastName": "Shin",
                  "abbrevName": "Shin SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sandra J Shin",
                  "orcid": null
                },
                {
                  "ForeName": "Myles",
                  "LastName": "Brown",
                  "abbrevName": "Brown M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Myles Brown",
                  "orcid": null
                },
                {
                  "ForeName": "Jenny",
                  "LastName": "Chang",
                  "abbrevName": "Chang JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jenny C Chang",
                  "orcid": null
                },
                {
                  "ForeName": "X",
                  "LastName": "Liu",
                  "abbrevName": "Liu XS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "X Shirley Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Laurie",
                  "LastName": "Glimcher",
                  "abbrevName": "Glimcher LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laurie H Glimcher",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature13119",
            "pmid": "24670641",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 508 2014",
            "title": "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway."
          }
        },
        {
          "pmid": "31529195",
          "pubmed": {
            "ISODate": "2019-09-01T00:00:00.000Z",
            "abstract": "Triple negative breast cancer (TNBC) is the most lethal breast cancer subtype. Extended periods of lactation protect against breast cancer development, but the mechanisms underlying this protection are unknown. We examined the effects of the milk protein alpha-casein over expression in the triple negative MDA-MB-231 breast cancer cell line. The effects of recombinant alpha-casein added exogenously to MDA-MB-231 breast cancer cells, and immortalised human fibroblasts were also investigated. We used transcriptional reporters to understand the signalling pathways downstream of alpha-casein in breast cancer cells and these fibroblasts that were activated by breast cancer cells. To extend our findings to the clinical setting, we analysed public gene expression datasets to further understand the relevance of these signalling pathways in triple negative breast cancer cells and patient samples. Finally, we used small molecular inhibitors to target relevant pathways and highlight these as potential candidates for the treatment of TN breast cancer. High levels of alpha-casein gene expression were predictive of good prognosis across 263 TNBC patient tumour samples. Alpha-casein over expression or exogenous addition reduces cancer stem cell (CSC) activity. HIF-1alpha was identified to be a key downstream target of alpha-casein, in both breast cancer cells and activated fibroblasts, and STAT transcription factors to be upstream of HIF-1alpha. Interestingly, HIF-1alpha is regulated by STAT3 in breast cancer cells, but STAT1 is the regulator of HIF-1alpha in activated fibroblasts. In analysis of 573 TNBC patient samples, alpha-casein expression, inversely correlated to HIF-1alpha, STAT3 and STAT1. STAT1 and STAT3 inhibitors target HIF-1alpha signalling in activated fibroblasts and MDA-MB-231 breast cancer cells respectively, and also abrogate CSC activities. Our findings provide an explanation for the protective effects of lactation in TNBC. Clinical data correlates high alpha-casein expression with increased recurrence-free survival in TNBC patients. Mechanistically, alpha-casein reduces breast cancer stem cell activity in vitro, and STAT3 and STAT1 were identified as regulators of pro-tumorigenic HIF-1alpha signalling in breast cancer cells and fibroblasts respectively.",
            "authors": {
              "abbreviation": "Kirsten E L Garner, Nathan J Hull, Andrew H Sims, ..., Robert B Clarke",
              "authorList": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "abbrevName": "Garner KEL",
                  "email": "Kirsten.garner@manchester.ac.uk",
                  "isCollectiveName": false,
                  "name": "Kirsten E L Garner",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Hull",
                  "abbrevName": "Hull NJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan J Hull",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Rebecca",
                  "LastName": "Lamb",
                  "abbrevName": "Lamb R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rebecca Lamb",
                  "orcid": null
                },
                {
                  "ForeName": "Robert",
                  "LastName": "Clarke",
                  "abbrevName": "Clarke RB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Robert B Clarke",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "email": [
                    "Kirsten.garner@manchester.ac.uk"
                  ],
                  "name": "Kirsten E L Garner"
                }
              ]
            },
            "doi": "10.1007/s10911-019-09435-1",
            "pmid": "31529195",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mammary Gland Biol Neoplasia 24 2019",
            "title": "The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts."
          }
        },
        {
          "pmid": "35867755",
          "pubmed": {
            "ISODate": "2022-07-12T00:00:00.000Z",
            "abstract": "Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Zhaoping Qiu, Weijie Guo, Bo Dong, ..., Yadi Wu",
              "authorList": [
                {
                  "ForeName": "Zhaoping",
                  "LastName": "Qiu",
                  "abbrevName": "Qiu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhaoping Qiu",
                  "orcid": null
                },
                {
                  "ForeName": "Weijie",
                  "LastName": "Guo",
                  "abbrevName": "Guo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weijie Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Dong",
                  "abbrevName": "Dong B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Dong",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Pan",
                  "LastName": "Deng",
                  "abbrevName": "Deng P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pan Deng",
                  "orcid": "0000-0003-2974-7389"
                },
                {
                  "ForeName": "Chi",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chi Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jinpeng",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jinpeng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                },
                {
                  "ForeName": "Rudolf",
                  "LastName": "Grosschedl",
                  "abbrevName": "Grosschedl R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rudolf Grosschedl",
                  "orcid": null
                },
                {
                  "ForeName": "Zhiyong",
                  "LastName": "Yu",
                  "abbrevName": "Yu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhiyong Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Jiong",
                  "LastName": "Deng",
                  "abbrevName": "Deng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiong Deng",
                  "orcid": null
                },
                {
                  "ForeName": "Yadi",
                  "LastName": "Wu",
                  "abbrevName": "Wu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadi Wu",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119518119",
            "pmid": "35867755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway."
          }
        },
        {
          "pmid": "36228375",
          "pubmed": {
            "ISODate": "2022-12-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has been shown that HIF-1α regulates the complex biological processes of TNBC, such as glycolysis, angiogenesis, invasion and metastasis, breast cancer stem cells (BCSCs) enrichment, and immune escape, to promote TNBC survival and development through the activation of downstream target genes. In addition, inflammatory mediators, oxygen levels, noncoding RNAs, complex signaling regulatory networks, epigenetic regulators are involved in the upstream regulatory expression of HIF-1α. However, further studies are needed to determine the potential and future directions of targeting HIF-1α in TNBC. This article discusses the expression of the HIF-1α transcription factor in TNBC. We also explored the mechanism by which HIF-1α drives TNBC progression. The potential significance of targeting HIF-1α for immunotherapy, chemotherapy, anti-angiogenic therapy, and photodynamic therapy is discussed. The intrinsic mechanism, existing problems and future directions of targeting HIF-1α are also studied.",
            "authors": {
              "abbreviation": "Qi Liu, Chengcheng Guan, Cui Liu, ..., Changgang Sun",
              "authorList": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "abbrevName": "Liu Q",
                  "email": "2020110892@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Qi Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "abbrevName": "Guan C",
                  "email": "2020110896@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chengcheng Guan",
                  "orcid": null
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "abbrevName": "Liu C",
                  "email": "2019101062@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Cui Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "abbrevName": "Li H",
                  "email": "2019101020@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Huayao Li",
                  "orcid": null
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "abbrevName": "Wu J",
                  "email": "2020111256@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Jibiao Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "abbrevName": "Sun C",
                  "email": "zyxyscg@wfmc.edu.cn",
                  "isCollectiveName": false,
                  "name": "Changgang Sun",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "email": [
                    "2020110892@sdutcm.edu.cn"
                  ],
                  "name": "Qi Liu"
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "email": [
                    "2020110896@sdutcm.edu.cn"
                  ],
                  "name": "Chengcheng Guan"
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "email": [
                    "2019101062@sdutcm.edu.cn"
                  ],
                  "name": "Cui Liu"
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "email": [
                    "2019101020@sdutcm.edu.cn"
                  ],
                  "name": "Huayao Li"
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "email": [
                    "2020111256@sdutcm.edu.cn"
                  ],
                  "name": "Jibiao Wu"
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "email": [
                    "zyxyscg@wfmc.edu.cn"
                  ],
                  "name": "Changgang Sun"
                }
              ]
            },
            "doi": "10.1016/j.biopha.2022.113861",
            "pmid": "36228375",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Biomed Pharmacother 156 2022",
            "title": "Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy."
          }
        },
        {
          "pmid": "30026228",
          "pubmed": {
            "ISODate": "2018-07-20T00:00:00.000Z",
            "abstract": "Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor κB activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.",
            "authors": {
              "abbreviation": "Jing Zhang, Tao Wu, Jeremy Simon, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": "0000-0001-5380-3905"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": "0000-0002-3961-9009"
                },
                {
                  "ForeName": "Ryoichi",
                  "LastName": "Saito",
                  "abbrevName": "Saito R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ryoichi Saito",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Xian-De",
                  "LastName": "Liu",
                  "abbrevName": "Liu XD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian-De Liu",
                  "orcid": "0000-0002-9639-0458"
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Jonasch",
                  "abbrevName": "Jonasch E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric Jonasch",
                  "orcid": "0000-0003-0943-2806"
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaosai",
                  "LastName": "Yao",
                  "abbrevName": "Yao X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaosai Yao",
                  "orcid": "0000-0001-9729-0726"
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Teh",
                  "abbrevName": "Teh BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Tean Teh",
                  "orcid": "0000-0003-1514-1124"
                },
                {
                  "ForeName": "Patrick",
                  "LastName": "Tan",
                  "abbrevName": "Tan P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Patrick Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": "0000-0003-3034-4421"
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": "0000-0001-5337-4901"
                },
                {
                  "ForeName": "Cortney",
                  "LastName": "Lawrence",
                  "abbrevName": "Lawrence C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cortney Lawrence",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Fan",
                  "abbrevName": "Fan J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Fan",
                  "orcid": "0000-0003-3842-2391"
                },
                {
                  "ForeName": "Jiang",
                  "LastName": "Geng",
                  "abbrevName": "Geng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiang Geng",
                  "orcid": "0000-0002-7202-2167"
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Joel",
                  "LastName": "Parker",
                  "abbrevName": "Parker JS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joel S Parker",
                  "orcid": "0000-0003-2080-6901"
                },
                {
                  "ForeName": "J",
                  "LastName": "Auman",
                  "abbrevName": "Auman JT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Todd Auman",
                  "orcid": "0000-0002-9328-8829"
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "W",
                  "LastName": "Rathmell",
                  "abbrevName": "Rathmell WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kimryn Rathmell",
                  "orcid": "0000-0002-4984-0225"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": "0000-0001-6540-6130"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": "0000-0002-0574-4856"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": "0000-0003-1246-1333"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "qing_zhang@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "qing_zhang@med.unc.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1126/science.aap8411",
            "pmid": "30026228",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 361 2018",
            "title": "VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma."
          }
        },
        {
          "pmid": "32770671",
          "pubmed": {
            "ISODate": "2020-12-01T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Lipogenesis has been considered as a critical player in HCC initiation and progression. However, the underlying mechanism is still not fully understood. Here, we identified zinc fingers and homeoboxes 2 (ZHX2), an HCC-associated tumor suppressor, as an important repressor of de novo lipogenesis. Ectopic expression of ZHX2 significantly inhibited de novo lipogenesis in HCC cells and decreased expression of FASN, ACL, ACC1, and SCD1. In accordance with this, ZHX2 was negatively associated with SREBP1c, the master regulator of de novo lipogenesis, in HCC cell lines and human specimens. Results from silencing and overexpression demonstrated that ZHX2 inhibited de novo lipogenesis and consequent HCC progression via repression of SREBP1c. Furthermore, treatment with the SREBP1c inhibitor fatostatin dampened the spontaneous formation of tumors in liver-specific Zhx2 knockout mice. Mechanistically, ZHX2 increased expression of miR-24-3p transcriptionally, which targeted SREBP1c and led to its degradation. In conclusion, our data suggest a novel mechanism through which ZHX2 suppresses HCC progression, which may provide a new strategy for the treatment of HCC. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",
            "authors": {
              "abbreviation": "Xiangguo Yu, Qinghai Lin, Zhuanchang Wu, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Yankun",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yankun Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Songbai",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Songbai Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chaojia",
                  "LastName": "Chen",
                  "abbrevName": "Chen C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chaojia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Chunyang",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunyang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": "0000-0002-8121-4718"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/path.5530",
            "pmid": "32770671",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Pathol 252 2020",
            "title": "ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p."
          }
        },
        {
          "pmid": "32778144",
          "pubmed": {
            "ISODate": "2020-08-10T00:00:00.000Z",
            "abstract": "BACKGROUND: Hypoxia plays a relevant role in tumor-related inflammation toward the metastatic spread and cancer aggressiveness. The pro-inflammatory cytokine interleukin-1β (IL-β) and its cognate receptor IL1R1 contribute to the initiation and progression of breast cancer determining pro-tumorigenic inflammatory responses. The transcriptional target of the hypoxia inducible factor-1α (HIF-1α) namely the G protein estrogen receptor (GPER) mediates a feedforward loop coupling IL-1β induction by breast cancer-associated fibroblasts (CAFs) to IL1R1 expression by breast cancer cells toward the regulation of target genes and relevant biological responses. METHODS: In order to ascertain the correlation of IL-β with HIF-1α and further hypoxia-related genes in triple-negative breast cancer (TNBC) patients, a bioinformatics analysis was performed using the information provided by The Invasive Breast Cancer Cohort of The Cancer Genome Atlas (TCGA) project and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets. Gene expression correlation, statistical analysis and gene set enrichment analysis (GSEA) were carried out with R studio packages. Pathway enrichment analysis was evaluated with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. TNBC cells and primary CAFs were used as model system. The molecular mechanisms implicated in the regulation of IL-1β by hypoxia toward a metastatic gene expression profile and invasive properties were assessed performing gene and protein expression studies, PCR arrays, gene silencing and immunofluorescence analysis, co-immunoprecipitation and ChiP assays, ELISA, cell spreading, invasion and spheroid formation. RESULTS: We first determined that IL-1β expression correlates with the levels of HIF-1α as well as with a hypoxia-related gene signature in TNBC patients. Next, we demonstrated that hypoxia triggers a functional liaison among HIF-1α, GPER and the IL-1β/IL1R1 signaling toward a metastatic gene signature and a feed-forward loop of IL-1β that leads to proliferative and invasive responses in TNBC cells. Furthermore, we found that the IL-1β released in the conditioned medium of TNBC cells exposed to hypoxic conditions promotes an invasive phenotype of CAFs. CONCLUSIONS: Our data shed new light on the role of hypoxia in the activation of the IL-1β/IL1R1 signaling, which in turn triggers aggressive features in both TNBC cells and CAFs. Hence, our findings provide novel evidence regarding the mechanisms through which the hypoxic tumor microenvironment may contribute to breast cancer progression and suggest further targets useful in more comprehensive therapeutic strategies.",
            "authors": {
              "abbreviation": "Rosamaria Lappano, Marianna Talia, Francesca Cirillo, ..., Marcello Maggiolini",
              "authorList": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "abbrevName": "Lappano R",
                  "email": "rosamaria.lappano@unical.it",
                  "isCollectiveName": false,
                  "name": "Rosamaria Lappano",
                  "orcid": null
                },
                {
                  "ForeName": "Marianna",
                  "LastName": "Talia",
                  "abbrevName": "Talia M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marianna Talia",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Cirillo",
                  "abbrevName": "Cirillo F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Cirillo",
                  "orcid": null
                },
                {
                  "ForeName": "Damiano",
                  "LastName": "Rigiracciolo",
                  "abbrevName": "Rigiracciolo DC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Damiano Cosimo Rigiracciolo",
                  "orcid": null
                },
                {
                  "ForeName": "Domenica",
                  "LastName": "Scordamaglia",
                  "abbrevName": "Scordamaglia D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Domenica Scordamaglia",
                  "orcid": null
                },
                {
                  "ForeName": "Rita",
                  "LastName": "Guzzi",
                  "abbrevName": "Guzzi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rita Guzzi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "Miglietta",
                  "abbrevName": "Miglietta AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna Maria Miglietta",
                  "orcid": null
                },
                {
                  "ForeName": "Ernestina",
                  "LastName": "De Francesco",
                  "abbrevName": "De Francesco EM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ernestina Marianna De Francesco",
                  "orcid": null
                },
                {
                  "ForeName": "Antonino",
                  "LastName": "Belfiore",
                  "abbrevName": "Belfiore A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonino Belfiore",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "abbrevName": "Maggiolini M",
                  "email": "marcello.maggiolini@unical.it",
                  "isCollectiveName": false,
                  "name": "Marcello Maggiolini",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "email": [
                    "rosamaria.lappano@unical.it"
                  ],
                  "name": "Rosamaria Lappano"
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "email": [
                    "marcello.maggiolini@unical.it"
                  ],
                  "name": "Marcello Maggiolini"
                }
              ]
            },
            "doi": "10.1186/s13046-020-01667-y",
            "pmid": "32778144",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Exp Clin Cancer Res 39 2020",
            "title": "The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)."
          }
        },
        {
          "pmid": "25195714",
          "pubmed": {
            "ISODate": "2014-10-01T00:00:00.000Z",
            "abstract": "Glypican 3 (GPC3) has been paid particular attention owing to its potential as diagnosis marker for hepatocellular carcinoma (HCC). Identifying the mechanisms regulating the reactivation of GPC3 in HCC appears to be clinically meaningful. Previous study identified zinc-fingers and homeoboxes 2 (ZHX2) as transcriptional factor responsible for postnatal repression of GPC3 in mice. Here, in this study, we provided the first evidence that down regulated ZHX2 is responsible for GPC3 reactivation in HCC. First, inverse correlation of ZHX2 with GPC3 expression was shown in cultured liver cell lines. Second, ZHX2 overexpression significantly decreased GPC3 expression, while ZHX2 knockdown effectively increased GPC3 level in different HCC cell lines. Consistently, dual luciferase and ChIP assay showed that ZHX2 dose-dependently suppressed GPC3 promoter activity by binding with the core promoter. More importantly, immunohistochemical staining demonstrated the inverse correlation between nuclear ZHX2 with GPC3 expression in HCC tissues. Further in vitro analysis showed that nuclear translocation was crucial for ZHX2 mediated repression on GPC3 transcription. Taken together, our results prove that ZHX2 suppresses GPC3 transcription by binding with its core promoter and reduced nucleic ZHX2 expression may be involved in GPC3 reactivation in HCC.",
            "authors": {
              "abbreviation": "Fang Luan, Peng Liu, Hongxin Ma, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Fang",
                  "LastName": "Luan",
                  "abbrevName": "Luan F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fang Luan",
                  "orcid": null
                },
                {
                  "ForeName": "Peng",
                  "LastName": "Liu",
                  "abbrevName": "Liu P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.biocel.2014.08.021",
            "pmid": "25195714",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Int J Biochem Cell Biol 55 2014",
            "title": "Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma."
          }
        },
        {
          "pmid": "32382017",
          "pubmed": {
            "ISODate": "2020-05-07T00:00:00.000Z",
            "abstract": "Zinc fingers and homeoboxes 2 (ZHX2) was found as a novel VHL substrate target, and acted as an oncogenic driver in ccRCC. However, the detailed mechanism of ZHX2 in ccRCC development remains elusive, and no research has focused on studying ZHX2 in drug resistance yet. A tissue microarray with 358 ccRCC samples was used to determine the expression of ZHX2 in ccRCC patients. VHL-deficient cell line 786-O and VHL-normal cell line CAKI-1 was used for lineage reprogramming by transfecting with lentivirus. The in vitro and in vivo experiments were performed with these new cell lines to determine the mechanism of ZHX2 in ccRCC development and drug resistance. Immunohistochemistry analysis showed that ZHX2 was not highly expressed in ccRCC tumor tissues, only 33.2% (119/358) patients have high ZHX2 expression. However, high ZHX2 was significantly associated with advanced Fuhrman grade (p = 0.004), and proved to be an independent prognosis factor for progression-free survival (p = 0.0003), while there is no significant correlation with overall survival. We further discovered that ZHX2 overexpression could increase VEGF secretion and transcriptional activate the MEK/ERK1/2 and promote its downstream targets. We also found ZHX2 overexpression induce Sunitinib resistance though activating autophagy and the combination treatment of Sunitinib and Chloroquine could significantly rescue the phenomenon. In summary, these results indicate that ZHX2 drivers cell growth, migration though increase VEGF expression, and transcriptional activate MEK/ERK1/2 signaling pathway, and could induce Sunitinib resistance by regulating self-protective autophagy, these may provide new insight in advanced ccRCC treatment.",
            "authors": {
              "abbreviation": "Liangsong Zhu, Rong Ding, Hao Yan, ..., Zongming Lin",
              "authorList": [
                {
                  "ForeName": "Liangsong",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liangsong Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Rong",
                  "LastName": "Ding",
                  "abbrevName": "Ding R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rong Ding",
                  "orcid": null
                },
                {
                  "ForeName": "Hao",
                  "LastName": "Yan",
                  "abbrevName": "Yan H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hao Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": "med-zhangjin@vip.sina.com",
                  "isCollectiveName": false,
                  "name": "Jin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "abbrevName": "Lin Z",
                  "email": "lin.zongming@zs-hospital.sh.cn",
                  "isCollectiveName": false,
                  "name": "Zongming Lin",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "email": [
                    "med-zhangjin@vip.sina.com"
                  ],
                  "name": "Jin Zhang"
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "email": [
                    "lin.zongming@zs-hospital.sh.cn"
                  ],
                  "name": "Zongming Lin"
                }
              ]
            },
            "doi": "10.1038/s41419-020-2541-x",
            "pmid": "32382017",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 11 2020",
            "title": "ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma."
          }
        },
        {
          "pmid": "28054302",
          "pubmed": {
            "ISODate": "2017-04-01T00:00:00.000Z",
            "abstract": "PURPOSE: Despite advances that have been made in systemic chemotherapy, the prognosis of advanced triple-negative breast cancer (TNBC) patients is still poor. The identification of key factors governing TNBC development is considered imperative for the development of novel effective therapeutic approaches. Previously, it has been reported that microRNA (miR)-761 may act as either a tumor suppressor or as an oncogene in different types of cancer. Here, we aimed at assessing the biological role of this miRNA in TNBC. METHODS: First, we measured the expression of miR-761 in primary breast cancer tissues and breast cancer-derived cell lines using qRT-PCR. Subsequently, over-expression and silencing experiments were performed to determine the role of miR-761 in TNBC cell proliferation, colony formation, migration and invasion in vitro. The in vivo role of miR-761 in TNBC growth and metastasis was determined in mouse models. Bioinformatics analyses, dual-luciferase reporter assays, Western blot analyses and rescue experiments were performed to identify miR-761 target gene(s). RESULTS: We found that miR-761 was up-regulated in primary breast cancer tissues and its derived cell lines and, particularly, in TNBC tissues and cell lines. We also found that exogenous miR-761 over-expression augmented in vitro TNBC cell proliferation, colony formation, migration and invasion, whereas miR-761 down-regulation impaired these features. In vivo, we found that miR-761 over-expression facilitated TNBC growth and lung metastasis. Mechanistically, miR-761 was found to negatively regulate the expression of tripartite motif-containing 29 (TRIM29) in TNBC cells by binding to the 3'-untranslated region of its mRNA. In conformity with these results, a significant negative correlation between miR-761 expression and TRIM29 protein expression was noted in primary TNBC tissues (r = -0.452, p = 0.0126). We also found that exogenous TRIM29 over-expression reversed the proliferative and invasive capacities of TNBC cells. CONCLUSIONS: Our data indicate that miR-761 acts as an oncogene in TNBC. This mode of action can, at least partially, be ascribed to the down-regulation of its target TRIM29. We suggest that miR-761 may serve as a promising therapeutic target for TNBC.",
            "authors": {
              "abbreviation": "Guang-Cheng Guo, Jia-Xiang Wang, Ming-Li Han, ..., Lin Li",
              "authorList": [
                {
                  "ForeName": "Guang-Cheng",
                  "LastName": "Guo",
                  "abbrevName": "Guo GC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guang-Cheng Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "abbrevName": "Wang JX",
                  "email": "ggc503@126.com",
                  "isCollectiveName": false,
                  "name": "Jia-Xiang Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Ming-Li",
                  "LastName": "Han",
                  "abbrevName": "Han ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ming-Li Han",
                  "orcid": null
                },
                {
                  "ForeName": "Lian-Ping",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang LP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lian-Ping Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Lin",
                  "LastName": "Li",
                  "abbrevName": "Li L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lin Li",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "email": [
                    "ggc503@126.com"
                  ],
                  "name": "Jia-Xiang Wang"
                }
              ]
            },
            "doi": "10.1007/s13402-016-0312-6",
            "pmid": "28054302",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cell Oncol (Dordr) 40 2017",
            "title": "microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression."
          }
        },
        {
          "pmid": "26825173",
          "pubmed": {
            "ISODate": "2016-03-15T00:00:00.000Z",
            "abstract": "Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.",
            "authors": {
              "abbreviation": "Tarah M Regan Anderson, Shi Hong Ma, Ganesh V Raj, ..., Carol A Lange",
              "authorList": [
                {
                  "ForeName": "Tarah",
                  "LastName": "Regan Anderson",
                  "abbrevName": "Regan Anderson TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tarah M Regan Anderson",
                  "orcid": null
                },
                {
                  "ForeName": "Shi",
                  "LastName": "Ma",
                  "abbrevName": "Ma SH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shi Hong Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Ganesh",
                  "LastName": "Raj",
                  "abbrevName": "Raj GV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ganesh V Raj",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Cidlowski",
                  "abbrevName": "Cidlowski JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John A Cidlowski",
                  "orcid": null
                },
                {
                  "ForeName": "Taylor",
                  "LastName": "Helle",
                  "abbrevName": "Helle TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Taylor M Helle",
                  "orcid": null
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Knutson",
                  "abbrevName": "Knutson TP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Todd P Knutson",
                  "orcid": null
                },
                {
                  "ForeName": "Raisa",
                  "LastName": "Krutilina",
                  "abbrevName": "Krutilina RI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raisa I Krutilina",
                  "orcid": null
                },
                {
                  "ForeName": "Tiffany",
                  "LastName": "Seagroves",
                  "abbrevName": "Seagroves TN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tiffany N Seagroves",
                  "orcid": null
                },
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "abbrevName": "Lange CA",
                  "email": "lange047@umn.edu",
                  "isCollectiveName": false,
                  "name": "Carol A Lange",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "email": [
                    "lange047@umn.edu"
                  ],
                  "name": "Carol A Lange"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-15-2510",
            "pmid": "26825173",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Cancer Res 76 2016",
            "title": "Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "27184798",
          "pubmed": {
            "ISODate": "2016-08-01T00:00:00.000Z",
            "abstract": "Dysregulated energy metabolism is one of the main mechanisms for uncontrolled growth in solid tumors. Hypoxia-inducible factor 1-alpha (HIF1α) is a transcription factor implicated in regulating several genes that are responsible for cell metabolism, including carbonic anhydrase IX (CAIX). The aim of this study is to determine the clinical significance of immunohistochemical metabolic alteration in early-stage triple negative breast cancer (TNBC) patients who received cyclophosphamide-based chemotherapy or radiotherapy and those with basal phenotype. Immunohistochemical staining for HIF1α and CAIX was performed to determine the correlation with clinicopathologic variables and survival outcome on tissue microarrays from 270 early-stage TNBC patients. In vitro experiments with multiple human TNBC cell lines, suppression of HIF1α by small interfering RNA (siRNA) significantly reduced CAIX protein expression in all cell lines. In multivariate analyses for different therapeutic modalities and basal phenotype, combined HIF1α and CAIX protein overexpression was significantly associated with disease-free survival in the total cohort (OR = 2.583, P = 0.002), stratified cohorts expressing basal phenotype (OR = 2.234, P = 0.021), and in those patients who received adjuvant chemotherapy (OR = 3.078, P = 0.023) and adjuvant radiotherapy (OR = 2.111, P = 0.050), respectively. In early TNBC, combined HIF1α and CAIX protein expression may serve as an unfavorable prognostic indicator particularly in patients treated with cyclophosphamide-based chemotherapy or radiotherapy as well as those with basal phenotype of breast cancer.",
            "authors": {
              "abbreviation": "Min-Sun Jin, Hyebin Lee, In Ae Park, ..., Han Suk Ryu",
              "authorList": [
                {
                  "ForeName": "Min-Sun",
                  "LastName": "Jin",
                  "abbrevName": "Jin MS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min-Sun Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Hyebin",
                  "LastName": "Lee",
                  "abbrevName": "Lee H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyebin Lee",
                  "orcid": null
                },
                {
                  "ForeName": "In",
                  "LastName": "Park",
                  "abbrevName": "Park IA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "In Ae Park",
                  "orcid": null
                },
                {
                  "ForeName": "Yul",
                  "LastName": "Chung",
                  "abbrevName": "Chung YR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yul Ri Chung",
                  "orcid": null
                },
                {
                  "ForeName": "Seock-Ah",
                  "LastName": "Im",
                  "abbrevName": "Im SA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Seock-Ah Im",
                  "orcid": null
                },
                {
                  "ForeName": "Kyung-Hun",
                  "LastName": "Lee",
                  "abbrevName": "Lee KH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyung-Hun Lee",
                  "orcid": null
                },
                {
                  "ForeName": "Hyeong-Gon",
                  "LastName": "Moon",
                  "abbrevName": "Moon HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyeong-Gon Moon",
                  "orcid": null
                },
                {
                  "ForeName": "Wonshik",
                  "LastName": "Han",
                  "abbrevName": "Han W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wonshik Han",
                  "orcid": null
                },
                {
                  "ForeName": "Kyubo",
                  "LastName": "Kim",
                  "abbrevName": "Kim K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyubo Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Tae-Yong",
                  "LastName": "Kim",
                  "abbrevName": "Kim TY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tae-Yong Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Dong-Young",
                  "LastName": "Noh",
                  "abbrevName": "Noh DY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dong-Young Noh",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "abbrevName": "Ryu HS",
                  "email": "karlnash@naver.com",
                  "isCollectiveName": false,
                  "name": "Han Suk Ryu",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "email": [
                    "karlnash@naver.com"
                  ],
                  "name": "Han Suk Ryu"
                }
              ]
            },
            "doi": "10.1007/s00428-016-1953-6",
            "pmid": "27184798",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Virchows Arch 469 2016",
            "title": "Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer."
          }
        },
        {
          "pmid": "28423652",
          "pubmed": {
            "ISODate": "2017-04-25T00:00:00.000Z",
            "abstract": "MiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR-29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b-1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.",
            "authors": {
              "abbreviation": "Rosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, ..., Riccardo Di Fiore",
              "authorList": [
                {
                  "ForeName": "Rosa",
                  "LastName": "Drago-Ferrante",
                  "abbrevName": "Drago-Ferrante R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Drago-Ferrante",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Pentimalli",
                  "abbrevName": "Pentimalli F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Pentimalli",
                  "orcid": null
                },
                {
                  "ForeName": "Daniela",
                  "LastName": "Carlisi",
                  "abbrevName": "Carlisi D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniela Carlisi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "De Blasio",
                  "abbrevName": "De Blasio A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna De Blasio",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Saliba",
                  "abbrevName": "Saliba C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Saliba",
                  "orcid": null
                },
                {
                  "ForeName": "Shawn",
                  "LastName": "Baldacchino",
                  "abbrevName": "Baldacchino S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shawn Baldacchino",
                  "orcid": null
                },
                {
                  "ForeName": "James",
                  "LastName": "Degaetano",
                  "abbrevName": "Degaetano J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James Degaetano",
                  "orcid": null
                },
                {
                  "ForeName": "Joseph",
                  "LastName": "Debono",
                  "abbrevName": "Debono J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joseph Debono",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Caruana-Dingli",
                  "abbrevName": "Caruana-Dingli G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Caruana-Dingli",
                  "orcid": null
                },
                {
                  "ForeName": "Godfrey",
                  "LastName": "Grech",
                  "abbrevName": "Grech G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Godfrey Grech",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Scerri",
                  "abbrevName": "Scerri C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Scerri",
                  "orcid": null
                },
                {
                  "ForeName": "Giovanni",
                  "LastName": "Tesoriere",
                  "abbrevName": "Tesoriere G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giovanni Tesoriere",
                  "orcid": null
                },
                {
                  "ForeName": "Antonio",
                  "LastName": "Giordano",
                  "abbrevName": "Giordano A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonio Giordano",
                  "orcid": null
                },
                {
                  "ForeName": "Renza",
                  "LastName": "Vento",
                  "abbrevName": "Vento R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Renza Vento",
                  "orcid": null
                },
                {
                  "ForeName": "Riccardo",
                  "LastName": "Di Fiore",
                  "abbrevName": "Di Fiore R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Riccardo Di Fiore",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.15960",
            "pmid": "28423652",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 8 2017",
            "title": "Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation."
          }
        },
        {
          "pmid": "27137755",
          "pubmed": {
            "ISODate": "2017-01-01T00:00:00.000Z",
            "abstract": "The aggressiveness of triple-negative breast cancer (TNBC), which lacks estrogen receptor, progesterone receptor and epidermal growth factor receptor 2 (HER2), represents a major challenge in breast cancer. Migratory and self-renewal capabilities are integral components of invasion, metastasis and recurrence of TNBC. Elevated hypoxia-inducible factor-1α (HIF-1α) expression is associated with aggressiveness of cancer. Nonetheless, how HIF-1α expression is regulated and how HIF-1α induces aggressive phenotype are not completely understood in TNBC. The cytotoxic effects of farnesyltransferase (FTase) inhibitors (FTIs) have been studied in cancer and leukemia cells. In contrast, the effect of FTIs on HIF-1α expression has not yet been studied. Here, we show that clinically relevant low-dose FTI, tipifarnib (300 nM), decreased HIF-1α expression, migration and tumorsphere formation in human MDA-MB-231 TNBC cells under a normoxic condition. In contrast, the low-dose FTIs did not inhibit cell growth and activity of the Ras pathway in MDA-MB 231 cells. Tipifarnib-induced decrease in HIF-1α expression was associated with amelioration of the Warburg effect, hypermetabolic state, increases in Snail expression and ATP release, and suppressed E-cadherin expression, major contributors to invasion, metastasis and recurrence of TBNC. These data suggest that FTIs may be capable of ameliorating the aggressive phenotype of TNBC by suppressing the HIF-1α-Snail pathway. J. Cell. Physiol. 232: 192-201, 2017. © 2016 Wiley Periodicals, Inc.",
            "authors": {
              "abbreviation": "Tomokazu Tanaka, Yuichi Ikegami, Harumasa Nakazawa, ..., Masao Kaneki",
              "authorList": [
                {
                  "ForeName": "Tomokazu",
                  "LastName": "Tanaka",
                  "abbrevName": "Tanaka T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tomokazu Tanaka",
                  "orcid": null
                },
                {
                  "ForeName": "Yuichi",
                  "LastName": "Ikegami",
                  "abbrevName": "Ikegami Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuichi Ikegami",
                  "orcid": null
                },
                {
                  "ForeName": "Harumasa",
                  "LastName": "Nakazawa",
                  "abbrevName": "Nakazawa H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Harumasa Nakazawa",
                  "orcid": null
                },
                {
                  "ForeName": "Naohide",
                  "LastName": "Kuriyama",
                  "abbrevName": "Kuriyama N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naohide Kuriyama",
                  "orcid": null
                },
                {
                  "ForeName": "Miwa",
                  "LastName": "Oki",
                  "abbrevName": "Oki M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Miwa Oki",
                  "orcid": null
                },
                {
                  "ForeName": "Jun-Ichi",
                  "LastName": "Hanai",
                  "abbrevName": "Hanai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun-Ichi Hanai",
                  "orcid": null
                },
                {
                  "ForeName": "Vikas",
                  "LastName": "Sukhatme",
                  "abbrevName": "Sukhatme VP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vikas P Sukhatme",
                  "orcid": null
                },
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "abbrevName": "Kaneki M",
                  "email": "mkaneki@helix.mgh.harvard.edu",
                  "isCollectiveName": false,
                  "name": "Masao Kaneki",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "email": [
                    "mkaneki@helix.mgh.harvard.edu"
                  ],
                  "name": "Masao Kaneki"
                }
              ]
            },
            "doi": "10.1002/jcp.25411",
            "pmid": "27137755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Cell Physiol 232 2017",
            "title": "Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro."
          }
        },
        {
          "pmid": "26751287",
          "pubmed": {
            "ISODate": "2016-02-01T00:00:00.000Z",
            "abstract": "Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively. These events cause HIF1α stabilization, HIF1α-p300 interaction, and activation of HIF1α transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to the EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1α Tyr 565 phosphorylation interferes with Pro 564 hydroxylation, leading to normoxic HIF1α stabilization. Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.",
            "authors": {
              "abbreviation": "Aifu Lin, Chunlai Li, Zhen Xing, ..., Liuqing Yang",
              "authorList": [
                {
                  "ForeName": "Aifu",
                  "LastName": "Lin",
                  "abbrevName": "Lin A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Aifu Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Chunlai",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunlai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Zhen",
                  "LastName": "Xing",
                  "abbrevName": "Xing Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhen Xing",
                  "orcid": null
                },
                {
                  "ForeName": "Qingsong",
                  "LastName": "Hu",
                  "abbrevName": "Hu Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingsong Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Ke",
                  "LastName": "Liang",
                  "abbrevName": "Liang K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ke Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Leng",
                  "LastName": "Han",
                  "abbrevName": "Han L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leng Han",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Wang",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Hawke",
                  "abbrevName": "Hawke DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David H Hawke",
                  "orcid": "0000-0002-6102-7843"
                },
                {
                  "ForeName": "Shouyu",
                  "LastName": "Wang",
                  "abbrevName": "Wang S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shouyu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yanyan",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yanyan Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yongkun",
                  "LastName": "Wei",
                  "abbrevName": "Wei Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yongkun Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Guolin",
                  "LastName": "Ma",
                  "abbrevName": "Ma G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guolin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Park",
                  "abbrevName": "Park PK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter K Park",
                  "orcid": null
                },
                {
                  "ForeName": "Jianwei",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianwei Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Zhibin",
                  "LastName": "Hu",
                  "abbrevName": "Hu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhibin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Yubin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yubin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Jeffery",
                  "LastName": "Marks",
                  "abbrevName": "Marks JR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeffery R Marks",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Han Liang",
                  "orcid": "0000-0001-7633-286X"
                },
                {
                  "ForeName": "Mien-Chie",
                  "LastName": "Hung",
                  "abbrevName": "Hung MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mien-Chie Hung",
                  "orcid": null
                },
                {
                  "ForeName": "Chunru",
                  "LastName": "Lin",
                  "abbrevName": "Lin C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunru Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Liuqing",
                  "LastName": "Yang",
                  "abbrevName": "Yang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liuqing Yang",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncb3295",
            "pmid": "26751287",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Nat Cell Biol 18 2016",
            "title": "The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer."
          }
        },
        {
          "pmid": "35188449",
          "pubmed": {
            "ISODate": "2022-05-01T00:00:00.000Z",
            "abstract": "There is no clear treatment guideline or individualized treatment plan for triple-negative breast cancer (TNBC). The aim of this study was to investigate more effective targets for TNBC-targeted therapy. MDA-MB-231 and BT549 cell lines were used to explore the function of LINC00649 on the proliferation, invasion, and migration of TNBC cells. A mice subcutaneous tumor model and a pulmonary metastasis model was established to identify the role of LINC00649 on the growth and metastasis of TNBC in vivo. LINC00649 was found to be a key molecule involved in the occurrence and development of TNBC by screening of public databases and detection of TNBC clinical samples. LINC00649 increased hypoxia-inducible factor 1α (HIF-1α) mRNA stability and protein expression by interacting with the nuclear factor 90 (NF90)/NF45 complex. In vitro, interference with LINC00649 inhibits MDA-MB-231 and BT549 cell proliferation, migration, and invasion, and the addition of HIF-1α revised this effect. In vivo experiments showed that LINC00649 promoted the growth and metastasis of TNBC. We demonstrated that LINC00649 interacts with the NF90/NF45 complex to increase the mRNA stability of HIF-1α and up-regulate HIF-1α expression, thereby inducing the proliferation, invasion, and migration of TNBC cells as well as tumor growth and metastasis.",
            "authors": {
              "abbreviation": "Jianhua Zhang, Chuang Du, Linfeng Zhang, ..., Jingruo Li",
              "authorList": [
                {
                  "ForeName": "Jianhua",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianhua Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Chuang",
                  "LastName": "Du",
                  "abbrevName": "Du C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chuang Du",
                  "orcid": null
                },
                {
                  "ForeName": "Linfeng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linfeng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yingying",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yingying Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jingruo",
                  "LastName": "Li",
                  "abbrevName": "Li J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jingruo Li",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384101.2022.2040283",
            "pmid": "35188449",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Cycle 21 2022",
            "title": "LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex."
          }
        },
        {
          "pmid": "26918606",
          "pubmed": {
            "ISODate": "2016-03-29T00:00:00.000Z",
            "abstract": "Eukaryotic elongation factor 2 kinase (eEF2K), an emerging molecular target for cancer therapy, contributes to cancer proliferation, cell survival, tumorigenesis, and invasion, disease progression and drug resistance. Although eEF2K is highly up-regulated in various cancers, the mechanism of gene regulation has not been elucidated. In this study, we examined the role of Forkhead Box M1 (FOXM1) proto-oncogenic transcription factor in triple negative breast cancer (TNBC) cells and the regulation of eEF2K. We found that FOXM1 is highly upregulated in TNBC and its knockdown by RNA interference (siRNA) significantly inhibited eEF2K expression and suppressed cell proliferation, colony formation, migration, invasion and induced apoptotic cell death, recapitulating the effects of eEF2K inhibition. Knockdown of FOXM1 inhibited regulators of cell cycle, migration/invasion and survival, including cyclin D1, Src and MAPK-ERK signaling pathways, respectively. We also demonstrated that FOXM1 (1B and 1C isoforms) directly binds to and transcriptionally regulates eEF2K gene expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. Furthermore, in vivo inhibition of FOXM1 by liposomal siRNA-nanoparticles suppressed growth of MDA-MB-231 TNBC tumor xenografts in orthotopic models. In conclusion, our study provides the first evidence about the transcriptional regulation of eEF2K in TNBC and the role of FOXM1 in mediating breast cancer cell proliferation, survival, migration/invasion, progression and tumorgenesis and highlighting the potential of FOXM1/eEF2K axis as a molecular target in breast and other cancers.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.7672",
            "pmid": "26918606",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 7 2016",
            "title": "FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells."
          }
        },
        {
          "pmid": "31264274",
          "pubmed": {
            "ISODate": "2019-10-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype which accounts for 15%-20% of all breast cancer cases. The management of TNBC has remained a challenge due to its lack of targeted therapy. Previously, we reported that homeobox C8 (HOXC8) was involved in metastasis and migration of breast cancer cells. By chromatin immunoprecipitation and luciferase assays, we found that HOXC8 functioned as a transcription factor to activate the transcription of matrix Gla protein (MGP) gene, leading to an increase in the proliferation, anchorage-independent growth, and migration of TNBC cells. We further demonstrated that MGP expression promoted the epithelial-mesenchymal transition (EMT) process of TNBC cells, but not the other subtypes of breast cancer, suggesting that MGP induced EMT to promote proliferation and migration of TNBC cells. Moreover, we found that MGP was upregulated in clinical breast specimens compared to normal breast tissues and high MGP expression was statistically associated with poor, relapse-free survival for TNBC patients, indicating that MGP is probably a novel biomarker or therapeutic target for TNBC patients. Together, our results showed that the HOXC8-MGP axis played an important role in the tumorigenesis of TNBC and might be a promising therapeutic target for TNBC treatment.",
            "authors": {
              "abbreviation": "Chen Gong, Jin Zou, Mingsheng Zhang, ..., Yong Li",
              "authorList": [
                {
                  "ForeName": "Chen",
                  "LastName": "Gong",
                  "abbrevName": "Gong C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zou",
                  "abbrevName": "Zou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zou",
                  "orcid": null
                },
                {
                  "ForeName": "Mingsheng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingsheng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Shanshan",
                  "LastName": "Xu",
                  "abbrevName": "Xu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shanshan Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Siqi",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siqi Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Mengqi",
                  "LastName": "Yang",
                  "abbrevName": "Yang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mengqi Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Dongjia",
                  "LastName": "Li",
                  "abbrevName": "Li D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dongjia Li",
                  "orcid": null
                },
                {
                  "ForeName": "Yun",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jialu",
                  "LastName": "Shi",
                  "abbrevName": "Shi J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jialu Shi",
                  "orcid": null
                },
                {
                  "ForeName": "Yong",
                  "LastName": "Li",
                  "abbrevName": "Li Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yong Li",
                  "orcid": "0000-0003-4681-263X"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/mc.23079",
            "pmid": "31264274",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Mol Carcinog 58 2019",
            "title": "Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer."
          }
        },
        {
          "pmid": "30964885",
          "pubmed": {
            "ISODate": "2019-01-01T00:00:00.000Z",
            "abstract": "Triple-Negative Breast Cancers (TNBCs) are the most difficult to treat subtype of breast cancer and are often associated with high nuclear expression of Snail and Cathepsin L (Cat L) protease. We have previously shown that Snail can increase Cat L expression/activity in prostate and breast cancer cells. This study investigated the role of CUX1 (a downstream substrate of Cat L) in TNBC. We showed that Cat L and CUX1 were highly expressed in TNBC patient tissue/cell lines, as compared to ER-positive samples, using cBioportal data and western blot/zymography analyses. Additionally, luciferase reporter and chromatin immunoprecipitation assays showed that CUX1 directly bound to estrogen receptor-alpha (ER-α) promoter in MDA-MB-468, a representative TNBC cell line, and that CUX1 siRNA could restore ER-α transcription and protein expression. Furthermore, Snail and CUX1 expression in various TNBC cell lines was inhibited by muscadine grape skin extract (MSKE, a natural grape product rich in anthocyanins) or Cat L inhibitor (Z-FY-CHO) leading to decreased cell invasion and migration. MSKE decreased cell viability and increased expression of apoptotic markers in MDA-MB-468 cells, with no effect on non-tumorigenic MCF10A cells. MSKE also decreased CUX1 binding to ER-α promoter and restored ER-α expression in TNBC cells, while both MSKE and CUX1 siRNA restored sensitivity to estradiol and 4-hydoxytamoxifen as shown by increased cell viability. Therefore, CUX1 activated by Snail-Cat L signaling may contribute to TNBC via ER-α repression, and may be a viable target for TNBC using natural products such as MSKE that targets cancer and not normal cells.",
            "authors": {
              "abbreviation": "Liza J Burton, Ohuod Hawsawi, Janae Sweeney, ..., Valerie Odero-Marah",
              "authorList": [
                {
                  "ForeName": "Liza",
                  "LastName": "Burton",
                  "abbrevName": "Burton LJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liza J Burton",
                  "orcid": null
                },
                {
                  "ForeName": "Ohuod",
                  "LastName": "Hawsawi",
                  "abbrevName": "Hawsawi O",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ohuod Hawsawi",
                  "orcid": null
                },
                {
                  "ForeName": "Janae",
                  "LastName": "Sweeney",
                  "abbrevName": "Sweeney J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Janae Sweeney",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Bowen",
                  "abbrevName": "Bowen N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan Bowen",
                  "orcid": "0000-0002-1609-6698"
                },
                {
                  "ForeName": "Tamaro",
                  "LastName": "Hudson",
                  "abbrevName": "Hudson T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tamaro Hudson",
                  "orcid": null
                },
                {
                  "ForeName": "Valerie",
                  "LastName": "Odero-Marah",
                  "abbrevName": "Odero-Marah V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Valerie Odero-Marah",
                  "orcid": "0000-0002-5238-9914"
                }
              ],
              "contacts": []
            },
            "doi": "10.1371/journal.pone.0214844",
            "pmid": "30964885",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "PLoS One 14 2019",
            "title": "CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE)."
          }
        },
        {
          "pmid": "28239645",
          "pubmed": {
            "ISODate": "2017-02-23T00:00:00.000Z",
            "abstract": "Elucidating the molecular basis of tumor metastasis is pivotal for eradicating cancer-related mortality. Triple-negative breast cancer (TNBC) encompasses a class of aggressive tumors characterized by high rates of recurrence and metastasis, as well as poor overall survival. Here, we find that the promyelocytic leukemia protein PML exerts a prometastatic function in TNBC that can be targeted by arsenic trioxide. We found that, in TNBC patients, constitutive HIF1A activity induces high expression of PML, along with a number of HIF1A target genes that promote metastasis at multiple levels. Intriguingly, PML controls the expression of these genes by binding to their regulatory regions along with HIF1A. This mechanism is specific to TNBC cells and does not occur in other subtypes of breast cancer where PML and prometastatic HIF1A target genes are underexpressed. As a consequence, PML promotes cell migration, invasion, and metastasis in TNBC cell and mouse models. Notably, pharmacological inhibition of PML with arsenic trioxide, a PML-degrading agent used to treat promyelocytic leukemia patients, delays tumor growth, impairs TNBC metastasis, and cooperates with chemotherapy by preventing metastatic dissemination. In conclusion, we report identification of a prometastatic pathway in TNBC and suggest clinical development toward the use of arsenic trioxide for TNBC patients.",
            "authors": {
              "abbreviation": "Manfredi Ponente, Letizia Campanini, Roberto Cuttano, ..., Rosa Bernardi",
              "authorList": [
                {
                  "ForeName": "Manfredi",
                  "LastName": "Ponente",
                  "abbrevName": "Ponente M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Manfredi Ponente",
                  "orcid": null
                },
                {
                  "ForeName": "Letizia",
                  "LastName": "Campanini",
                  "abbrevName": "Campanini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Letizia Campanini",
                  "orcid": null
                },
                {
                  "ForeName": "Roberto",
                  "LastName": "Cuttano",
                  "abbrevName": "Cuttano R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberto Cuttano",
                  "orcid": null
                },
                {
                  "ForeName": "Andrea",
                  "LastName": "Piunti",
                  "abbrevName": "Piunti A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrea Piunti",
                  "orcid": null
                },
                {
                  "ForeName": "Giacomo",
                  "LastName": "Delledonne",
                  "abbrevName": "Delledonne GA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giacomo A Delledonne",
                  "orcid": null
                },
                {
                  "ForeName": "Nadia",
                  "LastName": "Coltella",
                  "abbrevName": "Coltella N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nadia Coltella",
                  "orcid": null
                },
                {
                  "ForeName": "Roberta",
                  "LastName": "Valsecchi",
                  "abbrevName": "Valsecchi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberta Valsecchi",
                  "orcid": null
                },
                {
                  "ForeName": "Alessandra",
                  "LastName": "Villa",
                  "abbrevName": "Villa A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alessandra Villa",
                  "orcid": null
                },
                {
                  "ForeName": "Ugo",
                  "LastName": "Cavallaro",
                  "abbrevName": "Cavallaro U",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ugo Cavallaro",
                  "orcid": null
                },
                {
                  "ForeName": "Linda",
                  "LastName": "Pattini",
                  "abbrevName": "Pattini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linda Pattini",
                  "orcid": null
                },
                {
                  "ForeName": "Claudio",
                  "LastName": "Doglioni",
                  "abbrevName": "Doglioni C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Claudio Doglioni",
                  "orcid": null
                },
                {
                  "ForeName": "Rosa",
                  "LastName": "Bernardi",
                  "abbrevName": "Bernardi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Bernardi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1172/jci.insight.87380",
            "pmid": "28239645",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "JCI Insight 2 2017",
            "title": "PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes."
          }
        },
        {
          "pmid": "29333926",
          "pubmed": {
            "ISODate": "2018-04-03T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by poor patient prognosis and for which no targeted therapies are currently available. TNBC can be further categorized as either basal-like (BLBC) or quintuple-negative breast cancer (QNBC). In the present study, we aimed to identify novel molecular therapeutic targets for TNBC by analyzing the mRNA expression of TNBC-related genes in publicly available microarray data sets. We found that Engrailed 1 (EN1) was significantly overexpressed in TNBC. Using breast cancer cell lines, we found that EN1 was more highly expressed in TNBC than in other breast cancer subtypes. EN1 expression was analyzed in 199 TNBC paraffin-embedded tissue samples by immunohistochemistry. EN1 protein expression was positively associated with reduced overall survival (OS) rate in patients with QNBC, but not those with BLBC. The importance of EN1 expression in QNBC cell viability and tumorigenicity was evaluated using the QNBC cell lines, HCC38 and HCC1395. Based on our data, EN1 may promote the proliferation, migration, and multinucleation of QNBC cells, likely via the transcriptional activation of HDAC8, UTP11L, and ZIC3. We also demonstrated that actinomycin D effectively inhibits EN1 activity in QNBC cells. The results of the present study suggest that EN1 activity is highly clinically relevant to the survival prognosis of patients with QNBC and EN1 is a promising potential therapeutic target for future QNBC treatment.",
            "authors": {
              "abbreviation": "Yu Jin Kim, Minjung Sung, Ensel Oh, ..., Yoon-La Choi",
              "authorList": [
                {
                  "ForeName": "Yu",
                  "LastName": "Kim",
                  "abbrevName": "Kim YJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Jin Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Minjung",
                  "LastName": "Sung",
                  "abbrevName": "Sung M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minjung Sung",
                  "orcid": null
                },
                {
                  "ForeName": "Ensel",
                  "LastName": "Oh",
                  "abbrevName": "Oh E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ensel Oh",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Vrancken",
                  "abbrevName": "Vrancken MV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Van Vrancken",
                  "orcid": null
                },
                {
                  "ForeName": "Ji-Young",
                  "LastName": "Song",
                  "abbrevName": "Song JY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ji-Young Song",
                  "orcid": null
                },
                {
                  "ForeName": "Kyungsoo",
                  "LastName": "Jung",
                  "abbrevName": "Jung K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyungsoo Jung",
                  "orcid": null
                },
                {
                  "ForeName": "Yoon-La",
                  "LastName": "Choi",
                  "abbrevName": "Choi YL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yoon-La Choi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2018.1423913",
            "pmid": "29333926",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 19 2018",
            "title": "Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer."
          }
        },
        {
          "pmid": "32114388",
          "pubmed": {
            "ISODate": "2020-03-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Liver cancer stem cells (CSCs) are critical determinants of HCC relapse and therapeutic resistance, but the mechanisms underlying the maintenance of CSCs are poorly understood. We aimed to explore the role of tumor repressor Zinc-fingers and homeoboxes 2 (ZHX2) in liver CSCs. METHODS: CD133+ or EPCAM+ stem-like liver cancer cells were sorted from tumor tissues of HCC patients and HCC cell lines by flow cytometry. In addition, sorafenib-resistant cells, tumor-sphere forming cells and side population (SP) cells were respectively cultured and isolated as hepatic CSCs. The tumor-initiating and chemoresistance properties of ZHX2-overexpressing and ZHX2-knockdown cells were analyzed in vivo and in vitro. Microarray, luciferase reporter assay, chromatin immunoprecipitation (ChIP) and ChIP-on-chip analyses were performed to explore ZHX2 target genes. The expression of ZHX2 and its target gene were determined by quantitative RT-PCR, western blot, immunofluorescence and immunohistochemical staining in hepatoma cells and tumor and adjacent tissues from HCC patients. RESULTS: ZHX2 expression was significantly reduced in liver CSCs from different origins. ZHX2 deficiency led to enhanced liver tumor progression and expansion of CSC populations in vitro and in vivo. Re-expression of ZHX2 restricted capabilities of hepatic CSCs in supporting tumor initiation, self-renewal and sorafenib-resistance. Mechanically, ZHX2 suppressed liver CSCs via inhibiting KDM2A-mediated demethylation of histone H3 lysine 36 (H3K36) at the promoter regions of stemness-associated transcription factors, such as NANOG, SOX4 and OCT4. Moreover, patients with lower expression of ZHX2 and higher expression of KDM2A in tumor tissues showed significantly poorer survival. CONCLUSION: ZHX2 counteracts stem cell traits through transcriptionally repressing KDM2A in HCC. Our data will aid in a better understanding of molecular mechanisms underlying HCC relapse and drug resistance.",
            "authors": {
              "abbreviation": "Qinghai Lin, Zhuanchang Wu, Xuetian Yue, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying",
                  "LastName": "He",
                  "abbrevName": "He Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying He",
                  "orcid": null
                },
                {
                  "ForeName": "Yutong",
                  "LastName": "Ge",
                  "abbrevName": "Ge Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yutong Ge",
                  "orcid": null
                },
                {
                  "ForeName": "Siyu",
                  "LastName": "Tan",
                  "abbrevName": "Tan S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siyu Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Song",
                  "abbrevName": "Song H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Song",
                  "orcid": null
                },
                {
                  "ForeName": "Detian",
                  "LastName": "Yuan",
                  "abbrevName": "Yuan D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Detian Yuan",
                  "orcid": null
                },
                {
                  "ForeName": "Yaoqin",
                  "LastName": "Gong",
                  "abbrevName": "Gong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yaoqin Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.ebiom.2020.102676",
            "pmid": "32114388",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "EBioMedicine 53 2020",
            "title": "ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation."
          }
        },
        {
          "pmid": "34408002",
          "pubmed": {
            "ISODate": "2021-11-01T00:00:00.000Z",
            "abstract": "Genomic alterations are crucial for the development and progression of human cancers. Copy-number gains found in genes encoding metabolic enzymes may induce triple-negative breast cancer (TNBC) adaptation. However, little is known about how metabolic enzymes regulate TNBC metastasis. Using our previously constructed multiomic profiling of a TNBC cohort, we identified decaprenyl diphosphate synthase subunit 1 (PDSS1) as an essential gene for TNBC metastasis. PDSS1 expression was significantly upregulated in TNBC tissues compared with adjacent normal tissues and was positively associated with poor survival among patients with TNBC. PDSS1 knockdown inhibited TNBC cell migration, invasion, and distant metastasis. Mechanistically, PDSS1, but not a catalytically inactive mutant, positively regulated the cellular level of coenzyme Q10 (CoQ10) and intracellular calcium levels, thereby inducing CAMK2A phosphorylation, which is essential for STAT3 phosphorylation in the cytoplasm. Phosphorylated STAT3 entered the nucleus, promoting oncogenic STAT3 signaling and TNBC metastasis. STAT3 phosphorylation inhibitors (e.g., Stattic) effectively blocked PDSS1-induced cell migration and invasion in vitro and tumor metastasis in vivo. Taken together, our study highlights the importance of targeting the previously uncharacterized PDSS1/CAMK2A/STAT3 oncogenic signaling axis, expanding the repertoire of precision medicine in TNBC. SIGNIFICANCE: A novel metabolic gene PDSS1 is highly expressed in triple-negative breast cancer tissues and contributes to metastasis, serving as a potential therapeutic target for combating metastatic disease.",
            "authors": {
              "abbreviation": "Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li, ..., Yi-Zhou Jiang",
              "authorList": [
                {
                  "ForeName": "Tian-Jian",
                  "LastName": "Yu",
                  "abbrevName": "Yu TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tian-Jian Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying-Ying",
                  "LastName": "Liu",
                  "abbrevName": "Liu YY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying-Ying Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Xiao-Guang",
                  "LastName": "Li",
                  "abbrevName": "Li XG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiao-Guang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bi",
                  "LastName": "Lian",
                  "abbrevName": "Lian B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bi Lian",
                  "orcid": null
                },
                {
                  "ForeName": "Xun-Xi",
                  "LastName": "Lu",
                  "abbrevName": "Lu XX",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xun-Xi Lu",
                  "orcid": "0000-0002-5118-0377"
                },
                {
                  "ForeName": "Xi",
                  "LastName": "Jin",
                  "abbrevName": "Jin X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhi-Ming",
                  "LastName": "Shao",
                  "abbrevName": "Shao ZM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhi-Ming Shao",
                  "orcid": "0000-0001-8781-2455"
                },
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "abbrevName": "Hu X",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Xin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "abbrevName": "Di GH",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Gen-Hong Di",
                  "orcid": null
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "abbrevName": "Jiang YZ",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Yi-Zhou Jiang",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Xin Hu"
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Gen-Hong Di"
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Yi-Zhou Jiang"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-21-0747",
            "pmid": "34408002",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Res 81 2021",
            "title": "PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "33824311",
          "pubmed": {
            "ISODate": "2021-04-06T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive subtype with the worst prognosis and the highest metastatic and recurrence potential, which represents 15-20% of all breast cancers in Chinese females, and the 5-year overall survival rate is about 80% in Chinese women. Recently, emerging evidence suggested that aberrant alternative splicing (AS) plays a crucial role in tumorigenesis and progression. AS is generally controlled by AS-associated RNA binding proteins (RBPs). Monocyte chemotactic protein induced protein 1 (MCPIP1), a zinc finger RBP, functions as a tumor suppressor in many cancers. Here, we showed that MCPIP1 was downregulated in 80 TNBC tissues and five TNBC cell lines compared to adjacent paracancerous tissues and one human immortalized breast epithelial cell line, while its high expression levels were associated with increased overall survival in TNBC patients. We demonstrated that MCPIP1 overexpression dramatically suppressed cell cycle progression and proliferation of TNBC cells in vitro and repressed tumor growth in vivo. Mechanistically, MCPIP1 was first demonstrated to act as a splicing factor to regulate AS in TNBC cells. Furthermore, we demonstrated that MCPIP1 modulated NFIC AS to promote CTF5 synthesis, which acted as a negative regulator in TNBC cells. Subsequently, we showed that CTF5 participated in MCPIP1-mediated antiproliferative effect by transcriptionally repressing cyclin D1 expression, as well as downregulating its downstream signaling targets p-Rb and E2F1. Conclusively, our findings provided novel insights into the anti-oncogenic mechanism of MCPIP1, suggesting that MCPIP1 could serve as an alternative treatment target in TNBC.",
            "authors": {
              "abbreviation": "Fengxia Chen, Qingqing Wang, Xiaoyan Yu, ..., Yunfeng Zhou",
              "authorList": [
                {
                  "ForeName": "Fengxia",
                  "LastName": "Chen",
                  "abbrevName": "Chen F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fengxia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Qingqing",
                  "LastName": "Wang",
                  "abbrevName": "Wang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingqing Wang",
                  "orcid": "0000-0002-6440-582X"
                },
                {
                  "ForeName": "Xiaoyan",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaoyan Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ningning",
                  "LastName": "Yang",
                  "abbrevName": "Yang N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ningning Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Yuan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuan Wang",
                  "orcid": "0000-0003-1894-0853"
                },
                {
                  "ForeName": "Yangyang",
                  "LastName": "Zeng",
                  "abbrevName": "Zeng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yangyang Zeng",
                  "orcid": null
                },
                {
                  "ForeName": "Zhewen",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhewen Zheng",
                  "orcid": null
                },
                {
                  "ForeName": "Fuxiang",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fuxiang Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": "yfzhouwhu@163.com",
                  "isCollectiveName": false,
                  "name": "Yunfeng Zhou",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "email": [
                    "yfzhouwhu@163.com"
                  ],
                  "name": "Yunfeng Zhou"
                }
              ]
            },
            "doi": "10.1038/s41419-021-03661-4",
            "pmid": "33824311",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 12 2021",
            "title": "MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis."
          }
        },
        {
          "pmid": "24248265",
          "pubmed": {
            "ISODate": "2014-02-01T00:00:00.000Z",
            "abstract": "UNLABELLED: Targeted therapy against triple-negative breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor. One of the molecular hallmarks of triple-negative breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many critical aspects of cancer progression including metabolism, angiogenesis, invasion, metastasis, and stem cell maintenance. Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a molecular chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α. In this study, human MDA-MB-231 and MDA-MB-435 triple-negative breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly intravenous injections of ganetespib or vehicle following the development of palpable tumors. Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs. Ganetespib treatment also significantly reduced the number of Aldefluor-positive cancer stem cells in the primary tumor. Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer. KEY MESSAGES: Triple-negative breast cancers (TNBCs) respond poorly to available chemotherapy. TNBCs overexpress genes regulated by hypoxia-inducible factors (HIFs). Ganetespib induces degradation of HSP90 client proteins, including HIF-1α. Ganetespib inhibited TNBC orthotopic tumor growth, invasion, and metastasis. Ganetespib inhibited expression of HIF-1 target genes involved in TNBC progression.",
            "authors": {
              "abbreviation": "Lisha Xiang, Daniele M Gilkes, Pallavi Chaturvedi, ..., Gregg L Semenza",
              "authorList": [
                {
                  "ForeName": "Lisha",
                  "LastName": "Xiang",
                  "abbrevName": "Xiang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lisha Xiang",
                  "orcid": null
                },
                {
                  "ForeName": "Daniele",
                  "LastName": "Gilkes",
                  "abbrevName": "Gilkes DM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniele M Gilkes",
                  "orcid": null
                },
                {
                  "ForeName": "Pallavi",
                  "LastName": "Chaturvedi",
                  "abbrevName": "Chaturvedi P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pallavi Chaturvedi",
                  "orcid": null
                },
                {
                  "ForeName": "Weibo",
                  "LastName": "Luo",
                  "abbrevName": "Luo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weibo Luo",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxia",
                  "LastName": "Hu",
                  "abbrevName": "Hu H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxia Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Naoharu",
                  "LastName": "Takano",
                  "abbrevName": "Takano N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naoharu Takano",
                  "orcid": null
                },
                {
                  "ForeName": "Houjie",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Houjie Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gregg L Semenza",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1007/s00109-013-1102-5",
            "pmid": "24248265",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mol Med (Berl) 92 2014",
            "title": "Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer."
          }
        },
        {
          "pmid": "25920936",
          "pubmed": {
            "ISODate": "2015-01-01T00:00:00.000Z",
            "abstract": "Hypoxia is associated with poor response to treatment in various cancers. Hypoxia inducible factor 1 (HIF-1) is a major transcription factor that mediates adaptation of cancer cells to a hypoxic environment and regulates many genes that are involved in key cellular functions, including cell immortalization, stem cell maintenance, autocrine growth/survival, angiogenesis, invasion/metastasis, and resistance to chemotherapy. HIF-1α has been considered as an attractive therapeutic target for cancer treatment, but there is limited success in this research field. In the present study, we designed a recombinant lentivirus containing HIF-1α siRNA, developed stably transfected cell lines, and tested the anticancer effects of the siRNA on cancer cells in vitro and in vivo. Our results indicated that the stable downregulation of HIF-1α reversed chemoresistance, inhibited proliferation, migration and invasion of cancer cells, and slowed down the tumor growth in breast cancer xenograft models. In conclusion, the recombinant lentivirus containing HIF-1α siRNA provides a new avenue for developing novel therapy for triple negative breast cancer.",
            "authors": {
              "abbreviation": "Shuang Li, Qingzhu Wei, Qin Li, ..., Qiang Xiao",
              "authorList": [
                {
                  "ForeName": "Shuang",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Qingzhu",
                  "LastName": "Wei",
                  "abbrevName": "Wei Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingzhu Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Qin",
                  "LastName": "Li",
                  "abbrevName": "Li Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qin Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qiang",
                  "LastName": "Xiao",
                  "abbrevName": "Xiao Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qiang Xiao",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2015.1040958",
            "pmid": "25920936",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 16 2015",
            "title": "Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer."
          }
        },
        {
          "pmid": "31683461",
          "pubmed": {
            "ISODate": "2020-01-01T00:00:00.000Z",
            "abstract": "OBJECTIVE: To investigate the effect of ZHX2 on lung cancer cells proliferation and apoptosis. MATERIALS AND METHODS: The mRNA and protein expression of ZHX2 were detected by qRT-PCR and western blot, respectively. The human lung cancer cells were divided into Control, NC, ZHX2, SB, and ZHX2 + Ani groups. The cell proliferation was detected by CCK-8 assay and the cell migration and invasion were detected by Transwell assay. Cell apoptosis was detected by flow cytometry. Apoptosis and p38MAPK signaling pathway related proteins were detected by western blot. The nude mice model of lung cancer xenograft was constructed. The tumor volume and tumor weight were measured. The expression of PCNA protein in tumor tissues was detected by immunohistochemistry. The apoptosis of tumor cells was detected by TUNEL staining. The ZHX2 and p38MAPK signaling pathway related proteins in tumor tissues were detected by western blot. RESULTS: The expression of ZHX2 gene and protein in the cancer cell lines were significantly decreased. Compared with control and NC groups, the cells proliferation, migration and invasion were inhibited in ZHX2 and SB groups, while the apoptosis and apoptosis related proteins were increased (p< 0.05). Meanwhile, compared with ZHX2 group, the tumor growth rate, volume, weight, the percentage of PCNA-positive cells, and p-P38 MAPK/P38 MAPK were increased significantly in ZHX2 + Ani group, while the apoptotic index and the expression of MMP-9 protein were significantly decreased (p< 0.05). CONCLUSION: ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway.",
            "authors": {
              "abbreviation": "Xudong Tian, Yadong Wang, Shuhai Li, ..., Hui Tian",
              "authorList": [
                {
                  "ForeName": "Xudong",
                  "LastName": "Tian",
                  "abbrevName": "Tian X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xudong Tian",
                  "orcid": null
                },
                {
                  "ForeName": "Yadong",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadong Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Shuhai",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuhai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Weiming",
                  "LastName": "Yue",
                  "abbrevName": "Yue W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weiming Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Tian",
                  "abbrevName": "Tian H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Tian",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3233/CBM-190514",
            "pmid": "31683461",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cancer Biomark 27 2020",
            "title": "ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway."
          }
        },
        {
          "pmid": "28361350",
          "pubmed": {
            "ISODate": "2017-06-01T00:00:00.000Z",
            "abstract": "PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer and associated with early metastasis, drug resistance, and poor patient survival. Fork head box M1 (FOXM1) is considered as an emerging molecular target due to its oncogenic role and high overexpression profile in 85% in TNBC. However, molecular mechanisms by which FOXM1 transcription factor mediate its oncogenic effects are not fully understood. Integrin β1 is often upregulated in invasive breast cancers and associated with poor clinical outcome and shorter overall patient survival in TNBC. However, the mechanisms regulating integrin β1 (ITGB1) gene expression have not been well elucidated. METHODS: Normal breast epithelium (MCF10A) and TNBC cells (i.e., MDA-MB-231, BT-20 MDA-MB436) were used for the study. Small interfering RNA (siRNA)-based knockdown was used to inhibit Integrin β1 gene (mRNA) and protein expressions, which are detected by RT-PCR and Western blot, respectively. Chromatin immunoprecipitation (ChiP) and gene reporter (Luciferase) assays were used to demonstrate that FOXM1 transcription factor binds to the promoter of Integrin β1 gene and drives its expression. RESULTS: We demonstrated that FOXM1 directly binds to the promoter of integrin β1 gene and transcriptionally regulates its expression and activity of focal adhesion kinase (FAK) in TNBC cells. CONCLUSION: Our study suggests that FOXM1 transcription factor regulates Integrin β1 gene expression and that FOXM1/ Integrin-β1/FAK axis may play an important role in the progression of TNBC.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": "bozpolat@mdanderson.org",
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "email": [
                    "bozpolat@mdanderson.org"
                  ],
                  "name": "Bulent Ozpolat"
                }
              ]
            },
            "doi": "10.1007/s10549-017-4207-7",
            "pmid": "28361350",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Breast Cancer Res Treat 163 2017",
            "title": "FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer."
          }
        },
        {
          "pmid": "30784286",
          "pubmed": {
            "ISODate": "2019-05-23T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The unclear molecular mechanisms underlying could provide important theoretical basis for the prevention and control of HCC. This study performed chromatin immunoprecipitation-sequencing (ChIP-seq) to analyze the binding sites between zinc fingers and homeoboxes 2 (ZHX2) and its genome-wide target genes, and bioinformatics was used to analyze their gene transcription regulation network. Immunohistochemistry was used to detect the ZHX2 expression in HCC, and its association with the clinicopathological characteristics of HCC. Results of RT-PCR and western blot showed the expression of ZHX2 in HepG2 cells was obviously lower compared with normal liver cells. ZHX2 could be amplified in ChIP products, then ChIP-seq reveals there were 232 genes binding in promoter regions. GO analysis of functions revealed these genes were mainly associated with biological processes (BP), cellular components (CC), and molecular functions (MF). In addition, PTEN was found enriched in certain biological functions in BP analysis. Then, four pathways of these genes based on Kyoto Encyclopedia of Genes and Genomes (KEGG) were found P<0.05. Last analysis of immunohistochemistry showed the rates of ZHX2 expression and PTEN expression in paracancerous tissues both were significantly higher than that in HCC tissues (P=0.042; P<0.001), with negative correlations with AFP values (r=-0.246, P=0.040; r=-0.263, P=0.028). Further, PTEN expression was positively correlated with the differentiation level in HCC tissues (r=0.267, P=0.025). Spearman correlation analysis revealed that the expression profiles of ZHX2 and PTEN were positively correlated in HCC tissues (r=0.258, P=0.031). This study is the first to use ChIP-seq technology to analyze the specific regulatory mechanisms of the transcription suppressor ZHX2 in the context of HCC at the genome level.",
            "authors": {
              "abbreviation": "Z Lv, R He, M Huang, ..., G Chen",
              "authorList": [
                {
                  "ForeName": "Z",
                  "LastName": "Lv",
                  "abbrevName": "Lv Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Lv",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "He",
                  "abbrevName": "He R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R He",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Huang",
                  "abbrevName": "Huang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Huang",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Ma",
                  "abbrevName": "Ma J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Ma",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Chen",
                  "abbrevName": "Chen G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Chen",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.4149/neo_2018_180806N593",
            "pmid": "30784286",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Neoplasma 66 2019",
            "title": "Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation."
          }
        }
      ],
      "relatedPapersNotified": true,
      "secret": "read-only",
      "source": "admin",
      "status": "public",
      "tweet": null,
      "verified": false
    }
  ],
  "element": [
    {
      "_creationTimestamp": "2022-12-10T08:44:02.347Z",
      "_newestOpId": "08cf2332-41f9-4119-91ec-0228d8f84f48",
      "_ops": [],
      "association": {
        "charge": null,
        "combinedOrganismIndex": 2,
        "dbName": "NCBI Gene",
        "dbPrefix": "ncbigene",
        "dbXrefs": [
          {
            "db": "MIM",
            "id": "609185"
          },
          {
            "db": "HGNC",
            "id": "HGNC:18513"
          },
          {
            "db": "Ensembl",
            "id": "ENSG00000178764"
          }
        ],
        "defaultOrganismIndex": 2,
        "distance": 0,
        "esScore": 11.855772,
        "formulae": null,
        "id": "22882",
        "inchi": null,
        "inchiKey": null,
        "mass": null,
        "monoisotopicMass": null,
        "name": "ZHX2",
        "nameDistance": 0,
        "namespace": "ncbi",
        "organism": "9606",
        "organismIndex": 0,
        "organismName": "Homo sapiens",
        "overallDistance": 200000,
        "shortSynonyms": [
          "AFR1",
          "RAF",
          "zinc fingers and homeoboxes protein 2",
          "AFP regulator 1",
          "alpha-fetoprotein regulator 1",
          "regulator of AFP",
          "transcription factor ZHX2",
          "zinc finger and homeodomain protein 2",
          "zinc fingers and homeoboxes 2"
        ],
        "summary": null,
        "synonyms": [
          "AFR1",
          "RAF",
          "zinc fingers and homeoboxes protein 2",
          "AFP regulator 1",
          "alpha-fetoprotein regulator 1",
          "regulator of AFP",
          "transcription factor ZHX2",
          "zinc finger and homeodomain protein 2",
          "zinc fingers and homeoboxes 2"
        ],
        "type": "protein"
      },
      "completed": true,
      "description": "",
      "id": "13f57ee3-df7d-4ec8-b8ca-0efdd62f99d5",
      "liveId": "7615b7ab-4f47-467a-98ef-c49f1adb1fe1",
      "lock": null,
      "locked": false,
      "name": "ZHX2",
      "parentId": "3fd6a28f-483e-4eb4-ab6f-0a9025bd9cd1",
      "position": {
        "x": 316.0713463751438,
        "y": 148.49271192942072
      },
      "relatedPapers": [
        {
          "pmid": "25195714",
          "pubmed": {
            "ISODate": "2014-10-01T00:00:00.000Z",
            "abstract": "Glypican 3 (GPC3) has been paid particular attention owing to its potential as diagnosis marker for hepatocellular carcinoma (HCC). Identifying the mechanisms regulating the reactivation of GPC3 in HCC appears to be clinically meaningful. Previous study identified zinc-fingers and homeoboxes 2 (ZHX2) as transcriptional factor responsible for postnatal repression of GPC3 in mice. Here, in this study, we provided the first evidence that down regulated ZHX2 is responsible for GPC3 reactivation in HCC. First, inverse correlation of ZHX2 with GPC3 expression was shown in cultured liver cell lines. Second, ZHX2 overexpression significantly decreased GPC3 expression, while ZHX2 knockdown effectively increased GPC3 level in different HCC cell lines. Consistently, dual luciferase and ChIP assay showed that ZHX2 dose-dependently suppressed GPC3 promoter activity by binding with the core promoter. More importantly, immunohistochemical staining demonstrated the inverse correlation between nuclear ZHX2 with GPC3 expression in HCC tissues. Further in vitro analysis showed that nuclear translocation was crucial for ZHX2 mediated repression on GPC3 transcription. Taken together, our results prove that ZHX2 suppresses GPC3 transcription by binding with its core promoter and reduced nucleic ZHX2 expression may be involved in GPC3 reactivation in HCC.",
            "authors": {
              "abbreviation": "Fang Luan, Peng Liu, Hongxin Ma, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Fang",
                  "LastName": "Luan",
                  "abbrevName": "Luan F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fang Luan",
                  "orcid": null
                },
                {
                  "ForeName": "Peng",
                  "LastName": "Liu",
                  "abbrevName": "Liu P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.biocel.2014.08.021",
            "pmid": "25195714",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Int J Biochem Cell Biol 55 2014",
            "title": "Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma."
          }
        },
        {
          "pmid": "28239645",
          "pubmed": {
            "ISODate": "2017-02-23T00:00:00.000Z",
            "abstract": "Elucidating the molecular basis of tumor metastasis is pivotal for eradicating cancer-related mortality. Triple-negative breast cancer (TNBC) encompasses a class of aggressive tumors characterized by high rates of recurrence and metastasis, as well as poor overall survival. Here, we find that the promyelocytic leukemia protein PML exerts a prometastatic function in TNBC that can be targeted by arsenic trioxide. We found that, in TNBC patients, constitutive HIF1A activity induces high expression of PML, along with a number of HIF1A target genes that promote metastasis at multiple levels. Intriguingly, PML controls the expression of these genes by binding to their regulatory regions along with HIF1A. This mechanism is specific to TNBC cells and does not occur in other subtypes of breast cancer where PML and prometastatic HIF1A target genes are underexpressed. As a consequence, PML promotes cell migration, invasion, and metastasis in TNBC cell and mouse models. Notably, pharmacological inhibition of PML with arsenic trioxide, a PML-degrading agent used to treat promyelocytic leukemia patients, delays tumor growth, impairs TNBC metastasis, and cooperates with chemotherapy by preventing metastatic dissemination. In conclusion, we report identification of a prometastatic pathway in TNBC and suggest clinical development toward the use of arsenic trioxide for TNBC patients.",
            "authors": {
              "abbreviation": "Manfredi Ponente, Letizia Campanini, Roberto Cuttano, ..., Rosa Bernardi",
              "authorList": [
                {
                  "ForeName": "Manfredi",
                  "LastName": "Ponente",
                  "abbrevName": "Ponente M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Manfredi Ponente",
                  "orcid": null
                },
                {
                  "ForeName": "Letizia",
                  "LastName": "Campanini",
                  "abbrevName": "Campanini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Letizia Campanini",
                  "orcid": null
                },
                {
                  "ForeName": "Roberto",
                  "LastName": "Cuttano",
                  "abbrevName": "Cuttano R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberto Cuttano",
                  "orcid": null
                },
                {
                  "ForeName": "Andrea",
                  "LastName": "Piunti",
                  "abbrevName": "Piunti A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrea Piunti",
                  "orcid": null
                },
                {
                  "ForeName": "Giacomo",
                  "LastName": "Delledonne",
                  "abbrevName": "Delledonne GA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giacomo A Delledonne",
                  "orcid": null
                },
                {
                  "ForeName": "Nadia",
                  "LastName": "Coltella",
                  "abbrevName": "Coltella N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nadia Coltella",
                  "orcid": null
                },
                {
                  "ForeName": "Roberta",
                  "LastName": "Valsecchi",
                  "abbrevName": "Valsecchi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberta Valsecchi",
                  "orcid": null
                },
                {
                  "ForeName": "Alessandra",
                  "LastName": "Villa",
                  "abbrevName": "Villa A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alessandra Villa",
                  "orcid": null
                },
                {
                  "ForeName": "Ugo",
                  "LastName": "Cavallaro",
                  "abbrevName": "Cavallaro U",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ugo Cavallaro",
                  "orcid": null
                },
                {
                  "ForeName": "Linda",
                  "LastName": "Pattini",
                  "abbrevName": "Pattini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linda Pattini",
                  "orcid": null
                },
                {
                  "ForeName": "Claudio",
                  "LastName": "Doglioni",
                  "abbrevName": "Doglioni C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Claudio Doglioni",
                  "orcid": null
                },
                {
                  "ForeName": "Rosa",
                  "LastName": "Bernardi",
                  "abbrevName": "Bernardi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Bernardi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1172/jci.insight.87380",
            "pmid": "28239645",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "JCI Insight 2 2017",
            "title": "PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes."
          }
        },
        {
          "pmid": "28054302",
          "pubmed": {
            "ISODate": "2017-04-01T00:00:00.000Z",
            "abstract": "PURPOSE: Despite advances that have been made in systemic chemotherapy, the prognosis of advanced triple-negative breast cancer (TNBC) patients is still poor. The identification of key factors governing TNBC development is considered imperative for the development of novel effective therapeutic approaches. Previously, it has been reported that microRNA (miR)-761 may act as either a tumor suppressor or as an oncogene in different types of cancer. Here, we aimed at assessing the biological role of this miRNA in TNBC. METHODS: First, we measured the expression of miR-761 in primary breast cancer tissues and breast cancer-derived cell lines using qRT-PCR. Subsequently, over-expression and silencing experiments were performed to determine the role of miR-761 in TNBC cell proliferation, colony formation, migration and invasion in vitro. The in vivo role of miR-761 in TNBC growth and metastasis was determined in mouse models. Bioinformatics analyses, dual-luciferase reporter assays, Western blot analyses and rescue experiments were performed to identify miR-761 target gene(s). RESULTS: We found that miR-761 was up-regulated in primary breast cancer tissues and its derived cell lines and, particularly, in TNBC tissues and cell lines. We also found that exogenous miR-761 over-expression augmented in vitro TNBC cell proliferation, colony formation, migration and invasion, whereas miR-761 down-regulation impaired these features. In vivo, we found that miR-761 over-expression facilitated TNBC growth and lung metastasis. Mechanistically, miR-761 was found to negatively regulate the expression of tripartite motif-containing 29 (TRIM29) in TNBC cells by binding to the 3'-untranslated region of its mRNA. In conformity with these results, a significant negative correlation between miR-761 expression and TRIM29 protein expression was noted in primary TNBC tissues (r = -0.452, p = 0.0126). We also found that exogenous TRIM29 over-expression reversed the proliferative and invasive capacities of TNBC cells. CONCLUSIONS: Our data indicate that miR-761 acts as an oncogene in TNBC. This mode of action can, at least partially, be ascribed to the down-regulation of its target TRIM29. We suggest that miR-761 may serve as a promising therapeutic target for TNBC.",
            "authors": {
              "abbreviation": "Guang-Cheng Guo, Jia-Xiang Wang, Ming-Li Han, ..., Lin Li",
              "authorList": [
                {
                  "ForeName": "Guang-Cheng",
                  "LastName": "Guo",
                  "abbrevName": "Guo GC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guang-Cheng Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "abbrevName": "Wang JX",
                  "email": "ggc503@126.com",
                  "isCollectiveName": false,
                  "name": "Jia-Xiang Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Ming-Li",
                  "LastName": "Han",
                  "abbrevName": "Han ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ming-Li Han",
                  "orcid": null
                },
                {
                  "ForeName": "Lian-Ping",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang LP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lian-Ping Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Lin",
                  "LastName": "Li",
                  "abbrevName": "Li L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lin Li",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "email": [
                    "ggc503@126.com"
                  ],
                  "name": "Jia-Xiang Wang"
                }
              ]
            },
            "doi": "10.1007/s13402-016-0312-6",
            "pmid": "28054302",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cell Oncol (Dordr) 40 2017",
            "title": "microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression."
          }
        },
        {
          "pmid": "30026228",
          "pubmed": {
            "ISODate": "2018-07-20T00:00:00.000Z",
            "abstract": "Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor κB activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.",
            "authors": {
              "abbreviation": "Jing Zhang, Tao Wu, Jeremy Simon, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": "0000-0001-5380-3905"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": "0000-0002-3961-9009"
                },
                {
                  "ForeName": "Ryoichi",
                  "LastName": "Saito",
                  "abbrevName": "Saito R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ryoichi Saito",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Xian-De",
                  "LastName": "Liu",
                  "abbrevName": "Liu XD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian-De Liu",
                  "orcid": "0000-0002-9639-0458"
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Jonasch",
                  "abbrevName": "Jonasch E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric Jonasch",
                  "orcid": "0000-0003-0943-2806"
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaosai",
                  "LastName": "Yao",
                  "abbrevName": "Yao X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaosai Yao",
                  "orcid": "0000-0001-9729-0726"
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Teh",
                  "abbrevName": "Teh BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Tean Teh",
                  "orcid": "0000-0003-1514-1124"
                },
                {
                  "ForeName": "Patrick",
                  "LastName": "Tan",
                  "abbrevName": "Tan P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Patrick Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": "0000-0003-3034-4421"
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": "0000-0001-5337-4901"
                },
                {
                  "ForeName": "Cortney",
                  "LastName": "Lawrence",
                  "abbrevName": "Lawrence C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cortney Lawrence",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Fan",
                  "abbrevName": "Fan J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Fan",
                  "orcid": "0000-0003-3842-2391"
                },
                {
                  "ForeName": "Jiang",
                  "LastName": "Geng",
                  "abbrevName": "Geng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiang Geng",
                  "orcid": "0000-0002-7202-2167"
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Joel",
                  "LastName": "Parker",
                  "abbrevName": "Parker JS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joel S Parker",
                  "orcid": "0000-0003-2080-6901"
                },
                {
                  "ForeName": "J",
                  "LastName": "Auman",
                  "abbrevName": "Auman JT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Todd Auman",
                  "orcid": "0000-0002-9328-8829"
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "W",
                  "LastName": "Rathmell",
                  "abbrevName": "Rathmell WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kimryn Rathmell",
                  "orcid": "0000-0002-4984-0225"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": "0000-0001-6540-6130"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": "0000-0002-0574-4856"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": "0000-0003-1246-1333"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "qing_zhang@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "qing_zhang@med.unc.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1126/science.aap8411",
            "pmid": "30026228",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 361 2018",
            "title": "VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma."
          }
        },
        {
          "pmid": "26751287",
          "pubmed": {
            "ISODate": "2016-02-01T00:00:00.000Z",
            "abstract": "Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively. These events cause HIF1α stabilization, HIF1α-p300 interaction, and activation of HIF1α transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to the EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1α Tyr 565 phosphorylation interferes with Pro 564 hydroxylation, leading to normoxic HIF1α stabilization. Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.",
            "authors": {
              "abbreviation": "Aifu Lin, Chunlai Li, Zhen Xing, ..., Liuqing Yang",
              "authorList": [
                {
                  "ForeName": "Aifu",
                  "LastName": "Lin",
                  "abbrevName": "Lin A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Aifu Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Chunlai",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunlai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Zhen",
                  "LastName": "Xing",
                  "abbrevName": "Xing Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhen Xing",
                  "orcid": null
                },
                {
                  "ForeName": "Qingsong",
                  "LastName": "Hu",
                  "abbrevName": "Hu Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingsong Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Ke",
                  "LastName": "Liang",
                  "abbrevName": "Liang K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ke Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Leng",
                  "LastName": "Han",
                  "abbrevName": "Han L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leng Han",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Wang",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Hawke",
                  "abbrevName": "Hawke DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David H Hawke",
                  "orcid": "0000-0002-6102-7843"
                },
                {
                  "ForeName": "Shouyu",
                  "LastName": "Wang",
                  "abbrevName": "Wang S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shouyu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yanyan",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yanyan Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yongkun",
                  "LastName": "Wei",
                  "abbrevName": "Wei Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yongkun Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Guolin",
                  "LastName": "Ma",
                  "abbrevName": "Ma G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guolin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Park",
                  "abbrevName": "Park PK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter K Park",
                  "orcid": null
                },
                {
                  "ForeName": "Jianwei",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianwei Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Zhibin",
                  "LastName": "Hu",
                  "abbrevName": "Hu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhibin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Yubin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yubin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Jeffery",
                  "LastName": "Marks",
                  "abbrevName": "Marks JR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeffery R Marks",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Han Liang",
                  "orcid": "0000-0001-7633-286X"
                },
                {
                  "ForeName": "Mien-Chie",
                  "LastName": "Hung",
                  "abbrevName": "Hung MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mien-Chie Hung",
                  "orcid": null
                },
                {
                  "ForeName": "Chunru",
                  "LastName": "Lin",
                  "abbrevName": "Lin C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunru Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Liuqing",
                  "LastName": "Yang",
                  "abbrevName": "Yang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liuqing Yang",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncb3295",
            "pmid": "26751287",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Nat Cell Biol 18 2016",
            "title": "The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer."
          }
        },
        {
          "pmid": "27137755",
          "pubmed": {
            "ISODate": "2017-01-01T00:00:00.000Z",
            "abstract": "The aggressiveness of triple-negative breast cancer (TNBC), which lacks estrogen receptor, progesterone receptor and epidermal growth factor receptor 2 (HER2), represents a major challenge in breast cancer. Migratory and self-renewal capabilities are integral components of invasion, metastasis and recurrence of TNBC. Elevated hypoxia-inducible factor-1α (HIF-1α) expression is associated with aggressiveness of cancer. Nonetheless, how HIF-1α expression is regulated and how HIF-1α induces aggressive phenotype are not completely understood in TNBC. The cytotoxic effects of farnesyltransferase (FTase) inhibitors (FTIs) have been studied in cancer and leukemia cells. In contrast, the effect of FTIs on HIF-1α expression has not yet been studied. Here, we show that clinically relevant low-dose FTI, tipifarnib (300 nM), decreased HIF-1α expression, migration and tumorsphere formation in human MDA-MB-231 TNBC cells under a normoxic condition. In contrast, the low-dose FTIs did not inhibit cell growth and activity of the Ras pathway in MDA-MB 231 cells. Tipifarnib-induced decrease in HIF-1α expression was associated with amelioration of the Warburg effect, hypermetabolic state, increases in Snail expression and ATP release, and suppressed E-cadherin expression, major contributors to invasion, metastasis and recurrence of TBNC. These data suggest that FTIs may be capable of ameliorating the aggressive phenotype of TNBC by suppressing the HIF-1α-Snail pathway. J. Cell. Physiol. 232: 192-201, 2017. © 2016 Wiley Periodicals, Inc.",
            "authors": {
              "abbreviation": "Tomokazu Tanaka, Yuichi Ikegami, Harumasa Nakazawa, ..., Masao Kaneki",
              "authorList": [
                {
                  "ForeName": "Tomokazu",
                  "LastName": "Tanaka",
                  "abbrevName": "Tanaka T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tomokazu Tanaka",
                  "orcid": null
                },
                {
                  "ForeName": "Yuichi",
                  "LastName": "Ikegami",
                  "abbrevName": "Ikegami Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuichi Ikegami",
                  "orcid": null
                },
                {
                  "ForeName": "Harumasa",
                  "LastName": "Nakazawa",
                  "abbrevName": "Nakazawa H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Harumasa Nakazawa",
                  "orcid": null
                },
                {
                  "ForeName": "Naohide",
                  "LastName": "Kuriyama",
                  "abbrevName": "Kuriyama N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naohide Kuriyama",
                  "orcid": null
                },
                {
                  "ForeName": "Miwa",
                  "LastName": "Oki",
                  "abbrevName": "Oki M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Miwa Oki",
                  "orcid": null
                },
                {
                  "ForeName": "Jun-Ichi",
                  "LastName": "Hanai",
                  "abbrevName": "Hanai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun-Ichi Hanai",
                  "orcid": null
                },
                {
                  "ForeName": "Vikas",
                  "LastName": "Sukhatme",
                  "abbrevName": "Sukhatme VP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vikas P Sukhatme",
                  "orcid": null
                },
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "abbrevName": "Kaneki M",
                  "email": "mkaneki@helix.mgh.harvard.edu",
                  "isCollectiveName": false,
                  "name": "Masao Kaneki",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "email": [
                    "mkaneki@helix.mgh.harvard.edu"
                  ],
                  "name": "Masao Kaneki"
                }
              ]
            },
            "doi": "10.1002/jcp.25411",
            "pmid": "27137755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Cell Physiol 232 2017",
            "title": "Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro."
          }
        },
        {
          "pmid": "35188449",
          "pubmed": {
            "ISODate": "2022-05-01T00:00:00.000Z",
            "abstract": "There is no clear treatment guideline or individualized treatment plan for triple-negative breast cancer (TNBC). The aim of this study was to investigate more effective targets for TNBC-targeted therapy. MDA-MB-231 and BT549 cell lines were used to explore the function of LINC00649 on the proliferation, invasion, and migration of TNBC cells. A mice subcutaneous tumor model and a pulmonary metastasis model was established to identify the role of LINC00649 on the growth and metastasis of TNBC in vivo. LINC00649 was found to be a key molecule involved in the occurrence and development of TNBC by screening of public databases and detection of TNBC clinical samples. LINC00649 increased hypoxia-inducible factor 1α (HIF-1α) mRNA stability and protein expression by interacting with the nuclear factor 90 (NF90)/NF45 complex. In vitro, interference with LINC00649 inhibits MDA-MB-231 and BT549 cell proliferation, migration, and invasion, and the addition of HIF-1α revised this effect. In vivo experiments showed that LINC00649 promoted the growth and metastasis of TNBC. We demonstrated that LINC00649 interacts with the NF90/NF45 complex to increase the mRNA stability of HIF-1α and up-regulate HIF-1α expression, thereby inducing the proliferation, invasion, and migration of TNBC cells as well as tumor growth and metastasis.",
            "authors": {
              "abbreviation": "Jianhua Zhang, Chuang Du, Linfeng Zhang, ..., Jingruo Li",
              "authorList": [
                {
                  "ForeName": "Jianhua",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianhua Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Chuang",
                  "LastName": "Du",
                  "abbrevName": "Du C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chuang Du",
                  "orcid": null
                },
                {
                  "ForeName": "Linfeng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linfeng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yingying",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yingying Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jingruo",
                  "LastName": "Li",
                  "abbrevName": "Li J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jingruo Li",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384101.2022.2040283",
            "pmid": "35188449",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Cycle 21 2022",
            "title": "LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex."
          }
        },
        {
          "pmid": "33824311",
          "pubmed": {
            "ISODate": "2021-04-06T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive subtype with the worst prognosis and the highest metastatic and recurrence potential, which represents 15-20% of all breast cancers in Chinese females, and the 5-year overall survival rate is about 80% in Chinese women. Recently, emerging evidence suggested that aberrant alternative splicing (AS) plays a crucial role in tumorigenesis and progression. AS is generally controlled by AS-associated RNA binding proteins (RBPs). Monocyte chemotactic protein induced protein 1 (MCPIP1), a zinc finger RBP, functions as a tumor suppressor in many cancers. Here, we showed that MCPIP1 was downregulated in 80 TNBC tissues and five TNBC cell lines compared to adjacent paracancerous tissues and one human immortalized breast epithelial cell line, while its high expression levels were associated with increased overall survival in TNBC patients. We demonstrated that MCPIP1 overexpression dramatically suppressed cell cycle progression and proliferation of TNBC cells in vitro and repressed tumor growth in vivo. Mechanistically, MCPIP1 was first demonstrated to act as a splicing factor to regulate AS in TNBC cells. Furthermore, we demonstrated that MCPIP1 modulated NFIC AS to promote CTF5 synthesis, which acted as a negative regulator in TNBC cells. Subsequently, we showed that CTF5 participated in MCPIP1-mediated antiproliferative effect by transcriptionally repressing cyclin D1 expression, as well as downregulating its downstream signaling targets p-Rb and E2F1. Conclusively, our findings provided novel insights into the anti-oncogenic mechanism of MCPIP1, suggesting that MCPIP1 could serve as an alternative treatment target in TNBC.",
            "authors": {
              "abbreviation": "Fengxia Chen, Qingqing Wang, Xiaoyan Yu, ..., Yunfeng Zhou",
              "authorList": [
                {
                  "ForeName": "Fengxia",
                  "LastName": "Chen",
                  "abbrevName": "Chen F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fengxia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Qingqing",
                  "LastName": "Wang",
                  "abbrevName": "Wang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingqing Wang",
                  "orcid": "0000-0002-6440-582X"
                },
                {
                  "ForeName": "Xiaoyan",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaoyan Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ningning",
                  "LastName": "Yang",
                  "abbrevName": "Yang N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ningning Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Yuan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuan Wang",
                  "orcid": "0000-0003-1894-0853"
                },
                {
                  "ForeName": "Yangyang",
                  "LastName": "Zeng",
                  "abbrevName": "Zeng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yangyang Zeng",
                  "orcid": null
                },
                {
                  "ForeName": "Zhewen",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhewen Zheng",
                  "orcid": null
                },
                {
                  "ForeName": "Fuxiang",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fuxiang Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": "yfzhouwhu@163.com",
                  "isCollectiveName": false,
                  "name": "Yunfeng Zhou",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "email": [
                    "yfzhouwhu@163.com"
                  ],
                  "name": "Yunfeng Zhou"
                }
              ]
            },
            "doi": "10.1038/s41419-021-03661-4",
            "pmid": "33824311",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 12 2021",
            "title": "MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis."
          }
        },
        {
          "pmid": "25920936",
          "pubmed": {
            "ISODate": "2015-01-01T00:00:00.000Z",
            "abstract": "Hypoxia is associated with poor response to treatment in various cancers. Hypoxia inducible factor 1 (HIF-1) is a major transcription factor that mediates adaptation of cancer cells to a hypoxic environment and regulates many genes that are involved in key cellular functions, including cell immortalization, stem cell maintenance, autocrine growth/survival, angiogenesis, invasion/metastasis, and resistance to chemotherapy. HIF-1α has been considered as an attractive therapeutic target for cancer treatment, but there is limited success in this research field. In the present study, we designed a recombinant lentivirus containing HIF-1α siRNA, developed stably transfected cell lines, and tested the anticancer effects of the siRNA on cancer cells in vitro and in vivo. Our results indicated that the stable downregulation of HIF-1α reversed chemoresistance, inhibited proliferation, migration and invasion of cancer cells, and slowed down the tumor growth in breast cancer xenograft models. In conclusion, the recombinant lentivirus containing HIF-1α siRNA provides a new avenue for developing novel therapy for triple negative breast cancer.",
            "authors": {
              "abbreviation": "Shuang Li, Qingzhu Wei, Qin Li, ..., Qiang Xiao",
              "authorList": [
                {
                  "ForeName": "Shuang",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Qingzhu",
                  "LastName": "Wei",
                  "abbrevName": "Wei Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingzhu Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Qin",
                  "LastName": "Li",
                  "abbrevName": "Li Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qin Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qiang",
                  "LastName": "Xiao",
                  "abbrevName": "Xiao Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qiang Xiao",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2015.1040958",
            "pmid": "25920936",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 16 2015",
            "title": "Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer."
          }
        },
        {
          "pmid": "32114388",
          "pubmed": {
            "ISODate": "2020-03-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Liver cancer stem cells (CSCs) are critical determinants of HCC relapse and therapeutic resistance, but the mechanisms underlying the maintenance of CSCs are poorly understood. We aimed to explore the role of tumor repressor Zinc-fingers and homeoboxes 2 (ZHX2) in liver CSCs. METHODS: CD133+ or EPCAM+ stem-like liver cancer cells were sorted from tumor tissues of HCC patients and HCC cell lines by flow cytometry. In addition, sorafenib-resistant cells, tumor-sphere forming cells and side population (SP) cells were respectively cultured and isolated as hepatic CSCs. The tumor-initiating and chemoresistance properties of ZHX2-overexpressing and ZHX2-knockdown cells were analyzed in vivo and in vitro. Microarray, luciferase reporter assay, chromatin immunoprecipitation (ChIP) and ChIP-on-chip analyses were performed to explore ZHX2 target genes. The expression of ZHX2 and its target gene were determined by quantitative RT-PCR, western blot, immunofluorescence and immunohistochemical staining in hepatoma cells and tumor and adjacent tissues from HCC patients. RESULTS: ZHX2 expression was significantly reduced in liver CSCs from different origins. ZHX2 deficiency led to enhanced liver tumor progression and expansion of CSC populations in vitro and in vivo. Re-expression of ZHX2 restricted capabilities of hepatic CSCs in supporting tumor initiation, self-renewal and sorafenib-resistance. Mechanically, ZHX2 suppressed liver CSCs via inhibiting KDM2A-mediated demethylation of histone H3 lysine 36 (H3K36) at the promoter regions of stemness-associated transcription factors, such as NANOG, SOX4 and OCT4. Moreover, patients with lower expression of ZHX2 and higher expression of KDM2A in tumor tissues showed significantly poorer survival. CONCLUSION: ZHX2 counteracts stem cell traits through transcriptionally repressing KDM2A in HCC. Our data will aid in a better understanding of molecular mechanisms underlying HCC relapse and drug resistance.",
            "authors": {
              "abbreviation": "Qinghai Lin, Zhuanchang Wu, Xuetian Yue, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying",
                  "LastName": "He",
                  "abbrevName": "He Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying He",
                  "orcid": null
                },
                {
                  "ForeName": "Yutong",
                  "LastName": "Ge",
                  "abbrevName": "Ge Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yutong Ge",
                  "orcid": null
                },
                {
                  "ForeName": "Siyu",
                  "LastName": "Tan",
                  "abbrevName": "Tan S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siyu Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Song",
                  "abbrevName": "Song H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Song",
                  "orcid": null
                },
                {
                  "ForeName": "Detian",
                  "LastName": "Yuan",
                  "abbrevName": "Yuan D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Detian Yuan",
                  "orcid": null
                },
                {
                  "ForeName": "Yaoqin",
                  "LastName": "Gong",
                  "abbrevName": "Gong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yaoqin Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.ebiom.2020.102676",
            "pmid": "32114388",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "EBioMedicine 53 2020",
            "title": "ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation."
          }
        },
        {
          "pmid": "29333926",
          "pubmed": {
            "ISODate": "2018-04-03T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by poor patient prognosis and for which no targeted therapies are currently available. TNBC can be further categorized as either basal-like (BLBC) or quintuple-negative breast cancer (QNBC). In the present study, we aimed to identify novel molecular therapeutic targets for TNBC by analyzing the mRNA expression of TNBC-related genes in publicly available microarray data sets. We found that Engrailed 1 (EN1) was significantly overexpressed in TNBC. Using breast cancer cell lines, we found that EN1 was more highly expressed in TNBC than in other breast cancer subtypes. EN1 expression was analyzed in 199 TNBC paraffin-embedded tissue samples by immunohistochemistry. EN1 protein expression was positively associated with reduced overall survival (OS) rate in patients with QNBC, but not those with BLBC. The importance of EN1 expression in QNBC cell viability and tumorigenicity was evaluated using the QNBC cell lines, HCC38 and HCC1395. Based on our data, EN1 may promote the proliferation, migration, and multinucleation of QNBC cells, likely via the transcriptional activation of HDAC8, UTP11L, and ZIC3. We also demonstrated that actinomycin D effectively inhibits EN1 activity in QNBC cells. The results of the present study suggest that EN1 activity is highly clinically relevant to the survival prognosis of patients with QNBC and EN1 is a promising potential therapeutic target for future QNBC treatment.",
            "authors": {
              "abbreviation": "Yu Jin Kim, Minjung Sung, Ensel Oh, ..., Yoon-La Choi",
              "authorList": [
                {
                  "ForeName": "Yu",
                  "LastName": "Kim",
                  "abbrevName": "Kim YJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Jin Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Minjung",
                  "LastName": "Sung",
                  "abbrevName": "Sung M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minjung Sung",
                  "orcid": null
                },
                {
                  "ForeName": "Ensel",
                  "LastName": "Oh",
                  "abbrevName": "Oh E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ensel Oh",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Vrancken",
                  "abbrevName": "Vrancken MV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Van Vrancken",
                  "orcid": null
                },
                {
                  "ForeName": "Ji-Young",
                  "LastName": "Song",
                  "abbrevName": "Song JY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ji-Young Song",
                  "orcid": null
                },
                {
                  "ForeName": "Kyungsoo",
                  "LastName": "Jung",
                  "abbrevName": "Jung K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyungsoo Jung",
                  "orcid": null
                },
                {
                  "ForeName": "Yoon-La",
                  "LastName": "Choi",
                  "abbrevName": "Choi YL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yoon-La Choi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2018.1423913",
            "pmid": "29333926",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 19 2018",
            "title": "Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer."
          }
        },
        {
          "pmid": "31683461",
          "pubmed": {
            "ISODate": "2020-01-01T00:00:00.000Z",
            "abstract": "OBJECTIVE: To investigate the effect of ZHX2 on lung cancer cells proliferation and apoptosis. MATERIALS AND METHODS: The mRNA and protein expression of ZHX2 were detected by qRT-PCR and western blot, respectively. The human lung cancer cells were divided into Control, NC, ZHX2, SB, and ZHX2 + Ani groups. The cell proliferation was detected by CCK-8 assay and the cell migration and invasion were detected by Transwell assay. Cell apoptosis was detected by flow cytometry. Apoptosis and p38MAPK signaling pathway related proteins were detected by western blot. The nude mice model of lung cancer xenograft was constructed. The tumor volume and tumor weight were measured. The expression of PCNA protein in tumor tissues was detected by immunohistochemistry. The apoptosis of tumor cells was detected by TUNEL staining. The ZHX2 and p38MAPK signaling pathway related proteins in tumor tissues were detected by western blot. RESULTS: The expression of ZHX2 gene and protein in the cancer cell lines were significantly decreased. Compared with control and NC groups, the cells proliferation, migration and invasion were inhibited in ZHX2 and SB groups, while the apoptosis and apoptosis related proteins were increased (p< 0.05). Meanwhile, compared with ZHX2 group, the tumor growth rate, volume, weight, the percentage of PCNA-positive cells, and p-P38 MAPK/P38 MAPK were increased significantly in ZHX2 + Ani group, while the apoptotic index and the expression of MMP-9 protein were significantly decreased (p< 0.05). CONCLUSION: ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway.",
            "authors": {
              "abbreviation": "Xudong Tian, Yadong Wang, Shuhai Li, ..., Hui Tian",
              "authorList": [
                {
                  "ForeName": "Xudong",
                  "LastName": "Tian",
                  "abbrevName": "Tian X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xudong Tian",
                  "orcid": null
                },
                {
                  "ForeName": "Yadong",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadong Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Shuhai",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuhai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Weiming",
                  "LastName": "Yue",
                  "abbrevName": "Yue W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weiming Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Tian",
                  "abbrevName": "Tian H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Tian",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3233/CBM-190514",
            "pmid": "31683461",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cancer Biomark 27 2020",
            "title": "ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway."
          }
        },
        {
          "pmid": "36228375",
          "pubmed": {
            "ISODate": "2022-12-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has been shown that HIF-1α regulates the complex biological processes of TNBC, such as glycolysis, angiogenesis, invasion and metastasis, breast cancer stem cells (BCSCs) enrichment, and immune escape, to promote TNBC survival and development through the activation of downstream target genes. In addition, inflammatory mediators, oxygen levels, noncoding RNAs, complex signaling regulatory networks, epigenetic regulators are involved in the upstream regulatory expression of HIF-1α. However, further studies are needed to determine the potential and future directions of targeting HIF-1α in TNBC. This article discusses the expression of the HIF-1α transcription factor in TNBC. We also explored the mechanism by which HIF-1α drives TNBC progression. The potential significance of targeting HIF-1α for immunotherapy, chemotherapy, anti-angiogenic therapy, and photodynamic therapy is discussed. The intrinsic mechanism, existing problems and future directions of targeting HIF-1α are also studied.",
            "authors": {
              "abbreviation": "Qi Liu, Chengcheng Guan, Cui Liu, ..., Changgang Sun",
              "authorList": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "abbrevName": "Liu Q",
                  "email": "2020110892@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Qi Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "abbrevName": "Guan C",
                  "email": "2020110896@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chengcheng Guan",
                  "orcid": null
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "abbrevName": "Liu C",
                  "email": "2019101062@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Cui Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "abbrevName": "Li H",
                  "email": "2019101020@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Huayao Li",
                  "orcid": null
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "abbrevName": "Wu J",
                  "email": "2020111256@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Jibiao Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "abbrevName": "Sun C",
                  "email": "zyxyscg@wfmc.edu.cn",
                  "isCollectiveName": false,
                  "name": "Changgang Sun",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "email": [
                    "2020110892@sdutcm.edu.cn"
                  ],
                  "name": "Qi Liu"
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "email": [
                    "2020110896@sdutcm.edu.cn"
                  ],
                  "name": "Chengcheng Guan"
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "email": [
                    "2019101062@sdutcm.edu.cn"
                  ],
                  "name": "Cui Liu"
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "email": [
                    "2019101020@sdutcm.edu.cn"
                  ],
                  "name": "Huayao Li"
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "email": [
                    "2020111256@sdutcm.edu.cn"
                  ],
                  "name": "Jibiao Wu"
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "email": [
                    "zyxyscg@wfmc.edu.cn"
                  ],
                  "name": "Changgang Sun"
                }
              ]
            },
            "doi": "10.1016/j.biopha.2022.113861",
            "pmid": "36228375",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Biomed Pharmacother 156 2022",
            "title": "Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy."
          }
        },
        {
          "pmid": "32778144",
          "pubmed": {
            "ISODate": "2020-08-10T00:00:00.000Z",
            "abstract": "BACKGROUND: Hypoxia plays a relevant role in tumor-related inflammation toward the metastatic spread and cancer aggressiveness. The pro-inflammatory cytokine interleukin-1β (IL-β) and its cognate receptor IL1R1 contribute to the initiation and progression of breast cancer determining pro-tumorigenic inflammatory responses. The transcriptional target of the hypoxia inducible factor-1α (HIF-1α) namely the G protein estrogen receptor (GPER) mediates a feedforward loop coupling IL-1β induction by breast cancer-associated fibroblasts (CAFs) to IL1R1 expression by breast cancer cells toward the regulation of target genes and relevant biological responses. METHODS: In order to ascertain the correlation of IL-β with HIF-1α and further hypoxia-related genes in triple-negative breast cancer (TNBC) patients, a bioinformatics analysis was performed using the information provided by The Invasive Breast Cancer Cohort of The Cancer Genome Atlas (TCGA) project and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets. Gene expression correlation, statistical analysis and gene set enrichment analysis (GSEA) were carried out with R studio packages. Pathway enrichment analysis was evaluated with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. TNBC cells and primary CAFs were used as model system. The molecular mechanisms implicated in the regulation of IL-1β by hypoxia toward a metastatic gene expression profile and invasive properties were assessed performing gene and protein expression studies, PCR arrays, gene silencing and immunofluorescence analysis, co-immunoprecipitation and ChiP assays, ELISA, cell spreading, invasion and spheroid formation. RESULTS: We first determined that IL-1β expression correlates with the levels of HIF-1α as well as with a hypoxia-related gene signature in TNBC patients. Next, we demonstrated that hypoxia triggers a functional liaison among HIF-1α, GPER and the IL-1β/IL1R1 signaling toward a metastatic gene signature and a feed-forward loop of IL-1β that leads to proliferative and invasive responses in TNBC cells. Furthermore, we found that the IL-1β released in the conditioned medium of TNBC cells exposed to hypoxic conditions promotes an invasive phenotype of CAFs. CONCLUSIONS: Our data shed new light on the role of hypoxia in the activation of the IL-1β/IL1R1 signaling, which in turn triggers aggressive features in both TNBC cells and CAFs. Hence, our findings provide novel evidence regarding the mechanisms through which the hypoxic tumor microenvironment may contribute to breast cancer progression and suggest further targets useful in more comprehensive therapeutic strategies.",
            "authors": {
              "abbreviation": "Rosamaria Lappano, Marianna Talia, Francesca Cirillo, ..., Marcello Maggiolini",
              "authorList": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "abbrevName": "Lappano R",
                  "email": "rosamaria.lappano@unical.it",
                  "isCollectiveName": false,
                  "name": "Rosamaria Lappano",
                  "orcid": null
                },
                {
                  "ForeName": "Marianna",
                  "LastName": "Talia",
                  "abbrevName": "Talia M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marianna Talia",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Cirillo",
                  "abbrevName": "Cirillo F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Cirillo",
                  "orcid": null
                },
                {
                  "ForeName": "Damiano",
                  "LastName": "Rigiracciolo",
                  "abbrevName": "Rigiracciolo DC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Damiano Cosimo Rigiracciolo",
                  "orcid": null
                },
                {
                  "ForeName": "Domenica",
                  "LastName": "Scordamaglia",
                  "abbrevName": "Scordamaglia D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Domenica Scordamaglia",
                  "orcid": null
                },
                {
                  "ForeName": "Rita",
                  "LastName": "Guzzi",
                  "abbrevName": "Guzzi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rita Guzzi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "Miglietta",
                  "abbrevName": "Miglietta AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna Maria Miglietta",
                  "orcid": null
                },
                {
                  "ForeName": "Ernestina",
                  "LastName": "De Francesco",
                  "abbrevName": "De Francesco EM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ernestina Marianna De Francesco",
                  "orcid": null
                },
                {
                  "ForeName": "Antonino",
                  "LastName": "Belfiore",
                  "abbrevName": "Belfiore A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonino Belfiore",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "abbrevName": "Maggiolini M",
                  "email": "marcello.maggiolini@unical.it",
                  "isCollectiveName": false,
                  "name": "Marcello Maggiolini",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "email": [
                    "rosamaria.lappano@unical.it"
                  ],
                  "name": "Rosamaria Lappano"
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "email": [
                    "marcello.maggiolini@unical.it"
                  ],
                  "name": "Marcello Maggiolini"
                }
              ]
            },
            "doi": "10.1186/s13046-020-01667-y",
            "pmid": "32778144",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Exp Clin Cancer Res 39 2020",
            "title": "The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)."
          }
        },
        {
          "pmid": "24670641",
          "pubmed": {
            "ISODate": "2014-04-03T00:00:00.000Z",
            "abstract": "Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours, but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)--a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)--is a highly aggressive malignancy with limited treatment options. Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1α (HIF1α) is known to be hyperactivated in TNBCs. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Xi Chen, Dimitrios Iliopoulos, Qing Zhang, ..., Laurie H Glimcher",
              "authorList": [
                {
                  "ForeName": "Xi",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Dimitrios",
                  "LastName": "Iliopoulos",
                  "abbrevName": "Iliopoulos D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dimitrios Iliopoulos",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qianzi",
                  "LastName": "Tang",
                  "abbrevName": "Tang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qianzi Tang",
                  "orcid": null
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Greenblatt",
                  "abbrevName": "Greenblatt MB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew B Greenblatt",
                  "orcid": null
                },
                {
                  "ForeName": "Maria",
                  "LastName": "Hatziapostolou",
                  "abbrevName": "Hatziapostolou M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria Hatziapostolou",
                  "orcid": null
                },
                {
                  "ForeName": "Elgene",
                  "LastName": "Lim",
                  "abbrevName": "Lim E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elgene Lim",
                  "orcid": null
                },
                {
                  "ForeName": "Wai",
                  "LastName": "Tam",
                  "abbrevName": "Tam WL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wai Leong Tam",
                  "orcid": null
                },
                {
                  "ForeName": "Min",
                  "LastName": "Ni",
                  "abbrevName": "Ni M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min Ni",
                  "orcid": null
                },
                {
                  "ForeName": "Yiwen",
                  "LastName": "Chen",
                  "abbrevName": "Chen Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yiwen Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Junhua",
                  "LastName": "Mai",
                  "abbrevName": "Mai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Junhua Mai",
                  "orcid": null
                },
                {
                  "ForeName": "Haifa",
                  "LastName": "Shen",
                  "abbrevName": "Shen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haifa Shen",
                  "orcid": null
                },
                {
                  "ForeName": "Dorothy",
                  "LastName": "Hu",
                  "abbrevName": "Hu DZ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dorothy Z Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Stanley",
                  "LastName": "Adoro",
                  "abbrevName": "Adoro S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stanley Adoro",
                  "orcid": null
                },
                {
                  "ForeName": "Bella",
                  "LastName": "Hu",
                  "abbrevName": "Hu B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bella Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Minkyung",
                  "LastName": "Song",
                  "abbrevName": "Song M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minkyung Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chen",
                  "LastName": "Tan",
                  "abbrevName": "Tan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Melissa",
                  "LastName": "Landis",
                  "abbrevName": "Landis MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Melissa D Landis",
                  "orcid": null
                },
                {
                  "ForeName": "Mauro",
                  "LastName": "Ferrari",
                  "abbrevName": "Ferrari M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mauro Ferrari",
                  "orcid": null
                },
                {
                  "ForeName": "Sandra",
                  "LastName": "Shin",
                  "abbrevName": "Shin SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sandra J Shin",
                  "orcid": null
                },
                {
                  "ForeName": "Myles",
                  "LastName": "Brown",
                  "abbrevName": "Brown M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Myles Brown",
                  "orcid": null
                },
                {
                  "ForeName": "Jenny",
                  "LastName": "Chang",
                  "abbrevName": "Chang JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jenny C Chang",
                  "orcid": null
                },
                {
                  "ForeName": "X",
                  "LastName": "Liu",
                  "abbrevName": "Liu XS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "X Shirley Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Laurie",
                  "LastName": "Glimcher",
                  "abbrevName": "Glimcher LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laurie H Glimcher",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature13119",
            "pmid": "24670641",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 508 2014",
            "title": "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway."
          }
        },
        {
          "pmid": "32382017",
          "pubmed": {
            "ISODate": "2020-05-07T00:00:00.000Z",
            "abstract": "Zinc fingers and homeoboxes 2 (ZHX2) was found as a novel VHL substrate target, and acted as an oncogenic driver in ccRCC. However, the detailed mechanism of ZHX2 in ccRCC development remains elusive, and no research has focused on studying ZHX2 in drug resistance yet. A tissue microarray with 358 ccRCC samples was used to determine the expression of ZHX2 in ccRCC patients. VHL-deficient cell line 786-O and VHL-normal cell line CAKI-1 was used for lineage reprogramming by transfecting with lentivirus. The in vitro and in vivo experiments were performed with these new cell lines to determine the mechanism of ZHX2 in ccRCC development and drug resistance. Immunohistochemistry analysis showed that ZHX2 was not highly expressed in ccRCC tumor tissues, only 33.2% (119/358) patients have high ZHX2 expression. However, high ZHX2 was significantly associated with advanced Fuhrman grade (p = 0.004), and proved to be an independent prognosis factor for progression-free survival (p = 0.0003), while there is no significant correlation with overall survival. We further discovered that ZHX2 overexpression could increase VEGF secretion and transcriptional activate the MEK/ERK1/2 and promote its downstream targets. We also found ZHX2 overexpression induce Sunitinib resistance though activating autophagy and the combination treatment of Sunitinib and Chloroquine could significantly rescue the phenomenon. In summary, these results indicate that ZHX2 drivers cell growth, migration though increase VEGF expression, and transcriptional activate MEK/ERK1/2 signaling pathway, and could induce Sunitinib resistance by regulating self-protective autophagy, these may provide new insight in advanced ccRCC treatment.",
            "authors": {
              "abbreviation": "Liangsong Zhu, Rong Ding, Hao Yan, ..., Zongming Lin",
              "authorList": [
                {
                  "ForeName": "Liangsong",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liangsong Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Rong",
                  "LastName": "Ding",
                  "abbrevName": "Ding R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rong Ding",
                  "orcid": null
                },
                {
                  "ForeName": "Hao",
                  "LastName": "Yan",
                  "abbrevName": "Yan H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hao Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": "med-zhangjin@vip.sina.com",
                  "isCollectiveName": false,
                  "name": "Jin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "abbrevName": "Lin Z",
                  "email": "lin.zongming@zs-hospital.sh.cn",
                  "isCollectiveName": false,
                  "name": "Zongming Lin",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "email": [
                    "med-zhangjin@vip.sina.com"
                  ],
                  "name": "Jin Zhang"
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "email": [
                    "lin.zongming@zs-hospital.sh.cn"
                  ],
                  "name": "Zongming Lin"
                }
              ]
            },
            "doi": "10.1038/s41419-020-2541-x",
            "pmid": "32382017",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 11 2020",
            "title": "ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma."
          }
        },
        {
          "pmid": "31529195",
          "pubmed": {
            "ISODate": "2019-09-01T00:00:00.000Z",
            "abstract": "Triple negative breast cancer (TNBC) is the most lethal breast cancer subtype. Extended periods of lactation protect against breast cancer development, but the mechanisms underlying this protection are unknown. We examined the effects of the milk protein alpha-casein over expression in the triple negative MDA-MB-231 breast cancer cell line. The effects of recombinant alpha-casein added exogenously to MDA-MB-231 breast cancer cells, and immortalised human fibroblasts were also investigated. We used transcriptional reporters to understand the signalling pathways downstream of alpha-casein in breast cancer cells and these fibroblasts that were activated by breast cancer cells. To extend our findings to the clinical setting, we analysed public gene expression datasets to further understand the relevance of these signalling pathways in triple negative breast cancer cells and patient samples. Finally, we used small molecular inhibitors to target relevant pathways and highlight these as potential candidates for the treatment of TN breast cancer. High levels of alpha-casein gene expression were predictive of good prognosis across 263 TNBC patient tumour samples. Alpha-casein over expression or exogenous addition reduces cancer stem cell (CSC) activity. HIF-1alpha was identified to be a key downstream target of alpha-casein, in both breast cancer cells and activated fibroblasts, and STAT transcription factors to be upstream of HIF-1alpha. Interestingly, HIF-1alpha is regulated by STAT3 in breast cancer cells, but STAT1 is the regulator of HIF-1alpha in activated fibroblasts. In analysis of 573 TNBC patient samples, alpha-casein expression, inversely correlated to HIF-1alpha, STAT3 and STAT1. STAT1 and STAT3 inhibitors target HIF-1alpha signalling in activated fibroblasts and MDA-MB-231 breast cancer cells respectively, and also abrogate CSC activities. Our findings provide an explanation for the protective effects of lactation in TNBC. Clinical data correlates high alpha-casein expression with increased recurrence-free survival in TNBC patients. Mechanistically, alpha-casein reduces breast cancer stem cell activity in vitro, and STAT3 and STAT1 were identified as regulators of pro-tumorigenic HIF-1alpha signalling in breast cancer cells and fibroblasts respectively.",
            "authors": {
              "abbreviation": "Kirsten E L Garner, Nathan J Hull, Andrew H Sims, ..., Robert B Clarke",
              "authorList": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "abbrevName": "Garner KEL",
                  "email": "Kirsten.garner@manchester.ac.uk",
                  "isCollectiveName": false,
                  "name": "Kirsten E L Garner",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Hull",
                  "abbrevName": "Hull NJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan J Hull",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Rebecca",
                  "LastName": "Lamb",
                  "abbrevName": "Lamb R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rebecca Lamb",
                  "orcid": null
                },
                {
                  "ForeName": "Robert",
                  "LastName": "Clarke",
                  "abbrevName": "Clarke RB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Robert B Clarke",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "email": [
                    "Kirsten.garner@manchester.ac.uk"
                  ],
                  "name": "Kirsten E L Garner"
                }
              ]
            },
            "doi": "10.1007/s10911-019-09435-1",
            "pmid": "31529195",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mammary Gland Biol Neoplasia 24 2019",
            "title": "The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts."
          }
        },
        {
          "pmid": "32770671",
          "pubmed": {
            "ISODate": "2020-12-01T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Lipogenesis has been considered as a critical player in HCC initiation and progression. However, the underlying mechanism is still not fully understood. Here, we identified zinc fingers and homeoboxes 2 (ZHX2), an HCC-associated tumor suppressor, as an important repressor of de novo lipogenesis. Ectopic expression of ZHX2 significantly inhibited de novo lipogenesis in HCC cells and decreased expression of FASN, ACL, ACC1, and SCD1. In accordance with this, ZHX2 was negatively associated with SREBP1c, the master regulator of de novo lipogenesis, in HCC cell lines and human specimens. Results from silencing and overexpression demonstrated that ZHX2 inhibited de novo lipogenesis and consequent HCC progression via repression of SREBP1c. Furthermore, treatment with the SREBP1c inhibitor fatostatin dampened the spontaneous formation of tumors in liver-specific Zhx2 knockout mice. Mechanistically, ZHX2 increased expression of miR-24-3p transcriptionally, which targeted SREBP1c and led to its degradation. In conclusion, our data suggest a novel mechanism through which ZHX2 suppresses HCC progression, which may provide a new strategy for the treatment of HCC. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",
            "authors": {
              "abbreviation": "Xiangguo Yu, Qinghai Lin, Zhuanchang Wu, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Yankun",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yankun Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Songbai",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Songbai Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chaojia",
                  "LastName": "Chen",
                  "abbrevName": "Chen C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chaojia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Chunyang",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunyang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": "0000-0002-8121-4718"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/path.5530",
            "pmid": "32770671",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Pathol 252 2020",
            "title": "ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p."
          }
        },
        {
          "pmid": "31264274",
          "pubmed": {
            "ISODate": "2019-10-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype which accounts for 15%-20% of all breast cancer cases. The management of TNBC has remained a challenge due to its lack of targeted therapy. Previously, we reported that homeobox C8 (HOXC8) was involved in metastasis and migration of breast cancer cells. By chromatin immunoprecipitation and luciferase assays, we found that HOXC8 functioned as a transcription factor to activate the transcription of matrix Gla protein (MGP) gene, leading to an increase in the proliferation, anchorage-independent growth, and migration of TNBC cells. We further demonstrated that MGP expression promoted the epithelial-mesenchymal transition (EMT) process of TNBC cells, but not the other subtypes of breast cancer, suggesting that MGP induced EMT to promote proliferation and migration of TNBC cells. Moreover, we found that MGP was upregulated in clinical breast specimens compared to normal breast tissues and high MGP expression was statistically associated with poor, relapse-free survival for TNBC patients, indicating that MGP is probably a novel biomarker or therapeutic target for TNBC patients. Together, our results showed that the HOXC8-MGP axis played an important role in the tumorigenesis of TNBC and might be a promising therapeutic target for TNBC treatment.",
            "authors": {
              "abbreviation": "Chen Gong, Jin Zou, Mingsheng Zhang, ..., Yong Li",
              "authorList": [
                {
                  "ForeName": "Chen",
                  "LastName": "Gong",
                  "abbrevName": "Gong C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zou",
                  "abbrevName": "Zou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zou",
                  "orcid": null
                },
                {
                  "ForeName": "Mingsheng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingsheng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Shanshan",
                  "LastName": "Xu",
                  "abbrevName": "Xu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shanshan Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Siqi",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siqi Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Mengqi",
                  "LastName": "Yang",
                  "abbrevName": "Yang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mengqi Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Dongjia",
                  "LastName": "Li",
                  "abbrevName": "Li D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dongjia Li",
                  "orcid": null
                },
                {
                  "ForeName": "Yun",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jialu",
                  "LastName": "Shi",
                  "abbrevName": "Shi J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jialu Shi",
                  "orcid": null
                },
                {
                  "ForeName": "Yong",
                  "LastName": "Li",
                  "abbrevName": "Li Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yong Li",
                  "orcid": "0000-0003-4681-263X"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/mc.23079",
            "pmid": "31264274",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Mol Carcinog 58 2019",
            "title": "Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer."
          }
        },
        {
          "pmid": "35867755",
          "pubmed": {
            "ISODate": "2022-07-12T00:00:00.000Z",
            "abstract": "Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Zhaoping Qiu, Weijie Guo, Bo Dong, ..., Yadi Wu",
              "authorList": [
                {
                  "ForeName": "Zhaoping",
                  "LastName": "Qiu",
                  "abbrevName": "Qiu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhaoping Qiu",
                  "orcid": null
                },
                {
                  "ForeName": "Weijie",
                  "LastName": "Guo",
                  "abbrevName": "Guo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weijie Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Dong",
                  "abbrevName": "Dong B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Dong",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Pan",
                  "LastName": "Deng",
                  "abbrevName": "Deng P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pan Deng",
                  "orcid": "0000-0003-2974-7389"
                },
                {
                  "ForeName": "Chi",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chi Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jinpeng",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jinpeng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                },
                {
                  "ForeName": "Rudolf",
                  "LastName": "Grosschedl",
                  "abbrevName": "Grosschedl R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rudolf Grosschedl",
                  "orcid": null
                },
                {
                  "ForeName": "Zhiyong",
                  "LastName": "Yu",
                  "abbrevName": "Yu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhiyong Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Jiong",
                  "LastName": "Deng",
                  "abbrevName": "Deng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiong Deng",
                  "orcid": null
                },
                {
                  "ForeName": "Yadi",
                  "LastName": "Wu",
                  "abbrevName": "Wu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadi Wu",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119518119",
            "pmid": "35867755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway."
          }
        },
        {
          "pmid": "36037364",
          "pubmed": {
            "ISODate": "2022-09-06T00:00:00.000Z",
            "abstract": "Clear cell renal cell carcinoma (ccRCC) is characterized by the loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of an E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor α (HIF-α) (including HIF1α and HIF2α) and Zinc Fingers And Homeoboxes 2 (ZHX2). Our recent research showed that ZHX2 contributed to ccRCC tumorigenesis in a HIF-independent manner. However, it is still unknown whether ZHX2 could be modified through deubiquitination even in the absence of pVHL. Here, we performed a deubiquitinase (DUB) complementary DNA (cDNA) library binding screen and identified USP13 as a DUB that bound ZHX2 and promoted ZHX2 deubiquitination. As a result, USP13 promoted ZHX2 protein stability in an enzymatically dependent manner, and depletion of USP13 led to ZHX2 down-regulation in ccRCC. Functionally, USP13 depletion led to decreased cell proliferation measured by two-dimensional (2D) colony formation and three-dimensional (3D) anchorage-independent growth. Furthermore, USP13 was essential for ccRCC tumor growth in vivo, and the effect was partially mediated by its regulation on ZHX2. Our findings support that USP13 may be a key effector in ccRCC tumorigenesis.",
            "authors": {
              "abbreviation": "Haibiao Xie, Jin Zhou, Xijuan Liu, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": "0000-0001-6729-8479"
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Yawei",
                  "LastName": "Xu",
                  "abbrevName": "Xu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yawei Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Austin",
                  "LastName": "Hepperla",
                  "abbrevName": "Hepperla AJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Austin J Hepperla",
                  "orcid": "0000-0002-0107-2001"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hongwei",
                  "LastName": "Yao",
                  "abbrevName": "Yao H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongwei Yao",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": "0000-0002-9073-3835"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119854119",
            "pmid": "36037364",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer."
          }
        },
        {
          "pmid": "24248265",
          "pubmed": {
            "ISODate": "2014-02-01T00:00:00.000Z",
            "abstract": "UNLABELLED: Targeted therapy against triple-negative breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor. One of the molecular hallmarks of triple-negative breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many critical aspects of cancer progression including metabolism, angiogenesis, invasion, metastasis, and stem cell maintenance. Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a molecular chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α. In this study, human MDA-MB-231 and MDA-MB-435 triple-negative breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly intravenous injections of ganetespib or vehicle following the development of palpable tumors. Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs. Ganetespib treatment also significantly reduced the number of Aldefluor-positive cancer stem cells in the primary tumor. Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer. KEY MESSAGES: Triple-negative breast cancers (TNBCs) respond poorly to available chemotherapy. TNBCs overexpress genes regulated by hypoxia-inducible factors (HIFs). Ganetespib induces degradation of HSP90 client proteins, including HIF-1α. Ganetespib inhibited TNBC orthotopic tumor growth, invasion, and metastasis. Ganetespib inhibited expression of HIF-1 target genes involved in TNBC progression.",
            "authors": {
              "abbreviation": "Lisha Xiang, Daniele M Gilkes, Pallavi Chaturvedi, ..., Gregg L Semenza",
              "authorList": [
                {
                  "ForeName": "Lisha",
                  "LastName": "Xiang",
                  "abbrevName": "Xiang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lisha Xiang",
                  "orcid": null
                },
                {
                  "ForeName": "Daniele",
                  "LastName": "Gilkes",
                  "abbrevName": "Gilkes DM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniele M Gilkes",
                  "orcid": null
                },
                {
                  "ForeName": "Pallavi",
                  "LastName": "Chaturvedi",
                  "abbrevName": "Chaturvedi P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pallavi Chaturvedi",
                  "orcid": null
                },
                {
                  "ForeName": "Weibo",
                  "LastName": "Luo",
                  "abbrevName": "Luo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weibo Luo",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxia",
                  "LastName": "Hu",
                  "abbrevName": "Hu H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxia Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Naoharu",
                  "LastName": "Takano",
                  "abbrevName": "Takano N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naoharu Takano",
                  "orcid": null
                },
                {
                  "ForeName": "Houjie",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Houjie Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gregg L Semenza",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1007/s00109-013-1102-5",
            "pmid": "24248265",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mol Med (Berl) 92 2014",
            "title": "Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer."
          }
        },
        {
          "pmid": "26825173",
          "pubmed": {
            "ISODate": "2016-03-15T00:00:00.000Z",
            "abstract": "Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.",
            "authors": {
              "abbreviation": "Tarah M Regan Anderson, Shi Hong Ma, Ganesh V Raj, ..., Carol A Lange",
              "authorList": [
                {
                  "ForeName": "Tarah",
                  "LastName": "Regan Anderson",
                  "abbrevName": "Regan Anderson TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tarah M Regan Anderson",
                  "orcid": null
                },
                {
                  "ForeName": "Shi",
                  "LastName": "Ma",
                  "abbrevName": "Ma SH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shi Hong Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Ganesh",
                  "LastName": "Raj",
                  "abbrevName": "Raj GV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ganesh V Raj",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Cidlowski",
                  "abbrevName": "Cidlowski JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John A Cidlowski",
                  "orcid": null
                },
                {
                  "ForeName": "Taylor",
                  "LastName": "Helle",
                  "abbrevName": "Helle TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Taylor M Helle",
                  "orcid": null
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Knutson",
                  "abbrevName": "Knutson TP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Todd P Knutson",
                  "orcid": null
                },
                {
                  "ForeName": "Raisa",
                  "LastName": "Krutilina",
                  "abbrevName": "Krutilina RI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raisa I Krutilina",
                  "orcid": null
                },
                {
                  "ForeName": "Tiffany",
                  "LastName": "Seagroves",
                  "abbrevName": "Seagroves TN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tiffany N Seagroves",
                  "orcid": null
                },
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "abbrevName": "Lange CA",
                  "email": "lange047@umn.edu",
                  "isCollectiveName": false,
                  "name": "Carol A Lange",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "email": [
                    "lange047@umn.edu"
                  ],
                  "name": "Carol A Lange"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-15-2510",
            "pmid": "26825173",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Cancer Res 76 2016",
            "title": "Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "30964885",
          "pubmed": {
            "ISODate": "2019-01-01T00:00:00.000Z",
            "abstract": "Triple-Negative Breast Cancers (TNBCs) are the most difficult to treat subtype of breast cancer and are often associated with high nuclear expression of Snail and Cathepsin L (Cat L) protease. We have previously shown that Snail can increase Cat L expression/activity in prostate and breast cancer cells. This study investigated the role of CUX1 (a downstream substrate of Cat L) in TNBC. We showed that Cat L and CUX1 were highly expressed in TNBC patient tissue/cell lines, as compared to ER-positive samples, using cBioportal data and western blot/zymography analyses. Additionally, luciferase reporter and chromatin immunoprecipitation assays showed that CUX1 directly bound to estrogen receptor-alpha (ER-α) promoter in MDA-MB-468, a representative TNBC cell line, and that CUX1 siRNA could restore ER-α transcription and protein expression. Furthermore, Snail and CUX1 expression in various TNBC cell lines was inhibited by muscadine grape skin extract (MSKE, a natural grape product rich in anthocyanins) or Cat L inhibitor (Z-FY-CHO) leading to decreased cell invasion and migration. MSKE decreased cell viability and increased expression of apoptotic markers in MDA-MB-468 cells, with no effect on non-tumorigenic MCF10A cells. MSKE also decreased CUX1 binding to ER-α promoter and restored ER-α expression in TNBC cells, while both MSKE and CUX1 siRNA restored sensitivity to estradiol and 4-hydoxytamoxifen as shown by increased cell viability. Therefore, CUX1 activated by Snail-Cat L signaling may contribute to TNBC via ER-α repression, and may be a viable target for TNBC using natural products such as MSKE that targets cancer and not normal cells.",
            "authors": {
              "abbreviation": "Liza J Burton, Ohuod Hawsawi, Janae Sweeney, ..., Valerie Odero-Marah",
              "authorList": [
                {
                  "ForeName": "Liza",
                  "LastName": "Burton",
                  "abbrevName": "Burton LJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liza J Burton",
                  "orcid": null
                },
                {
                  "ForeName": "Ohuod",
                  "LastName": "Hawsawi",
                  "abbrevName": "Hawsawi O",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ohuod Hawsawi",
                  "orcid": null
                },
                {
                  "ForeName": "Janae",
                  "LastName": "Sweeney",
                  "abbrevName": "Sweeney J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Janae Sweeney",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Bowen",
                  "abbrevName": "Bowen N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan Bowen",
                  "orcid": "0000-0002-1609-6698"
                },
                {
                  "ForeName": "Tamaro",
                  "LastName": "Hudson",
                  "abbrevName": "Hudson T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tamaro Hudson",
                  "orcid": null
                },
                {
                  "ForeName": "Valerie",
                  "LastName": "Odero-Marah",
                  "abbrevName": "Odero-Marah V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Valerie Odero-Marah",
                  "orcid": "0000-0002-5238-9914"
                }
              ],
              "contacts": []
            },
            "doi": "10.1371/journal.pone.0214844",
            "pmid": "30964885",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "PLoS One 14 2019",
            "title": "CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE)."
          }
        },
        {
          "pmid": "28361350",
          "pubmed": {
            "ISODate": "2017-06-01T00:00:00.000Z",
            "abstract": "PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer and associated with early metastasis, drug resistance, and poor patient survival. Fork head box M1 (FOXM1) is considered as an emerging molecular target due to its oncogenic role and high overexpression profile in 85% in TNBC. However, molecular mechanisms by which FOXM1 transcription factor mediate its oncogenic effects are not fully understood. Integrin β1 is often upregulated in invasive breast cancers and associated with poor clinical outcome and shorter overall patient survival in TNBC. However, the mechanisms regulating integrin β1 (ITGB1) gene expression have not been well elucidated. METHODS: Normal breast epithelium (MCF10A) and TNBC cells (i.e., MDA-MB-231, BT-20 MDA-MB436) were used for the study. Small interfering RNA (siRNA)-based knockdown was used to inhibit Integrin β1 gene (mRNA) and protein expressions, which are detected by RT-PCR and Western blot, respectively. Chromatin immunoprecipitation (ChiP) and gene reporter (Luciferase) assays were used to demonstrate that FOXM1 transcription factor binds to the promoter of Integrin β1 gene and drives its expression. RESULTS: We demonstrated that FOXM1 directly binds to the promoter of integrin β1 gene and transcriptionally regulates its expression and activity of focal adhesion kinase (FAK) in TNBC cells. CONCLUSION: Our study suggests that FOXM1 transcription factor regulates Integrin β1 gene expression and that FOXM1/ Integrin-β1/FAK axis may play an important role in the progression of TNBC.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": "bozpolat@mdanderson.org",
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "email": [
                    "bozpolat@mdanderson.org"
                  ],
                  "name": "Bulent Ozpolat"
                }
              ]
            },
            "doi": "10.1007/s10549-017-4207-7",
            "pmid": "28361350",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Breast Cancer Res Treat 163 2017",
            "title": "FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer."
          }
        },
        {
          "pmid": "26918606",
          "pubmed": {
            "ISODate": "2016-03-29T00:00:00.000Z",
            "abstract": "Eukaryotic elongation factor 2 kinase (eEF2K), an emerging molecular target for cancer therapy, contributes to cancer proliferation, cell survival, tumorigenesis, and invasion, disease progression and drug resistance. Although eEF2K is highly up-regulated in various cancers, the mechanism of gene regulation has not been elucidated. In this study, we examined the role of Forkhead Box M1 (FOXM1) proto-oncogenic transcription factor in triple negative breast cancer (TNBC) cells and the regulation of eEF2K. We found that FOXM1 is highly upregulated in TNBC and its knockdown by RNA interference (siRNA) significantly inhibited eEF2K expression and suppressed cell proliferation, colony formation, migration, invasion and induced apoptotic cell death, recapitulating the effects of eEF2K inhibition. Knockdown of FOXM1 inhibited regulators of cell cycle, migration/invasion and survival, including cyclin D1, Src and MAPK-ERK signaling pathways, respectively. We also demonstrated that FOXM1 (1B and 1C isoforms) directly binds to and transcriptionally regulates eEF2K gene expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. Furthermore, in vivo inhibition of FOXM1 by liposomal siRNA-nanoparticles suppressed growth of MDA-MB-231 TNBC tumor xenografts in orthotopic models. In conclusion, our study provides the first evidence about the transcriptional regulation of eEF2K in TNBC and the role of FOXM1 in mediating breast cancer cell proliferation, survival, migration/invasion, progression and tumorgenesis and highlighting the potential of FOXM1/eEF2K axis as a molecular target in breast and other cancers.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.7672",
            "pmid": "26918606",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 7 2016",
            "title": "FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells."
          }
        },
        {
          "pmid": "27184798",
          "pubmed": {
            "ISODate": "2016-08-01T00:00:00.000Z",
            "abstract": "Dysregulated energy metabolism is one of the main mechanisms for uncontrolled growth in solid tumors. Hypoxia-inducible factor 1-alpha (HIF1α) is a transcription factor implicated in regulating several genes that are responsible for cell metabolism, including carbonic anhydrase IX (CAIX). The aim of this study is to determine the clinical significance of immunohistochemical metabolic alteration in early-stage triple negative breast cancer (TNBC) patients who received cyclophosphamide-based chemotherapy or radiotherapy and those with basal phenotype. Immunohistochemical staining for HIF1α and CAIX was performed to determine the correlation with clinicopathologic variables and survival outcome on tissue microarrays from 270 early-stage TNBC patients. In vitro experiments with multiple human TNBC cell lines, suppression of HIF1α by small interfering RNA (siRNA) significantly reduced CAIX protein expression in all cell lines. In multivariate analyses for different therapeutic modalities and basal phenotype, combined HIF1α and CAIX protein overexpression was significantly associated with disease-free survival in the total cohort (OR = 2.583, P = 0.002), stratified cohorts expressing basal phenotype (OR = 2.234, P = 0.021), and in those patients who received adjuvant chemotherapy (OR = 3.078, P = 0.023) and adjuvant radiotherapy (OR = 2.111, P = 0.050), respectively. In early TNBC, combined HIF1α and CAIX protein expression may serve as an unfavorable prognostic indicator particularly in patients treated with cyclophosphamide-based chemotherapy or radiotherapy as well as those with basal phenotype of breast cancer.",
            "authors": {
              "abbreviation": "Min-Sun Jin, Hyebin Lee, In Ae Park, ..., Han Suk Ryu",
              "authorList": [
                {
                  "ForeName": "Min-Sun",
                  "LastName": "Jin",
                  "abbrevName": "Jin MS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min-Sun Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Hyebin",
                  "LastName": "Lee",
                  "abbrevName": "Lee H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyebin Lee",
                  "orcid": null
                },
                {
                  "ForeName": "In",
                  "LastName": "Park",
                  "abbrevName": "Park IA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "In Ae Park",
                  "orcid": null
                },
                {
                  "ForeName": "Yul",
                  "LastName": "Chung",
                  "abbrevName": "Chung YR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yul Ri Chung",
                  "orcid": null
                },
                {
                  "ForeName": "Seock-Ah",
                  "LastName": "Im",
                  "abbrevName": "Im SA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Seock-Ah Im",
                  "orcid": null
                },
                {
                  "ForeName": "Kyung-Hun",
                  "LastName": "Lee",
                  "abbrevName": "Lee KH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyung-Hun Lee",
                  "orcid": null
                },
                {
                  "ForeName": "Hyeong-Gon",
                  "LastName": "Moon",
                  "abbrevName": "Moon HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyeong-Gon Moon",
                  "orcid": null
                },
                {
                  "ForeName": "Wonshik",
                  "LastName": "Han",
                  "abbrevName": "Han W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wonshik Han",
                  "orcid": null
                },
                {
                  "ForeName": "Kyubo",
                  "LastName": "Kim",
                  "abbrevName": "Kim K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyubo Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Tae-Yong",
                  "LastName": "Kim",
                  "abbrevName": "Kim TY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tae-Yong Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Dong-Young",
                  "LastName": "Noh",
                  "abbrevName": "Noh DY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dong-Young Noh",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "abbrevName": "Ryu HS",
                  "email": "karlnash@naver.com",
                  "isCollectiveName": false,
                  "name": "Han Suk Ryu",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "email": [
                    "karlnash@naver.com"
                  ],
                  "name": "Han Suk Ryu"
                }
              ]
            },
            "doi": "10.1007/s00428-016-1953-6",
            "pmid": "27184798",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Virchows Arch 469 2016",
            "title": "Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer."
          }
        },
        {
          "pmid": "34408002",
          "pubmed": {
            "ISODate": "2021-11-01T00:00:00.000Z",
            "abstract": "Genomic alterations are crucial for the development and progression of human cancers. Copy-number gains found in genes encoding metabolic enzymes may induce triple-negative breast cancer (TNBC) adaptation. However, little is known about how metabolic enzymes regulate TNBC metastasis. Using our previously constructed multiomic profiling of a TNBC cohort, we identified decaprenyl diphosphate synthase subunit 1 (PDSS1) as an essential gene for TNBC metastasis. PDSS1 expression was significantly upregulated in TNBC tissues compared with adjacent normal tissues and was positively associated with poor survival among patients with TNBC. PDSS1 knockdown inhibited TNBC cell migration, invasion, and distant metastasis. Mechanistically, PDSS1, but not a catalytically inactive mutant, positively regulated the cellular level of coenzyme Q10 (CoQ10) and intracellular calcium levels, thereby inducing CAMK2A phosphorylation, which is essential for STAT3 phosphorylation in the cytoplasm. Phosphorylated STAT3 entered the nucleus, promoting oncogenic STAT3 signaling and TNBC metastasis. STAT3 phosphorylation inhibitors (e.g., Stattic) effectively blocked PDSS1-induced cell migration and invasion in vitro and tumor metastasis in vivo. Taken together, our study highlights the importance of targeting the previously uncharacterized PDSS1/CAMK2A/STAT3 oncogenic signaling axis, expanding the repertoire of precision medicine in TNBC. SIGNIFICANCE: A novel metabolic gene PDSS1 is highly expressed in triple-negative breast cancer tissues and contributes to metastasis, serving as a potential therapeutic target for combating metastatic disease.",
            "authors": {
              "abbreviation": "Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li, ..., Yi-Zhou Jiang",
              "authorList": [
                {
                  "ForeName": "Tian-Jian",
                  "LastName": "Yu",
                  "abbrevName": "Yu TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tian-Jian Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying-Ying",
                  "LastName": "Liu",
                  "abbrevName": "Liu YY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying-Ying Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Xiao-Guang",
                  "LastName": "Li",
                  "abbrevName": "Li XG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiao-Guang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bi",
                  "LastName": "Lian",
                  "abbrevName": "Lian B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bi Lian",
                  "orcid": null
                },
                {
                  "ForeName": "Xun-Xi",
                  "LastName": "Lu",
                  "abbrevName": "Lu XX",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xun-Xi Lu",
                  "orcid": "0000-0002-5118-0377"
                },
                {
                  "ForeName": "Xi",
                  "LastName": "Jin",
                  "abbrevName": "Jin X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhi-Ming",
                  "LastName": "Shao",
                  "abbrevName": "Shao ZM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhi-Ming Shao",
                  "orcid": "0000-0001-8781-2455"
                },
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "abbrevName": "Hu X",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Xin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "abbrevName": "Di GH",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Gen-Hong Di",
                  "orcid": null
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "abbrevName": "Jiang YZ",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Yi-Zhou Jiang",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Xin Hu"
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Gen-Hong Di"
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Yi-Zhou Jiang"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-21-0747",
            "pmid": "34408002",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Res 81 2021",
            "title": "PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "28423652",
          "pubmed": {
            "ISODate": "2017-04-25T00:00:00.000Z",
            "abstract": "MiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR-29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b-1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.",
            "authors": {
              "abbreviation": "Rosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, ..., Riccardo Di Fiore",
              "authorList": [
                {
                  "ForeName": "Rosa",
                  "LastName": "Drago-Ferrante",
                  "abbrevName": "Drago-Ferrante R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Drago-Ferrante",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Pentimalli",
                  "abbrevName": "Pentimalli F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Pentimalli",
                  "orcid": null
                },
                {
                  "ForeName": "Daniela",
                  "LastName": "Carlisi",
                  "abbrevName": "Carlisi D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniela Carlisi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "De Blasio",
                  "abbrevName": "De Blasio A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna De Blasio",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Saliba",
                  "abbrevName": "Saliba C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Saliba",
                  "orcid": null
                },
                {
                  "ForeName": "Shawn",
                  "LastName": "Baldacchino",
                  "abbrevName": "Baldacchino S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shawn Baldacchino",
                  "orcid": null
                },
                {
                  "ForeName": "James",
                  "LastName": "Degaetano",
                  "abbrevName": "Degaetano J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James Degaetano",
                  "orcid": null
                },
                {
                  "ForeName": "Joseph",
                  "LastName": "Debono",
                  "abbrevName": "Debono J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joseph Debono",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Caruana-Dingli",
                  "abbrevName": "Caruana-Dingli G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Caruana-Dingli",
                  "orcid": null
                },
                {
                  "ForeName": "Godfrey",
                  "LastName": "Grech",
                  "abbrevName": "Grech G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Godfrey Grech",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Scerri",
                  "abbrevName": "Scerri C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Scerri",
                  "orcid": null
                },
                {
                  "ForeName": "Giovanni",
                  "LastName": "Tesoriere",
                  "abbrevName": "Tesoriere G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giovanni Tesoriere",
                  "orcid": null
                },
                {
                  "ForeName": "Antonio",
                  "LastName": "Giordano",
                  "abbrevName": "Giordano A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonio Giordano",
                  "orcid": null
                },
                {
                  "ForeName": "Renza",
                  "LastName": "Vento",
                  "abbrevName": "Vento R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Renza Vento",
                  "orcid": null
                },
                {
                  "ForeName": "Riccardo",
                  "LastName": "Di Fiore",
                  "abbrevName": "Di Fiore R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Riccardo Di Fiore",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.15960",
            "pmid": "28423652",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 8 2017",
            "title": "Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation."
          }
        },
        {
          "pmid": "30784286",
          "pubmed": {
            "ISODate": "2019-05-23T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The unclear molecular mechanisms underlying could provide important theoretical basis for the prevention and control of HCC. This study performed chromatin immunoprecipitation-sequencing (ChIP-seq) to analyze the binding sites between zinc fingers and homeoboxes 2 (ZHX2) and its genome-wide target genes, and bioinformatics was used to analyze their gene transcription regulation network. Immunohistochemistry was used to detect the ZHX2 expression in HCC, and its association with the clinicopathological characteristics of HCC. Results of RT-PCR and western blot showed the expression of ZHX2 in HepG2 cells was obviously lower compared with normal liver cells. ZHX2 could be amplified in ChIP products, then ChIP-seq reveals there were 232 genes binding in promoter regions. GO analysis of functions revealed these genes were mainly associated with biological processes (BP), cellular components (CC), and molecular functions (MF). In addition, PTEN was found enriched in certain biological functions in BP analysis. Then, four pathways of these genes based on Kyoto Encyclopedia of Genes and Genomes (KEGG) were found P<0.05. Last analysis of immunohistochemistry showed the rates of ZHX2 expression and PTEN expression in paracancerous tissues both were significantly higher than that in HCC tissues (P=0.042; P<0.001), with negative correlations with AFP values (r=-0.246, P=0.040; r=-0.263, P=0.028). Further, PTEN expression was positively correlated with the differentiation level in HCC tissues (r=0.267, P=0.025). Spearman correlation analysis revealed that the expression profiles of ZHX2 and PTEN were positively correlated in HCC tissues (r=0.258, P=0.031). This study is the first to use ChIP-seq technology to analyze the specific regulatory mechanisms of the transcription suppressor ZHX2 in the context of HCC at the genome level.",
            "authors": {
              "abbreviation": "Z Lv, R He, M Huang, ..., G Chen",
              "authorList": [
                {
                  "ForeName": "Z",
                  "LastName": "Lv",
                  "abbrevName": "Lv Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Lv",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "He",
                  "abbrevName": "He R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R He",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Huang",
                  "abbrevName": "Huang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Huang",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Ma",
                  "abbrevName": "Ma J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Ma",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Chen",
                  "abbrevName": "Chen G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Chen",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.4149/neo_2018_180806N593",
            "pmid": "30784286",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Neoplasma 66 2019",
            "title": "Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation."
          }
        }
      ],
      "secret": "read-only",
      "type": "protein"
    },
    {
      "_creationTimestamp": "2022-12-10T08:45:48.864Z",
      "_newestOpId": "f19c1925-2d93-406c-9abe-60c1b4db5686",
      "_ops": [],
      "association": {
        "combinedOrganismIndex": 0,
        "dbName": "NCBI Gene",
        "dbPrefix": "ncbigene",
        "dbXrefs": [
          {
            "db": "MIM",
            "id": "603348"
          },
          {
            "db": "HGNC",
            "id": "HGNC:4910"
          },
          {
            "db": "Ensembl",
            "id": "ENSG00000100644"
          }
        ],
        "defaultOrganismIndex": 2,
        "distance": 0,
        "esScore": 11.863279,
        "id": "3091",
        "name": "HIF1A",
        "nameDistance": 0,
        "namespace": "ncbi",
        "organism": "9606",
        "organismIndex": 0,
        "organismName": "Homo sapiens",
        "overallDistance": 0,
        "shortSynonyms": [
          "HIF-1-alpha",
          "HIF-1A",
          "HIF-1alpha",
          "HIF1",
          "HIF1-ALPHA",
          "hypoxia-inducible factor1alpha",
          "hypoxia inducible factor 1 subunit alpha",
          "PAS domain-containing protein 8\", \"Class E basic helix-loop-helix protein 78\", \"Member of PAS protein 1",
          "member of PAS superfamily 1",
          "MOP1"
        ],
        "synonyms": [
          "HIF-1-alpha",
          "HIF-1A",
          "HIF-1alpha",
          "HIF1",
          "HIF1-ALPHA",
          "MOP1",
          "PASD8",
          "bHLHe78",
          "hypoxia-inducible factor 1-alpha",
          "ARNT interacting protein",
          "PAS domain-containing protein 8",
          "PAS domain-containing protein 8\", \"Class E basic helix-loop-helix protein 78\", \"Member of PAS protein 1",
          "basic-helix-loop-helix-PAS protein MOP1",
          "class E basic helix-loop-helix protein 78",
          "hypoxia inducible factor 1 alpha subunit",
          "hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",
          "hypoxia-inducible factor1alpha",
          "member of PAS protein 1",
          "member of PAS superfamily 1",
          "hypoxia inducible factor 1 subunit alpha"
        ],
        "type": "protein"
      },
      "completed": true,
      "description": "",
      "id": "3295573e-31b2-40c4-99f1-4dbf6a34990a",
      "liveId": "85109400-9680-4b2c-a8c7-6fe0fbc2b96a",
      "lock": null,
      "locked": false,
      "name": "HIF1a",
      "parentId": "3fd6a28f-483e-4eb4-ab6f-0a9025bd9cd1",
      "position": {
        "x": 342.41983122362853,
        "y": 147.3563482930571
      },
      "relatedPapers": [
        {
          "pmid": "30026228",
          "pubmed": {
            "ISODate": "2018-07-20T00:00:00.000Z",
            "abstract": "Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor κB activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.",
            "authors": {
              "abbreviation": "Jing Zhang, Tao Wu, Jeremy Simon, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": "0000-0001-5380-3905"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": "0000-0002-3961-9009"
                },
                {
                  "ForeName": "Ryoichi",
                  "LastName": "Saito",
                  "abbrevName": "Saito R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ryoichi Saito",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Xian-De",
                  "LastName": "Liu",
                  "abbrevName": "Liu XD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian-De Liu",
                  "orcid": "0000-0002-9639-0458"
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Jonasch",
                  "abbrevName": "Jonasch E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric Jonasch",
                  "orcid": "0000-0003-0943-2806"
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaosai",
                  "LastName": "Yao",
                  "abbrevName": "Yao X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaosai Yao",
                  "orcid": "0000-0001-9729-0726"
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Teh",
                  "abbrevName": "Teh BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Tean Teh",
                  "orcid": "0000-0003-1514-1124"
                },
                {
                  "ForeName": "Patrick",
                  "LastName": "Tan",
                  "abbrevName": "Tan P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Patrick Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": "0000-0003-3034-4421"
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": "0000-0001-5337-4901"
                },
                {
                  "ForeName": "Cortney",
                  "LastName": "Lawrence",
                  "abbrevName": "Lawrence C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cortney Lawrence",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Fan",
                  "abbrevName": "Fan J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Fan",
                  "orcid": "0000-0003-3842-2391"
                },
                {
                  "ForeName": "Jiang",
                  "LastName": "Geng",
                  "abbrevName": "Geng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiang Geng",
                  "orcid": "0000-0002-7202-2167"
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Joel",
                  "LastName": "Parker",
                  "abbrevName": "Parker JS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joel S Parker",
                  "orcid": "0000-0003-2080-6901"
                },
                {
                  "ForeName": "J",
                  "LastName": "Auman",
                  "abbrevName": "Auman JT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Todd Auman",
                  "orcid": "0000-0002-9328-8829"
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "W",
                  "LastName": "Rathmell",
                  "abbrevName": "Rathmell WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kimryn Rathmell",
                  "orcid": "0000-0002-4984-0225"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": "0000-0001-6540-6130"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": "0000-0002-0574-4856"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": "0000-0003-1246-1333"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "qing_zhang@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "qing_zhang@med.unc.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1126/science.aap8411",
            "pmid": "30026228",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 361 2018",
            "title": "VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma."
          }
        },
        {
          "pmid": "27137755",
          "pubmed": {
            "ISODate": "2017-01-01T00:00:00.000Z",
            "abstract": "The aggressiveness of triple-negative breast cancer (TNBC), which lacks estrogen receptor, progesterone receptor and epidermal growth factor receptor 2 (HER2), represents a major challenge in breast cancer. Migratory and self-renewal capabilities are integral components of invasion, metastasis and recurrence of TNBC. Elevated hypoxia-inducible factor-1α (HIF-1α) expression is associated with aggressiveness of cancer. Nonetheless, how HIF-1α expression is regulated and how HIF-1α induces aggressive phenotype are not completely understood in TNBC. The cytotoxic effects of farnesyltransferase (FTase) inhibitors (FTIs) have been studied in cancer and leukemia cells. In contrast, the effect of FTIs on HIF-1α expression has not yet been studied. Here, we show that clinically relevant low-dose FTI, tipifarnib (300 nM), decreased HIF-1α expression, migration and tumorsphere formation in human MDA-MB-231 TNBC cells under a normoxic condition. In contrast, the low-dose FTIs did not inhibit cell growth and activity of the Ras pathway in MDA-MB 231 cells. Tipifarnib-induced decrease in HIF-1α expression was associated with amelioration of the Warburg effect, hypermetabolic state, increases in Snail expression and ATP release, and suppressed E-cadherin expression, major contributors to invasion, metastasis and recurrence of TBNC. These data suggest that FTIs may be capable of ameliorating the aggressive phenotype of TNBC by suppressing the HIF-1α-Snail pathway. J. Cell. Physiol. 232: 192-201, 2017. © 2016 Wiley Periodicals, Inc.",
            "authors": {
              "abbreviation": "Tomokazu Tanaka, Yuichi Ikegami, Harumasa Nakazawa, ..., Masao Kaneki",
              "authorList": [
                {
                  "ForeName": "Tomokazu",
                  "LastName": "Tanaka",
                  "abbrevName": "Tanaka T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tomokazu Tanaka",
                  "orcid": null
                },
                {
                  "ForeName": "Yuichi",
                  "LastName": "Ikegami",
                  "abbrevName": "Ikegami Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuichi Ikegami",
                  "orcid": null
                },
                {
                  "ForeName": "Harumasa",
                  "LastName": "Nakazawa",
                  "abbrevName": "Nakazawa H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Harumasa Nakazawa",
                  "orcid": null
                },
                {
                  "ForeName": "Naohide",
                  "LastName": "Kuriyama",
                  "abbrevName": "Kuriyama N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naohide Kuriyama",
                  "orcid": null
                },
                {
                  "ForeName": "Miwa",
                  "LastName": "Oki",
                  "abbrevName": "Oki M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Miwa Oki",
                  "orcid": null
                },
                {
                  "ForeName": "Jun-Ichi",
                  "LastName": "Hanai",
                  "abbrevName": "Hanai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun-Ichi Hanai",
                  "orcid": null
                },
                {
                  "ForeName": "Vikas",
                  "LastName": "Sukhatme",
                  "abbrevName": "Sukhatme VP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vikas P Sukhatme",
                  "orcid": null
                },
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "abbrevName": "Kaneki M",
                  "email": "mkaneki@helix.mgh.harvard.edu",
                  "isCollectiveName": false,
                  "name": "Masao Kaneki",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "email": [
                    "mkaneki@helix.mgh.harvard.edu"
                  ],
                  "name": "Masao Kaneki"
                }
              ]
            },
            "doi": "10.1002/jcp.25411",
            "pmid": "27137755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Cell Physiol 232 2017",
            "title": "Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro."
          }
        },
        {
          "pmid": "32382017",
          "pubmed": {
            "ISODate": "2020-05-07T00:00:00.000Z",
            "abstract": "Zinc fingers and homeoboxes 2 (ZHX2) was found as a novel VHL substrate target, and acted as an oncogenic driver in ccRCC. However, the detailed mechanism of ZHX2 in ccRCC development remains elusive, and no research has focused on studying ZHX2 in drug resistance yet. A tissue microarray with 358 ccRCC samples was used to determine the expression of ZHX2 in ccRCC patients. VHL-deficient cell line 786-O and VHL-normal cell line CAKI-1 was used for lineage reprogramming by transfecting with lentivirus. The in vitro and in vivo experiments were performed with these new cell lines to determine the mechanism of ZHX2 in ccRCC development and drug resistance. Immunohistochemistry analysis showed that ZHX2 was not highly expressed in ccRCC tumor tissues, only 33.2% (119/358) patients have high ZHX2 expression. However, high ZHX2 was significantly associated with advanced Fuhrman grade (p = 0.004), and proved to be an independent prognosis factor for progression-free survival (p = 0.0003), while there is no significant correlation with overall survival. We further discovered that ZHX2 overexpression could increase VEGF secretion and transcriptional activate the MEK/ERK1/2 and promote its downstream targets. We also found ZHX2 overexpression induce Sunitinib resistance though activating autophagy and the combination treatment of Sunitinib and Chloroquine could significantly rescue the phenomenon. In summary, these results indicate that ZHX2 drivers cell growth, migration though increase VEGF expression, and transcriptional activate MEK/ERK1/2 signaling pathway, and could induce Sunitinib resistance by regulating self-protective autophagy, these may provide new insight in advanced ccRCC treatment.",
            "authors": {
              "abbreviation": "Liangsong Zhu, Rong Ding, Hao Yan, ..., Zongming Lin",
              "authorList": [
                {
                  "ForeName": "Liangsong",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liangsong Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Rong",
                  "LastName": "Ding",
                  "abbrevName": "Ding R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rong Ding",
                  "orcid": null
                },
                {
                  "ForeName": "Hao",
                  "LastName": "Yan",
                  "abbrevName": "Yan H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hao Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": "med-zhangjin@vip.sina.com",
                  "isCollectiveName": false,
                  "name": "Jin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "abbrevName": "Lin Z",
                  "email": "lin.zongming@zs-hospital.sh.cn",
                  "isCollectiveName": false,
                  "name": "Zongming Lin",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "email": [
                    "med-zhangjin@vip.sina.com"
                  ],
                  "name": "Jin Zhang"
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "email": [
                    "lin.zongming@zs-hospital.sh.cn"
                  ],
                  "name": "Zongming Lin"
                }
              ]
            },
            "doi": "10.1038/s41419-020-2541-x",
            "pmid": "32382017",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 11 2020",
            "title": "ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma."
          }
        },
        {
          "pmid": "29333926",
          "pubmed": {
            "ISODate": "2018-04-03T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by poor patient prognosis and for which no targeted therapies are currently available. TNBC can be further categorized as either basal-like (BLBC) or quintuple-negative breast cancer (QNBC). In the present study, we aimed to identify novel molecular therapeutic targets for TNBC by analyzing the mRNA expression of TNBC-related genes in publicly available microarray data sets. We found that Engrailed 1 (EN1) was significantly overexpressed in TNBC. Using breast cancer cell lines, we found that EN1 was more highly expressed in TNBC than in other breast cancer subtypes. EN1 expression was analyzed in 199 TNBC paraffin-embedded tissue samples by immunohistochemistry. EN1 protein expression was positively associated with reduced overall survival (OS) rate in patients with QNBC, but not those with BLBC. The importance of EN1 expression in QNBC cell viability and tumorigenicity was evaluated using the QNBC cell lines, HCC38 and HCC1395. Based on our data, EN1 may promote the proliferation, migration, and multinucleation of QNBC cells, likely via the transcriptional activation of HDAC8, UTP11L, and ZIC3. We also demonstrated that actinomycin D effectively inhibits EN1 activity in QNBC cells. The results of the present study suggest that EN1 activity is highly clinically relevant to the survival prognosis of patients with QNBC and EN1 is a promising potential therapeutic target for future QNBC treatment.",
            "authors": {
              "abbreviation": "Yu Jin Kim, Minjung Sung, Ensel Oh, ..., Yoon-La Choi",
              "authorList": [
                {
                  "ForeName": "Yu",
                  "LastName": "Kim",
                  "abbrevName": "Kim YJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Jin Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Minjung",
                  "LastName": "Sung",
                  "abbrevName": "Sung M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minjung Sung",
                  "orcid": null
                },
                {
                  "ForeName": "Ensel",
                  "LastName": "Oh",
                  "abbrevName": "Oh E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ensel Oh",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Vrancken",
                  "abbrevName": "Vrancken MV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Van Vrancken",
                  "orcid": null
                },
                {
                  "ForeName": "Ji-Young",
                  "LastName": "Song",
                  "abbrevName": "Song JY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ji-Young Song",
                  "orcid": null
                },
                {
                  "ForeName": "Kyungsoo",
                  "LastName": "Jung",
                  "abbrevName": "Jung K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyungsoo Jung",
                  "orcid": null
                },
                {
                  "ForeName": "Yoon-La",
                  "LastName": "Choi",
                  "abbrevName": "Choi YL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yoon-La Choi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2018.1423913",
            "pmid": "29333926",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 19 2018",
            "title": "Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer."
          }
        },
        {
          "pmid": "35867755",
          "pubmed": {
            "ISODate": "2022-07-12T00:00:00.000Z",
            "abstract": "Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Zhaoping Qiu, Weijie Guo, Bo Dong, ..., Yadi Wu",
              "authorList": [
                {
                  "ForeName": "Zhaoping",
                  "LastName": "Qiu",
                  "abbrevName": "Qiu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhaoping Qiu",
                  "orcid": null
                },
                {
                  "ForeName": "Weijie",
                  "LastName": "Guo",
                  "abbrevName": "Guo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weijie Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Dong",
                  "abbrevName": "Dong B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Dong",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Pan",
                  "LastName": "Deng",
                  "abbrevName": "Deng P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pan Deng",
                  "orcid": "0000-0003-2974-7389"
                },
                {
                  "ForeName": "Chi",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chi Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jinpeng",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jinpeng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                },
                {
                  "ForeName": "Rudolf",
                  "LastName": "Grosschedl",
                  "abbrevName": "Grosschedl R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rudolf Grosschedl",
                  "orcid": null
                },
                {
                  "ForeName": "Zhiyong",
                  "LastName": "Yu",
                  "abbrevName": "Yu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhiyong Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Jiong",
                  "LastName": "Deng",
                  "abbrevName": "Deng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiong Deng",
                  "orcid": null
                },
                {
                  "ForeName": "Yadi",
                  "LastName": "Wu",
                  "abbrevName": "Wu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadi Wu",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119518119",
            "pmid": "35867755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway."
          }
        },
        {
          "pmid": "26751287",
          "pubmed": {
            "ISODate": "2016-02-01T00:00:00.000Z",
            "abstract": "Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively. These events cause HIF1α stabilization, HIF1α-p300 interaction, and activation of HIF1α transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to the EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1α Tyr 565 phosphorylation interferes with Pro 564 hydroxylation, leading to normoxic HIF1α stabilization. Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.",
            "authors": {
              "abbreviation": "Aifu Lin, Chunlai Li, Zhen Xing, ..., Liuqing Yang",
              "authorList": [
                {
                  "ForeName": "Aifu",
                  "LastName": "Lin",
                  "abbrevName": "Lin A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Aifu Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Chunlai",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunlai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Zhen",
                  "LastName": "Xing",
                  "abbrevName": "Xing Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhen Xing",
                  "orcid": null
                },
                {
                  "ForeName": "Qingsong",
                  "LastName": "Hu",
                  "abbrevName": "Hu Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingsong Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Ke",
                  "LastName": "Liang",
                  "abbrevName": "Liang K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ke Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Leng",
                  "LastName": "Han",
                  "abbrevName": "Han L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leng Han",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Wang",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Hawke",
                  "abbrevName": "Hawke DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David H Hawke",
                  "orcid": "0000-0002-6102-7843"
                },
                {
                  "ForeName": "Shouyu",
                  "LastName": "Wang",
                  "abbrevName": "Wang S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shouyu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yanyan",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yanyan Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yongkun",
                  "LastName": "Wei",
                  "abbrevName": "Wei Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yongkun Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Guolin",
                  "LastName": "Ma",
                  "abbrevName": "Ma G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guolin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Park",
                  "abbrevName": "Park PK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter K Park",
                  "orcid": null
                },
                {
                  "ForeName": "Jianwei",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianwei Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Zhibin",
                  "LastName": "Hu",
                  "abbrevName": "Hu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhibin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Yubin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yubin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Jeffery",
                  "LastName": "Marks",
                  "abbrevName": "Marks JR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeffery R Marks",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Han Liang",
                  "orcid": "0000-0001-7633-286X"
                },
                {
                  "ForeName": "Mien-Chie",
                  "LastName": "Hung",
                  "abbrevName": "Hung MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mien-Chie Hung",
                  "orcid": null
                },
                {
                  "ForeName": "Chunru",
                  "LastName": "Lin",
                  "abbrevName": "Lin C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunru Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Liuqing",
                  "LastName": "Yang",
                  "abbrevName": "Yang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liuqing Yang",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncb3295",
            "pmid": "26751287",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Nat Cell Biol 18 2016",
            "title": "The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer."
          }
        },
        {
          "pmid": "26918606",
          "pubmed": {
            "ISODate": "2016-03-29T00:00:00.000Z",
            "abstract": "Eukaryotic elongation factor 2 kinase (eEF2K), an emerging molecular target for cancer therapy, contributes to cancer proliferation, cell survival, tumorigenesis, and invasion, disease progression and drug resistance. Although eEF2K is highly up-regulated in various cancers, the mechanism of gene regulation has not been elucidated. In this study, we examined the role of Forkhead Box M1 (FOXM1) proto-oncogenic transcription factor in triple negative breast cancer (TNBC) cells and the regulation of eEF2K. We found that FOXM1 is highly upregulated in TNBC and its knockdown by RNA interference (siRNA) significantly inhibited eEF2K expression and suppressed cell proliferation, colony formation, migration, invasion and induced apoptotic cell death, recapitulating the effects of eEF2K inhibition. Knockdown of FOXM1 inhibited regulators of cell cycle, migration/invasion and survival, including cyclin D1, Src and MAPK-ERK signaling pathways, respectively. We also demonstrated that FOXM1 (1B and 1C isoforms) directly binds to and transcriptionally regulates eEF2K gene expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. Furthermore, in vivo inhibition of FOXM1 by liposomal siRNA-nanoparticles suppressed growth of MDA-MB-231 TNBC tumor xenografts in orthotopic models. In conclusion, our study provides the first evidence about the transcriptional regulation of eEF2K in TNBC and the role of FOXM1 in mediating breast cancer cell proliferation, survival, migration/invasion, progression and tumorgenesis and highlighting the potential of FOXM1/eEF2K axis as a molecular target in breast and other cancers.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.7672",
            "pmid": "26918606",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 7 2016",
            "title": "FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells."
          }
        },
        {
          "pmid": "24670641",
          "pubmed": {
            "ISODate": "2014-04-03T00:00:00.000Z",
            "abstract": "Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours, but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)--a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)--is a highly aggressive malignancy with limited treatment options. Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1α (HIF1α) is known to be hyperactivated in TNBCs. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Xi Chen, Dimitrios Iliopoulos, Qing Zhang, ..., Laurie H Glimcher",
              "authorList": [
                {
                  "ForeName": "Xi",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Dimitrios",
                  "LastName": "Iliopoulos",
                  "abbrevName": "Iliopoulos D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dimitrios Iliopoulos",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qianzi",
                  "LastName": "Tang",
                  "abbrevName": "Tang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qianzi Tang",
                  "orcid": null
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Greenblatt",
                  "abbrevName": "Greenblatt MB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew B Greenblatt",
                  "orcid": null
                },
                {
                  "ForeName": "Maria",
                  "LastName": "Hatziapostolou",
                  "abbrevName": "Hatziapostolou M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria Hatziapostolou",
                  "orcid": null
                },
                {
                  "ForeName": "Elgene",
                  "LastName": "Lim",
                  "abbrevName": "Lim E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elgene Lim",
                  "orcid": null
                },
                {
                  "ForeName": "Wai",
                  "LastName": "Tam",
                  "abbrevName": "Tam WL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wai Leong Tam",
                  "orcid": null
                },
                {
                  "ForeName": "Min",
                  "LastName": "Ni",
                  "abbrevName": "Ni M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min Ni",
                  "orcid": null
                },
                {
                  "ForeName": "Yiwen",
                  "LastName": "Chen",
                  "abbrevName": "Chen Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yiwen Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Junhua",
                  "LastName": "Mai",
                  "abbrevName": "Mai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Junhua Mai",
                  "orcid": null
                },
                {
                  "ForeName": "Haifa",
                  "LastName": "Shen",
                  "abbrevName": "Shen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haifa Shen",
                  "orcid": null
                },
                {
                  "ForeName": "Dorothy",
                  "LastName": "Hu",
                  "abbrevName": "Hu DZ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dorothy Z Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Stanley",
                  "LastName": "Adoro",
                  "abbrevName": "Adoro S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stanley Adoro",
                  "orcid": null
                },
                {
                  "ForeName": "Bella",
                  "LastName": "Hu",
                  "abbrevName": "Hu B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bella Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Minkyung",
                  "LastName": "Song",
                  "abbrevName": "Song M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minkyung Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chen",
                  "LastName": "Tan",
                  "abbrevName": "Tan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Melissa",
                  "LastName": "Landis",
                  "abbrevName": "Landis MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Melissa D Landis",
                  "orcid": null
                },
                {
                  "ForeName": "Mauro",
                  "LastName": "Ferrari",
                  "abbrevName": "Ferrari M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mauro Ferrari",
                  "orcid": null
                },
                {
                  "ForeName": "Sandra",
                  "LastName": "Shin",
                  "abbrevName": "Shin SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sandra J Shin",
                  "orcid": null
                },
                {
                  "ForeName": "Myles",
                  "LastName": "Brown",
                  "abbrevName": "Brown M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Myles Brown",
                  "orcid": null
                },
                {
                  "ForeName": "Jenny",
                  "LastName": "Chang",
                  "abbrevName": "Chang JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jenny C Chang",
                  "orcid": null
                },
                {
                  "ForeName": "X",
                  "LastName": "Liu",
                  "abbrevName": "Liu XS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "X Shirley Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Laurie",
                  "LastName": "Glimcher",
                  "abbrevName": "Glimcher LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laurie H Glimcher",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature13119",
            "pmid": "24670641",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 508 2014",
            "title": "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway."
          }
        },
        {
          "pmid": "32770671",
          "pubmed": {
            "ISODate": "2020-12-01T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Lipogenesis has been considered as a critical player in HCC initiation and progression. However, the underlying mechanism is still not fully understood. Here, we identified zinc fingers and homeoboxes 2 (ZHX2), an HCC-associated tumor suppressor, as an important repressor of de novo lipogenesis. Ectopic expression of ZHX2 significantly inhibited de novo lipogenesis in HCC cells and decreased expression of FASN, ACL, ACC1, and SCD1. In accordance with this, ZHX2 was negatively associated with SREBP1c, the master regulator of de novo lipogenesis, in HCC cell lines and human specimens. Results from silencing and overexpression demonstrated that ZHX2 inhibited de novo lipogenesis and consequent HCC progression via repression of SREBP1c. Furthermore, treatment with the SREBP1c inhibitor fatostatin dampened the spontaneous formation of tumors in liver-specific Zhx2 knockout mice. Mechanistically, ZHX2 increased expression of miR-24-3p transcriptionally, which targeted SREBP1c and led to its degradation. In conclusion, our data suggest a novel mechanism through which ZHX2 suppresses HCC progression, which may provide a new strategy for the treatment of HCC. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",
            "authors": {
              "abbreviation": "Xiangguo Yu, Qinghai Lin, Zhuanchang Wu, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Yankun",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yankun Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Songbai",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Songbai Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chaojia",
                  "LastName": "Chen",
                  "abbrevName": "Chen C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chaojia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Chunyang",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunyang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": "0000-0002-8121-4718"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/path.5530",
            "pmid": "32770671",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Pathol 252 2020",
            "title": "ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p."
          }
        },
        {
          "pmid": "32114388",
          "pubmed": {
            "ISODate": "2020-03-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Liver cancer stem cells (CSCs) are critical determinants of HCC relapse and therapeutic resistance, but the mechanisms underlying the maintenance of CSCs are poorly understood. We aimed to explore the role of tumor repressor Zinc-fingers and homeoboxes 2 (ZHX2) in liver CSCs. METHODS: CD133+ or EPCAM+ stem-like liver cancer cells were sorted from tumor tissues of HCC patients and HCC cell lines by flow cytometry. In addition, sorafenib-resistant cells, tumor-sphere forming cells and side population (SP) cells were respectively cultured and isolated as hepatic CSCs. The tumor-initiating and chemoresistance properties of ZHX2-overexpressing and ZHX2-knockdown cells were analyzed in vivo and in vitro. Microarray, luciferase reporter assay, chromatin immunoprecipitation (ChIP) and ChIP-on-chip analyses were performed to explore ZHX2 target genes. The expression of ZHX2 and its target gene were determined by quantitative RT-PCR, western blot, immunofluorescence and immunohistochemical staining in hepatoma cells and tumor and adjacent tissues from HCC patients. RESULTS: ZHX2 expression was significantly reduced in liver CSCs from different origins. ZHX2 deficiency led to enhanced liver tumor progression and expansion of CSC populations in vitro and in vivo. Re-expression of ZHX2 restricted capabilities of hepatic CSCs in supporting tumor initiation, self-renewal and sorafenib-resistance. Mechanically, ZHX2 suppressed liver CSCs via inhibiting KDM2A-mediated demethylation of histone H3 lysine 36 (H3K36) at the promoter regions of stemness-associated transcription factors, such as NANOG, SOX4 and OCT4. Moreover, patients with lower expression of ZHX2 and higher expression of KDM2A in tumor tissues showed significantly poorer survival. CONCLUSION: ZHX2 counteracts stem cell traits through transcriptionally repressing KDM2A in HCC. Our data will aid in a better understanding of molecular mechanisms underlying HCC relapse and drug resistance.",
            "authors": {
              "abbreviation": "Qinghai Lin, Zhuanchang Wu, Xuetian Yue, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying",
                  "LastName": "He",
                  "abbrevName": "He Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying He",
                  "orcid": null
                },
                {
                  "ForeName": "Yutong",
                  "LastName": "Ge",
                  "abbrevName": "Ge Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yutong Ge",
                  "orcid": null
                },
                {
                  "ForeName": "Siyu",
                  "LastName": "Tan",
                  "abbrevName": "Tan S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siyu Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Song",
                  "abbrevName": "Song H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Song",
                  "orcid": null
                },
                {
                  "ForeName": "Detian",
                  "LastName": "Yuan",
                  "abbrevName": "Yuan D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Detian Yuan",
                  "orcid": null
                },
                {
                  "ForeName": "Yaoqin",
                  "LastName": "Gong",
                  "abbrevName": "Gong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yaoqin Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.ebiom.2020.102676",
            "pmid": "32114388",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "EBioMedicine 53 2020",
            "title": "ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation."
          }
        },
        {
          "pmid": "26825173",
          "pubmed": {
            "ISODate": "2016-03-15T00:00:00.000Z",
            "abstract": "Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.",
            "authors": {
              "abbreviation": "Tarah M Regan Anderson, Shi Hong Ma, Ganesh V Raj, ..., Carol A Lange",
              "authorList": [
                {
                  "ForeName": "Tarah",
                  "LastName": "Regan Anderson",
                  "abbrevName": "Regan Anderson TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tarah M Regan Anderson",
                  "orcid": null
                },
                {
                  "ForeName": "Shi",
                  "LastName": "Ma",
                  "abbrevName": "Ma SH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shi Hong Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Ganesh",
                  "LastName": "Raj",
                  "abbrevName": "Raj GV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ganesh V Raj",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Cidlowski",
                  "abbrevName": "Cidlowski JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John A Cidlowski",
                  "orcid": null
                },
                {
                  "ForeName": "Taylor",
                  "LastName": "Helle",
                  "abbrevName": "Helle TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Taylor M Helle",
                  "orcid": null
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Knutson",
                  "abbrevName": "Knutson TP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Todd P Knutson",
                  "orcid": null
                },
                {
                  "ForeName": "Raisa",
                  "LastName": "Krutilina",
                  "abbrevName": "Krutilina RI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raisa I Krutilina",
                  "orcid": null
                },
                {
                  "ForeName": "Tiffany",
                  "LastName": "Seagroves",
                  "abbrevName": "Seagroves TN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tiffany N Seagroves",
                  "orcid": null
                },
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "abbrevName": "Lange CA",
                  "email": "lange047@umn.edu",
                  "isCollectiveName": false,
                  "name": "Carol A Lange",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "email": [
                    "lange047@umn.edu"
                  ],
                  "name": "Carol A Lange"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-15-2510",
            "pmid": "26825173",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Cancer Res 76 2016",
            "title": "Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "30964885",
          "pubmed": {
            "ISODate": "2019-01-01T00:00:00.000Z",
            "abstract": "Triple-Negative Breast Cancers (TNBCs) are the most difficult to treat subtype of breast cancer and are often associated with high nuclear expression of Snail and Cathepsin L (Cat L) protease. We have previously shown that Snail can increase Cat L expression/activity in prostate and breast cancer cells. This study investigated the role of CUX1 (a downstream substrate of Cat L) in TNBC. We showed that Cat L and CUX1 were highly expressed in TNBC patient tissue/cell lines, as compared to ER-positive samples, using cBioportal data and western blot/zymography analyses. Additionally, luciferase reporter and chromatin immunoprecipitation assays showed that CUX1 directly bound to estrogen receptor-alpha (ER-α) promoter in MDA-MB-468, a representative TNBC cell line, and that CUX1 siRNA could restore ER-α transcription and protein expression. Furthermore, Snail and CUX1 expression in various TNBC cell lines was inhibited by muscadine grape skin extract (MSKE, a natural grape product rich in anthocyanins) or Cat L inhibitor (Z-FY-CHO) leading to decreased cell invasion and migration. MSKE decreased cell viability and increased expression of apoptotic markers in MDA-MB-468 cells, with no effect on non-tumorigenic MCF10A cells. MSKE also decreased CUX1 binding to ER-α promoter and restored ER-α expression in TNBC cells, while both MSKE and CUX1 siRNA restored sensitivity to estradiol and 4-hydoxytamoxifen as shown by increased cell viability. Therefore, CUX1 activated by Snail-Cat L signaling may contribute to TNBC via ER-α repression, and may be a viable target for TNBC using natural products such as MSKE that targets cancer and not normal cells.",
            "authors": {
              "abbreviation": "Liza J Burton, Ohuod Hawsawi, Janae Sweeney, ..., Valerie Odero-Marah",
              "authorList": [
                {
                  "ForeName": "Liza",
                  "LastName": "Burton",
                  "abbrevName": "Burton LJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liza J Burton",
                  "orcid": null
                },
                {
                  "ForeName": "Ohuod",
                  "LastName": "Hawsawi",
                  "abbrevName": "Hawsawi O",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ohuod Hawsawi",
                  "orcid": null
                },
                {
                  "ForeName": "Janae",
                  "LastName": "Sweeney",
                  "abbrevName": "Sweeney J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Janae Sweeney",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Bowen",
                  "abbrevName": "Bowen N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan Bowen",
                  "orcid": "0000-0002-1609-6698"
                },
                {
                  "ForeName": "Tamaro",
                  "LastName": "Hudson",
                  "abbrevName": "Hudson T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tamaro Hudson",
                  "orcid": null
                },
                {
                  "ForeName": "Valerie",
                  "LastName": "Odero-Marah",
                  "abbrevName": "Odero-Marah V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Valerie Odero-Marah",
                  "orcid": "0000-0002-5238-9914"
                }
              ],
              "contacts": []
            },
            "doi": "10.1371/journal.pone.0214844",
            "pmid": "30964885",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "PLoS One 14 2019",
            "title": "CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE)."
          }
        },
        {
          "pmid": "36037364",
          "pubmed": {
            "ISODate": "2022-09-06T00:00:00.000Z",
            "abstract": "Clear cell renal cell carcinoma (ccRCC) is characterized by the loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of an E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor α (HIF-α) (including HIF1α and HIF2α) and Zinc Fingers And Homeoboxes 2 (ZHX2). Our recent research showed that ZHX2 contributed to ccRCC tumorigenesis in a HIF-independent manner. However, it is still unknown whether ZHX2 could be modified through deubiquitination even in the absence of pVHL. Here, we performed a deubiquitinase (DUB) complementary DNA (cDNA) library binding screen and identified USP13 as a DUB that bound ZHX2 and promoted ZHX2 deubiquitination. As a result, USP13 promoted ZHX2 protein stability in an enzymatically dependent manner, and depletion of USP13 led to ZHX2 down-regulation in ccRCC. Functionally, USP13 depletion led to decreased cell proliferation measured by two-dimensional (2D) colony formation and three-dimensional (3D) anchorage-independent growth. Furthermore, USP13 was essential for ccRCC tumor growth in vivo, and the effect was partially mediated by its regulation on ZHX2. Our findings support that USP13 may be a key effector in ccRCC tumorigenesis.",
            "authors": {
              "abbreviation": "Haibiao Xie, Jin Zhou, Xijuan Liu, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": "0000-0001-6729-8479"
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Yawei",
                  "LastName": "Xu",
                  "abbrevName": "Xu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yawei Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Austin",
                  "LastName": "Hepperla",
                  "abbrevName": "Hepperla AJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Austin J Hepperla",
                  "orcid": "0000-0002-0107-2001"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hongwei",
                  "LastName": "Yao",
                  "abbrevName": "Yao H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongwei Yao",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": "0000-0002-9073-3835"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119854119",
            "pmid": "36037364",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer."
          }
        },
        {
          "pmid": "25920936",
          "pubmed": {
            "ISODate": "2015-01-01T00:00:00.000Z",
            "abstract": "Hypoxia is associated with poor response to treatment in various cancers. Hypoxia inducible factor 1 (HIF-1) is a major transcription factor that mediates adaptation of cancer cells to a hypoxic environment and regulates many genes that are involved in key cellular functions, including cell immortalization, stem cell maintenance, autocrine growth/survival, angiogenesis, invasion/metastasis, and resistance to chemotherapy. HIF-1α has been considered as an attractive therapeutic target for cancer treatment, but there is limited success in this research field. In the present study, we designed a recombinant lentivirus containing HIF-1α siRNA, developed stably transfected cell lines, and tested the anticancer effects of the siRNA on cancer cells in vitro and in vivo. Our results indicated that the stable downregulation of HIF-1α reversed chemoresistance, inhibited proliferation, migration and invasion of cancer cells, and slowed down the tumor growth in breast cancer xenograft models. In conclusion, the recombinant lentivirus containing HIF-1α siRNA provides a new avenue for developing novel therapy for triple negative breast cancer.",
            "authors": {
              "abbreviation": "Shuang Li, Qingzhu Wei, Qin Li, ..., Qiang Xiao",
              "authorList": [
                {
                  "ForeName": "Shuang",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Qingzhu",
                  "LastName": "Wei",
                  "abbrevName": "Wei Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingzhu Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Qin",
                  "LastName": "Li",
                  "abbrevName": "Li Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qin Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qiang",
                  "LastName": "Xiao",
                  "abbrevName": "Xiao Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qiang Xiao",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2015.1040958",
            "pmid": "25920936",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 16 2015",
            "title": "Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer."
          }
        },
        {
          "pmid": "25195714",
          "pubmed": {
            "ISODate": "2014-10-01T00:00:00.000Z",
            "abstract": "Glypican 3 (GPC3) has been paid particular attention owing to its potential as diagnosis marker for hepatocellular carcinoma (HCC). Identifying the mechanisms regulating the reactivation of GPC3 in HCC appears to be clinically meaningful. Previous study identified zinc-fingers and homeoboxes 2 (ZHX2) as transcriptional factor responsible for postnatal repression of GPC3 in mice. Here, in this study, we provided the first evidence that down regulated ZHX2 is responsible for GPC3 reactivation in HCC. First, inverse correlation of ZHX2 with GPC3 expression was shown in cultured liver cell lines. Second, ZHX2 overexpression significantly decreased GPC3 expression, while ZHX2 knockdown effectively increased GPC3 level in different HCC cell lines. Consistently, dual luciferase and ChIP assay showed that ZHX2 dose-dependently suppressed GPC3 promoter activity by binding with the core promoter. More importantly, immunohistochemical staining demonstrated the inverse correlation between nuclear ZHX2 with GPC3 expression in HCC tissues. Further in vitro analysis showed that nuclear translocation was crucial for ZHX2 mediated repression on GPC3 transcription. Taken together, our results prove that ZHX2 suppresses GPC3 transcription by binding with its core promoter and reduced nucleic ZHX2 expression may be involved in GPC3 reactivation in HCC.",
            "authors": {
              "abbreviation": "Fang Luan, Peng Liu, Hongxin Ma, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Fang",
                  "LastName": "Luan",
                  "abbrevName": "Luan F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fang Luan",
                  "orcid": null
                },
                {
                  "ForeName": "Peng",
                  "LastName": "Liu",
                  "abbrevName": "Liu P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.biocel.2014.08.021",
            "pmid": "25195714",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Int J Biochem Cell Biol 55 2014",
            "title": "Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma."
          }
        },
        {
          "pmid": "28054302",
          "pubmed": {
            "ISODate": "2017-04-01T00:00:00.000Z",
            "abstract": "PURPOSE: Despite advances that have been made in systemic chemotherapy, the prognosis of advanced triple-negative breast cancer (TNBC) patients is still poor. The identification of key factors governing TNBC development is considered imperative for the development of novel effective therapeutic approaches. Previously, it has been reported that microRNA (miR)-761 may act as either a tumor suppressor or as an oncogene in different types of cancer. Here, we aimed at assessing the biological role of this miRNA in TNBC. METHODS: First, we measured the expression of miR-761 in primary breast cancer tissues and breast cancer-derived cell lines using qRT-PCR. Subsequently, over-expression and silencing experiments were performed to determine the role of miR-761 in TNBC cell proliferation, colony formation, migration and invasion in vitro. The in vivo role of miR-761 in TNBC growth and metastasis was determined in mouse models. Bioinformatics analyses, dual-luciferase reporter assays, Western blot analyses and rescue experiments were performed to identify miR-761 target gene(s). RESULTS: We found that miR-761 was up-regulated in primary breast cancer tissues and its derived cell lines and, particularly, in TNBC tissues and cell lines. We also found that exogenous miR-761 over-expression augmented in vitro TNBC cell proliferation, colony formation, migration and invasion, whereas miR-761 down-regulation impaired these features. In vivo, we found that miR-761 over-expression facilitated TNBC growth and lung metastasis. Mechanistically, miR-761 was found to negatively regulate the expression of tripartite motif-containing 29 (TRIM29) in TNBC cells by binding to the 3'-untranslated region of its mRNA. In conformity with these results, a significant negative correlation between miR-761 expression and TRIM29 protein expression was noted in primary TNBC tissues (r = -0.452, p = 0.0126). We also found that exogenous TRIM29 over-expression reversed the proliferative and invasive capacities of TNBC cells. CONCLUSIONS: Our data indicate that miR-761 acts as an oncogene in TNBC. This mode of action can, at least partially, be ascribed to the down-regulation of its target TRIM29. We suggest that miR-761 may serve as a promising therapeutic target for TNBC.",
            "authors": {
              "abbreviation": "Guang-Cheng Guo, Jia-Xiang Wang, Ming-Li Han, ..., Lin Li",
              "authorList": [
                {
                  "ForeName": "Guang-Cheng",
                  "LastName": "Guo",
                  "abbrevName": "Guo GC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guang-Cheng Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "abbrevName": "Wang JX",
                  "email": "ggc503@126.com",
                  "isCollectiveName": false,
                  "name": "Jia-Xiang Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Ming-Li",
                  "LastName": "Han",
                  "abbrevName": "Han ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ming-Li Han",
                  "orcid": null
                },
                {
                  "ForeName": "Lian-Ping",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang LP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lian-Ping Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Lin",
                  "LastName": "Li",
                  "abbrevName": "Li L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lin Li",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "email": [
                    "ggc503@126.com"
                  ],
                  "name": "Jia-Xiang Wang"
                }
              ]
            },
            "doi": "10.1007/s13402-016-0312-6",
            "pmid": "28054302",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cell Oncol (Dordr) 40 2017",
            "title": "microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression."
          }
        },
        {
          "pmid": "28361350",
          "pubmed": {
            "ISODate": "2017-06-01T00:00:00.000Z",
            "abstract": "PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer and associated with early metastasis, drug resistance, and poor patient survival. Fork head box M1 (FOXM1) is considered as an emerging molecular target due to its oncogenic role and high overexpression profile in 85% in TNBC. However, molecular mechanisms by which FOXM1 transcription factor mediate its oncogenic effects are not fully understood. Integrin β1 is often upregulated in invasive breast cancers and associated with poor clinical outcome and shorter overall patient survival in TNBC. However, the mechanisms regulating integrin β1 (ITGB1) gene expression have not been well elucidated. METHODS: Normal breast epithelium (MCF10A) and TNBC cells (i.e., MDA-MB-231, BT-20 MDA-MB436) were used for the study. Small interfering RNA (siRNA)-based knockdown was used to inhibit Integrin β1 gene (mRNA) and protein expressions, which are detected by RT-PCR and Western blot, respectively. Chromatin immunoprecipitation (ChiP) and gene reporter (Luciferase) assays were used to demonstrate that FOXM1 transcription factor binds to the promoter of Integrin β1 gene and drives its expression. RESULTS: We demonstrated that FOXM1 directly binds to the promoter of integrin β1 gene and transcriptionally regulates its expression and activity of focal adhesion kinase (FAK) in TNBC cells. CONCLUSION: Our study suggests that FOXM1 transcription factor regulates Integrin β1 gene expression and that FOXM1/ Integrin-β1/FAK axis may play an important role in the progression of TNBC.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": "bozpolat@mdanderson.org",
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "email": [
                    "bozpolat@mdanderson.org"
                  ],
                  "name": "Bulent Ozpolat"
                }
              ]
            },
            "doi": "10.1007/s10549-017-4207-7",
            "pmid": "28361350",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Breast Cancer Res Treat 163 2017",
            "title": "FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer."
          }
        },
        {
          "pmid": "28423652",
          "pubmed": {
            "ISODate": "2017-04-25T00:00:00.000Z",
            "abstract": "MiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR-29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b-1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.",
            "authors": {
              "abbreviation": "Rosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, ..., Riccardo Di Fiore",
              "authorList": [
                {
                  "ForeName": "Rosa",
                  "LastName": "Drago-Ferrante",
                  "abbrevName": "Drago-Ferrante R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Drago-Ferrante",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Pentimalli",
                  "abbrevName": "Pentimalli F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Pentimalli",
                  "orcid": null
                },
                {
                  "ForeName": "Daniela",
                  "LastName": "Carlisi",
                  "abbrevName": "Carlisi D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniela Carlisi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "De Blasio",
                  "abbrevName": "De Blasio A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna De Blasio",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Saliba",
                  "abbrevName": "Saliba C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Saliba",
                  "orcid": null
                },
                {
                  "ForeName": "Shawn",
                  "LastName": "Baldacchino",
                  "abbrevName": "Baldacchino S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shawn Baldacchino",
                  "orcid": null
                },
                {
                  "ForeName": "James",
                  "LastName": "Degaetano",
                  "abbrevName": "Degaetano J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James Degaetano",
                  "orcid": null
                },
                {
                  "ForeName": "Joseph",
                  "LastName": "Debono",
                  "abbrevName": "Debono J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joseph Debono",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Caruana-Dingli",
                  "abbrevName": "Caruana-Dingli G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Caruana-Dingli",
                  "orcid": null
                },
                {
                  "ForeName": "Godfrey",
                  "LastName": "Grech",
                  "abbrevName": "Grech G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Godfrey Grech",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Scerri",
                  "abbrevName": "Scerri C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Scerri",
                  "orcid": null
                },
                {
                  "ForeName": "Giovanni",
                  "LastName": "Tesoriere",
                  "abbrevName": "Tesoriere G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giovanni Tesoriere",
                  "orcid": null
                },
                {
                  "ForeName": "Antonio",
                  "LastName": "Giordano",
                  "abbrevName": "Giordano A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonio Giordano",
                  "orcid": null
                },
                {
                  "ForeName": "Renza",
                  "LastName": "Vento",
                  "abbrevName": "Vento R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Renza Vento",
                  "orcid": null
                },
                {
                  "ForeName": "Riccardo",
                  "LastName": "Di Fiore",
                  "abbrevName": "Di Fiore R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Riccardo Di Fiore",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.15960",
            "pmid": "28423652",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 8 2017",
            "title": "Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation."
          }
        },
        {
          "pmid": "36228375",
          "pubmed": {
            "ISODate": "2022-12-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has been shown that HIF-1α regulates the complex biological processes of TNBC, such as glycolysis, angiogenesis, invasion and metastasis, breast cancer stem cells (BCSCs) enrichment, and immune escape, to promote TNBC survival and development through the activation of downstream target genes. In addition, inflammatory mediators, oxygen levels, noncoding RNAs, complex signaling regulatory networks, epigenetic regulators are involved in the upstream regulatory expression of HIF-1α. However, further studies are needed to determine the potential and future directions of targeting HIF-1α in TNBC. This article discusses the expression of the HIF-1α transcription factor in TNBC. We also explored the mechanism by which HIF-1α drives TNBC progression. The potential significance of targeting HIF-1α for immunotherapy, chemotherapy, anti-angiogenic therapy, and photodynamic therapy is discussed. The intrinsic mechanism, existing problems and future directions of targeting HIF-1α are also studied.",
            "authors": {
              "abbreviation": "Qi Liu, Chengcheng Guan, Cui Liu, ..., Changgang Sun",
              "authorList": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "abbrevName": "Liu Q",
                  "email": "2020110892@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Qi Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "abbrevName": "Guan C",
                  "email": "2020110896@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chengcheng Guan",
                  "orcid": null
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "abbrevName": "Liu C",
                  "email": "2019101062@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Cui Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "abbrevName": "Li H",
                  "email": "2019101020@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Huayao Li",
                  "orcid": null
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "abbrevName": "Wu J",
                  "email": "2020111256@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Jibiao Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "abbrevName": "Sun C",
                  "email": "zyxyscg@wfmc.edu.cn",
                  "isCollectiveName": false,
                  "name": "Changgang Sun",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "email": [
                    "2020110892@sdutcm.edu.cn"
                  ],
                  "name": "Qi Liu"
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "email": [
                    "2020110896@sdutcm.edu.cn"
                  ],
                  "name": "Chengcheng Guan"
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "email": [
                    "2019101062@sdutcm.edu.cn"
                  ],
                  "name": "Cui Liu"
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "email": [
                    "2019101020@sdutcm.edu.cn"
                  ],
                  "name": "Huayao Li"
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "email": [
                    "2020111256@sdutcm.edu.cn"
                  ],
                  "name": "Jibiao Wu"
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "email": [
                    "zyxyscg@wfmc.edu.cn"
                  ],
                  "name": "Changgang Sun"
                }
              ]
            },
            "doi": "10.1016/j.biopha.2022.113861",
            "pmid": "36228375",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Biomed Pharmacother 156 2022",
            "title": "Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy."
          }
        },
        {
          "pmid": "28239645",
          "pubmed": {
            "ISODate": "2017-02-23T00:00:00.000Z",
            "abstract": "Elucidating the molecular basis of tumor metastasis is pivotal for eradicating cancer-related mortality. Triple-negative breast cancer (TNBC) encompasses a class of aggressive tumors characterized by high rates of recurrence and metastasis, as well as poor overall survival. Here, we find that the promyelocytic leukemia protein PML exerts a prometastatic function in TNBC that can be targeted by arsenic trioxide. We found that, in TNBC patients, constitutive HIF1A activity induces high expression of PML, along with a number of HIF1A target genes that promote metastasis at multiple levels. Intriguingly, PML controls the expression of these genes by binding to their regulatory regions along with HIF1A. This mechanism is specific to TNBC cells and does not occur in other subtypes of breast cancer where PML and prometastatic HIF1A target genes are underexpressed. As a consequence, PML promotes cell migration, invasion, and metastasis in TNBC cell and mouse models. Notably, pharmacological inhibition of PML with arsenic trioxide, a PML-degrading agent used to treat promyelocytic leukemia patients, delays tumor growth, impairs TNBC metastasis, and cooperates with chemotherapy by preventing metastatic dissemination. In conclusion, we report identification of a prometastatic pathway in TNBC and suggest clinical development toward the use of arsenic trioxide for TNBC patients.",
            "authors": {
              "abbreviation": "Manfredi Ponente, Letizia Campanini, Roberto Cuttano, ..., Rosa Bernardi",
              "authorList": [
                {
                  "ForeName": "Manfredi",
                  "LastName": "Ponente",
                  "abbrevName": "Ponente M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Manfredi Ponente",
                  "orcid": null
                },
                {
                  "ForeName": "Letizia",
                  "LastName": "Campanini",
                  "abbrevName": "Campanini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Letizia Campanini",
                  "orcid": null
                },
                {
                  "ForeName": "Roberto",
                  "LastName": "Cuttano",
                  "abbrevName": "Cuttano R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberto Cuttano",
                  "orcid": null
                },
                {
                  "ForeName": "Andrea",
                  "LastName": "Piunti",
                  "abbrevName": "Piunti A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrea Piunti",
                  "orcid": null
                },
                {
                  "ForeName": "Giacomo",
                  "LastName": "Delledonne",
                  "abbrevName": "Delledonne GA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giacomo A Delledonne",
                  "orcid": null
                },
                {
                  "ForeName": "Nadia",
                  "LastName": "Coltella",
                  "abbrevName": "Coltella N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nadia Coltella",
                  "orcid": null
                },
                {
                  "ForeName": "Roberta",
                  "LastName": "Valsecchi",
                  "abbrevName": "Valsecchi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberta Valsecchi",
                  "orcid": null
                },
                {
                  "ForeName": "Alessandra",
                  "LastName": "Villa",
                  "abbrevName": "Villa A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alessandra Villa",
                  "orcid": null
                },
                {
                  "ForeName": "Ugo",
                  "LastName": "Cavallaro",
                  "abbrevName": "Cavallaro U",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ugo Cavallaro",
                  "orcid": null
                },
                {
                  "ForeName": "Linda",
                  "LastName": "Pattini",
                  "abbrevName": "Pattini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linda Pattini",
                  "orcid": null
                },
                {
                  "ForeName": "Claudio",
                  "LastName": "Doglioni",
                  "abbrevName": "Doglioni C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Claudio Doglioni",
                  "orcid": null
                },
                {
                  "ForeName": "Rosa",
                  "LastName": "Bernardi",
                  "abbrevName": "Bernardi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Bernardi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1172/jci.insight.87380",
            "pmid": "28239645",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "JCI Insight 2 2017",
            "title": "PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes."
          }
        },
        {
          "pmid": "32778144",
          "pubmed": {
            "ISODate": "2020-08-10T00:00:00.000Z",
            "abstract": "BACKGROUND: Hypoxia plays a relevant role in tumor-related inflammation toward the metastatic spread and cancer aggressiveness. The pro-inflammatory cytokine interleukin-1β (IL-β) and its cognate receptor IL1R1 contribute to the initiation and progression of breast cancer determining pro-tumorigenic inflammatory responses. The transcriptional target of the hypoxia inducible factor-1α (HIF-1α) namely the G protein estrogen receptor (GPER) mediates a feedforward loop coupling IL-1β induction by breast cancer-associated fibroblasts (CAFs) to IL1R1 expression by breast cancer cells toward the regulation of target genes and relevant biological responses. METHODS: In order to ascertain the correlation of IL-β with HIF-1α and further hypoxia-related genes in triple-negative breast cancer (TNBC) patients, a bioinformatics analysis was performed using the information provided by The Invasive Breast Cancer Cohort of The Cancer Genome Atlas (TCGA) project and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets. Gene expression correlation, statistical analysis and gene set enrichment analysis (GSEA) were carried out with R studio packages. Pathway enrichment analysis was evaluated with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. TNBC cells and primary CAFs were used as model system. The molecular mechanisms implicated in the regulation of IL-1β by hypoxia toward a metastatic gene expression profile and invasive properties were assessed performing gene and protein expression studies, PCR arrays, gene silencing and immunofluorescence analysis, co-immunoprecipitation and ChiP assays, ELISA, cell spreading, invasion and spheroid formation. RESULTS: We first determined that IL-1β expression correlates with the levels of HIF-1α as well as with a hypoxia-related gene signature in TNBC patients. Next, we demonstrated that hypoxia triggers a functional liaison among HIF-1α, GPER and the IL-1β/IL1R1 signaling toward a metastatic gene signature and a feed-forward loop of IL-1β that leads to proliferative and invasive responses in TNBC cells. Furthermore, we found that the IL-1β released in the conditioned medium of TNBC cells exposed to hypoxic conditions promotes an invasive phenotype of CAFs. CONCLUSIONS: Our data shed new light on the role of hypoxia in the activation of the IL-1β/IL1R1 signaling, which in turn triggers aggressive features in both TNBC cells and CAFs. Hence, our findings provide novel evidence regarding the mechanisms through which the hypoxic tumor microenvironment may contribute to breast cancer progression and suggest further targets useful in more comprehensive therapeutic strategies.",
            "authors": {
              "abbreviation": "Rosamaria Lappano, Marianna Talia, Francesca Cirillo, ..., Marcello Maggiolini",
              "authorList": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "abbrevName": "Lappano R",
                  "email": "rosamaria.lappano@unical.it",
                  "isCollectiveName": false,
                  "name": "Rosamaria Lappano",
                  "orcid": null
                },
                {
                  "ForeName": "Marianna",
                  "LastName": "Talia",
                  "abbrevName": "Talia M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marianna Talia",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Cirillo",
                  "abbrevName": "Cirillo F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Cirillo",
                  "orcid": null
                },
                {
                  "ForeName": "Damiano",
                  "LastName": "Rigiracciolo",
                  "abbrevName": "Rigiracciolo DC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Damiano Cosimo Rigiracciolo",
                  "orcid": null
                },
                {
                  "ForeName": "Domenica",
                  "LastName": "Scordamaglia",
                  "abbrevName": "Scordamaglia D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Domenica Scordamaglia",
                  "orcid": null
                },
                {
                  "ForeName": "Rita",
                  "LastName": "Guzzi",
                  "abbrevName": "Guzzi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rita Guzzi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "Miglietta",
                  "abbrevName": "Miglietta AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna Maria Miglietta",
                  "orcid": null
                },
                {
                  "ForeName": "Ernestina",
                  "LastName": "De Francesco",
                  "abbrevName": "De Francesco EM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ernestina Marianna De Francesco",
                  "orcid": null
                },
                {
                  "ForeName": "Antonino",
                  "LastName": "Belfiore",
                  "abbrevName": "Belfiore A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonino Belfiore",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "abbrevName": "Maggiolini M",
                  "email": "marcello.maggiolini@unical.it",
                  "isCollectiveName": false,
                  "name": "Marcello Maggiolini",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "email": [
                    "rosamaria.lappano@unical.it"
                  ],
                  "name": "Rosamaria Lappano"
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "email": [
                    "marcello.maggiolini@unical.it"
                  ],
                  "name": "Marcello Maggiolini"
                }
              ]
            },
            "doi": "10.1186/s13046-020-01667-y",
            "pmid": "32778144",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Exp Clin Cancer Res 39 2020",
            "title": "The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)."
          }
        },
        {
          "pmid": "27184798",
          "pubmed": {
            "ISODate": "2016-08-01T00:00:00.000Z",
            "abstract": "Dysregulated energy metabolism is one of the main mechanisms for uncontrolled growth in solid tumors. Hypoxia-inducible factor 1-alpha (HIF1α) is a transcription factor implicated in regulating several genes that are responsible for cell metabolism, including carbonic anhydrase IX (CAIX). The aim of this study is to determine the clinical significance of immunohistochemical metabolic alteration in early-stage triple negative breast cancer (TNBC) patients who received cyclophosphamide-based chemotherapy or radiotherapy and those with basal phenotype. Immunohistochemical staining for HIF1α and CAIX was performed to determine the correlation with clinicopathologic variables and survival outcome on tissue microarrays from 270 early-stage TNBC patients. In vitro experiments with multiple human TNBC cell lines, suppression of HIF1α by small interfering RNA (siRNA) significantly reduced CAIX protein expression in all cell lines. In multivariate analyses for different therapeutic modalities and basal phenotype, combined HIF1α and CAIX protein overexpression was significantly associated with disease-free survival in the total cohort (OR = 2.583, P = 0.002), stratified cohorts expressing basal phenotype (OR = 2.234, P = 0.021), and in those patients who received adjuvant chemotherapy (OR = 3.078, P = 0.023) and adjuvant radiotherapy (OR = 2.111, P = 0.050), respectively. In early TNBC, combined HIF1α and CAIX protein expression may serve as an unfavorable prognostic indicator particularly in patients treated with cyclophosphamide-based chemotherapy or radiotherapy as well as those with basal phenotype of breast cancer.",
            "authors": {
              "abbreviation": "Min-Sun Jin, Hyebin Lee, In Ae Park, ..., Han Suk Ryu",
              "authorList": [
                {
                  "ForeName": "Min-Sun",
                  "LastName": "Jin",
                  "abbrevName": "Jin MS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min-Sun Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Hyebin",
                  "LastName": "Lee",
                  "abbrevName": "Lee H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyebin Lee",
                  "orcid": null
                },
                {
                  "ForeName": "In",
                  "LastName": "Park",
                  "abbrevName": "Park IA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "In Ae Park",
                  "orcid": null
                },
                {
                  "ForeName": "Yul",
                  "LastName": "Chung",
                  "abbrevName": "Chung YR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yul Ri Chung",
                  "orcid": null
                },
                {
                  "ForeName": "Seock-Ah",
                  "LastName": "Im",
                  "abbrevName": "Im SA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Seock-Ah Im",
                  "orcid": null
                },
                {
                  "ForeName": "Kyung-Hun",
                  "LastName": "Lee",
                  "abbrevName": "Lee KH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyung-Hun Lee",
                  "orcid": null
                },
                {
                  "ForeName": "Hyeong-Gon",
                  "LastName": "Moon",
                  "abbrevName": "Moon HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyeong-Gon Moon",
                  "orcid": null
                },
                {
                  "ForeName": "Wonshik",
                  "LastName": "Han",
                  "abbrevName": "Han W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wonshik Han",
                  "orcid": null
                },
                {
                  "ForeName": "Kyubo",
                  "LastName": "Kim",
                  "abbrevName": "Kim K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyubo Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Tae-Yong",
                  "LastName": "Kim",
                  "abbrevName": "Kim TY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tae-Yong Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Dong-Young",
                  "LastName": "Noh",
                  "abbrevName": "Noh DY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dong-Young Noh",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "abbrevName": "Ryu HS",
                  "email": "karlnash@naver.com",
                  "isCollectiveName": false,
                  "name": "Han Suk Ryu",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "email": [
                    "karlnash@naver.com"
                  ],
                  "name": "Han Suk Ryu"
                }
              ]
            },
            "doi": "10.1007/s00428-016-1953-6",
            "pmid": "27184798",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Virchows Arch 469 2016",
            "title": "Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer."
          }
        },
        {
          "pmid": "31683461",
          "pubmed": {
            "ISODate": "2020-01-01T00:00:00.000Z",
            "abstract": "OBJECTIVE: To investigate the effect of ZHX2 on lung cancer cells proliferation and apoptosis. MATERIALS AND METHODS: The mRNA and protein expression of ZHX2 were detected by qRT-PCR and western blot, respectively. The human lung cancer cells were divided into Control, NC, ZHX2, SB, and ZHX2 + Ani groups. The cell proliferation was detected by CCK-8 assay and the cell migration and invasion were detected by Transwell assay. Cell apoptosis was detected by flow cytometry. Apoptosis and p38MAPK signaling pathway related proteins were detected by western blot. The nude mice model of lung cancer xenograft was constructed. The tumor volume and tumor weight were measured. The expression of PCNA protein in tumor tissues was detected by immunohistochemistry. The apoptosis of tumor cells was detected by TUNEL staining. The ZHX2 and p38MAPK signaling pathway related proteins in tumor tissues were detected by western blot. RESULTS: The expression of ZHX2 gene and protein in the cancer cell lines were significantly decreased. Compared with control and NC groups, the cells proliferation, migration and invasion were inhibited in ZHX2 and SB groups, while the apoptosis and apoptosis related proteins were increased (p< 0.05). Meanwhile, compared with ZHX2 group, the tumor growth rate, volume, weight, the percentage of PCNA-positive cells, and p-P38 MAPK/P38 MAPK were increased significantly in ZHX2 + Ani group, while the apoptotic index and the expression of MMP-9 protein were significantly decreased (p< 0.05). CONCLUSION: ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway.",
            "authors": {
              "abbreviation": "Xudong Tian, Yadong Wang, Shuhai Li, ..., Hui Tian",
              "authorList": [
                {
                  "ForeName": "Xudong",
                  "LastName": "Tian",
                  "abbrevName": "Tian X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xudong Tian",
                  "orcid": null
                },
                {
                  "ForeName": "Yadong",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadong Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Shuhai",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuhai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Weiming",
                  "LastName": "Yue",
                  "abbrevName": "Yue W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weiming Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Tian",
                  "abbrevName": "Tian H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Tian",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3233/CBM-190514",
            "pmid": "31683461",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cancer Biomark 27 2020",
            "title": "ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway."
          }
        },
        {
          "pmid": "34408002",
          "pubmed": {
            "ISODate": "2021-11-01T00:00:00.000Z",
            "abstract": "Genomic alterations are crucial for the development and progression of human cancers. Copy-number gains found in genes encoding metabolic enzymes may induce triple-negative breast cancer (TNBC) adaptation. However, little is known about how metabolic enzymes regulate TNBC metastasis. Using our previously constructed multiomic profiling of a TNBC cohort, we identified decaprenyl diphosphate synthase subunit 1 (PDSS1) as an essential gene for TNBC metastasis. PDSS1 expression was significantly upregulated in TNBC tissues compared with adjacent normal tissues and was positively associated with poor survival among patients with TNBC. PDSS1 knockdown inhibited TNBC cell migration, invasion, and distant metastasis. Mechanistically, PDSS1, but not a catalytically inactive mutant, positively regulated the cellular level of coenzyme Q10 (CoQ10) and intracellular calcium levels, thereby inducing CAMK2A phosphorylation, which is essential for STAT3 phosphorylation in the cytoplasm. Phosphorylated STAT3 entered the nucleus, promoting oncogenic STAT3 signaling and TNBC metastasis. STAT3 phosphorylation inhibitors (e.g., Stattic) effectively blocked PDSS1-induced cell migration and invasion in vitro and tumor metastasis in vivo. Taken together, our study highlights the importance of targeting the previously uncharacterized PDSS1/CAMK2A/STAT3 oncogenic signaling axis, expanding the repertoire of precision medicine in TNBC. SIGNIFICANCE: A novel metabolic gene PDSS1 is highly expressed in triple-negative breast cancer tissues and contributes to metastasis, serving as a potential therapeutic target for combating metastatic disease.",
            "authors": {
              "abbreviation": "Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li, ..., Yi-Zhou Jiang",
              "authorList": [
                {
                  "ForeName": "Tian-Jian",
                  "LastName": "Yu",
                  "abbrevName": "Yu TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tian-Jian Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying-Ying",
                  "LastName": "Liu",
                  "abbrevName": "Liu YY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying-Ying Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Xiao-Guang",
                  "LastName": "Li",
                  "abbrevName": "Li XG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiao-Guang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bi",
                  "LastName": "Lian",
                  "abbrevName": "Lian B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bi Lian",
                  "orcid": null
                },
                {
                  "ForeName": "Xun-Xi",
                  "LastName": "Lu",
                  "abbrevName": "Lu XX",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xun-Xi Lu",
                  "orcid": "0000-0002-5118-0377"
                },
                {
                  "ForeName": "Xi",
                  "LastName": "Jin",
                  "abbrevName": "Jin X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhi-Ming",
                  "LastName": "Shao",
                  "abbrevName": "Shao ZM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhi-Ming Shao",
                  "orcid": "0000-0001-8781-2455"
                },
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "abbrevName": "Hu X",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Xin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "abbrevName": "Di GH",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Gen-Hong Di",
                  "orcid": null
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "abbrevName": "Jiang YZ",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Yi-Zhou Jiang",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Xin Hu"
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Gen-Hong Di"
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Yi-Zhou Jiang"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-21-0747",
            "pmid": "34408002",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Res 81 2021",
            "title": "PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "31529195",
          "pubmed": {
            "ISODate": "2019-09-01T00:00:00.000Z",
            "abstract": "Triple negative breast cancer (TNBC) is the most lethal breast cancer subtype. Extended periods of lactation protect against breast cancer development, but the mechanisms underlying this protection are unknown. We examined the effects of the milk protein alpha-casein over expression in the triple negative MDA-MB-231 breast cancer cell line. The effects of recombinant alpha-casein added exogenously to MDA-MB-231 breast cancer cells, and immortalised human fibroblasts were also investigated. We used transcriptional reporters to understand the signalling pathways downstream of alpha-casein in breast cancer cells and these fibroblasts that were activated by breast cancer cells. To extend our findings to the clinical setting, we analysed public gene expression datasets to further understand the relevance of these signalling pathways in triple negative breast cancer cells and patient samples. Finally, we used small molecular inhibitors to target relevant pathways and highlight these as potential candidates for the treatment of TN breast cancer. High levels of alpha-casein gene expression were predictive of good prognosis across 263 TNBC patient tumour samples. Alpha-casein over expression or exogenous addition reduces cancer stem cell (CSC) activity. HIF-1alpha was identified to be a key downstream target of alpha-casein, in both breast cancer cells and activated fibroblasts, and STAT transcription factors to be upstream of HIF-1alpha. Interestingly, HIF-1alpha is regulated by STAT3 in breast cancer cells, but STAT1 is the regulator of HIF-1alpha in activated fibroblasts. In analysis of 573 TNBC patient samples, alpha-casein expression, inversely correlated to HIF-1alpha, STAT3 and STAT1. STAT1 and STAT3 inhibitors target HIF-1alpha signalling in activated fibroblasts and MDA-MB-231 breast cancer cells respectively, and also abrogate CSC activities. Our findings provide an explanation for the protective effects of lactation in TNBC. Clinical data correlates high alpha-casein expression with increased recurrence-free survival in TNBC patients. Mechanistically, alpha-casein reduces breast cancer stem cell activity in vitro, and STAT3 and STAT1 were identified as regulators of pro-tumorigenic HIF-1alpha signalling in breast cancer cells and fibroblasts respectively.",
            "authors": {
              "abbreviation": "Kirsten E L Garner, Nathan J Hull, Andrew H Sims, ..., Robert B Clarke",
              "authorList": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "abbrevName": "Garner KEL",
                  "email": "Kirsten.garner@manchester.ac.uk",
                  "isCollectiveName": false,
                  "name": "Kirsten E L Garner",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Hull",
                  "abbrevName": "Hull NJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan J Hull",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Rebecca",
                  "LastName": "Lamb",
                  "abbrevName": "Lamb R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rebecca Lamb",
                  "orcid": null
                },
                {
                  "ForeName": "Robert",
                  "LastName": "Clarke",
                  "abbrevName": "Clarke RB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Robert B Clarke",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "email": [
                    "Kirsten.garner@manchester.ac.uk"
                  ],
                  "name": "Kirsten E L Garner"
                }
              ]
            },
            "doi": "10.1007/s10911-019-09435-1",
            "pmid": "31529195",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mammary Gland Biol Neoplasia 24 2019",
            "title": "The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts."
          }
        },
        {
          "pmid": "24248265",
          "pubmed": {
            "ISODate": "2014-02-01T00:00:00.000Z",
            "abstract": "UNLABELLED: Targeted therapy against triple-negative breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor. One of the molecular hallmarks of triple-negative breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many critical aspects of cancer progression including metabolism, angiogenesis, invasion, metastasis, and stem cell maintenance. Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a molecular chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α. In this study, human MDA-MB-231 and MDA-MB-435 triple-negative breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly intravenous injections of ganetespib or vehicle following the development of palpable tumors. Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs. Ganetespib treatment also significantly reduced the number of Aldefluor-positive cancer stem cells in the primary tumor. Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer. KEY MESSAGES: Triple-negative breast cancers (TNBCs) respond poorly to available chemotherapy. TNBCs overexpress genes regulated by hypoxia-inducible factors (HIFs). Ganetespib induces degradation of HSP90 client proteins, including HIF-1α. Ganetespib inhibited TNBC orthotopic tumor growth, invasion, and metastasis. Ganetespib inhibited expression of HIF-1 target genes involved in TNBC progression.",
            "authors": {
              "abbreviation": "Lisha Xiang, Daniele M Gilkes, Pallavi Chaturvedi, ..., Gregg L Semenza",
              "authorList": [
                {
                  "ForeName": "Lisha",
                  "LastName": "Xiang",
                  "abbrevName": "Xiang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lisha Xiang",
                  "orcid": null
                },
                {
                  "ForeName": "Daniele",
                  "LastName": "Gilkes",
                  "abbrevName": "Gilkes DM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniele M Gilkes",
                  "orcid": null
                },
                {
                  "ForeName": "Pallavi",
                  "LastName": "Chaturvedi",
                  "abbrevName": "Chaturvedi P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pallavi Chaturvedi",
                  "orcid": null
                },
                {
                  "ForeName": "Weibo",
                  "LastName": "Luo",
                  "abbrevName": "Luo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weibo Luo",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxia",
                  "LastName": "Hu",
                  "abbrevName": "Hu H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxia Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Naoharu",
                  "LastName": "Takano",
                  "abbrevName": "Takano N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naoharu Takano",
                  "orcid": null
                },
                {
                  "ForeName": "Houjie",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Houjie Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gregg L Semenza",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1007/s00109-013-1102-5",
            "pmid": "24248265",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mol Med (Berl) 92 2014",
            "title": "Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer."
          }
        },
        {
          "pmid": "31264274",
          "pubmed": {
            "ISODate": "2019-10-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype which accounts for 15%-20% of all breast cancer cases. The management of TNBC has remained a challenge due to its lack of targeted therapy. Previously, we reported that homeobox C8 (HOXC8) was involved in metastasis and migration of breast cancer cells. By chromatin immunoprecipitation and luciferase assays, we found that HOXC8 functioned as a transcription factor to activate the transcription of matrix Gla protein (MGP) gene, leading to an increase in the proliferation, anchorage-independent growth, and migration of TNBC cells. We further demonstrated that MGP expression promoted the epithelial-mesenchymal transition (EMT) process of TNBC cells, but not the other subtypes of breast cancer, suggesting that MGP induced EMT to promote proliferation and migration of TNBC cells. Moreover, we found that MGP was upregulated in clinical breast specimens compared to normal breast tissues and high MGP expression was statistically associated with poor, relapse-free survival for TNBC patients, indicating that MGP is probably a novel biomarker or therapeutic target for TNBC patients. Together, our results showed that the HOXC8-MGP axis played an important role in the tumorigenesis of TNBC and might be a promising therapeutic target for TNBC treatment.",
            "authors": {
              "abbreviation": "Chen Gong, Jin Zou, Mingsheng Zhang, ..., Yong Li",
              "authorList": [
                {
                  "ForeName": "Chen",
                  "LastName": "Gong",
                  "abbrevName": "Gong C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zou",
                  "abbrevName": "Zou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zou",
                  "orcid": null
                },
                {
                  "ForeName": "Mingsheng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingsheng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Shanshan",
                  "LastName": "Xu",
                  "abbrevName": "Xu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shanshan Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Siqi",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siqi Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Mengqi",
                  "LastName": "Yang",
                  "abbrevName": "Yang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mengqi Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Dongjia",
                  "LastName": "Li",
                  "abbrevName": "Li D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dongjia Li",
                  "orcid": null
                },
                {
                  "ForeName": "Yun",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jialu",
                  "LastName": "Shi",
                  "abbrevName": "Shi J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jialu Shi",
                  "orcid": null
                },
                {
                  "ForeName": "Yong",
                  "LastName": "Li",
                  "abbrevName": "Li Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yong Li",
                  "orcid": "0000-0003-4681-263X"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/mc.23079",
            "pmid": "31264274",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Mol Carcinog 58 2019",
            "title": "Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer."
          }
        },
        {
          "pmid": "33824311",
          "pubmed": {
            "ISODate": "2021-04-06T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive subtype with the worst prognosis and the highest metastatic and recurrence potential, which represents 15-20% of all breast cancers in Chinese females, and the 5-year overall survival rate is about 80% in Chinese women. Recently, emerging evidence suggested that aberrant alternative splicing (AS) plays a crucial role in tumorigenesis and progression. AS is generally controlled by AS-associated RNA binding proteins (RBPs). Monocyte chemotactic protein induced protein 1 (MCPIP1), a zinc finger RBP, functions as a tumor suppressor in many cancers. Here, we showed that MCPIP1 was downregulated in 80 TNBC tissues and five TNBC cell lines compared to adjacent paracancerous tissues and one human immortalized breast epithelial cell line, while its high expression levels were associated with increased overall survival in TNBC patients. We demonstrated that MCPIP1 overexpression dramatically suppressed cell cycle progression and proliferation of TNBC cells in vitro and repressed tumor growth in vivo. Mechanistically, MCPIP1 was first demonstrated to act as a splicing factor to regulate AS in TNBC cells. Furthermore, we demonstrated that MCPIP1 modulated NFIC AS to promote CTF5 synthesis, which acted as a negative regulator in TNBC cells. Subsequently, we showed that CTF5 participated in MCPIP1-mediated antiproliferative effect by transcriptionally repressing cyclin D1 expression, as well as downregulating its downstream signaling targets p-Rb and E2F1. Conclusively, our findings provided novel insights into the anti-oncogenic mechanism of MCPIP1, suggesting that MCPIP1 could serve as an alternative treatment target in TNBC.",
            "authors": {
              "abbreviation": "Fengxia Chen, Qingqing Wang, Xiaoyan Yu, ..., Yunfeng Zhou",
              "authorList": [
                {
                  "ForeName": "Fengxia",
                  "LastName": "Chen",
                  "abbrevName": "Chen F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fengxia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Qingqing",
                  "LastName": "Wang",
                  "abbrevName": "Wang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingqing Wang",
                  "orcid": "0000-0002-6440-582X"
                },
                {
                  "ForeName": "Xiaoyan",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaoyan Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ningning",
                  "LastName": "Yang",
                  "abbrevName": "Yang N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ningning Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Yuan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuan Wang",
                  "orcid": "0000-0003-1894-0853"
                },
                {
                  "ForeName": "Yangyang",
                  "LastName": "Zeng",
                  "abbrevName": "Zeng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yangyang Zeng",
                  "orcid": null
                },
                {
                  "ForeName": "Zhewen",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhewen Zheng",
                  "orcid": null
                },
                {
                  "ForeName": "Fuxiang",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fuxiang Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": "yfzhouwhu@163.com",
                  "isCollectiveName": false,
                  "name": "Yunfeng Zhou",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "email": [
                    "yfzhouwhu@163.com"
                  ],
                  "name": "Yunfeng Zhou"
                }
              ]
            },
            "doi": "10.1038/s41419-021-03661-4",
            "pmid": "33824311",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 12 2021",
            "title": "MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis."
          }
        },
        {
          "pmid": "35188449",
          "pubmed": {
            "ISODate": "2022-05-01T00:00:00.000Z",
            "abstract": "There is no clear treatment guideline or individualized treatment plan for triple-negative breast cancer (TNBC). The aim of this study was to investigate more effective targets for TNBC-targeted therapy. MDA-MB-231 and BT549 cell lines were used to explore the function of LINC00649 on the proliferation, invasion, and migration of TNBC cells. A mice subcutaneous tumor model and a pulmonary metastasis model was established to identify the role of LINC00649 on the growth and metastasis of TNBC in vivo. LINC00649 was found to be a key molecule involved in the occurrence and development of TNBC by screening of public databases and detection of TNBC clinical samples. LINC00649 increased hypoxia-inducible factor 1α (HIF-1α) mRNA stability and protein expression by interacting with the nuclear factor 90 (NF90)/NF45 complex. In vitro, interference with LINC00649 inhibits MDA-MB-231 and BT549 cell proliferation, migration, and invasion, and the addition of HIF-1α revised this effect. In vivo experiments showed that LINC00649 promoted the growth and metastasis of TNBC. We demonstrated that LINC00649 interacts with the NF90/NF45 complex to increase the mRNA stability of HIF-1α and up-regulate HIF-1α expression, thereby inducing the proliferation, invasion, and migration of TNBC cells as well as tumor growth and metastasis.",
            "authors": {
              "abbreviation": "Jianhua Zhang, Chuang Du, Linfeng Zhang, ..., Jingruo Li",
              "authorList": [
                {
                  "ForeName": "Jianhua",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianhua Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Chuang",
                  "LastName": "Du",
                  "abbrevName": "Du C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chuang Du",
                  "orcid": null
                },
                {
                  "ForeName": "Linfeng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linfeng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yingying",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yingying Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jingruo",
                  "LastName": "Li",
                  "abbrevName": "Li J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jingruo Li",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384101.2022.2040283",
            "pmid": "35188449",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Cycle 21 2022",
            "title": "LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex."
          }
        },
        {
          "pmid": "30784286",
          "pubmed": {
            "ISODate": "2019-05-23T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The unclear molecular mechanisms underlying could provide important theoretical basis for the prevention and control of HCC. This study performed chromatin immunoprecipitation-sequencing (ChIP-seq) to analyze the binding sites between zinc fingers and homeoboxes 2 (ZHX2) and its genome-wide target genes, and bioinformatics was used to analyze their gene transcription regulation network. Immunohistochemistry was used to detect the ZHX2 expression in HCC, and its association with the clinicopathological characteristics of HCC. Results of RT-PCR and western blot showed the expression of ZHX2 in HepG2 cells was obviously lower compared with normal liver cells. ZHX2 could be amplified in ChIP products, then ChIP-seq reveals there were 232 genes binding in promoter regions. GO analysis of functions revealed these genes were mainly associated with biological processes (BP), cellular components (CC), and molecular functions (MF). In addition, PTEN was found enriched in certain biological functions in BP analysis. Then, four pathways of these genes based on Kyoto Encyclopedia of Genes and Genomes (KEGG) were found P<0.05. Last analysis of immunohistochemistry showed the rates of ZHX2 expression and PTEN expression in paracancerous tissues both were significantly higher than that in HCC tissues (P=0.042; P<0.001), with negative correlations with AFP values (r=-0.246, P=0.040; r=-0.263, P=0.028). Further, PTEN expression was positively correlated with the differentiation level in HCC tissues (r=0.267, P=0.025). Spearman correlation analysis revealed that the expression profiles of ZHX2 and PTEN were positively correlated in HCC tissues (r=0.258, P=0.031). This study is the first to use ChIP-seq technology to analyze the specific regulatory mechanisms of the transcription suppressor ZHX2 in the context of HCC at the genome level.",
            "authors": {
              "abbreviation": "Z Lv, R He, M Huang, ..., G Chen",
              "authorList": [
                {
                  "ForeName": "Z",
                  "LastName": "Lv",
                  "abbrevName": "Lv Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Lv",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "He",
                  "abbrevName": "He R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R He",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Huang",
                  "abbrevName": "Huang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Huang",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Ma",
                  "abbrevName": "Ma J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Ma",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Chen",
                  "abbrevName": "Chen G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Chen",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.4149/neo_2018_180806N593",
            "pmid": "30784286",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Neoplasma 66 2019",
            "title": "Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation."
          }
        }
      ],
      "secret": "read-only",
      "type": "protein"
    },
    {
      "_creationTimestamp": "2022-12-10T08:46:24.367Z",
      "_newestOpId": "86b98413-ceb6-4d6d-8b1b-9ba64b977913",
      "_ops": [],
      "association": null,
      "completed": false,
      "description": "",
      "entries": [
        {
          "id": "13f57ee3-df7d-4ec8-b8ca-0efdd62f99d5"
        },
        {
          "id": "3295573e-31b2-40c4-99f1-4dbf6a34990a"
        }
      ],
      "id": "3fd6a28f-483e-4eb4-ab6f-0a9025bd9cd1",
      "liveId": "4684fd14-2146-4c30-b96c-31440207b731",
      "lock": null,
      "locked": false,
      "name": "",
      "position": {
        "x": -190.08016877637147,
        "y": -157.6436517069429
      },
      "relatedPapers": [
        {
          "pmid": "26918606",
          "pubmed": {
            "ISODate": "2016-03-29T00:00:00.000Z",
            "abstract": "Eukaryotic elongation factor 2 kinase (eEF2K), an emerging molecular target for cancer therapy, contributes to cancer proliferation, cell survival, tumorigenesis, and invasion, disease progression and drug resistance. Although eEF2K is highly up-regulated in various cancers, the mechanism of gene regulation has not been elucidated. In this study, we examined the role of Forkhead Box M1 (FOXM1) proto-oncogenic transcription factor in triple negative breast cancer (TNBC) cells and the regulation of eEF2K. We found that FOXM1 is highly upregulated in TNBC and its knockdown by RNA interference (siRNA) significantly inhibited eEF2K expression and suppressed cell proliferation, colony formation, migration, invasion and induced apoptotic cell death, recapitulating the effects of eEF2K inhibition. Knockdown of FOXM1 inhibited regulators of cell cycle, migration/invasion and survival, including cyclin D1, Src and MAPK-ERK signaling pathways, respectively. We also demonstrated that FOXM1 (1B and 1C isoforms) directly binds to and transcriptionally regulates eEF2K gene expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. Furthermore, in vivo inhibition of FOXM1 by liposomal siRNA-nanoparticles suppressed growth of MDA-MB-231 TNBC tumor xenografts in orthotopic models. In conclusion, our study provides the first evidence about the transcriptional regulation of eEF2K in TNBC and the role of FOXM1 in mediating breast cancer cell proliferation, survival, migration/invasion, progression and tumorgenesis and highlighting the potential of FOXM1/eEF2K axis as a molecular target in breast and other cancers.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Ahmed Ashour, Nermin Kahraman, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.7672",
            "pmid": "26918606",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 7 2016",
            "title": "FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells."
          }
        },
        {
          "pmid": "26751287",
          "pubmed": {
            "ISODate": "2016-02-01T00:00:00.000Z",
            "abstract": "Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively. These events cause HIF1α stabilization, HIF1α-p300 interaction, and activation of HIF1α transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to the EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1α Tyr 565 phosphorylation interferes with Pro 564 hydroxylation, leading to normoxic HIF1α stabilization. Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.",
            "authors": {
              "abbreviation": "Aifu Lin, Chunlai Li, Zhen Xing, ..., Liuqing Yang",
              "authorList": [
                {
                  "ForeName": "Aifu",
                  "LastName": "Lin",
                  "abbrevName": "Lin A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Aifu Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Chunlai",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunlai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Zhen",
                  "LastName": "Xing",
                  "abbrevName": "Xing Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhen Xing",
                  "orcid": null
                },
                {
                  "ForeName": "Qingsong",
                  "LastName": "Hu",
                  "abbrevName": "Hu Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingsong Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Ke",
                  "LastName": "Liang",
                  "abbrevName": "Liang K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ke Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Leng",
                  "LastName": "Han",
                  "abbrevName": "Han L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leng Han",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Wang",
                  "orcid": null
                },
                {
                  "ForeName": "David",
                  "LastName": "Hawke",
                  "abbrevName": "Hawke DH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "David H Hawke",
                  "orcid": "0000-0002-6102-7843"
                },
                {
                  "ForeName": "Shouyu",
                  "LastName": "Wang",
                  "abbrevName": "Wang S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shouyu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yanyan",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yanyan Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yongkun",
                  "LastName": "Wei",
                  "abbrevName": "Wei Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yongkun Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Guolin",
                  "LastName": "Ma",
                  "abbrevName": "Ma G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guolin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Peter",
                  "LastName": "Park",
                  "abbrevName": "Park PK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peter K Park",
                  "orcid": null
                },
                {
                  "ForeName": "Jianwei",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianwei Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Zhibin",
                  "LastName": "Hu",
                  "abbrevName": "Hu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhibin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Yubin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yubin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Jeffery",
                  "LastName": "Marks",
                  "abbrevName": "Marks JR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeffery R Marks",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Han Liang",
                  "orcid": "0000-0001-7633-286X"
                },
                {
                  "ForeName": "Mien-Chie",
                  "LastName": "Hung",
                  "abbrevName": "Hung MC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mien-Chie Hung",
                  "orcid": null
                },
                {
                  "ForeName": "Chunru",
                  "LastName": "Lin",
                  "abbrevName": "Lin C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunru Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Liuqing",
                  "LastName": "Yang",
                  "abbrevName": "Yang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liuqing Yang",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/ncb3295",
            "pmid": "26751287",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Nat Cell Biol 18 2016",
            "title": "The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer."
          }
        },
        {
          "pmid": "28361350",
          "pubmed": {
            "ISODate": "2017-06-01T00:00:00.000Z",
            "abstract": "PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer and associated with early metastasis, drug resistance, and poor patient survival. Fork head box M1 (FOXM1) is considered as an emerging molecular target due to its oncogenic role and high overexpression profile in 85% in TNBC. However, molecular mechanisms by which FOXM1 transcription factor mediate its oncogenic effects are not fully understood. Integrin β1 is often upregulated in invasive breast cancers and associated with poor clinical outcome and shorter overall patient survival in TNBC. However, the mechanisms regulating integrin β1 (ITGB1) gene expression have not been well elucidated. METHODS: Normal breast epithelium (MCF10A) and TNBC cells (i.e., MDA-MB-231, BT-20 MDA-MB436) were used for the study. Small interfering RNA (siRNA)-based knockdown was used to inhibit Integrin β1 gene (mRNA) and protein expressions, which are detected by RT-PCR and Western blot, respectively. Chromatin immunoprecipitation (ChiP) and gene reporter (Luciferase) assays were used to demonstrate that FOXM1 transcription factor binds to the promoter of Integrin β1 gene and drives its expression. RESULTS: We demonstrated that FOXM1 directly binds to the promoter of integrin β1 gene and transcriptionally regulates its expression and activity of focal adhesion kinase (FAK) in TNBC cells. CONCLUSION: Our study suggests that FOXM1 transcription factor regulates Integrin β1 gene expression and that FOXM1/ Integrin-β1/FAK axis may play an important role in the progression of TNBC.",
            "authors": {
              "abbreviation": "Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, Bulent Ozpolat",
              "authorList": [
                {
                  "ForeName": "Zuhal",
                  "LastName": "Hamurcu",
                  "abbrevName": "Hamurcu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zuhal Hamurcu",
                  "orcid": null
                },
                {
                  "ForeName": "Nermin",
                  "LastName": "Kahraman",
                  "abbrevName": "Kahraman N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nermin Kahraman",
                  "orcid": null
                },
                {
                  "ForeName": "Ahmed",
                  "LastName": "Ashour",
                  "abbrevName": "Ashour A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ahmed Ashour",
                  "orcid": null
                },
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "abbrevName": "Ozpolat B",
                  "email": "bozpolat@mdanderson.org",
                  "isCollectiveName": false,
                  "name": "Bulent Ozpolat",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Bulent",
                  "LastName": "Ozpolat",
                  "email": [
                    "bozpolat@mdanderson.org"
                  ],
                  "name": "Bulent Ozpolat"
                }
              ]
            },
            "doi": "10.1007/s10549-017-4207-7",
            "pmid": "28361350",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Breast Cancer Res Treat 163 2017",
            "title": "FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer."
          }
        },
        {
          "pmid": "30964885",
          "pubmed": {
            "ISODate": "2019-01-01T00:00:00.000Z",
            "abstract": "Triple-Negative Breast Cancers (TNBCs) are the most difficult to treat subtype of breast cancer and are often associated with high nuclear expression of Snail and Cathepsin L (Cat L) protease. We have previously shown that Snail can increase Cat L expression/activity in prostate and breast cancer cells. This study investigated the role of CUX1 (a downstream substrate of Cat L) in TNBC. We showed that Cat L and CUX1 were highly expressed in TNBC patient tissue/cell lines, as compared to ER-positive samples, using cBioportal data and western blot/zymography analyses. Additionally, luciferase reporter and chromatin immunoprecipitation assays showed that CUX1 directly bound to estrogen receptor-alpha (ER-α) promoter in MDA-MB-468, a representative TNBC cell line, and that CUX1 siRNA could restore ER-α transcription and protein expression. Furthermore, Snail and CUX1 expression in various TNBC cell lines was inhibited by muscadine grape skin extract (MSKE, a natural grape product rich in anthocyanins) or Cat L inhibitor (Z-FY-CHO) leading to decreased cell invasion and migration. MSKE decreased cell viability and increased expression of apoptotic markers in MDA-MB-468 cells, with no effect on non-tumorigenic MCF10A cells. MSKE also decreased CUX1 binding to ER-α promoter and restored ER-α expression in TNBC cells, while both MSKE and CUX1 siRNA restored sensitivity to estradiol and 4-hydoxytamoxifen as shown by increased cell viability. Therefore, CUX1 activated by Snail-Cat L signaling may contribute to TNBC via ER-α repression, and may be a viable target for TNBC using natural products such as MSKE that targets cancer and not normal cells.",
            "authors": {
              "abbreviation": "Liza J Burton, Ohuod Hawsawi, Janae Sweeney, ..., Valerie Odero-Marah",
              "authorList": [
                {
                  "ForeName": "Liza",
                  "LastName": "Burton",
                  "abbrevName": "Burton LJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liza J Burton",
                  "orcid": null
                },
                {
                  "ForeName": "Ohuod",
                  "LastName": "Hawsawi",
                  "abbrevName": "Hawsawi O",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ohuod Hawsawi",
                  "orcid": null
                },
                {
                  "ForeName": "Janae",
                  "LastName": "Sweeney",
                  "abbrevName": "Sweeney J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Janae Sweeney",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Bowen",
                  "abbrevName": "Bowen N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan Bowen",
                  "orcid": "0000-0002-1609-6698"
                },
                {
                  "ForeName": "Tamaro",
                  "LastName": "Hudson",
                  "abbrevName": "Hudson T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tamaro Hudson",
                  "orcid": null
                },
                {
                  "ForeName": "Valerie",
                  "LastName": "Odero-Marah",
                  "abbrevName": "Odero-Marah V",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Valerie Odero-Marah",
                  "orcid": "0000-0002-5238-9914"
                }
              ],
              "contacts": []
            },
            "doi": "10.1371/journal.pone.0214844",
            "pmid": "30964885",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "PLoS One 14 2019",
            "title": "CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE)."
          }
        },
        {
          "pmid": "27184798",
          "pubmed": {
            "ISODate": "2016-08-01T00:00:00.000Z",
            "abstract": "Dysregulated energy metabolism is one of the main mechanisms for uncontrolled growth in solid tumors. Hypoxia-inducible factor 1-alpha (HIF1α) is a transcription factor implicated in regulating several genes that are responsible for cell metabolism, including carbonic anhydrase IX (CAIX). The aim of this study is to determine the clinical significance of immunohistochemical metabolic alteration in early-stage triple negative breast cancer (TNBC) patients who received cyclophosphamide-based chemotherapy or radiotherapy and those with basal phenotype. Immunohistochemical staining for HIF1α and CAIX was performed to determine the correlation with clinicopathologic variables and survival outcome on tissue microarrays from 270 early-stage TNBC patients. In vitro experiments with multiple human TNBC cell lines, suppression of HIF1α by small interfering RNA (siRNA) significantly reduced CAIX protein expression in all cell lines. In multivariate analyses for different therapeutic modalities and basal phenotype, combined HIF1α and CAIX protein overexpression was significantly associated with disease-free survival in the total cohort (OR = 2.583, P = 0.002), stratified cohorts expressing basal phenotype (OR = 2.234, P = 0.021), and in those patients who received adjuvant chemotherapy (OR = 3.078, P = 0.023) and adjuvant radiotherapy (OR = 2.111, P = 0.050), respectively. In early TNBC, combined HIF1α and CAIX protein expression may serve as an unfavorable prognostic indicator particularly in patients treated with cyclophosphamide-based chemotherapy or radiotherapy as well as those with basal phenotype of breast cancer.",
            "authors": {
              "abbreviation": "Min-Sun Jin, Hyebin Lee, In Ae Park, ..., Han Suk Ryu",
              "authorList": [
                {
                  "ForeName": "Min-Sun",
                  "LastName": "Jin",
                  "abbrevName": "Jin MS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min-Sun Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Hyebin",
                  "LastName": "Lee",
                  "abbrevName": "Lee H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyebin Lee",
                  "orcid": null
                },
                {
                  "ForeName": "In",
                  "LastName": "Park",
                  "abbrevName": "Park IA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "In Ae Park",
                  "orcid": null
                },
                {
                  "ForeName": "Yul",
                  "LastName": "Chung",
                  "abbrevName": "Chung YR",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yul Ri Chung",
                  "orcid": null
                },
                {
                  "ForeName": "Seock-Ah",
                  "LastName": "Im",
                  "abbrevName": "Im SA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Seock-Ah Im",
                  "orcid": null
                },
                {
                  "ForeName": "Kyung-Hun",
                  "LastName": "Lee",
                  "abbrevName": "Lee KH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyung-Hun Lee",
                  "orcid": null
                },
                {
                  "ForeName": "Hyeong-Gon",
                  "LastName": "Moon",
                  "abbrevName": "Moon HG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hyeong-Gon Moon",
                  "orcid": null
                },
                {
                  "ForeName": "Wonshik",
                  "LastName": "Han",
                  "abbrevName": "Han W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wonshik Han",
                  "orcid": null
                },
                {
                  "ForeName": "Kyubo",
                  "LastName": "Kim",
                  "abbrevName": "Kim K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyubo Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Tae-Yong",
                  "LastName": "Kim",
                  "abbrevName": "Kim TY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tae-Yong Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Dong-Young",
                  "LastName": "Noh",
                  "abbrevName": "Noh DY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dong-Young Noh",
                  "orcid": null
                },
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "abbrevName": "Ryu HS",
                  "email": "karlnash@naver.com",
                  "isCollectiveName": false,
                  "name": "Han Suk Ryu",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Han",
                  "LastName": "Ryu",
                  "email": [
                    "karlnash@naver.com"
                  ],
                  "name": "Han Suk Ryu"
                }
              ]
            },
            "doi": "10.1007/s00428-016-1953-6",
            "pmid": "27184798",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Virchows Arch 469 2016",
            "title": "Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer."
          }
        },
        {
          "pmid": "31529195",
          "pubmed": {
            "ISODate": "2019-09-01T00:00:00.000Z",
            "abstract": "Triple negative breast cancer (TNBC) is the most lethal breast cancer subtype. Extended periods of lactation protect against breast cancer development, but the mechanisms underlying this protection are unknown. We examined the effects of the milk protein alpha-casein over expression in the triple negative MDA-MB-231 breast cancer cell line. The effects of recombinant alpha-casein added exogenously to MDA-MB-231 breast cancer cells, and immortalised human fibroblasts were also investigated. We used transcriptional reporters to understand the signalling pathways downstream of alpha-casein in breast cancer cells and these fibroblasts that were activated by breast cancer cells. To extend our findings to the clinical setting, we analysed public gene expression datasets to further understand the relevance of these signalling pathways in triple negative breast cancer cells and patient samples. Finally, we used small molecular inhibitors to target relevant pathways and highlight these as potential candidates for the treatment of TN breast cancer. High levels of alpha-casein gene expression were predictive of good prognosis across 263 TNBC patient tumour samples. Alpha-casein over expression or exogenous addition reduces cancer stem cell (CSC) activity. HIF-1alpha was identified to be a key downstream target of alpha-casein, in both breast cancer cells and activated fibroblasts, and STAT transcription factors to be upstream of HIF-1alpha. Interestingly, HIF-1alpha is regulated by STAT3 in breast cancer cells, but STAT1 is the regulator of HIF-1alpha in activated fibroblasts. In analysis of 573 TNBC patient samples, alpha-casein expression, inversely correlated to HIF-1alpha, STAT3 and STAT1. STAT1 and STAT3 inhibitors target HIF-1alpha signalling in activated fibroblasts and MDA-MB-231 breast cancer cells respectively, and also abrogate CSC activities. Our findings provide an explanation for the protective effects of lactation in TNBC. Clinical data correlates high alpha-casein expression with increased recurrence-free survival in TNBC patients. Mechanistically, alpha-casein reduces breast cancer stem cell activity in vitro, and STAT3 and STAT1 were identified as regulators of pro-tumorigenic HIF-1alpha signalling in breast cancer cells and fibroblasts respectively.",
            "authors": {
              "abbreviation": "Kirsten E L Garner, Nathan J Hull, Andrew H Sims, ..., Robert B Clarke",
              "authorList": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "abbrevName": "Garner KEL",
                  "email": "Kirsten.garner@manchester.ac.uk",
                  "isCollectiveName": false,
                  "name": "Kirsten E L Garner",
                  "orcid": null
                },
                {
                  "ForeName": "Nathan",
                  "LastName": "Hull",
                  "abbrevName": "Hull NJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nathan J Hull",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Rebecca",
                  "LastName": "Lamb",
                  "abbrevName": "Lamb R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rebecca Lamb",
                  "orcid": null
                },
                {
                  "ForeName": "Robert",
                  "LastName": "Clarke",
                  "abbrevName": "Clarke RB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Robert B Clarke",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Kirsten",
                  "LastName": "Garner",
                  "email": [
                    "Kirsten.garner@manchester.ac.uk"
                  ],
                  "name": "Kirsten E L Garner"
                }
              ]
            },
            "doi": "10.1007/s10911-019-09435-1",
            "pmid": "31529195",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mammary Gland Biol Neoplasia 24 2019",
            "title": "The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts."
          }
        },
        {
          "pmid": "35867755",
          "pubmed": {
            "ISODate": "2022-07-12T00:00:00.000Z",
            "abstract": "Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Zhaoping Qiu, Weijie Guo, Bo Dong, ..., Yadi Wu",
              "authorList": [
                {
                  "ForeName": "Zhaoping",
                  "LastName": "Qiu",
                  "abbrevName": "Qiu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhaoping Qiu",
                  "orcid": null
                },
                {
                  "ForeName": "Weijie",
                  "LastName": "Guo",
                  "abbrevName": "Guo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weijie Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Bo",
                  "LastName": "Dong",
                  "abbrevName": "Dong B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bo Dong",
                  "orcid": null
                },
                {
                  "ForeName": "Yu",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Pan",
                  "LastName": "Deng",
                  "abbrevName": "Deng P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pan Deng",
                  "orcid": "0000-0003-2974-7389"
                },
                {
                  "ForeName": "Chi",
                  "LastName": "Wang",
                  "abbrevName": "Wang C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chi Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jinpeng",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jinpeng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                },
                {
                  "ForeName": "Rudolf",
                  "LastName": "Grosschedl",
                  "abbrevName": "Grosschedl R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rudolf Grosschedl",
                  "orcid": null
                },
                {
                  "ForeName": "Zhiyong",
                  "LastName": "Yu",
                  "abbrevName": "Yu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhiyong Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Jiong",
                  "LastName": "Deng",
                  "abbrevName": "Deng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiong Deng",
                  "orcid": null
                },
                {
                  "ForeName": "Yadi",
                  "LastName": "Wu",
                  "abbrevName": "Wu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadi Wu",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119518119",
            "pmid": "35867755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway."
          }
        },
        {
          "pmid": "26825173",
          "pubmed": {
            "ISODate": "2016-03-15T00:00:00.000Z",
            "abstract": "Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.",
            "authors": {
              "abbreviation": "Tarah M Regan Anderson, Shi Hong Ma, Ganesh V Raj, ..., Carol A Lange",
              "authorList": [
                {
                  "ForeName": "Tarah",
                  "LastName": "Regan Anderson",
                  "abbrevName": "Regan Anderson TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tarah M Regan Anderson",
                  "orcid": null
                },
                {
                  "ForeName": "Shi",
                  "LastName": "Ma",
                  "abbrevName": "Ma SH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shi Hong Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Ganesh",
                  "LastName": "Raj",
                  "abbrevName": "Raj GV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ganesh V Raj",
                  "orcid": null
                },
                {
                  "ForeName": "John",
                  "LastName": "Cidlowski",
                  "abbrevName": "Cidlowski JA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "John A Cidlowski",
                  "orcid": null
                },
                {
                  "ForeName": "Taylor",
                  "LastName": "Helle",
                  "abbrevName": "Helle TM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Taylor M Helle",
                  "orcid": null
                },
                {
                  "ForeName": "Todd",
                  "LastName": "Knutson",
                  "abbrevName": "Knutson TP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Todd P Knutson",
                  "orcid": null
                },
                {
                  "ForeName": "Raisa",
                  "LastName": "Krutilina",
                  "abbrevName": "Krutilina RI",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Raisa I Krutilina",
                  "orcid": null
                },
                {
                  "ForeName": "Tiffany",
                  "LastName": "Seagroves",
                  "abbrevName": "Seagroves TN",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tiffany N Seagroves",
                  "orcid": null
                },
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "abbrevName": "Lange CA",
                  "email": "lange047@umn.edu",
                  "isCollectiveName": false,
                  "name": "Carol A Lange",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Carol",
                  "LastName": "Lange",
                  "email": [
                    "lange047@umn.edu"
                  ],
                  "name": "Carol A Lange"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-15-2510",
            "pmid": "26825173",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              }
            ],
            "reference": "Cancer Res 76 2016",
            "title": "Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "24248265",
          "pubmed": {
            "ISODate": "2014-02-01T00:00:00.000Z",
            "abstract": "UNLABELLED: Targeted therapy against triple-negative breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor. One of the molecular hallmarks of triple-negative breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many critical aspects of cancer progression including metabolism, angiogenesis, invasion, metastasis, and stem cell maintenance. Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a molecular chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α. In this study, human MDA-MB-231 and MDA-MB-435 triple-negative breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly intravenous injections of ganetespib or vehicle following the development of palpable tumors. Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs. Ganetespib treatment also significantly reduced the number of Aldefluor-positive cancer stem cells in the primary tumor. Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metabolism, invasion, and metastasis, thereby providing a molecular basis for observed effects of the drug on the growth and metastasis of triple-negative breast cancer. KEY MESSAGES: Triple-negative breast cancers (TNBCs) respond poorly to available chemotherapy. TNBCs overexpress genes regulated by hypoxia-inducible factors (HIFs). Ganetespib induces degradation of HSP90 client proteins, including HIF-1α. Ganetespib inhibited TNBC orthotopic tumor growth, invasion, and metastasis. Ganetespib inhibited expression of HIF-1 target genes involved in TNBC progression.",
            "authors": {
              "abbreviation": "Lisha Xiang, Daniele M Gilkes, Pallavi Chaturvedi, ..., Gregg L Semenza",
              "authorList": [
                {
                  "ForeName": "Lisha",
                  "LastName": "Xiang",
                  "abbrevName": "Xiang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lisha Xiang",
                  "orcid": null
                },
                {
                  "ForeName": "Daniele",
                  "LastName": "Gilkes",
                  "abbrevName": "Gilkes DM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniele M Gilkes",
                  "orcid": null
                },
                {
                  "ForeName": "Pallavi",
                  "LastName": "Chaturvedi",
                  "abbrevName": "Chaturvedi P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Pallavi Chaturvedi",
                  "orcid": null
                },
                {
                  "ForeName": "Weibo",
                  "LastName": "Luo",
                  "abbrevName": "Luo W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weibo Luo",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxia",
                  "LastName": "Hu",
                  "abbrevName": "Hu H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxia Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Naoharu",
                  "LastName": "Takano",
                  "abbrevName": "Takano N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naoharu Takano",
                  "orcid": null
                },
                {
                  "ForeName": "Houjie",
                  "LastName": "Liang",
                  "abbrevName": "Liang H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Houjie Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Gregg",
                  "LastName": "Semenza",
                  "abbrevName": "Semenza GL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gregg L Semenza",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1007/s00109-013-1102-5",
            "pmid": "24248265",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Mol Med (Berl) 92 2014",
            "title": "Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer."
          }
        },
        {
          "pmid": "30784286",
          "pubmed": {
            "ISODate": "2019-05-23T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The unclear molecular mechanisms underlying could provide important theoretical basis for the prevention and control of HCC. This study performed chromatin immunoprecipitation-sequencing (ChIP-seq) to analyze the binding sites between zinc fingers and homeoboxes 2 (ZHX2) and its genome-wide target genes, and bioinformatics was used to analyze their gene transcription regulation network. Immunohistochemistry was used to detect the ZHX2 expression in HCC, and its association with the clinicopathological characteristics of HCC. Results of RT-PCR and western blot showed the expression of ZHX2 in HepG2 cells was obviously lower compared with normal liver cells. ZHX2 could be amplified in ChIP products, then ChIP-seq reveals there were 232 genes binding in promoter regions. GO analysis of functions revealed these genes were mainly associated with biological processes (BP), cellular components (CC), and molecular functions (MF). In addition, PTEN was found enriched in certain biological functions in BP analysis. Then, four pathways of these genes based on Kyoto Encyclopedia of Genes and Genomes (KEGG) were found P<0.05. Last analysis of immunohistochemistry showed the rates of ZHX2 expression and PTEN expression in paracancerous tissues both were significantly higher than that in HCC tissues (P=0.042; P<0.001), with negative correlations with AFP values (r=-0.246, P=0.040; r=-0.263, P=0.028). Further, PTEN expression was positively correlated with the differentiation level in HCC tissues (r=0.267, P=0.025). Spearman correlation analysis revealed that the expression profiles of ZHX2 and PTEN were positively correlated in HCC tissues (r=0.258, P=0.031). This study is the first to use ChIP-seq technology to analyze the specific regulatory mechanisms of the transcription suppressor ZHX2 in the context of HCC at the genome level.",
            "authors": {
              "abbreviation": "Z Lv, R He, M Huang, ..., G Chen",
              "authorList": [
                {
                  "ForeName": "Z",
                  "LastName": "Lv",
                  "abbrevName": "Lv Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Z Lv",
                  "orcid": null
                },
                {
                  "ForeName": "R",
                  "LastName": "He",
                  "abbrevName": "He R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "R He",
                  "orcid": null
                },
                {
                  "ForeName": "M",
                  "LastName": "Huang",
                  "abbrevName": "Huang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "M Huang",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "J",
                  "LastName": "Ma",
                  "abbrevName": "Ma J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Ma",
                  "orcid": null
                },
                {
                  "ForeName": "G",
                  "LastName": "Chen",
                  "abbrevName": "Chen G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "G Chen",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.4149/neo_2018_180806N593",
            "pmid": "30784286",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Neoplasma 66 2019",
            "title": "Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation."
          }
        },
        {
          "pmid": "32114388",
          "pubmed": {
            "ISODate": "2020-03-01T00:00:00.000Z",
            "abstract": "BACKGROUND: Liver cancer stem cells (CSCs) are critical determinants of HCC relapse and therapeutic resistance, but the mechanisms underlying the maintenance of CSCs are poorly understood. We aimed to explore the role of tumor repressor Zinc-fingers and homeoboxes 2 (ZHX2) in liver CSCs. METHODS: CD133+ or EPCAM+ stem-like liver cancer cells were sorted from tumor tissues of HCC patients and HCC cell lines by flow cytometry. In addition, sorafenib-resistant cells, tumor-sphere forming cells and side population (SP) cells were respectively cultured and isolated as hepatic CSCs. The tumor-initiating and chemoresistance properties of ZHX2-overexpressing and ZHX2-knockdown cells were analyzed in vivo and in vitro. Microarray, luciferase reporter assay, chromatin immunoprecipitation (ChIP) and ChIP-on-chip analyses were performed to explore ZHX2 target genes. The expression of ZHX2 and its target gene were determined by quantitative RT-PCR, western blot, immunofluorescence and immunohistochemical staining in hepatoma cells and tumor and adjacent tissues from HCC patients. RESULTS: ZHX2 expression was significantly reduced in liver CSCs from different origins. ZHX2 deficiency led to enhanced liver tumor progression and expansion of CSC populations in vitro and in vivo. Re-expression of ZHX2 restricted capabilities of hepatic CSCs in supporting tumor initiation, self-renewal and sorafenib-resistance. Mechanically, ZHX2 suppressed liver CSCs via inhibiting KDM2A-mediated demethylation of histone H3 lysine 36 (H3K36) at the promoter regions of stemness-associated transcription factors, such as NANOG, SOX4 and OCT4. Moreover, patients with lower expression of ZHX2 and higher expression of KDM2A in tumor tissues showed significantly poorer survival. CONCLUSION: ZHX2 counteracts stem cell traits through transcriptionally repressing KDM2A in HCC. Our data will aid in a better understanding of molecular mechanisms underlying HCC relapse and drug resistance.",
            "authors": {
              "abbreviation": "Qinghai Lin, Zhuanchang Wu, Xuetian Yue, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying",
                  "LastName": "He",
                  "abbrevName": "He Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying He",
                  "orcid": null
                },
                {
                  "ForeName": "Yutong",
                  "LastName": "Ge",
                  "abbrevName": "Ge Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yutong Ge",
                  "orcid": null
                },
                {
                  "ForeName": "Siyu",
                  "LastName": "Tan",
                  "abbrevName": "Tan S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siyu Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Song",
                  "abbrevName": "Song H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Song",
                  "orcid": null
                },
                {
                  "ForeName": "Detian",
                  "LastName": "Yuan",
                  "abbrevName": "Yuan D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Detian Yuan",
                  "orcid": null
                },
                {
                  "ForeName": "Yaoqin",
                  "LastName": "Gong",
                  "abbrevName": "Gong Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yaoqin Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.ebiom.2020.102676",
            "pmid": "32114388",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "EBioMedicine 53 2020",
            "title": "ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation."
          }
        },
        {
          "pmid": "32382017",
          "pubmed": {
            "ISODate": "2020-05-07T00:00:00.000Z",
            "abstract": "Zinc fingers and homeoboxes 2 (ZHX2) was found as a novel VHL substrate target, and acted as an oncogenic driver in ccRCC. However, the detailed mechanism of ZHX2 in ccRCC development remains elusive, and no research has focused on studying ZHX2 in drug resistance yet. A tissue microarray with 358 ccRCC samples was used to determine the expression of ZHX2 in ccRCC patients. VHL-deficient cell line 786-O and VHL-normal cell line CAKI-1 was used for lineage reprogramming by transfecting with lentivirus. The in vitro and in vivo experiments were performed with these new cell lines to determine the mechanism of ZHX2 in ccRCC development and drug resistance. Immunohistochemistry analysis showed that ZHX2 was not highly expressed in ccRCC tumor tissues, only 33.2% (119/358) patients have high ZHX2 expression. However, high ZHX2 was significantly associated with advanced Fuhrman grade (p = 0.004), and proved to be an independent prognosis factor for progression-free survival (p = 0.0003), while there is no significant correlation with overall survival. We further discovered that ZHX2 overexpression could increase VEGF secretion and transcriptional activate the MEK/ERK1/2 and promote its downstream targets. We also found ZHX2 overexpression induce Sunitinib resistance though activating autophagy and the combination treatment of Sunitinib and Chloroquine could significantly rescue the phenomenon. In summary, these results indicate that ZHX2 drivers cell growth, migration though increase VEGF expression, and transcriptional activate MEK/ERK1/2 signaling pathway, and could induce Sunitinib resistance by regulating self-protective autophagy, these may provide new insight in advanced ccRCC treatment.",
            "authors": {
              "abbreviation": "Liangsong Zhu, Rong Ding, Hao Yan, ..., Zongming Lin",
              "authorList": [
                {
                  "ForeName": "Liangsong",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Liangsong Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Rong",
                  "LastName": "Ding",
                  "abbrevName": "Ding R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rong Ding",
                  "orcid": null
                },
                {
                  "ForeName": "Hao",
                  "LastName": "Yan",
                  "abbrevName": "Yan H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hao Yan",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": "med-zhangjin@vip.sina.com",
                  "isCollectiveName": false,
                  "name": "Jin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "abbrevName": "Lin Z",
                  "email": "lin.zongming@zs-hospital.sh.cn",
                  "isCollectiveName": false,
                  "name": "Zongming Lin",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jin",
                  "LastName": "Zhang",
                  "email": [
                    "med-zhangjin@vip.sina.com"
                  ],
                  "name": "Jin Zhang"
                },
                {
                  "ForeName": "Zongming",
                  "LastName": "Lin",
                  "email": [
                    "lin.zongming@zs-hospital.sh.cn"
                  ],
                  "name": "Zongming Lin"
                }
              ]
            },
            "doi": "10.1038/s41419-020-2541-x",
            "pmid": "32382017",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 11 2020",
            "title": "ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma."
          }
        },
        {
          "pmid": "36228375",
          "pubmed": {
            "ISODate": "2022-12-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has been shown that HIF-1α regulates the complex biological processes of TNBC, such as glycolysis, angiogenesis, invasion and metastasis, breast cancer stem cells (BCSCs) enrichment, and immune escape, to promote TNBC survival and development through the activation of downstream target genes. In addition, inflammatory mediators, oxygen levels, noncoding RNAs, complex signaling regulatory networks, epigenetic regulators are involved in the upstream regulatory expression of HIF-1α. However, further studies are needed to determine the potential and future directions of targeting HIF-1α in TNBC. This article discusses the expression of the HIF-1α transcription factor in TNBC. We also explored the mechanism by which HIF-1α drives TNBC progression. The potential significance of targeting HIF-1α for immunotherapy, chemotherapy, anti-angiogenic therapy, and photodynamic therapy is discussed. The intrinsic mechanism, existing problems and future directions of targeting HIF-1α are also studied.",
            "authors": {
              "abbreviation": "Qi Liu, Chengcheng Guan, Cui Liu, ..., Changgang Sun",
              "authorList": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "abbrevName": "Liu Q",
                  "email": "2020110892@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Qi Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "abbrevName": "Guan C",
                  "email": "2020110896@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chengcheng Guan",
                  "orcid": null
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "abbrevName": "Liu C",
                  "email": "2019101062@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Cui Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "abbrevName": "Li H",
                  "email": "2019101020@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Huayao Li",
                  "orcid": null
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "abbrevName": "Wu J",
                  "email": "2020111256@sdutcm.edu.cn",
                  "isCollectiveName": false,
                  "name": "Jibiao Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "abbrevName": "Sun C",
                  "email": "zyxyscg@wfmc.edu.cn",
                  "isCollectiveName": false,
                  "name": "Changgang Sun",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qi",
                  "LastName": "Liu",
                  "email": [
                    "2020110892@sdutcm.edu.cn"
                  ],
                  "name": "Qi Liu"
                },
                {
                  "ForeName": "Chengcheng",
                  "LastName": "Guan",
                  "email": [
                    "2020110896@sdutcm.edu.cn"
                  ],
                  "name": "Chengcheng Guan"
                },
                {
                  "ForeName": "Cui",
                  "LastName": "Liu",
                  "email": [
                    "2019101062@sdutcm.edu.cn"
                  ],
                  "name": "Cui Liu"
                },
                {
                  "ForeName": "Huayao",
                  "LastName": "Li",
                  "email": [
                    "2019101020@sdutcm.edu.cn"
                  ],
                  "name": "Huayao Li"
                },
                {
                  "ForeName": "Jibiao",
                  "LastName": "Wu",
                  "email": [
                    "2020111256@sdutcm.edu.cn"
                  ],
                  "name": "Jibiao Wu"
                },
                {
                  "ForeName": "Changgang",
                  "LastName": "Sun",
                  "email": [
                    "zyxyscg@wfmc.edu.cn"
                  ],
                  "name": "Changgang Sun"
                }
              ]
            },
            "doi": "10.1016/j.biopha.2022.113861",
            "pmid": "36228375",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D016454",
                "value": "Review"
              }
            ],
            "reference": "Biomed Pharmacother 156 2022",
            "title": "Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy."
          }
        },
        {
          "pmid": "33824311",
          "pubmed": {
            "ISODate": "2021-04-06T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive subtype with the worst prognosis and the highest metastatic and recurrence potential, which represents 15-20% of all breast cancers in Chinese females, and the 5-year overall survival rate is about 80% in Chinese women. Recently, emerging evidence suggested that aberrant alternative splicing (AS) plays a crucial role in tumorigenesis and progression. AS is generally controlled by AS-associated RNA binding proteins (RBPs). Monocyte chemotactic protein induced protein 1 (MCPIP1), a zinc finger RBP, functions as a tumor suppressor in many cancers. Here, we showed that MCPIP1 was downregulated in 80 TNBC tissues and five TNBC cell lines compared to adjacent paracancerous tissues and one human immortalized breast epithelial cell line, while its high expression levels were associated with increased overall survival in TNBC patients. We demonstrated that MCPIP1 overexpression dramatically suppressed cell cycle progression and proliferation of TNBC cells in vitro and repressed tumor growth in vivo. Mechanistically, MCPIP1 was first demonstrated to act as a splicing factor to regulate AS in TNBC cells. Furthermore, we demonstrated that MCPIP1 modulated NFIC AS to promote CTF5 synthesis, which acted as a negative regulator in TNBC cells. Subsequently, we showed that CTF5 participated in MCPIP1-mediated antiproliferative effect by transcriptionally repressing cyclin D1 expression, as well as downregulating its downstream signaling targets p-Rb and E2F1. Conclusively, our findings provided novel insights into the anti-oncogenic mechanism of MCPIP1, suggesting that MCPIP1 could serve as an alternative treatment target in TNBC.",
            "authors": {
              "abbreviation": "Fengxia Chen, Qingqing Wang, Xiaoyan Yu, ..., Yunfeng Zhou",
              "authorList": [
                {
                  "ForeName": "Fengxia",
                  "LastName": "Chen",
                  "abbrevName": "Chen F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fengxia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Qingqing",
                  "LastName": "Wang",
                  "abbrevName": "Wang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingqing Wang",
                  "orcid": "0000-0002-6440-582X"
                },
                {
                  "ForeName": "Xiaoyan",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaoyan Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ningning",
                  "LastName": "Yang",
                  "abbrevName": "Yang N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ningning Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Yuan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuan Wang",
                  "orcid": "0000-0003-1894-0853"
                },
                {
                  "ForeName": "Yangyang",
                  "LastName": "Zeng",
                  "abbrevName": "Zeng Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yangyang Zeng",
                  "orcid": null
                },
                {
                  "ForeName": "Zhewen",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhewen Zheng",
                  "orcid": null
                },
                {
                  "ForeName": "Fuxiang",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fuxiang Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou Y",
                  "email": "yfzhouwhu@163.com",
                  "isCollectiveName": false,
                  "name": "Yunfeng Zhou",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Yunfeng",
                  "LastName": "Zhou",
                  "email": [
                    "yfzhouwhu@163.com"
                  ],
                  "name": "Yunfeng Zhou"
                }
              ]
            },
            "doi": "10.1038/s41419-021-03661-4",
            "pmid": "33824311",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Death Dis 12 2021",
            "title": "MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis."
          }
        },
        {
          "pmid": "28239645",
          "pubmed": {
            "ISODate": "2017-02-23T00:00:00.000Z",
            "abstract": "Elucidating the molecular basis of tumor metastasis is pivotal for eradicating cancer-related mortality. Triple-negative breast cancer (TNBC) encompasses a class of aggressive tumors characterized by high rates of recurrence and metastasis, as well as poor overall survival. Here, we find that the promyelocytic leukemia protein PML exerts a prometastatic function in TNBC that can be targeted by arsenic trioxide. We found that, in TNBC patients, constitutive HIF1A activity induces high expression of PML, along with a number of HIF1A target genes that promote metastasis at multiple levels. Intriguingly, PML controls the expression of these genes by binding to their regulatory regions along with HIF1A. This mechanism is specific to TNBC cells and does not occur in other subtypes of breast cancer where PML and prometastatic HIF1A target genes are underexpressed. As a consequence, PML promotes cell migration, invasion, and metastasis in TNBC cell and mouse models. Notably, pharmacological inhibition of PML with arsenic trioxide, a PML-degrading agent used to treat promyelocytic leukemia patients, delays tumor growth, impairs TNBC metastasis, and cooperates with chemotherapy by preventing metastatic dissemination. In conclusion, we report identification of a prometastatic pathway in TNBC and suggest clinical development toward the use of arsenic trioxide for TNBC patients.",
            "authors": {
              "abbreviation": "Manfredi Ponente, Letizia Campanini, Roberto Cuttano, ..., Rosa Bernardi",
              "authorList": [
                {
                  "ForeName": "Manfredi",
                  "LastName": "Ponente",
                  "abbrevName": "Ponente M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Manfredi Ponente",
                  "orcid": null
                },
                {
                  "ForeName": "Letizia",
                  "LastName": "Campanini",
                  "abbrevName": "Campanini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Letizia Campanini",
                  "orcid": null
                },
                {
                  "ForeName": "Roberto",
                  "LastName": "Cuttano",
                  "abbrevName": "Cuttano R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberto Cuttano",
                  "orcid": null
                },
                {
                  "ForeName": "Andrea",
                  "LastName": "Piunti",
                  "abbrevName": "Piunti A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrea Piunti",
                  "orcid": null
                },
                {
                  "ForeName": "Giacomo",
                  "LastName": "Delledonne",
                  "abbrevName": "Delledonne GA",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giacomo A Delledonne",
                  "orcid": null
                },
                {
                  "ForeName": "Nadia",
                  "LastName": "Coltella",
                  "abbrevName": "Coltella N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Nadia Coltella",
                  "orcid": null
                },
                {
                  "ForeName": "Roberta",
                  "LastName": "Valsecchi",
                  "abbrevName": "Valsecchi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Roberta Valsecchi",
                  "orcid": null
                },
                {
                  "ForeName": "Alessandra",
                  "LastName": "Villa",
                  "abbrevName": "Villa A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Alessandra Villa",
                  "orcid": null
                },
                {
                  "ForeName": "Ugo",
                  "LastName": "Cavallaro",
                  "abbrevName": "Cavallaro U",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ugo Cavallaro",
                  "orcid": null
                },
                {
                  "ForeName": "Linda",
                  "LastName": "Pattini",
                  "abbrevName": "Pattini L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linda Pattini",
                  "orcid": null
                },
                {
                  "ForeName": "Claudio",
                  "LastName": "Doglioni",
                  "abbrevName": "Doglioni C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Claudio Doglioni",
                  "orcid": null
                },
                {
                  "ForeName": "Rosa",
                  "LastName": "Bernardi",
                  "abbrevName": "Bernardi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Bernardi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1172/jci.insight.87380",
            "pmid": "28239645",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "JCI Insight 2 2017",
            "title": "PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes."
          }
        },
        {
          "pmid": "34408002",
          "pubmed": {
            "ISODate": "2021-11-01T00:00:00.000Z",
            "abstract": "Genomic alterations are crucial for the development and progression of human cancers. Copy-number gains found in genes encoding metabolic enzymes may induce triple-negative breast cancer (TNBC) adaptation. However, little is known about how metabolic enzymes regulate TNBC metastasis. Using our previously constructed multiomic profiling of a TNBC cohort, we identified decaprenyl diphosphate synthase subunit 1 (PDSS1) as an essential gene for TNBC metastasis. PDSS1 expression was significantly upregulated in TNBC tissues compared with adjacent normal tissues and was positively associated with poor survival among patients with TNBC. PDSS1 knockdown inhibited TNBC cell migration, invasion, and distant metastasis. Mechanistically, PDSS1, but not a catalytically inactive mutant, positively regulated the cellular level of coenzyme Q10 (CoQ10) and intracellular calcium levels, thereby inducing CAMK2A phosphorylation, which is essential for STAT3 phosphorylation in the cytoplasm. Phosphorylated STAT3 entered the nucleus, promoting oncogenic STAT3 signaling and TNBC metastasis. STAT3 phosphorylation inhibitors (e.g., Stattic) effectively blocked PDSS1-induced cell migration and invasion in vitro and tumor metastasis in vivo. Taken together, our study highlights the importance of targeting the previously uncharacterized PDSS1/CAMK2A/STAT3 oncogenic signaling axis, expanding the repertoire of precision medicine in TNBC. SIGNIFICANCE: A novel metabolic gene PDSS1 is highly expressed in triple-negative breast cancer tissues and contributes to metastasis, serving as a potential therapeutic target for combating metastatic disease.",
            "authors": {
              "abbreviation": "Tian-Jian Yu, Ying-Ying Liu, Xiao-Guang Li, ..., Yi-Zhou Jiang",
              "authorList": [
                {
                  "ForeName": "Tian-Jian",
                  "LastName": "Yu",
                  "abbrevName": "Yu TJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tian-Jian Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Ying-Ying",
                  "LastName": "Liu",
                  "abbrevName": "Liu YY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ying-Ying Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Xiao-Guang",
                  "LastName": "Li",
                  "abbrevName": "Li XG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiao-Guang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bi",
                  "LastName": "Lian",
                  "abbrevName": "Lian B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bi Lian",
                  "orcid": null
                },
                {
                  "ForeName": "Xun-Xi",
                  "LastName": "Lu",
                  "abbrevName": "Lu XX",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xun-Xi Lu",
                  "orcid": "0000-0002-5118-0377"
                },
                {
                  "ForeName": "Xi",
                  "LastName": "Jin",
                  "abbrevName": "Jin X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Jin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhi-Ming",
                  "LastName": "Shao",
                  "abbrevName": "Shao ZM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhi-Ming Shao",
                  "orcid": "0000-0001-8781-2455"
                },
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "abbrevName": "Hu X",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Xin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "abbrevName": "Di GH",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Gen-Hong Di",
                  "orcid": null
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "abbrevName": "Jiang YZ",
                  "email": "yizhoujiang@fudan.edu.cn",
                  "isCollectiveName": false,
                  "name": "Yi-Zhou Jiang",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Xin",
                  "LastName": "Hu",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Xin Hu"
                },
                {
                  "ForeName": "Gen-Hong",
                  "LastName": "Di",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Gen-Hong Di"
                },
                {
                  "ForeName": "Yi-Zhou",
                  "LastName": "Jiang",
                  "email": [
                    "yizhoujiang@fudan.edu.cn",
                    "genhongdi@163.com",
                    "xinhu@fudan.edu.cn"
                  ],
                  "name": "Yi-Zhou Jiang"
                }
              ]
            },
            "doi": "10.1158/0008-5472.CAN-21-0747",
            "pmid": "34408002",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Res 81 2021",
            "title": "PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer."
          }
        },
        {
          "pmid": "27137755",
          "pubmed": {
            "ISODate": "2017-01-01T00:00:00.000Z",
            "abstract": "The aggressiveness of triple-negative breast cancer (TNBC), which lacks estrogen receptor, progesterone receptor and epidermal growth factor receptor 2 (HER2), represents a major challenge in breast cancer. Migratory and self-renewal capabilities are integral components of invasion, metastasis and recurrence of TNBC. Elevated hypoxia-inducible factor-1α (HIF-1α) expression is associated with aggressiveness of cancer. Nonetheless, how HIF-1α expression is regulated and how HIF-1α induces aggressive phenotype are not completely understood in TNBC. The cytotoxic effects of farnesyltransferase (FTase) inhibitors (FTIs) have been studied in cancer and leukemia cells. In contrast, the effect of FTIs on HIF-1α expression has not yet been studied. Here, we show that clinically relevant low-dose FTI, tipifarnib (300 nM), decreased HIF-1α expression, migration and tumorsphere formation in human MDA-MB-231 TNBC cells under a normoxic condition. In contrast, the low-dose FTIs did not inhibit cell growth and activity of the Ras pathway in MDA-MB 231 cells. Tipifarnib-induced decrease in HIF-1α expression was associated with amelioration of the Warburg effect, hypermetabolic state, increases in Snail expression and ATP release, and suppressed E-cadherin expression, major contributors to invasion, metastasis and recurrence of TBNC. These data suggest that FTIs may be capable of ameliorating the aggressive phenotype of TNBC by suppressing the HIF-1α-Snail pathway. J. Cell. Physiol. 232: 192-201, 2017. © 2016 Wiley Periodicals, Inc.",
            "authors": {
              "abbreviation": "Tomokazu Tanaka, Yuichi Ikegami, Harumasa Nakazawa, ..., Masao Kaneki",
              "authorList": [
                {
                  "ForeName": "Tomokazu",
                  "LastName": "Tanaka",
                  "abbrevName": "Tanaka T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tomokazu Tanaka",
                  "orcid": null
                },
                {
                  "ForeName": "Yuichi",
                  "LastName": "Ikegami",
                  "abbrevName": "Ikegami Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yuichi Ikegami",
                  "orcid": null
                },
                {
                  "ForeName": "Harumasa",
                  "LastName": "Nakazawa",
                  "abbrevName": "Nakazawa H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Harumasa Nakazawa",
                  "orcid": null
                },
                {
                  "ForeName": "Naohide",
                  "LastName": "Kuriyama",
                  "abbrevName": "Kuriyama N",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Naohide Kuriyama",
                  "orcid": null
                },
                {
                  "ForeName": "Miwa",
                  "LastName": "Oki",
                  "abbrevName": "Oki M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Miwa Oki",
                  "orcid": null
                },
                {
                  "ForeName": "Jun-Ichi",
                  "LastName": "Hanai",
                  "abbrevName": "Hanai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun-Ichi Hanai",
                  "orcid": null
                },
                {
                  "ForeName": "Vikas",
                  "LastName": "Sukhatme",
                  "abbrevName": "Sukhatme VP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Vikas P Sukhatme",
                  "orcid": null
                },
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "abbrevName": "Kaneki M",
                  "email": "mkaneki@helix.mgh.harvard.edu",
                  "isCollectiveName": false,
                  "name": "Masao Kaneki",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Masao",
                  "LastName": "Kaneki",
                  "email": [
                    "mkaneki@helix.mgh.harvard.edu"
                  ],
                  "name": "Masao Kaneki"
                }
              ]
            },
            "doi": "10.1002/jcp.25411",
            "pmid": "27137755",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Cell Physiol 232 2017",
            "title": "Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro."
          }
        },
        {
          "pmid": "31264274",
          "pubmed": {
            "ISODate": "2019-10-01T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype which accounts for 15%-20% of all breast cancer cases. The management of TNBC has remained a challenge due to its lack of targeted therapy. Previously, we reported that homeobox C8 (HOXC8) was involved in metastasis and migration of breast cancer cells. By chromatin immunoprecipitation and luciferase assays, we found that HOXC8 functioned as a transcription factor to activate the transcription of matrix Gla protein (MGP) gene, leading to an increase in the proliferation, anchorage-independent growth, and migration of TNBC cells. We further demonstrated that MGP expression promoted the epithelial-mesenchymal transition (EMT) process of TNBC cells, but not the other subtypes of breast cancer, suggesting that MGP induced EMT to promote proliferation and migration of TNBC cells. Moreover, we found that MGP was upregulated in clinical breast specimens compared to normal breast tissues and high MGP expression was statistically associated with poor, relapse-free survival for TNBC patients, indicating that MGP is probably a novel biomarker or therapeutic target for TNBC patients. Together, our results showed that the HOXC8-MGP axis played an important role in the tumorigenesis of TNBC and might be a promising therapeutic target for TNBC treatment.",
            "authors": {
              "abbreviation": "Chen Gong, Jin Zou, Mingsheng Zhang, ..., Yong Li",
              "authorList": [
                {
                  "ForeName": "Chen",
                  "LastName": "Gong",
                  "abbrevName": "Gong C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zou",
                  "abbrevName": "Zou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zou",
                  "orcid": null
                },
                {
                  "ForeName": "Mingsheng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingsheng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Shanshan",
                  "LastName": "Xu",
                  "abbrevName": "Xu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shanshan Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Siqi",
                  "LastName": "Zhu",
                  "abbrevName": "Zhu S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Siqi Zhu",
                  "orcid": null
                },
                {
                  "ForeName": "Mengqi",
                  "LastName": "Yang",
                  "abbrevName": "Yang M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mengqi Yang",
                  "orcid": null
                },
                {
                  "ForeName": "Dongjia",
                  "LastName": "Li",
                  "abbrevName": "Li D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dongjia Li",
                  "orcid": null
                },
                {
                  "ForeName": "Yun",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Jialu",
                  "LastName": "Shi",
                  "abbrevName": "Shi J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jialu Shi",
                  "orcid": null
                },
                {
                  "ForeName": "Yong",
                  "LastName": "Li",
                  "abbrevName": "Li Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yong Li",
                  "orcid": "0000-0003-4681-263X"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/mc.23079",
            "pmid": "31264274",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Mol Carcinog 58 2019",
            "title": "Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer."
          }
        },
        {
          "pmid": "31683461",
          "pubmed": {
            "ISODate": "2020-01-01T00:00:00.000Z",
            "abstract": "OBJECTIVE: To investigate the effect of ZHX2 on lung cancer cells proliferation and apoptosis. MATERIALS AND METHODS: The mRNA and protein expression of ZHX2 were detected by qRT-PCR and western blot, respectively. The human lung cancer cells were divided into Control, NC, ZHX2, SB, and ZHX2 + Ani groups. The cell proliferation was detected by CCK-8 assay and the cell migration and invasion were detected by Transwell assay. Cell apoptosis was detected by flow cytometry. Apoptosis and p38MAPK signaling pathway related proteins were detected by western blot. The nude mice model of lung cancer xenograft was constructed. The tumor volume and tumor weight were measured. The expression of PCNA protein in tumor tissues was detected by immunohistochemistry. The apoptosis of tumor cells was detected by TUNEL staining. The ZHX2 and p38MAPK signaling pathway related proteins in tumor tissues were detected by western blot. RESULTS: The expression of ZHX2 gene and protein in the cancer cell lines were significantly decreased. Compared with control and NC groups, the cells proliferation, migration and invasion were inhibited in ZHX2 and SB groups, while the apoptosis and apoptosis related proteins were increased (p< 0.05). Meanwhile, compared with ZHX2 group, the tumor growth rate, volume, weight, the percentage of PCNA-positive cells, and p-P38 MAPK/P38 MAPK were increased significantly in ZHX2 + Ani group, while the apoptotic index and the expression of MMP-9 protein were significantly decreased (p< 0.05). CONCLUSION: ZHX2 could inhibit proliferation and promote apoptosis of lung cancer cells by inhibiting p38MAPK signaling pathway.",
            "authors": {
              "abbreviation": "Xudong Tian, Yadong Wang, Shuhai Li, ..., Hui Tian",
              "authorList": [
                {
                  "ForeName": "Xudong",
                  "LastName": "Tian",
                  "abbrevName": "Tian X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xudong Tian",
                  "orcid": null
                },
                {
                  "ForeName": "Yadong",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yadong Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Shuhai",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuhai Li",
                  "orcid": null
                },
                {
                  "ForeName": "Weiming",
                  "LastName": "Yue",
                  "abbrevName": "Yue W",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Weiming Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Hui",
                  "LastName": "Tian",
                  "abbrevName": "Tian H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hui Tian",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.3233/CBM-190514",
            "pmid": "31683461",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cancer Biomark 27 2020",
            "title": "ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway."
          }
        },
        {
          "pmid": "36037364",
          "pubmed": {
            "ISODate": "2022-09-06T00:00:00.000Z",
            "abstract": "Clear cell renal cell carcinoma (ccRCC) is characterized by the loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of an E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor α (HIF-α) (including HIF1α and HIF2α) and Zinc Fingers And Homeoboxes 2 (ZHX2). Our recent research showed that ZHX2 contributed to ccRCC tumorigenesis in a HIF-independent manner. However, it is still unknown whether ZHX2 could be modified through deubiquitination even in the absence of pVHL. Here, we performed a deubiquitinase (DUB) complementary DNA (cDNA) library binding screen and identified USP13 as a DUB that bound ZHX2 and promoted ZHX2 deubiquitination. As a result, USP13 promoted ZHX2 protein stability in an enzymatically dependent manner, and depletion of USP13 led to ZHX2 down-regulation in ccRCC. Functionally, USP13 depletion led to decreased cell proliferation measured by two-dimensional (2D) colony formation and three-dimensional (3D) anchorage-independent growth. Furthermore, USP13 was essential for ccRCC tumor growth in vivo, and the effect was partially mediated by its regulation on ZHX2. Our findings support that USP13 may be a key effector in ccRCC tumorigenesis.",
            "authors": {
              "abbreviation": "Haibiao Xie, Jin Zhou, Xijuan Liu, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Haibiao",
                  "LastName": "Xie",
                  "abbrevName": "Xie H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haibiao Xie",
                  "orcid": "0000-0001-6729-8479"
                },
                {
                  "ForeName": "Jin",
                  "LastName": "Zhou",
                  "abbrevName": "Zhou J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jin Zhou",
                  "orcid": null
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Yawei",
                  "LastName": "Xu",
                  "abbrevName": "Xu Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yawei Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Austin",
                  "LastName": "Hepperla",
                  "abbrevName": "Hepperla AJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Austin J Hepperla",
                  "orcid": "0000-0002-0107-2001"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon JM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy M Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Hongwei",
                  "LastName": "Yao",
                  "abbrevName": "Yao H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongwei Yao",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": "0000-0002-9073-3835"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": null
                },
                {
                  "ForeName": "Kan",
                  "LastName": "Gong",
                  "abbrevName": "Gong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kan Gong",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": []
            },
            "doi": "10.1073/pnas.2119854119",
            "pmid": "36037364",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Proc Natl Acad Sci U S A 119 2022",
            "title": "USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer."
          }
        },
        {
          "pmid": "25195714",
          "pubmed": {
            "ISODate": "2014-10-01T00:00:00.000Z",
            "abstract": "Glypican 3 (GPC3) has been paid particular attention owing to its potential as diagnosis marker for hepatocellular carcinoma (HCC). Identifying the mechanisms regulating the reactivation of GPC3 in HCC appears to be clinically meaningful. Previous study identified zinc-fingers and homeoboxes 2 (ZHX2) as transcriptional factor responsible for postnatal repression of GPC3 in mice. Here, in this study, we provided the first evidence that down regulated ZHX2 is responsible for GPC3 reactivation in HCC. First, inverse correlation of ZHX2 with GPC3 expression was shown in cultured liver cell lines. Second, ZHX2 overexpression significantly decreased GPC3 expression, while ZHX2 knockdown effectively increased GPC3 level in different HCC cell lines. Consistently, dual luciferase and ChIP assay showed that ZHX2 dose-dependently suppressed GPC3 promoter activity by binding with the core promoter. More importantly, immunohistochemical staining demonstrated the inverse correlation between nuclear ZHX2 with GPC3 expression in HCC tissues. Further in vitro analysis showed that nuclear translocation was crucial for ZHX2 mediated repression on GPC3 transcription. Taken together, our results prove that ZHX2 suppresses GPC3 transcription by binding with its core promoter and reduced nucleic ZHX2 expression may be involved in GPC3 reactivation in HCC.",
            "authors": {
              "abbreviation": "Fang Luan, Peng Liu, Hongxin Ma, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Fang",
                  "LastName": "Luan",
                  "abbrevName": "Luan F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Fang Luan",
                  "orcid": null
                },
                {
                  "ForeName": "Peng",
                  "LastName": "Liu",
                  "abbrevName": "Liu P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Peng Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Hongxin",
                  "LastName": "Ma",
                  "abbrevName": "Ma H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Hongxin Ma",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Liu",
                  "abbrevName": "Liu J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": "machunhong@sdu.edu.cn",
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "email": [
                    "machunhong@sdu.edu.cn"
                  ],
                  "name": "Chunhong Ma"
                }
              ]
            },
            "doi": "10.1016/j.biocel.2014.08.021",
            "pmid": "25195714",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Int J Biochem Cell Biol 55 2014",
            "title": "Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma."
          }
        },
        {
          "pmid": "29333926",
          "pubmed": {
            "ISODate": "2018-04-03T00:00:00.000Z",
            "abstract": "Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by poor patient prognosis and for which no targeted therapies are currently available. TNBC can be further categorized as either basal-like (BLBC) or quintuple-negative breast cancer (QNBC). In the present study, we aimed to identify novel molecular therapeutic targets for TNBC by analyzing the mRNA expression of TNBC-related genes in publicly available microarray data sets. We found that Engrailed 1 (EN1) was significantly overexpressed in TNBC. Using breast cancer cell lines, we found that EN1 was more highly expressed in TNBC than in other breast cancer subtypes. EN1 expression was analyzed in 199 TNBC paraffin-embedded tissue samples by immunohistochemistry. EN1 protein expression was positively associated with reduced overall survival (OS) rate in patients with QNBC, but not those with BLBC. The importance of EN1 expression in QNBC cell viability and tumorigenicity was evaluated using the QNBC cell lines, HCC38 and HCC1395. Based on our data, EN1 may promote the proliferation, migration, and multinucleation of QNBC cells, likely via the transcriptional activation of HDAC8, UTP11L, and ZIC3. We also demonstrated that actinomycin D effectively inhibits EN1 activity in QNBC cells. The results of the present study suggest that EN1 activity is highly clinically relevant to the survival prognosis of patients with QNBC and EN1 is a promising potential therapeutic target for future QNBC treatment.",
            "authors": {
              "abbreviation": "Yu Jin Kim, Minjung Sung, Ensel Oh, ..., Yoon-La Choi",
              "authorList": [
                {
                  "ForeName": "Yu",
                  "LastName": "Kim",
                  "abbrevName": "Kim YJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yu Jin Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Minjung",
                  "LastName": "Sung",
                  "abbrevName": "Sung M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minjung Sung",
                  "orcid": null
                },
                {
                  "ForeName": "Ensel",
                  "LastName": "Oh",
                  "abbrevName": "Oh E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ensel Oh",
                  "orcid": null
                },
                {
                  "ForeName": "Michael",
                  "LastName": "Vrancken",
                  "abbrevName": "Vrancken MV",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Michael Van Vrancken",
                  "orcid": null
                },
                {
                  "ForeName": "Ji-Young",
                  "LastName": "Song",
                  "abbrevName": "Song JY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ji-Young Song",
                  "orcid": null
                },
                {
                  "ForeName": "Kyungsoo",
                  "LastName": "Jung",
                  "abbrevName": "Jung K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kyungsoo Jung",
                  "orcid": null
                },
                {
                  "ForeName": "Yoon-La",
                  "LastName": "Choi",
                  "abbrevName": "Choi YL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yoon-La Choi",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2018.1423913",
            "pmid": "29333926",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 19 2018",
            "title": "Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer."
          }
        },
        {
          "pmid": "32770671",
          "pubmed": {
            "ISODate": "2020-12-01T00:00:00.000Z",
            "abstract": "Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Lipogenesis has been considered as a critical player in HCC initiation and progression. However, the underlying mechanism is still not fully understood. Here, we identified zinc fingers and homeoboxes 2 (ZHX2), an HCC-associated tumor suppressor, as an important repressor of de novo lipogenesis. Ectopic expression of ZHX2 significantly inhibited de novo lipogenesis in HCC cells and decreased expression of FASN, ACL, ACC1, and SCD1. In accordance with this, ZHX2 was negatively associated with SREBP1c, the master regulator of de novo lipogenesis, in HCC cell lines and human specimens. Results from silencing and overexpression demonstrated that ZHX2 inhibited de novo lipogenesis and consequent HCC progression via repression of SREBP1c. Furthermore, treatment with the SREBP1c inhibitor fatostatin dampened the spontaneous formation of tumors in liver-specific Zhx2 knockout mice. Mechanistically, ZHX2 increased expression of miR-24-3p transcriptionally, which targeted SREBP1c and led to its degradation. In conclusion, our data suggest a novel mechanism through which ZHX2 suppresses HCC progression, which may provide a new strategy for the treatment of HCC. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.",
            "authors": {
              "abbreviation": "Xiangguo Yu, Qinghai Lin, Zhuanchang Wu, ..., Chunhong Ma",
              "authorList": [
                {
                  "ForeName": "Xiangguo",
                  "LastName": "Yu",
                  "abbrevName": "Yu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiangguo Yu",
                  "orcid": null
                },
                {
                  "ForeName": "Qinghai",
                  "LastName": "Lin",
                  "abbrevName": "Lin Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qinghai Lin",
                  "orcid": null
                },
                {
                  "ForeName": "Zhuanchang",
                  "LastName": "Wu",
                  "abbrevName": "Wu Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zhuanchang Wu",
                  "orcid": null
                },
                {
                  "ForeName": "Yankun",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yankun Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Tixiao",
                  "LastName": "Wang",
                  "abbrevName": "Wang T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tixiao Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Songbai",
                  "LastName": "Zhao",
                  "abbrevName": "Zhao S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Songbai Zhao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaojia",
                  "LastName": "Song",
                  "abbrevName": "Song X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaojia Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chaojia",
                  "LastName": "Chen",
                  "abbrevName": "Chen C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chaojia Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Zehua",
                  "LastName": "Wang",
                  "abbrevName": "Wang Z",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Zehua Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Leiqi",
                  "LastName": "Xu",
                  "abbrevName": "Xu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Leiqi Xu",
                  "orcid": null
                },
                {
                  "ForeName": "Chunyang",
                  "LastName": "Li",
                  "abbrevName": "Li C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunyang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Lifen",
                  "LastName": "Gao",
                  "abbrevName": "Gao L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lifen Gao",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaohong",
                  "LastName": "Liang",
                  "abbrevName": "Liang X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaohong Liang",
                  "orcid": null
                },
                {
                  "ForeName": "Xuetian",
                  "LastName": "Yue",
                  "abbrevName": "Yue X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xuetian Yue",
                  "orcid": null
                },
                {
                  "ForeName": "Chunhong",
                  "LastName": "Ma",
                  "abbrevName": "Ma C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chunhong Ma",
                  "orcid": "0000-0002-8121-4718"
                }
              ],
              "contacts": []
            },
            "doi": "10.1002/path.5530",
            "pmid": "32770671",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "J Pathol 252 2020",
            "title": "ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p."
          }
        },
        {
          "pmid": "28423652",
          "pubmed": {
            "ISODate": "2017-04-25T00:00:00.000Z",
            "abstract": "MiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR-29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b-1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.",
            "authors": {
              "abbreviation": "Rosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, ..., Riccardo Di Fiore",
              "authorList": [
                {
                  "ForeName": "Rosa",
                  "LastName": "Drago-Ferrante",
                  "abbrevName": "Drago-Ferrante R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rosa Drago-Ferrante",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Pentimalli",
                  "abbrevName": "Pentimalli F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Pentimalli",
                  "orcid": null
                },
                {
                  "ForeName": "Daniela",
                  "LastName": "Carlisi",
                  "abbrevName": "Carlisi D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Daniela Carlisi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "De Blasio",
                  "abbrevName": "De Blasio A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna De Blasio",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Saliba",
                  "abbrevName": "Saliba C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Saliba",
                  "orcid": null
                },
                {
                  "ForeName": "Shawn",
                  "LastName": "Baldacchino",
                  "abbrevName": "Baldacchino S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shawn Baldacchino",
                  "orcid": null
                },
                {
                  "ForeName": "James",
                  "LastName": "Degaetano",
                  "abbrevName": "Degaetano J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "James Degaetano",
                  "orcid": null
                },
                {
                  "ForeName": "Joseph",
                  "LastName": "Debono",
                  "abbrevName": "Debono J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joseph Debono",
                  "orcid": null
                },
                {
                  "ForeName": "Gordon",
                  "LastName": "Caruana-Dingli",
                  "abbrevName": "Caruana-Dingli G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Gordon Caruana-Dingli",
                  "orcid": null
                },
                {
                  "ForeName": "Godfrey",
                  "LastName": "Grech",
                  "abbrevName": "Grech G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Godfrey Grech",
                  "orcid": null
                },
                {
                  "ForeName": "Christian",
                  "LastName": "Scerri",
                  "abbrevName": "Scerri C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Christian Scerri",
                  "orcid": null
                },
                {
                  "ForeName": "Giovanni",
                  "LastName": "Tesoriere",
                  "abbrevName": "Tesoriere G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giovanni Tesoriere",
                  "orcid": null
                },
                {
                  "ForeName": "Antonio",
                  "LastName": "Giordano",
                  "abbrevName": "Giordano A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonio Giordano",
                  "orcid": null
                },
                {
                  "ForeName": "Renza",
                  "LastName": "Vento",
                  "abbrevName": "Vento R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Renza Vento",
                  "orcid": null
                },
                {
                  "ForeName": "Riccardo",
                  "LastName": "Di Fiore",
                  "abbrevName": "Di Fiore R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Riccardo Di Fiore",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.18632/oncotarget.15960",
            "pmid": "28423652",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Oncotarget 8 2017",
            "title": "Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation."
          }
        },
        {
          "pmid": "35188449",
          "pubmed": {
            "ISODate": "2022-05-01T00:00:00.000Z",
            "abstract": "There is no clear treatment guideline or individualized treatment plan for triple-negative breast cancer (TNBC). The aim of this study was to investigate more effective targets for TNBC-targeted therapy. MDA-MB-231 and BT549 cell lines were used to explore the function of LINC00649 on the proliferation, invasion, and migration of TNBC cells. A mice subcutaneous tumor model and a pulmonary metastasis model was established to identify the role of LINC00649 on the growth and metastasis of TNBC in vivo. LINC00649 was found to be a key molecule involved in the occurrence and development of TNBC by screening of public databases and detection of TNBC clinical samples. LINC00649 increased hypoxia-inducible factor 1α (HIF-1α) mRNA stability and protein expression by interacting with the nuclear factor 90 (NF90)/NF45 complex. In vitro, interference with LINC00649 inhibits MDA-MB-231 and BT549 cell proliferation, migration, and invasion, and the addition of HIF-1α revised this effect. In vivo experiments showed that LINC00649 promoted the growth and metastasis of TNBC. We demonstrated that LINC00649 interacts with the NF90/NF45 complex to increase the mRNA stability of HIF-1α and up-regulate HIF-1α expression, thereby inducing the proliferation, invasion, and migration of TNBC cells as well as tumor growth and metastasis.",
            "authors": {
              "abbreviation": "Jianhua Zhang, Chuang Du, Linfeng Zhang, ..., Jingruo Li",
              "authorList": [
                {
                  "ForeName": "Jianhua",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jianhua Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Chuang",
                  "LastName": "Du",
                  "abbrevName": "Du C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chuang Du",
                  "orcid": null
                },
                {
                  "ForeName": "Linfeng",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Linfeng Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Yan",
                  "LastName": "Wang",
                  "abbrevName": "Wang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yan Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Yingying",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yingying Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Jingruo",
                  "LastName": "Li",
                  "abbrevName": "Li J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jingruo Li",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384101.2022.2040283",
            "pmid": "35188449",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cell Cycle 21 2022",
            "title": "LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1α through the NF90/NF45 complex."
          }
        },
        {
          "pmid": "32778144",
          "pubmed": {
            "ISODate": "2020-08-10T00:00:00.000Z",
            "abstract": "BACKGROUND: Hypoxia plays a relevant role in tumor-related inflammation toward the metastatic spread and cancer aggressiveness. The pro-inflammatory cytokine interleukin-1β (IL-β) and its cognate receptor IL1R1 contribute to the initiation and progression of breast cancer determining pro-tumorigenic inflammatory responses. The transcriptional target of the hypoxia inducible factor-1α (HIF-1α) namely the G protein estrogen receptor (GPER) mediates a feedforward loop coupling IL-1β induction by breast cancer-associated fibroblasts (CAFs) to IL1R1 expression by breast cancer cells toward the regulation of target genes and relevant biological responses. METHODS: In order to ascertain the correlation of IL-β with HIF-1α and further hypoxia-related genes in triple-negative breast cancer (TNBC) patients, a bioinformatics analysis was performed using the information provided by The Invasive Breast Cancer Cohort of The Cancer Genome Atlas (TCGA) project and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets. Gene expression correlation, statistical analysis and gene set enrichment analysis (GSEA) were carried out with R studio packages. Pathway enrichment analysis was evaluated with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. TNBC cells and primary CAFs were used as model system. The molecular mechanisms implicated in the regulation of IL-1β by hypoxia toward a metastatic gene expression profile and invasive properties were assessed performing gene and protein expression studies, PCR arrays, gene silencing and immunofluorescence analysis, co-immunoprecipitation and ChiP assays, ELISA, cell spreading, invasion and spheroid formation. RESULTS: We first determined that IL-1β expression correlates with the levels of HIF-1α as well as with a hypoxia-related gene signature in TNBC patients. Next, we demonstrated that hypoxia triggers a functional liaison among HIF-1α, GPER and the IL-1β/IL1R1 signaling toward a metastatic gene signature and a feed-forward loop of IL-1β that leads to proliferative and invasive responses in TNBC cells. Furthermore, we found that the IL-1β released in the conditioned medium of TNBC cells exposed to hypoxic conditions promotes an invasive phenotype of CAFs. CONCLUSIONS: Our data shed new light on the role of hypoxia in the activation of the IL-1β/IL1R1 signaling, which in turn triggers aggressive features in both TNBC cells and CAFs. Hence, our findings provide novel evidence regarding the mechanisms through which the hypoxic tumor microenvironment may contribute to breast cancer progression and suggest further targets useful in more comprehensive therapeutic strategies.",
            "authors": {
              "abbreviation": "Rosamaria Lappano, Marianna Talia, Francesca Cirillo, ..., Marcello Maggiolini",
              "authorList": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "abbrevName": "Lappano R",
                  "email": "rosamaria.lappano@unical.it",
                  "isCollectiveName": false,
                  "name": "Rosamaria Lappano",
                  "orcid": null
                },
                {
                  "ForeName": "Marianna",
                  "LastName": "Talia",
                  "abbrevName": "Talia M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marianna Talia",
                  "orcid": null
                },
                {
                  "ForeName": "Francesca",
                  "LastName": "Cirillo",
                  "abbrevName": "Cirillo F",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Francesca Cirillo",
                  "orcid": null
                },
                {
                  "ForeName": "Damiano",
                  "LastName": "Rigiracciolo",
                  "abbrevName": "Rigiracciolo DC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Damiano Cosimo Rigiracciolo",
                  "orcid": null
                },
                {
                  "ForeName": "Domenica",
                  "LastName": "Scordamaglia",
                  "abbrevName": "Scordamaglia D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Domenica Scordamaglia",
                  "orcid": null
                },
                {
                  "ForeName": "Rita",
                  "LastName": "Guzzi",
                  "abbrevName": "Guzzi R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Rita Guzzi",
                  "orcid": null
                },
                {
                  "ForeName": "Anna",
                  "LastName": "Miglietta",
                  "abbrevName": "Miglietta AM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Anna Maria Miglietta",
                  "orcid": null
                },
                {
                  "ForeName": "Ernestina",
                  "LastName": "De Francesco",
                  "abbrevName": "De Francesco EM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ernestina Marianna De Francesco",
                  "orcid": null
                },
                {
                  "ForeName": "Antonino",
                  "LastName": "Belfiore",
                  "abbrevName": "Belfiore A",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Antonino Belfiore",
                  "orcid": null
                },
                {
                  "ForeName": "Andrew",
                  "LastName": "Sims",
                  "abbrevName": "Sims AH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Andrew H Sims",
                  "orcid": null
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "abbrevName": "Maggiolini M",
                  "email": "marcello.maggiolini@unical.it",
                  "isCollectiveName": false,
                  "name": "Marcello Maggiolini",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Rosamaria",
                  "LastName": "Lappano",
                  "email": [
                    "rosamaria.lappano@unical.it"
                  ],
                  "name": "Rosamaria Lappano"
                },
                {
                  "ForeName": "Marcello",
                  "LastName": "Maggiolini",
                  "email": [
                    "marcello.maggiolini@unical.it"
                  ],
                  "name": "Marcello Maggiolini"
                }
              ]
            },
            "doi": "10.1186/s13046-020-01667-y",
            "pmid": "32778144",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "J Exp Clin Cancer Res 39 2020",
            "title": "The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs)."
          }
        },
        {
          "pmid": "25920936",
          "pubmed": {
            "ISODate": "2015-01-01T00:00:00.000Z",
            "abstract": "Hypoxia is associated with poor response to treatment in various cancers. Hypoxia inducible factor 1 (HIF-1) is a major transcription factor that mediates adaptation of cancer cells to a hypoxic environment and regulates many genes that are involved in key cellular functions, including cell immortalization, stem cell maintenance, autocrine growth/survival, angiogenesis, invasion/metastasis, and resistance to chemotherapy. HIF-1α has been considered as an attractive therapeutic target for cancer treatment, but there is limited success in this research field. In the present study, we designed a recombinant lentivirus containing HIF-1α siRNA, developed stably transfected cell lines, and tested the anticancer effects of the siRNA on cancer cells in vitro and in vivo. Our results indicated that the stable downregulation of HIF-1α reversed chemoresistance, inhibited proliferation, migration and invasion of cancer cells, and slowed down the tumor growth in breast cancer xenograft models. In conclusion, the recombinant lentivirus containing HIF-1α siRNA provides a new avenue for developing novel therapy for triple negative breast cancer.",
            "authors": {
              "abbreviation": "Shuang Li, Qingzhu Wei, Qin Li, ..., Qiang Xiao",
              "authorList": [
                {
                  "ForeName": "Shuang",
                  "LastName": "Li",
                  "abbrevName": "Li S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Shuang Li",
                  "orcid": null
                },
                {
                  "ForeName": "Qingzhu",
                  "LastName": "Wei",
                  "abbrevName": "Wei Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qingzhu Wei",
                  "orcid": null
                },
                {
                  "ForeName": "Qin",
                  "LastName": "Li",
                  "abbrevName": "Li Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qin Li",
                  "orcid": null
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qiang",
                  "LastName": "Xiao",
                  "abbrevName": "Xiao Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qiang Xiao",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1080/15384047.2015.1040958",
            "pmid": "25920936",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Cancer Biol Ther 16 2015",
            "title": "Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer."
          }
        },
        {
          "pmid": "30026228",
          "pubmed": {
            "ISODate": "2018-07-20T00:00:00.000Z",
            "abstract": "Inactivation of the von Hippel-Lindau (VHL) E3 ubiquitin ligase protein is a hallmark of clear cell renal cell carcinoma (ccRCC). Identifying how pathways affected by VHL loss contribute to ccRCC remains challenging. We used a genome-wide in vitro expression strategy to identify proteins that bind VHL when hydroxylated. Zinc fingers and homeoboxes 2 (ZHX2) was found as a VHL target, and its hydroxylation allowed VHL to regulate its protein stability. Tumor cells from ccRCC patients with VHL loss-of-function mutations usually had increased abundance and nuclear localization of ZHX2. Functionally, depletion of ZHX2 inhibited VHL-deficient ccRCC cell growth in vitro and in vivo. Mechanistically, integrated chromatin immunoprecipitation sequencing and microarray analysis showed that ZHX2 promoted nuclear factor κB activation. These studies reveal ZHX2 as a potential therapeutic target for ccRCC.",
            "authors": {
              "abbreviation": "Jing Zhang, Tao Wu, Jeremy Simon, ..., Qing Zhang",
              "authorList": [
                {
                  "ForeName": "Jing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jing Zhang",
                  "orcid": "0000-0001-6438-9113"
                },
                {
                  "ForeName": "Tao",
                  "LastName": "Wu",
                  "abbrevName": "Wu T",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Tao Wu",
                  "orcid": "0000-0001-5380-3905"
                },
                {
                  "ForeName": "Jeremy",
                  "LastName": "Simon",
                  "abbrevName": "Simon J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jeremy Simon",
                  "orcid": "0000-0003-3906-1663"
                },
                {
                  "ForeName": "Mamoru",
                  "LastName": "Takada",
                  "abbrevName": "Takada M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mamoru Takada",
                  "orcid": "0000-0002-3961-9009"
                },
                {
                  "ForeName": "Ryoichi",
                  "LastName": "Saito",
                  "abbrevName": "Saito R",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ryoichi Saito",
                  "orcid": null
                },
                {
                  "ForeName": "Cheng",
                  "LastName": "Fan",
                  "abbrevName": "Fan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cheng Fan",
                  "orcid": null
                },
                {
                  "ForeName": "Xian-De",
                  "LastName": "Liu",
                  "abbrevName": "Liu XD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian-De Liu",
                  "orcid": "0000-0002-9639-0458"
                },
                {
                  "ForeName": "Eric",
                  "LastName": "Jonasch",
                  "abbrevName": "Jonasch E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Eric Jonasch",
                  "orcid": "0000-0003-0943-2806"
                },
                {
                  "ForeName": "Ling",
                  "LastName": "Xie",
                  "abbrevName": "Xie L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ling Xie",
                  "orcid": null
                },
                {
                  "ForeName": "Xian",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xian Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Xiaosai",
                  "LastName": "Yao",
                  "abbrevName": "Yao X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xiaosai Yao",
                  "orcid": "0000-0001-9729-0726"
                },
                {
                  "ForeName": "Bin",
                  "LastName": "Teh",
                  "abbrevName": "Teh BT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bin Tean Teh",
                  "orcid": "0000-0003-1514-1124"
                },
                {
                  "ForeName": "Patrick",
                  "LastName": "Tan",
                  "abbrevName": "Tan P",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Patrick Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Xingnan",
                  "LastName": "Zheng",
                  "abbrevName": "Zheng X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xingnan Zheng",
                  "orcid": "0000-0003-3034-4421"
                },
                {
                  "ForeName": "Mingjie",
                  "LastName": "Li",
                  "abbrevName": "Li M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mingjie Li",
                  "orcid": "0000-0001-5337-4901"
                },
                {
                  "ForeName": "Cortney",
                  "LastName": "Lawrence",
                  "abbrevName": "Lawrence C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Cortney Lawrence",
                  "orcid": null
                },
                {
                  "ForeName": "Jie",
                  "LastName": "Fan",
                  "abbrevName": "Fan J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jie Fan",
                  "orcid": "0000-0003-3842-2391"
                },
                {
                  "ForeName": "Jiang",
                  "LastName": "Geng",
                  "abbrevName": "Geng J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jiang Geng",
                  "orcid": "0000-0002-7202-2167"
                },
                {
                  "ForeName": "Xijuan",
                  "LastName": "Liu",
                  "abbrevName": "Liu X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xijuan Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Lianxin",
                  "LastName": "Hu",
                  "abbrevName": "Hu L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lianxin Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Jun",
                  "LastName": "Wang",
                  "abbrevName": "Wang J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jun Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Chengheng",
                  "LastName": "Liao",
                  "abbrevName": "Liao C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chengheng Liao",
                  "orcid": null
                },
                {
                  "ForeName": "Kai",
                  "LastName": "Hong",
                  "abbrevName": "Hong K",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Kai Hong",
                  "orcid": null
                },
                {
                  "ForeName": "Giada",
                  "LastName": "Zurlo",
                  "abbrevName": "Zurlo G",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Giada Zurlo",
                  "orcid": null
                },
                {
                  "ForeName": "Joel",
                  "LastName": "Parker",
                  "abbrevName": "Parker JS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Joel S Parker",
                  "orcid": "0000-0003-2080-6901"
                },
                {
                  "ForeName": "J",
                  "LastName": "Auman",
                  "abbrevName": "Auman JT",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "J Todd Auman",
                  "orcid": "0000-0002-9328-8829"
                },
                {
                  "ForeName": "Charles",
                  "LastName": "Perou",
                  "abbrevName": "Perou CM",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Charles M Perou",
                  "orcid": "0000-0001-9827-2247"
                },
                {
                  "ForeName": "W",
                  "LastName": "Rathmell",
                  "abbrevName": "Rathmell WK",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "W Kimryn Rathmell",
                  "orcid": "0000-0002-4984-0225"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kim",
                  "abbrevName": "Kim WY",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William Y Kim",
                  "orcid": null
                },
                {
                  "ForeName": "Marc",
                  "LastName": "Kirschner",
                  "abbrevName": "Kirschner MW",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Marc W Kirschner",
                  "orcid": "0000-0001-6540-6130"
                },
                {
                  "ForeName": "William",
                  "LastName": "Kaelin",
                  "abbrevName": "Kaelin WG",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "William G Kaelin",
                  "orcid": "0000-0002-0574-4856"
                },
                {
                  "ForeName": "Albert",
                  "LastName": "Baldwin",
                  "abbrevName": "Baldwin AS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Albert S Baldwin",
                  "orcid": "0000-0003-1246-1333"
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": "qing_zhang@med.unc.edu",
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": "0000-0002-6595-8995"
                }
              ],
              "contacts": [
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "email": [
                    "qing_zhang@med.unc.edu"
                  ],
                  "name": "Qing Zhang"
                }
              ]
            },
            "doi": "10.1126/science.aap8411",
            "pmid": "30026228",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Science 361 2018",
            "title": "VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma."
          }
        },
        {
          "pmid": "24670641",
          "pubmed": {
            "ISODate": "2014-04-03T00:00:00.000Z",
            "abstract": "Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours, but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)--a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)--is a highly aggressive malignancy with limited treatment options. Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1α (HIF1α) is known to be hyperactivated in TNBCs. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.",
            "authors": {
              "abbreviation": "Xi Chen, Dimitrios Iliopoulos, Qing Zhang, ..., Laurie H Glimcher",
              "authorList": [
                {
                  "ForeName": "Xi",
                  "LastName": "Chen",
                  "abbrevName": "Chen X",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Xi Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Dimitrios",
                  "LastName": "Iliopoulos",
                  "abbrevName": "Iliopoulos D",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dimitrios Iliopoulos",
                  "orcid": null
                },
                {
                  "ForeName": "Qing",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qing Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Qianzi",
                  "LastName": "Tang",
                  "abbrevName": "Tang Q",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Qianzi Tang",
                  "orcid": null
                },
                {
                  "ForeName": "Matthew",
                  "LastName": "Greenblatt",
                  "abbrevName": "Greenblatt MB",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Matthew B Greenblatt",
                  "orcid": null
                },
                {
                  "ForeName": "Maria",
                  "LastName": "Hatziapostolou",
                  "abbrevName": "Hatziapostolou M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Maria Hatziapostolou",
                  "orcid": null
                },
                {
                  "ForeName": "Elgene",
                  "LastName": "Lim",
                  "abbrevName": "Lim E",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Elgene Lim",
                  "orcid": null
                },
                {
                  "ForeName": "Wai",
                  "LastName": "Tam",
                  "abbrevName": "Tam WL",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Wai Leong Tam",
                  "orcid": null
                },
                {
                  "ForeName": "Min",
                  "LastName": "Ni",
                  "abbrevName": "Ni M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Min Ni",
                  "orcid": null
                },
                {
                  "ForeName": "Yiwen",
                  "LastName": "Chen",
                  "abbrevName": "Chen Y",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Yiwen Chen",
                  "orcid": null
                },
                {
                  "ForeName": "Junhua",
                  "LastName": "Mai",
                  "abbrevName": "Mai J",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Junhua Mai",
                  "orcid": null
                },
                {
                  "ForeName": "Haifa",
                  "LastName": "Shen",
                  "abbrevName": "Shen H",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Haifa Shen",
                  "orcid": null
                },
                {
                  "ForeName": "Dorothy",
                  "LastName": "Hu",
                  "abbrevName": "Hu DZ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Dorothy Z Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Stanley",
                  "LastName": "Adoro",
                  "abbrevName": "Adoro S",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Stanley Adoro",
                  "orcid": null
                },
                {
                  "ForeName": "Bella",
                  "LastName": "Hu",
                  "abbrevName": "Hu B",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Bella Hu",
                  "orcid": null
                },
                {
                  "ForeName": "Minkyung",
                  "LastName": "Song",
                  "abbrevName": "Song M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Minkyung Song",
                  "orcid": null
                },
                {
                  "ForeName": "Chen",
                  "LastName": "Tan",
                  "abbrevName": "Tan C",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Chen Tan",
                  "orcid": null
                },
                {
                  "ForeName": "Melissa",
                  "LastName": "Landis",
                  "abbrevName": "Landis MD",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Melissa D Landis",
                  "orcid": null
                },
                {
                  "ForeName": "Mauro",
                  "LastName": "Ferrari",
                  "abbrevName": "Ferrari M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Mauro Ferrari",
                  "orcid": null
                },
                {
                  "ForeName": "Sandra",
                  "LastName": "Shin",
                  "abbrevName": "Shin SJ",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Sandra J Shin",
                  "orcid": null
                },
                {
                  "ForeName": "Myles",
                  "LastName": "Brown",
                  "abbrevName": "Brown M",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Myles Brown",
                  "orcid": null
                },
                {
                  "ForeName": "Jenny",
                  "LastName": "Chang",
                  "abbrevName": "Chang JC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Jenny C Chang",
                  "orcid": null
                },
                {
                  "ForeName": "X",
                  "LastName": "Liu",
                  "abbrevName": "Liu XS",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "X Shirley Liu",
                  "orcid": null
                },
                {
                  "ForeName": "Laurie",
                  "LastName": "Glimcher",
                  "abbrevName": "Glimcher LH",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Laurie H Glimcher",
                  "orcid": null
                }
              ],
              "contacts": []
            },
            "doi": "10.1038/nature13119",
            "pmid": "24670641",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              },
              {
                "UI": "D052061",
                "value": "Research Support, N.I.H., Extramural"
              },
              {
                "UI": "D013485",
                "value": "Research Support, Non-U.S. Gov't"
              }
            ],
            "reference": "Nature 508 2014",
            "title": "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway."
          }
        },
        {
          "pmid": "28054302",
          "pubmed": {
            "ISODate": "2017-04-01T00:00:00.000Z",
            "abstract": "PURPOSE: Despite advances that have been made in systemic chemotherapy, the prognosis of advanced triple-negative breast cancer (TNBC) patients is still poor. The identification of key factors governing TNBC development is considered imperative for the development of novel effective therapeutic approaches. Previously, it has been reported that microRNA (miR)-761 may act as either a tumor suppressor or as an oncogene in different types of cancer. Here, we aimed at assessing the biological role of this miRNA in TNBC. METHODS: First, we measured the expression of miR-761 in primary breast cancer tissues and breast cancer-derived cell lines using qRT-PCR. Subsequently, over-expression and silencing experiments were performed to determine the role of miR-761 in TNBC cell proliferation, colony formation, migration and invasion in vitro. The in vivo role of miR-761 in TNBC growth and metastasis was determined in mouse models. Bioinformatics analyses, dual-luciferase reporter assays, Western blot analyses and rescue experiments were performed to identify miR-761 target gene(s). RESULTS: We found that miR-761 was up-regulated in primary breast cancer tissues and its derived cell lines and, particularly, in TNBC tissues and cell lines. We also found that exogenous miR-761 over-expression augmented in vitro TNBC cell proliferation, colony formation, migration and invasion, whereas miR-761 down-regulation impaired these features. In vivo, we found that miR-761 over-expression facilitated TNBC growth and lung metastasis. Mechanistically, miR-761 was found to negatively regulate the expression of tripartite motif-containing 29 (TRIM29) in TNBC cells by binding to the 3'-untranslated region of its mRNA. In conformity with these results, a significant negative correlation between miR-761 expression and TRIM29 protein expression was noted in primary TNBC tissues (r = -0.452, p = 0.0126). We also found that exogenous TRIM29 over-expression reversed the proliferative and invasive capacities of TNBC cells. CONCLUSIONS: Our data indicate that miR-761 acts as an oncogene in TNBC. This mode of action can, at least partially, be ascribed to the down-regulation of its target TRIM29. We suggest that miR-761 may serve as a promising therapeutic target for TNBC.",
            "authors": {
              "abbreviation": "Guang-Cheng Guo, Jia-Xiang Wang, Ming-Li Han, ..., Lin Li",
              "authorList": [
                {
                  "ForeName": "Guang-Cheng",
                  "LastName": "Guo",
                  "abbrevName": "Guo GC",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Guang-Cheng Guo",
                  "orcid": null
                },
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "abbrevName": "Wang JX",
                  "email": "ggc503@126.com",
                  "isCollectiveName": false,
                  "name": "Jia-Xiang Wang",
                  "orcid": null
                },
                {
                  "ForeName": "Ming-Li",
                  "LastName": "Han",
                  "abbrevName": "Han ML",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Ming-Li Han",
                  "orcid": null
                },
                {
                  "ForeName": "Lian-Ping",
                  "LastName": "Zhang",
                  "abbrevName": "Zhang LP",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lian-Ping Zhang",
                  "orcid": null
                },
                {
                  "ForeName": "Lin",
                  "LastName": "Li",
                  "abbrevName": "Li L",
                  "email": null,
                  "isCollectiveName": false,
                  "name": "Lin Li",
                  "orcid": null
                }
              ],
              "contacts": [
                {
                  "ForeName": "Jia-Xiang",
                  "LastName": "Wang",
                  "email": [
                    "ggc503@126.com"
                  ],
                  "name": "Jia-Xiang Wang"
                }
              ]
            },
            "doi": "10.1007/s13402-016-0312-6",
            "pmid": "28054302",
            "pubTypes": [
              {
                "UI": "D016428",
                "value": "Journal Article"
              }
            ],
            "reference": "Cell Oncol (Dordr) 40 2017",
            "title": "microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression."
          }
        }
      ],
      "secret": "read-only",
      "type": "complex"
    }
  ]
}